stock_LLY r_up	said:1 treat:1 disorders:1 --:1 drug:1 research:1 early:1 clinical:1 experimental:1 new:1 has:1 studies:1 its:1 unit:1 stage:1
stock_LLY r_down	saying:2 excessive:3 issued:3 over:1 committed:1 its:2 causes:1 graph:1 has:1 risk:2 long-acting:9 possible:1 early:1 inflation:1 not:2 amp:2 --:3 worried:1 slide:2 steps:1 sedation:3 injectable:4 set:1 woes:2 second:1 oil:3 discussions:1 declined:4 recession:1 said:7 slick:2 shares:1 state:1 supporting:1 timeline:1 seventh:1 news:1 manufacturer:1 received:1 ahead:1 drug:7 trial:2 receives:1 action:1 approve:5 first:1 already:1 slipped:1 civil:1 square:1 determine:1 market:1 additional:3 next:2 needed:2 clinical:1 suit:1 type:1 until:1 more:2 ``:2 form:7 company:6 slump:1 slides:2 understand:1 prices:1 injection:1 dosing:1 keeping:1 schizophrenia:4 n't:4 patients:3 ongoing:1 were:1 slid:1 investors:1 certain:2 '':2 defending:1 slip:2 blockbuster:1 information:7 needs:1 mired:1 agency:2 1:1 stock:1 week:1 experienced:1 's:5 letter:4 stocks:3 off:1 well:1
stock_LLY r_down	received:1 keeping:1 company:1 niche:1 competition:1 antidepressant:1 lucrative:1 generics:1 faces:1 approval:1 its:1
stock_LLY r_up	restless:1 his:2 bold:1 would:1 show:1 business:1 much:1 into:1 half:1 year:1 predictions:1 getting:1 transform:1 n't:1 does:2 have:1 tenure:1 investors:1 company:1 than:1 he:1
stock_LLY r_up	mental:1 would:1 require:1 bill:1 equal:1 coverage:1 pass:1 poised:1 ailments:1 physical:1
stock_LLY r_down	attorney:1 associated:1 drug:2 its:1 said:1 adequately:1 failed:1 state:1 arguments:1 's:1 opening:1 warn:1 effects:1 doctors:1 lawsuit:1 --:1 dangerous:1 against:1 maker:1 n't:2 patients:1 side:1
stock_LLY r_up	move:1 terminate:1 expects:1 go:1 its:2 issues:1 developer:1 $:2 environment:1 charge:1 program:4 has:2 discontinue:1 120:1 not:1 drugmaker:1 --:2 slide:2 week:1 says:3 heightens:1 testing:2 related:1 economic:1 's:1 makers:1 out:3 recession:3 said:3 decision:1 since:1 version:1 safety:2 7:1 new:1 increasing:1 public:1 business:1 uncertainties:1 million:2 inhaled:2 agreement:1 manufacturing:1 last:1 drug:4 insulin:3 other:1 major:1 into:2 due:1 considering:1 pharmaceutical:1 would:1 informed:1 negative:1 next:1 inhaled-insulin:2 entered:1 territory:1 ``:1 efficacy:1 company:2 aware:1 known:1 90:1 case:1 pull:2 abandoned:1 regulator:1 abandon:1 cents:2 share:1 '':1 n't:1 say:1 pulling:1 reviewing:1 have:1 partner:2 technology:1 any:1 develop:2 rather:1 make:1 field:1 concerns:1 5:1 which:1 economy:1 development:4 product:3 first-quarter:1 plans:1 may:2 update:1 stocks:3 data:1 diabetes:1 third:1 jitters:2 joining:1
stock_LLY r_down	program:1 major:1 gaining:2 cents:2 terminate:1 results:1 related:1 trade:1 down:1 player:1 see:1 session:1 makers:1 decline:1 said:2 banks:1 field:1 trials:1 decision:1 shares:2 its:3 their:1 other:1 pivotal:1 closed:1 biggest:2 active:1 announced:1 stock:1 development:2 product:1 after:1 's:4 than:1 whose:1 discontinue:1 million:1 inhaled:2 volume:1 expected:1 backed:1 stocks:2 beginning:1 94:1 declining:2 quarter:1 last:1 third:1 16:1 18:1 companies:1 drug:1 products:1 insulin:2 release:1 more:1
stock_LLY r_up	insulin:2 financial:1 help:1 betting:1 move:2 lending:1 related:1 one:1 laggard:2 revving:1 out:1 rooms:1 broader:1 news:2 home:1 still:1 decisions:1 its:2 market:1 fill:1 decline:1 said:1 develop:1 extend:1 engines:1 has:1 positive:1 temporary:1 shares:1 their:2 program:1 inhaled:2 new:1 fall:3 developers:1 markets:1 tourists:1 stock:1 development:1 pact:1 product:1 global:1 's:3 mostly:2 boosted:1 price:1 discontinue:1 most:1 races:1 twin:1 despite:1 world:1 stocks:6 day:2 partner:1 territory:1 stabilize:1 car:1 into:1 up:1 recession:1 slide:3 products:1 common:1 second:2 climb:3 pulled:1 order:1
stock_LLY r_down	program:1 says:1 campaign:1 over:2 190:1 states:1 second:1 used:1 including:1 drug:2 unapproved:1 off-label:1 accuses:1 recover:1 children:1 decade:1 pharmaceutical:1 said:1 antipsychotic:1 disorders:1 nervous:1 make:1 system:1 least:1 research:1 state:1 other:1 assistance:1 9:2 has:1 seeks:1 more:2 treating:2 collaborate:1 's:2 drugs:1 marketing:1 company:2 million:1 running:1 uses:1 suing:1 promote:1 lawsuit:2 than:2 $:1 pact:1 central:1 --:2 maybe:1 medical:1 spent:1 signed:1 nine:1 illegal:1 maker:1 joining:1
stock_LLY r_down	strongly:1 exclusive:1 medication:1 statements:1 unapproved:1 office:1 revenue:1 into:1 testing:1 ``:1 sales:1 competition:1 60:1 likely:1 growth:1 including:1 licensing:1 have:1 suing:2 blockbuster:1 its:4 depression:1 dropoff:1 enters:1 develop:1 antipsychotic:1 lead:1 generic:1 affects:1 had:1 severe:1 quickly:1 state:1 other:1 treat:2 which:1 biggest:1 entered:1 company:2 therapies:1 2012:3 worldwide:1 product:1 over:1 's:7 disagrees:1 see:1 marketing:2 collaboration:1 agreement:1 expansion:1 possible:1 early:1 market:1 said:1 hands:1 compound:1 press:1 based:1 now:1 continued:1 he:1 '':1 regarding:1 made:1 illegally:1 granting:1 rights:1 uses:1 label:1 drug:4 side:1 2002:1 patients:1 nine:1 announced:1 pediatric:1 release:1 accounts:1 states:1 maker:1 launched:1 joining:1
stock_LLY r_down	development:2 testing:1 sales:2 130:1 including:1 licensing:1 if:1 pharmaceutical:1 $:2 potential:1 7:1 therapies:1 worldwide:1 royalties:1 product:1 successfully:1 's:1 which:1 may:1 marketing:1 company:1 million:2 early:1 upfront:1 payment:1 diabetes:1 received:1 milestones:1 rights:1 receive:2 well:1 up:1
stock_LLY r_up	dosing:1 product:2 said:1 's:3 risk:1 --:1 confusion:1 over:1 redesigned:1 been:1 antidepressant:1 packaging:1 drugs:1 cut:1 which:1 included:1 errors:1 has:1 medication:1 other:1
stock_LLY r_up	urinary:1 being:1 over:1 executive:1 centralized:1 its:5 retention:1 cut:2 treatment:1 has:4 updated:1 risk:1 --:3 medicines:2 officer:1 force:1 bleeding:1 some:1 back:1 close:1 said:4 lead:2 decision:1 factory:1 shares:1 label:1 marketing:1 new:1 led:1 confusion:1 drug:3 insulin:2 action:1 comment:2 among:1 named:1 packaging:1 pregnancy:1 initial:1 been:3 maintenance:1 expected:1 midday:1 glucose:1 formally:1 posting:1 drugs:1 warn:1 jobs:1 announcing:1 18:1 require:1 work:1 patients:2 authorization:1 were:1 10th:1 treated:1 control:1 150:1 medication:1 almost:1 site:1 dosing:1 canceled:1 trials:1 agency:1 40:1 also:1 other:1 higher:3 product:3 used:1 's:5 plans:1 after:2 workforce:1 falls:1 applications:1 errors:1 scale:1 included:1 stocks:3 diabetes:3 third:1 redesigned:1 antidepressant:1 chief:1 withdraw:1
stock_LLY r_up	named:1 financial:1 help:1 investors:1 list:1 results:1 experts:1 lively:2 have:1 underperforming:1 its:1 market:7 increase:1 believe:1 recently:1 bottom:1 make:2 get:1 due:1 governance:1 any:1 current:1 concerns:1 5:2 take:1 frothy:1 role:1 poor:1 then:1 's:3 which:1 views:2 big:1 collaboration:1 formed:1 disagreement:1 volume:1 reason:1 leadership:3 promote:1 disagree:1 approved:1 made:1 sectors:1 --:1 makes:1 companies:1 drug:1 whether:1 turnaround:1 2008:1 corporate:1
stock_LLY r_up	development:2 named:1 5:2 costly:1 deal:1 over:3 starting:1 brought:1 against:1 drug:3 allowed:1 11th:1 settlement:3 technology:2 its:1 select:1 pharmaceutical:3 said:3 $:7 million:3 treated:1 make:1 had:1 comments:1 research:1 other:1 state:3 clinical:1 potentially:1 disclosed:1 widely:1 plus:1 struck:1 include:2 announced:1 discovery:1 available:1 used:1 may:1 which:1 closes:1 any:1 marketing:1 company:5 were:1 agreement:1 early:1 ensure:1 future:1 lawsuit:1 payment:1 antipsychotic:1 pact:1 term:1 15:5 programs:1 --:1 involved:1 signed:1 n't:1 trial:1 settle:1 three-year:1 2005:1 claims:1 similar:1 expands:1 book:1 researchers:1
stock_LLY r_up	week:1 all:1 set:1 executive:2 share:1 up:1 schizophrenia:1 improvements:1 including:1 lagging:1 further:1 next:2 its:1 expensive:1 plans:1 votes:2 necessarily:1 antipsychotic:1 5th:1 three:1 governance:2 response:1 better:1 chief:1 3:2 medicine:1 long-time:1 ground:3 price:2 more:1 poor:1 's:3 scientific:1 drugs:1 journal:1 lose:3 lower:1 but:2 cheaper:1 fund:1 pharma:2 said:1 negative:1 citing:1 biotechnology:1 article:1 month:1 beginning:1 than:1 re-election:1 recent:1 treating:1 10:2 stocks:3 episode:1 older:1 --:1 changes:1 conglomerates:1 proposals:1 according:1 reports:1 withhold:2 n't:1 directors:1 pension:1 published:1 become:1 stock:1 corporate:2 first:1
stock_LLY r_down	week:1 set:1 cited:1 executive:2 month:2 lagging:3 its:1 votes:4 said:1 three:3 governance:3 next:3 chief:1 citing:2 long-time:1 price:3 stock:3 poor:3 's:3 plans:2 3:4 re-election:3 fund:3 reason:1 article:1 up:3 withhold:4 directors:3 pension:3 published:1 become:1 corporate:3
stock_LLY r_up	heart:1 associated:1 can:2 being:1 tested:1 trade:1 active:1 see:2 session:1 's:9 protein:1 any:1 if:1 whose:1 said:1 additional:1 start:1 generic:1 studying:1 create:1 shares:1 their:1 investigational:1 clinical:2 treatment:1 biggest:2 moderate:1 announced:1 more:1 gaining:2 plunge:2 hit:1 sticky:1 pharmaceutical:1 company:1 cheaper:1 expected:1 beta:1 slow:1 wake:1 gain:2 others:2 not:1 stocks:2 data:1 declining:2 both:1 mild:1 effective:1 showed:1 battling:1 --:1 study:2 companies:1 disease:3 drug:1 called:1 trial:1 retreating:1 cholesterol:1 release:1 inhibitor:1 skids:1
stock_LLY r_up	's:2
stock_LLY r_down	trend:1 global:1 some:1 years:1 expensive:1 pharmaceutical:1 generic:1 strategy:1 their:1 new:1 giants:1 them:1 may:1 drugs:1 hand:1 ones:1 such:1 trying:1 developing:1 --:1 pits:1 companies:1 cash:1 against:1 making:1 risky:1
stock_LLY r_down	cancer:1 number:1 warning:2 lung:1 battered:3 have:1 developer:1 marketed:1 shares:1 product:1 users:1 triggered:1 may:1 inhaled:1 early:1 mixed:1 news:1 stocks:1 rival:1 insulin:1 were:2 small:1 trading:1
stock_LLY r_up	disclosure:1 cancer:5 developed:2 number:2 '':1 lung:5 drug:1 determine:1 seen:1 its:3 signals:1 said:1 no:1 trials:1 able:1 label:2 spokesman:1 inhaled-insulin:3 has:1 's:1 troubled:1 ``:1 patient:1 users:1 though:1 company:1 after:1 inhaled:2 reflect:1 link:2 updates:2 product:1 day:1 updating:1 had:1 cause:1 whether:1 warned:1 --:1 labeling:1 n't:1 experimental:1 patients:1 insulin:2 small:2 taking:1 comes:1 eyed:2
stock_LLY r_down	exotic:1 physicians:1 consulting:1 's:1 attend:1 conferences:1 manufacturers:1 --:1 medical:1 doctors:1 educational:1 drug:1 nation:1 fees:1 sponsoring:1 free:1 have:1 largest:1 device:1 years:1 trips:1
stock_LLY r_down	firm:1 ``:1 's:2 --:1 companies:1 allows:1 virtual:1 '':1 drugs:2 version:1 models:1 effects:2 pediatric:1 new:1 test:1 using:1 children:1 launched:1 software:1
stock_LLY r_down	spikes:1 combination:1 scan:1 drugs:1 certain:1 medical:1 problems:1 one:1 patterns:1 medication:1 systems:1 real-time:1 hidden:1 might:1 linked:1 launching:1 first:1
stock_LLY r_up	reduce:1 expects:1 second:1 cuts:1 accounting:1 operation:1 employment:1 its:1 pharmaceutical:1 said:1 voluntary:1 workers:1 research:1 charge:1 program:1 exit:1 take:1 500:3 development:1 plans:1 offering:1 company:1 streamline:1 manufacturing:2 up:1 portion:1 small:1 quarter:1 order:1
stock_LLY r_down	some:1 60:1 tablets:1 jobs:1 its:1 market:1 osteoporosis:2 litigation:1 said:2 tentative:1 generic:2 granted:1 application:1 version:2 treatment:1 new:1 500:1 's:1 offering:1 company:1 streamlines:1 cut:1 approval:1 manufacturing:2 buyouts:1 regarding:1 up:1 drug:4 patent:1 products:1 insulin:1
stock_LLY r_down	aided:1 just:1 dollar:1 focus:4 ended:1 session:1 comments:2 year-earlier:2 its:3 competition:1 blow:1 whose:1 $:10 earned:1 rose:2 point:1 expectations:3 analyst:1 add:2 enthusiasm:1 struggling:1 modestly:1 tests:1 hit:1 gains:2 rise:1 results:2 five:1 effects:1 cushion:1 report:4 disappointed:1 net:7 drugmaker:1 1.06:4 --:2 companies:1 doubled:3 damped:1 payments:1 popular:2 doubles:1 quarter:1 gaining:2 right:1 financial:2 some:1 back:1 related:1 year:5 's:21 provided:1 missed:2 consumers:1 profit:5 shares:1 seller:1 misses:1 7:1 new:4 falling:1 earlier:3 hefty:1 million:4 notable:1 reported:5 takeover:1 offset:1 strong:4 declining:2 antipsychotic:2 both:1 hits:2 last:2 carried:1 items:2 months:1 drug:3 mixed:2 share:7 slightly:3 maker:1 first:2 major:2 slipped:1 revenue:4 three:1 down:1 medication:2 losses:1 open:1 dysfunction:3 conference:1 given:1 top:1 due:2 call:1 stock:1 biggest:2 markets:1 more:5 mostly:3 sessions:1 drugs:2 tax:2 company:1 but:5 slides:2 taken:2 reflecting:1 gain:3 sharply:1 demand:2 than:4 97:4 posted:2 made:1 double:2 up:1 matter:1 were:2 weakens:1 weaker:3 cents:8 certain:1 moved:1 sales:7 dropped:1 slip:2 accounting:2 moves:1 saw:1 increased:1 4.4:2 compared:1 end:2 weakened:1 generic:1 47:4 make:1 detail:1 1:1 also:1 other:1 earnings:9 income:5 reminder:1 higher:3 poor:1 oil:3 first-quarter:9 generic-drug:1 highs:4 after:3 falls:1 77:1 modest:1 driven:1 shift:1 stocks:12 transcript:1 billion:4 lower:5 erectile:3 charges:2 futures:2 antidepressant:3 week:1 2007:1 time:1 weigh:2 resolution:1 dragged:1 profits:2
stock_LLY r_down	heart:1 pound:1 help:2 woes:2 being:2 sixth:1 testing:1 revamping:1 starting:2 trade:1 cost:1 include:1 shares:1 recommendation:3 should:2 its:2 before:3 bolster:1 information:1 needs:1 evaluation:2 $:1 deserves:1 generic:1 beginning:1 available:1 slide:2 governance:1 children:1 failed:1 production:1 medications:1 board:1 which:1 capital:1 --:2 falling:1 has:3 issue:1 deficit:2 slips:2 plant:3 attention:2 's:7 drugs:3 given:1 screen:1 sparked:1 problems:1 shareholders:1 short:1 value:1 significant:1 treatment:2 cardiac:2 news:1 stocks:3 come:1 bank:2 billion:2 also:1 lower:1 12:1 rights:1 debate:1 disorder:2 up:1 drug:1 credit:1 admit:1 massive:1 leading:1 according:2 approve:1 receive:2 first:1
stock_LLY r_up	added:1 25.5:1 $:1 biopharma:1 million:1 shares:1 's:2
stock_LLY r_up	less:1 one:1 election:1 bylaws:1 vote:1 shareholders:1 said:1 her:1 approved:1 majority:2 according:1 main:1 his:1 's:2 offer:1 company:2 votes:1 resign:1 standard:1 director:2 immediately:1 than:1 change:1 gets:1 require:1 elections:1 filing:1 cast:1 maker:1
stock_LLY r_up	elect:1 committee:1 less:1 accept:1 elected:1 bylaws:1 vote:2 should:1 shareholders:1 said:1 approved:1 majority:2 offers:1 board:1 reject:1 taken:1 advise:1 gets:1 resignation:1 meant:1 's:3 offer:1 company:2 votes:1 resign:2 director:2 immediately:1 than:1 change:1 whether:2 require:2 according:1 drug:1 filing:1 directors:3 were:1 action:1 other:1 maker:1
stock_LLY r_down	interest-rate:1 pharmaceutical:1 rejection:1 ahead:1 slipped:1 reeling:1 ease:2 futures:3 drug:1 caution:3 key:2 regulatory:1 surprise:1 decision:1 still:3 prevails:2 stock:3
stock_LLY r_up	sector:1 rate-cut:2 lifted:1 committee:1 investors:1 two-day:1 executive:1 highly:1 growth:1 broader:1 technology:1 its:1 market:1 move:2 end:2 weakened:1 also:1 decision:2 opportunities:1 indexes:2 announcements:1 rates:1 earnings:1 interest:1 expected:1 new:1 meeting:3 remaining:1 stock:1 realigning:1 finish:1 's:2 mostly:3 started:1 bid:1 but:1 anticipated:1 policy:1 key:1 upbeat:1 prices:1 news:1 stocks:3 data:1 begins:2 lower:5 cautious:1 target:1 ahead:3 ranks:1 corporate:1 event:1 emerging-markets:1 round:1 new-business:1 chief:1 economic:1 mixed:1 slightly:1 began:1
stock_LLY r_down	's:2 weakness:1 drug:1 maker:1 noting:1 top-line:1 downgraded:1
stock_LLY r_down	amp:2
stock_LLY r_down	force:1 previously:1 agreed:1 sales:1 its:3 said:2 children:1 pharmaceuticals:1 treatment:1 provides:1 cause:1 treat:1 treating:1 expires:1 's:1 which:1 marketing:1 company:1 third-party:1 approved:1 diabetes:1 pact:1 regarding:1 adolescents:1 31:1 drug:2 2009:1 disorder:1 first:1
stock_LLY r_down	buyouts:1 accepted:1 jobs:1 voluntary:1 their:1 335:3 employees:1 30:1 drug:1 spokesman:1 --:1 said:1 have:1 end:1 total:1 maker:1
stock_LLY r_down	disclose:1 endorsed:1 prescription:1 would:1 --:1 industry:1 require:1 bill:1 drug:1 ranks:1 payments:1 broke:1 doctors:1 got:1 boost:1 makers:1
stock_LLY r_up	his:1 1.7:1 slower:1 cancer:3 previously:1 soon:2 growth:3 lung:2 forecast:1 broader:1 year:1 80:1 estimated:1 use:1 $:4 lead:1 support:1 initial:2 had:1 40:1 approved:1 current:1 which:1 expected:1 new:2 newly:1 higher:1 used:2 's:2 than:2 million:1 delayed:2 but:1 sales:3 drug:1 75:1 uses:1 nearly:1 chemotherapy:2 average:1 data:1 analyst:1 after:2 billion:3 last:1 double:1 study:3 annual:1 up:1 together:1 2006:1 predicted:2 2012:2 could:2
stock_LLY r_up	his:3 1.7:3 cancer:4 soon:3 four:1 growth:3 lung:3 forecast:3 broader:3 year:3 ailing:1 estimated:3 current:3 use:3 appear:1 million:3 bottom:1 support:3 initial:3 had:3 40:3 approved:3 late:1 prognosis:1 which:3 chemotherapy:3 newly:3 include:1 thousands:1 higher:3 used:3 's:3 than:3 after:3 delayed:3 sales:6 early:1 released:1 uses:3 additional:1 new:3 article:2 data:3 analyst:3 $:6 billion:3 last:3 lead:3 --:1 study:6 up:3 together:3 healthy:1 while:1 2006:3 published:2 2012:3 studies:2 could:6
stock_LLY r_down	retire:1 number:1 years:1 '':1 full:1 reducing:1 affairs:1 said:2 22:1 been:1 department:1 has:1 bureaucracy:1 ``:1 executive:1 pharmaceutical:1 company:2 after:1 management:1 regulatory:1 president:2 appointed:1 structure:1 service:1 vice:2 minimize:1 medical:2 chief:1 leadership:1 officer:1 making:1 global:1 changes:1 professor:1
stock_LLY r_up	bureaucracy:1 ``:1 said:1 minimize:1 management:1 number:1 '':1 leadership:1 making:1 reducing:1 changes:1 its:1 structure:1
stock_LLY r_down	amp:2
stock_LLY r_up	comment:1 major:1 investors:1 site:1 month:1 experts:1 out:1 information:1 said:2 analyst:1 come:1 winner:1 detail:1 next:1 note:1 new:1 diabetes:2 meeting:1 's:1 drugs:1 company:1 compound:1 such:1 data:1 appears:2 bank:1 posted:1 comparison:1 effective:1 --:1 companies:1 drug:1 analysts:1 retail:1 experimental:1
stock_LLY r_down	among:2 set:1 cancer:2 certain:1 primary:1 relative:1 lung:1 against:1 have:2 year:1 battle:1 its:1 pharmaceutical:1 said:2 showcase:1 beginning:1 make:1 been:1 cell:1 their:1 splash:1 health:1 types:1 policy:1 forcing:1 meeting:1 survival:2 hope:1 more:1 product:1 's:1 successful:1 company:2 overall:1 met:1 suffering:1 recent:1 groups:1 address:1 effort:1 bigger:1 care:1 endpoint:1 improved:1 showed:2 --:1 medical:1 companies:2 drug:1 large:1 trial:1 patients:1 efforts:1 2009:1
stock_LLY r_up	chronic:3 session:1 drug:1 approval:1 pain:3 whose:1 management:1 based:1 trials:1 shares:1 approved:1 application:1 clinical:1 declining:2 biggest:2 new:2 gaining:2 's:3 seeking:1 company:1 knee:1 said:1 active:1 during:1 stocks:2 pharmaceutical:1 supplemental:1 submission:1 companies:1 submitted:1 indication:1 were:1
stock_LLY r_down	exhibit:1 major:1 set:1 often:1 cancer:5 also:1 had:1 meetings:1 some:2 gathering:1 feature:1 product:1 through:1 doubled:1 article:2 surgery:2 denying:2 approved:1 drugs:1 use:1 pens:1 eligible:1 espresso:1 citing:2 custom:1 their:1 state:2 other:1 treatment:1 which:1 new:1 meeting:2 more:1 them:2 used:1 's:4 food:2 big:2 survival:1 prescribe:1 pancreatic:1 free:3 gifts:2 encourage:1 here:2 overall:1 doctors:3 such:2 law:2 than:1 types:1 logos:1 runs:1 like:1 bars:1 --:3 medical:3 annual:1 companies:3 up:1 drug:4 limiting:2 n't:1 patients:2 published:2 found:1 corporate:1 study:1
stock_LLY r_up	set:1 some:1 month:1 clot:1 experts:1 shares:1 makers:1 before:1 announcement:1 medications:1 suggest:1 decision:1 two:1 per:1 fight:1 increase:1 health:1 medicine:1 issue:1 's:2 share:1 company:1 cheap:1 expected:1 not:1 problem:1 buying:1 helped:1 made:1 could:1 double-digit:1 drug:1 growing:1 2008:1 options:1
stock_LLY r_up	pipeline:1 's:2 top:1 major:1 see:1 line:1
stock_LLY r_down	proved:2 down:1 second:1 its:2 information:1 8.7:1 rose:1 comments:1 price:1 more:2 's:2 company:1 after:2 reported:2 fell:2 updates:1 diabetes:2 effective:2 --:2 drug:2 trial:2 stock:1 starting:1 experimental:2 head-to-head:2
stock_LLY r_down	proved:1 developed:1 soon:1 competition:1 second:1 its:1 8.7:1 shares:1 concerns:1 compares:1 treatment:2 more:1 product:1 's:2 company:1 after:1 reported:1 fell:1 article:1 strong:1 day:1 diabetes:2 effective:1 --:1 rival:1 could:1 drug:3 facing:1 trial:1 published:1 study:1 late-stage:1 maker:1 experimental:1 head-to-head:1
stock_LLY r_down	developed:3 move:1 soon:3 competition:5 leads:2 held:1 second:2 diabetics:1 unveiled:1 sugar:1 its:4 strong:2 shares:3 skid:1 concerns:5 meeting:1 new:2 diabetes:3 type:1 more:1 product:2 scientific:1 than:1 slides:2 released:1 part:1 controlling:1 blood:1 fall:1 2:1 stocks:3 weekend:1 day:2 drugmaker:3 lower:3 effective:1 showed:1 --:1 rival:2 could:3 drug:7 facing:3 study:2
stock_LLY r_down	seeing:1 least:1 trade:1 known:1 likely:1 session:1 looks:1 slip:1 its:1 market:1 even:1 whose:1 rivals:2 data:3 two:1 shares:2 also:1 version:1 biggest:2 new:1 effectiveness:1 meeting:2 gaining:2 conference:1 releasing:1 's:5 long-acting:1 rebound:1 after:1 unveil:2 heat:1 favorable:1 key:1 active:1 stocks:5 rebounds:2 declining:2 diabetes:2 rival:1 study:1 industry:1 companies:1 up:1 drug:1 n't:2 trial:1 products:1 attention:1 dip:2 medical:2 gain:1
stock_LLY r_down	``:1 boxed:1 findings:1 warnings:1 drugs:2 certain:1 labels:1 people:1 '':1 older:1 add:1 recent:1 dangerous:1 following:1 strong:1 might:1 antipsychotic:1
stock_LLY r_down	comment:1 show:3 into:1 move:1 some:3 results:4 highly:3 bapineuzumab:3 previous:1 partners:3 said:4 support:1 initial:2 two:1 comments:2 analyst:3 treatment:3 mid-stage:3 details:2 development:1 's:9 anticipated:3 appears:3 effective:3 --:3 study:3 disease:3 drug:4 patients:3 drugmakers:1 decision:1 experimental:3 late-stage:1
stock_LLY r_down	10:3 them:1 any:1 's:2 consider:1 investors:1 investing:2 midyear:1 changed:2 up:1 investment:1 themes:3 doing:3 '08:2 can:1 key:1 our:2 if:1 changes:1 check:1 expect:1
stock_LLY r_up	said:1 review:1 months:1 anti-clotting:1 three:1 drug:1 period:1 their:1 3:2 extended:1 prasugrel:1
stock_LLY r_down	's:3 being:1 whether:1 developed:1 anticlotting:1 delayed:1 setback:1 drug:1 ruling:1 suffered:1 approve:1 its:1
stock_LLY r_up	even:1 good:1 bump:1 cholesterol:1 put:1 see:1 gain:2 news:1 mixed:3 performance:1 drugs:1 stocks:3
stock_LLY r_down	some:1 labels:1 's:2 --:1 stronger:1 epilepsy:1 recommending:1 treatments:1 drug:1 regulator:1 drugs:1 while:1 warning:1 including:1 treatment:1 backed:1 approval:1 several:1 panel:1
stock_LLY r_up	adjust:1 oil-for-food:1 allegations:1 oilmen:1 alleged:2 '':2 say:1 conspiracy:1 trading:1 lawyer:1 corrupt:1 market:1 regime:1 additional:1 no:1 lawsuit:1 make:1 tougher:1 two:1 comments:1 their:1 program:2 safety:1 details:1 statement:1 under:2 new:2 struggling:1 dozens:1 corruption:1 reap:1 lowering:1 ``:2 sued:1 's:9 plans:1 stance:1 government:2 drugs:1 engaged:1 odds:1 billions:1 members:1 filed:1 regulatory:1 beginning:1 paying:1 climate:1 has:1 benefits:1 --:1 dollars:1 companies:4 altering:1 economic:1 kickbacks:1 including:1 executives:1 order:1 first:1
stock_LLY r_down	millions:1 program:3 force:1 oil-for-food:1 some:1 oilmen:1 alleged:2 '':1 held:1 conspiracy:1 trading:1 corrupt:1 casting:1 its:1 regime:1 $:1 severance:1 pay:2 had:1 two:1 failed:1 charge:1 clinical:1 widely:1 under:2 employee:1 new:1 has:1 cause:1 corruption:1 announced:1 reap:1 ``:1 sued:1 's:7 theory:1 government:2 doubt:1 company:1 kickbacks:1 hundreds:1 members:1 filed:1 engaged:1 lawsuit:2 paying:1 dozens:1 benefits:1 --:1 dollars:1 companies:2 disease:1 drug:1 trial:1 settle:1 economic:1 withdraw:1 discrimination:1 including:1 order:1 experimental:1
stock_LLY r_down	criticism:2 financial:2 hoping:2 executive:1 direct:2 eliminating:2 11th:1 education:1 hospitals:1 improperly:2 giant:1 support:2 other:1 details:1 teaching:1 offered:2 supported:1 's:2 company:1 third-party:2 continuing:1 fund:1 doctors:2 beginning:2 those:1 reaction:1 17th:1 medical:2 companies:3 drug:2 institutions:1 courses:3 continue:1 policies:1 temper:2
stock_LLY r_up	criticism:1 financial:1 offered:1 third-party:1 companies:1 direct:1 temper:1 courses:1 eliminating:1 doctors:1 effort:1 support:1 improperly:1
stock_LLY r_down	majors:1 pharmaceutical:2 said:1 --:1 invest:1 domestic:1 accelerating:1 research:1 while:1 development:1 acquisitions:1 talks:1 international:2 its:2 unit:1 drugmaker:1
stock_LLY r_up	sector:1 financial:1 investors:1 caused:1 into:1 health-care:1 plunge:1 64:1 matching:1 after:1 $:2 shares:1 3:1 winners:1 spike:1 out:1 sent:1 buy:1 's:1 offer:1 price:1 million:1 agreement:1 oil:1 hours:1 prices:1 stocks:1 second-quarter:1 soared:1 recent:1 sectors:1 signed:1 losers:1
stock_LLY r_down	sector:1 proposed:1 agreed:1 dollar:2 leads:1 session:3 still:1 its:1 ground:1 $:12 merger:1 under:1 covered:1 definitive:1 press:1 positions:1 release:1 upward:1 250,000:1 back:2 matching:1 out:1 said:1 lead:2 broad:1 shares:1 52-week:1 3:2 developer:1 climbs:2 million:3 agreement:1 hours:1 safe-haven:1 news:1 vaccine:1 last:1 drug:2 plus:1 drugmakers:3 cancer:1 64:2 fee:1 additional:1 system:1 their:1 2:1 doubling:1 more:1 buy:2 offer:1 dips:2 than:1 straight:3 up:1 signed:1 n't:1 below:1 closing:1 investors:1 share:1 expenses:1 high:1 rally:2 gains:1 pay:1 make:1 stake:1 if:1 company:1 1.37:1 gaining:1 oil:2 's:2 may:1 price:3 after:1 most:1 termination:1 stocks:3 soared:1 third:3 required:1 well:1 completed:1 healthcare:1 biotechnology:1
stock_LLY r_down	gaining:2 code:1 methods:1 deal:1 testing:1 some:1 product:1 trade:1 curb:1 unveiled:1 its:1 significantly:1 pharmaceutical:1 little:1 said:2 group:1 would:1 attraction:1 rose:1 influence:1 sciences:1 slash:1 forming:1 biggest:2 new:2 firms:1 include:1 drug-discovery:1 development:1 do:1 life:1 move:1 's:3 critics:1 marketing:1 company:1 after:1 expected:1 cut:1 designed:1 key:1 doctors:1 ethics:1 stocks:2 declining:2 eager:1 --:1 industry:1 drug:2 costs:2 analysts:1 venture:1 highlights:1 trading:1 create:1
stock_LLY r_up	holds:1 proposed:1 alternatives:2 existing:1 through:1 shareholders:1 said:2 stake:1 intends:1 which:1 include:1 independence:1 offering:1 may:1 company:1 possibly:1 explore:1 others:1 continued:1 rights:1 filing:1 acquisition:1
stock_LLY r_up	--:4 n't:2
stock_LLY r_down	week:2 major:1 holds:1 proposed:1 alternatives:1 results:1 vote:1 special:1 shareholders:1 said:1 20:3 deal:1 merger:1 stake:1 intends:1 earnings:1 which:1 dozens:1 meeting:1 across:1 scheduled:1 's:3 posting:1 brings:1 company:1 reported:1 explore:1 gamut:1 second-quarter:1 last:1 --:1 companies:1 reports:1 components:1
stock_LLY r_up	whose:1 's:1 --:1 companies:1 focus:2 shares:1 trade:1 active:1 see:1 session:1 expected:1
stock_LLY r_up	0.9:1 illness:1 mental:1 cancer:1 4:1 share:1 sales:3 helped:2 second:1 trading:1 drug:1 close:1 income:2 moves:1 $:3 its:3 down:1 cardiovascular:1 treat:1 3.85:1 also:1 profit:1 top:1 45:3 due:2 shares:1 their:1 charge:1 rates:1 earnings:4 premarket:1 year-ago:2 taken:1 net:2 recent:1 target:1 dramatically:1 higher:2 cost-cutting:1 rise:1 's:1 increased:2 exchange:1 drugs:2 hefty:1 spike:2 but:1 reiterated:1 early:1 reported:1 restructuring:1 lowered:1 year’s:1 offset:1 during:1 strong:1 second-quarter:3 posted:2 acquisition-related:1 improved:1 last:1 excluding:1 largely:1 charges:3 items:1 disease:1 reports:3 antidepressant:1 costs:1 acquisition:1 view:1 were:1 2008:2 quarter:2 maker:1 profits:1 favorable:1
stock_LLY r_down	stock:1 saying:1 illness:1 mental:1 cancer:1 sales:1 quarters:1 helped:1 trading:1 comments:1 second-quarter:1 its:1 cardiovascular:1 treat:1 surprises:2 shares:1 strategy:3 advisories:2 earnings:1 fourth:1 new:1 higher:2 's:1 increased:1 though:1 drugs:1 after:3 update:2 but:2 slides:2 reported:1 gain:1 fall:1 prices:1 world:1 stocks:3 beginning:1 day:1 drugmaker:1 roundup:1 improved:1 third:1 updates:1 future:1 companies:1 disease:1 reports:1 edge:2 afternoon:1 announces:1 executives:1 corporate:1 profits:2 latest:1
stock_LLY r_down	's:2
stock_LLY r_down	believed:1 plunged:1 move:2 some:1 results:1 slowing:1 up:2 disappointing:1 brain:2 bapineuzumab:3 trading:1 mixed:1 have:1 remove:1 carry:1 partner:1 appeared:1 end:1 $:2 been:1 had:1 damage:1 shares:3 their:3 genetic:1 clinical:4 role:1 treatment:1 mid-stage:1 certain:1 release:1 weeks:1 showing:1 midday:1 more:2 sink:2 play:1 plunge:1 's:14 breakthrough:1 may:1 bid:1 after:3 released:3 therapy:3 additional:1 they:1 not:1 stocks:4 data:3 day:3 reports:1 recent:1 suggested:1 helped:1 13:1 substance:1 effective:2 being:1 40:1 --:2 study:3 companies:2 disease:2 drug:3 called:1 patients:1 trial:2 while:3 were:1 small:1 studies:2 could:1 experimental:1 battered:2
stock_LLY r_down	weight:1 filed:1 sales:1 pushed:1 schizophrenia:1 trained:1 nursing-home:1 beyond:1 its:3 documents:2 court:1 bipolar:1 linked:1 citing:2 's:6 prescribe:1 site:1 reported:1 said:1 uses:1 gain:1 doctors:2 downplay:1 lawsuit:1 approved:1 diabetes:1 employees:1 drug:2 ignoring:1 while:1 risks:2 encourage:1 disorder:1
stock_LLY r_up	gaining:2 whose:1 's:3 seeing:1 companies:1 shares:1 trade:1 active:1 session:1 biggest:2 stocks:2 declining:2
stock_LLY r_up	billion:1 development:1 1.6:3 $:3 deal:1 agreed:1 transform:1 research:1 approaches:1 have:1 10-year:1 intended:1
stock_LLY r_up	comment:1 saying:2 all:2 costly:2 background:1 investors:2 requiring:2 assumptions:1 highly:1 '':1 underlying:1 unlikely:3 financial:1 estimated:2 subject:1 litigation:3 information:3 swings:1 would:2 provide:3 leading:2 former:1 chairman:1 statement:1 lawmakers:2 sent:2 disclose:2 ``:1 users:1 huge:1 said:1 letter:3 meaningful:3 firms:2 change:1 --:2 reliable:1 companies:3 drug:2 costs:3 ongoing:3
stock_LLY r_up	disclose:1 litigation:1 objecting:1 continuing:1 would:1 proposed:1 leading:1 require:1 companies:1 all:1 drug:1 n't:2 costs:1 rule:1 letter:1 lawmakers:1 estimated:1 makers:1 sent:1
stock_LLY r_down	business:1 contract:1 long-term:1 growth:1 upside:1 services:1
stock_LLY r_down	called:1 people:1 generation:1 caused:1 over:1 doctors:1 soon:1 years:2 brain:2 's:7 aggressive:1 research:1 makers:1 market:2 even:1 mid-:1 span:1 trials:1 ease:1 three:1 its:1 symptoms:1 drugs:1 finally:2 clinical:1 way:4 sepsis:1 new:3 widespread:1 several:1 decades:1 victims:2 behind:1 may:1 hit:1 stop:1 treatments:1 infection:1 questioning:1 therapy:1 they:1 progress:1 believe:1 bringing:1 destruction:1 made:1 older:1 --:1 might:1 could:5 work:1 disease:4 drug:1 've:1 cause:1 leading:1 first:1 cells:1 researchers:1 late-stage:1
stock_LLY r_down	advisory:1 all:1 six:1 deaths:2 issued:1 down:1 warning:2 including:1 reports:1 slip:2 its:1 working:1 bears:1 marketed:1 two:1 shares:1 label:1 safety:1 widely:1 has:2 used:1 components:1 government:1 after:1 falls:2 reported:1 regulators:1 fell:1 sharply:1 despite:1 news:1 cases:1 stocks:3 retreat:1 diabetes:3 received:1 --:1 taking:1 30:1 stronger:1 drug:5 patients:1 continue:1 warnings:1 wounded:1 dip:1 dragged:1
stock_LLY r_down	biotech:1 two-week:2 over:2 leads:1 second:1 its:1 ground:1 group:1 lead:2 shares:1 concerns:1 safety:1 health:1 firms:1 selling:1 led:1 triggered:1 wave:1 drag:2 lows:2 stocks:6 day:1 diabetes:1 lower:3 drop:1 drug:4 lose:1 worries:1 fresh:1
stock_LLY r_down	sector:1 0.9:1 2.5:1 financial:1 shrinks:1 proposed:1 produces:2 low-cost:1 agreed:3 hard:1 share:1 hurting:1 used:2 slowdown:1 down:4 losing:1 hormone:2 including:1 controversial:2 cows:2 spending:1 plunge:1 nations:1 affected:1 its:1 special:1 hit:1 index:2 said:1 4.1:1 $:8 tough:1 merger:1 pay:2 acquire:1 stockholders:1 stocks:2 milk:2 1:1 their:1 3:1 production:2 dairy:2 market:1 closed:1 biggest:1 meeting:1 brand:1 day:1 crunch:1 plant:1 buy:1 's:4 business:3 4.4:1 300:2 dollar:1 company:1 million:2 commercial:1 agreement:1 woes:1 cheaper:1 trading:1 fell:1 intellectual:1 rising:1 regulatory:1 hurt:1 continued:1 approved:1 lower:1 ended:1 boost:2 industry:1 companies:2 steam:1 other:1 credit:1 while:1 were:1 biotechnology:1 property:1 filing:1 profits:1
stock_LLY r_down	development:1 slid:1 into:4 doctors:1 turned:1 while:1 negative:3 down:1 oncology:1 session:1 agents:1 shares:1 broader:2 wander:1 declined:1 one:1 $:1 mortgage:2 since:1 bearish:1 been:1 its:1 1:1 concerns:2 health:2 market:2 fourth:1 consecutive:1 entered:1 has:2 lingering:2 4:1 lookout:1 modestly:1 move:2 's:1 users:1 0.5:1 agreement:1 early:1 gain:1 advised:1 news:1 stocks:7 pancreas:1 territory:3 amid:1 industry:2 drug:1 slide:3 afternoon:3 diabetes:1 action:4 stock:1 downswing:1
stock_LLY r_down	said:1 pain:1 effective:1 appeared:1 study:1 chronic:1 treatment:1 reducing:1 its:1 depression:1 recent:1
stock_LLY r_down	significantly:1 deaths:4 previously:1 four:1 not:1 total:1 yet:1 depression:1 conference:1 said:1 six:1 had:1 been:1 its:2 disclosed:1 new:2 public:1 treatment:1 pain:1 company:1 after:2 but:1 hours:1 reported:2 regulators:1 fall:1 report:2 data:1 released:1 diabetes:2 made:1 chronic:1 taking:4 according:1 drug:2 patients:4 study:1 reduced:1
stock_LLY r_down	biotech:1 outlook:1 weaker:2 discuss:2 woes:2 tumble:2 sales:2 posts:1 into:1 move:1 turned:1 surprisingly:1 trade:1 four:1 prices:1 see:1 actively:1 trading:2 drug:3 have:1 year:1 hit:1 morning:1 clothing:1 its:1 down:1 impact:1 whose:1 said:1 group:1 lead:1 profit:1 remainder:1 higher:3 pull:2 negative:1 shares:5 orders:1 late:1 issues:1 13:1 died:1 strong:1 expected:2 durable-goods:1 has:1 durables:2 second-quarter:1 more:1 gaining:2 oil:1 's:3 users:1 sending:2 retailer:1 stung:2 after:5 took:1 focus:2 biggest:2 turf:1 offset:1 report:2 stocks:5 active:1 day:1 declining:2 diabetes:3 received:1 lower:3 territory:1 reverse:1 ominous:1 futures:3 companies:1 reports:1 spending:1 turn:2 session:1 back:2 positive:1 worries:1 serious:1 decliners:1 stock:5
stock_LLY r_up	cancer:1 woes:2 tumble:2 concerns:1 dive:1 safety:1 due:1 shares:1 trial:1 clinical:1 therapy:1 drug:2 key:1 mixed:1 news:1 stocks:1 prostate:1 its:1
stock_LLY r_down	among:1 pummeled:1 ad:1 being:1 product:1 '':1 session:1 have:1 its:1 if:1 lengthy:1 upswing:2 negative:1 shares:1 does:2 include:1 gaining:1 ``:1 after:1 rules:1 rise:1 possible:1 effects:1 previous:1 news:1 stocks:1 diabetes:1 reading:1 name:1 popularity:1 drug:2 n't:2 directly:1 advertising:1 drugmakers:1 side:1 gain:1
stock_LLY r_up	's:2
stock_LLY r_down	proposed:1 osteoporosis:1 compared:1 develop:1 $:1 would:1 federal:1 trials:1 much:1 treat:1 new:1 fractures:1 's:4 risk:1 company:1 million:1 regulators:1 said:1 women:1 paying:1 lower:1 showed:1 --:1 disease:1 drug:2 spine:1 patients:1 725:1 placebo:1
stock_LLY r_down	there:1 painkiller:1 being:1 health-care:1 powerful:1 proven:1 early:1 unveiled:2 array:1 throughout:1 makers:1 concern:1 information:1 21st:2 said:1 20:1 no:1 agency:1 system:1 its:1 adverse:1 potential:2 details:1 listing:1 policy:1 new:2 events:1 treatment:1 development:1 's:2 relationship:1 wide:1 drugs:3 between:1 possible:1 includes:1 warn:1 part:1 effects:2 background:1 report:2 reiterated:1 diabetes:1 professionals:1 pancreatic:1 --:2 also:1 list:2 drug:2 patients:2 without:1 context:1 investigating:2 side:2
stock_LLY r_up	comparable:1 '':1 its:1 trials:1 since:1 clinical:1 safety:1 excluded:1 ``:1 efficacy:1 company:1 results:2 but:1 primary:1 met:1 they:1 not:1 injection:1 reported:1 insulin:1 were:1 endpoints:1
stock_LLY r_down	4.5:1 billion:1 ``:1 's:1 touts:2 calls:1 offer:1 inadequate:1 bid:2 suitor:1 discloses:1 '':1 more:1 willing:1 another:2 pay:1 buyout:3 unnamed:1 $:1
stock_LLY r_down	financial:1 fallout:1 investors:1 into:3 one:1 officials:1 broader:3 follow:3 crisis:1 market:3 bankruptcy:1 certainly:1 monitoring:1 negative:1 eager:1 grapple:1 does:1 largest:1 territory:1 red:2 's:1 possible:1 but:1 they:1 filed:1 news:1 stocks:3 discuss:1 developments:1 has:1 many:1 companies:1 n't:3 were:1 institutions:1 mean:1
stock_LLY r_down	investors:1 results:1 walk:1 its:1 said:1 away:1 shares:2 1:1 troubling:1 might:1 sliding:1 good:1 's:2 payouts:1 inhaled:1 bid:1 safe:1 weak:1 slides:2 takeover:3 favorable:1 doubts:2 news:1 stocks:4 diabetes:1 effective:1 showed:1 solid:1 could:1 cash:1 times:1 try:1 patients:1 yields:1 insulin:1 mixed:3 study:1 decision:1 bet:2 bond:1
stock_LLY r_down	received:1 ``:2 hormone:1 $:1 business:1 antitrust:1 produces:1 acquire:1 300:1 '':2 production:1 used:1 dairy:1 controversial:1 cows:1 approval:1 has:1 boost:1 milk:1 million:1
stock_LLY r_up	named:1 previously:1 retire:1 ended:1 broader:3 year:1 its:1 market:3 pharmaceutical:1 swings:2 end:1 additional:1 1:3 also:1 state:1 concerns:1 chairman:2 midday:1 board:3 his:1 's:2 seesaws:1 company:1 designated:1 mixed:3 said:2 emeritus:1 post:1 stocks:3 he:1 replaces:1 industry:1 banking:1 directors:1 tenure:1 action:1 starting:1 31:1
stock_LLY r_up	cost-cutting:1 after:1 15:1 help:1 announcing:1 move:1 drugs:1 months:1 sales:1 reduction:1 turning:1 contractors:1 force:1 hawk:1 its:2 outside:1
stock_LLY r_down	months:1 revenue:3 period:1 year:2 2.6:1 said:3 $:4 also:1 profit:1 six:1 least:1 sciences:1 listed:1 which:1 9.6:1 earlier:1 loss:2 track:1 company:2 million:4 but:1 reported:1 first-half:1 compared:2 net:1 grow:1 5.5:1 ago:1 10:3 made:1 --:1 30:1
stock_LLY r_up	says:1 doing:1 money:1 disclosing:1 fellow:1 individual:1 our:2 confidence:1 much:1 potential:1 economy:1 begin:1 global:1 advice:1 nationally:1 paid:1 courage:1 doctors:1 services:1 amp:2 man:1 speeches:1 invest:1 so:1 time:1 other:1
stock_LLY r_up	advisory:1 consider:1 certain:1 disclosing:1 treatment:1 one:1 same:1 moves:1 children:1 announcement:1 use:1 said:2 would:1 system:1 least:1 may:1 state:1 health:1 treat:1 has:1 more:1 do:1 begin:1 's:4 drugs:1 wake:1 doctors:1 such:1 panel:1 publicly:1 --:1 rival:1 drug:3 regulator:1 payments:1 disorder:1 maker:1 others:1 recommended:2
stock_LLY r_up	sector:1 just:1 course:2 its:2 advertisements:1 attractive:1 do:1 downs:1 they:1 bit:1 like:1 --:2 50:1 morning:1 banking:1 yields:1 did:1 disorder:1 ups:1 prasugrel:1 because:1 financial:1 hard:1 zero:1 even:1 said:1 review:1 track:1 safety:1 were:1 quite:1 dire:1 approval:1 reverse:2 many:2 drug:1 turn:1 misleading:1 experimental:1 load:1 own:3 omitted:1 says:1 remains:1 negative:1 fast:1 their:1 way:1 territory:1 head:2 north:2 complete:1 drugs:1 funds:3 company:1 specialty:1 but:1 fund:1 analyst:1 up:1 spending:1 n't:2 broad-based:1 heart:1 investors:2 certain:1 ``:3 promotional:1 '':2 optimistic:1 have:1 any:1 sell:1 information:1 mutual:1 goal:1 no:1 varies:1 other:1 which:1 answer:1 higher:1 gaining:1 's:4 may:1 after:1 important:1 designed:1 stocks:5 materials:1
stock_LLY r_down	sector:2 agency:1 just:1 over:1 6.1:1 managers:1 $:1 advertisements:1 attractive:1 has:2 sent:1 do:1 hurting:1 around:1 big:1 downs:1 they:1 bit:1 formal:1 like:1 --:2 50:1 banking:1 yields:1 either:1 disorder:1 ups:1 because:1 financial:1 hard:1 past:1 zero:1 year:1 financials:2 subject:1 even:1 index:1 said:2 may:1 safety:1 told:1 quite:1 dire:1 article:1 many:3 broad-based:1 misleading:1 published:1 maker:1 load:1 major:1 own:3 letters:1 omitted:1 been:1 says:1 pharmaceutical:1 due:1 fast:1 their:1 way:1 proposal:1 ``:3 diligence:1 drugs:1 funds:3 company:1 acquire:1 specialty:1 fund:1 analyst:1 made:1 up:1 n't:1 were:1 bet:1 investors:2 certain:1 promotional:1 '':2 warning:1 have:2 any:1 information:1 mutual:1 end:1 no:2 make:1 offer:1 varies:1 other:1 which:1 worst-performing:1 answer:1 's:1 track:1 important:1 designed:1 stocks:2 billion:1 longer:1 materials:1 withdraw:1
stock_LLY r_up	tumble:2 topics:1 down:3 broader:1 crash:1 dives:1 market:1 votes:2 management:1 banking:1 provide:1 crucial:1 bailout:2 voted:1 has:1 plunge:1 's:2 offer:1 after:2 crippled:1 news:1 stocks:3 elite:1 programs:1 high-end:1 industry:1 bill:2 courses:1 following:1 aid:1 resolution:1 executives:1
stock_LLY r_down	better:1 have:1 cancer:1 certain:1 global:1 sales:1 see:1 growth:2 lung:1 determine:1 best:1 if:1 tumor:1 management:1 targeting:1 $:2 working:1 federal:1 leading:1 lung-cancer:1 cell:1 their:1 3:1 clinical:1 treat:1 7:1 factor:2 through:1 capital:1 opportunity:1 treatment:1 's:4 government:1 equivalent:1 between:1 part:1 known:1 difference:1 effort:1 pharmaceutical:1 billion:2 attempt:1 look:1 17:1 16:1 --:1 study:3 companies:1 cash:1 35:1 large:1 patients:2 release:1 found:1 makes:1 launched:1
stock_LLY r_down	cancer-drug:1 help:1 sell-off:2 course:1 broader:3 talks:6 portfolio:1 its:1 developer:2 $:6 merger:2 passage:1 citing:1 bailout:1 has:3 rescue:1 familiar:1 inflation:1 report:2 advanced:1 mystery:1 economy:2 6.1:4 woes:1 people:2 revised:1 700:1 charting:1 likely:1 economic:2 investment:1 even:1 recession:1 profit:1 enough:1 version:1 reported:1 takeover:1 engaged:1 restrictions:1 package:2 many:1 could:1 drug:1 keep:1 fell:1 horizon:1 long-term:2 fallen:1 cancer:1 into:1 rising:1 market:5 decline:1 jobless:1 been:1 anyone:1 indicate:1 ``:1 buy:3 offer:1 short-selling:1 dismal:1 join:3 up:1 n't:2 matter:1 can:1 bidder:1 spotlight:2 futures:4 share:1 '':1 warning:1 dropped:1 ready:1 fears:2 concerns:1 performance:1 stock:5 extended:1 's:1 reportedly:2 after:1 wasn’t:1 important:1 70:1 stocks:4 data:1 approved:1 billion:5 lower:2 especially:1 amid:3 counter:1 claims:1
stock_LLY r_down	comment:1 biotech:2 already:1 6.1:2 tumble:1 being:1 move:2 700:1 focus:1 making:2 '':1 hopes:1 alliance:1 signed:1 have:1 pass:1 establish:1 interest:2 said:2 questions:2 $:3 fears:2 two:2 stocks:2 add:1 concerns:1 raises:2 economy:1 statement:1 company:2 discovery:1 development:2 billion:3 ``:1 's:6 updated:1 may:2 bid:2 after:1 prudence:2 but:2 joint:1 offsetting:1 plan:1 fall:2 services:1 mystery:2 hold:1 approved:1 pact:1 unidentified:2 prices:1 reported:2 --:3 bidder:2 steeply:2 companies:2 equal:1 drug:3 economic:2 solve:2 venture:2 weigh:2 providing:1 stock:1 stakes:1
stock_LLY r_down	cancer-drug:1 saying:1 all:1 sharply:1 proposed:1 seeing:2 sell-off:1 global:1 unsolicited:3 years:1 four:1 6.5:11 6.1:1 world:1 battle:2 its:7 rescue:2 developer:1 announcement:1 $:28 rose:3 had:3 written:1 should:1 16.6:1 equity:1 suffered:1 include:2 recasts:1 dispute:1 outbid:1 finance:1 bid:3 didn’t:1 cutting:1 worst:1 nearly:2 not:1 affect:1 ending:3 disappointed:1 lost:3 --:5 drop:1 try:1 did:2 slide:2 repaired:2 worldwide:2 says:1 deal:7 some:1 searching:3 trading:1 sea:1 83:1 out:2 throughout:2 stands:1 broad:1 acting:1 bailout:2 new:1 conditions:1 bold:1 extend:2 superior:3 passage:2 owns:1 agreement:3 others:1 regulatory:1 chairman:1 along:1 declining:2 8.4:1 settling:1 last:1 acquisition:2 getting:1 months:3 drug:2 plunging:1 credit:1 chemical:1 planned:1 defeat:1 retail:2 maker:2 comes:1 first:1 comment:1 among:2 ability:1 own:1 lending:1 month:1 one:1 60:2 62:1 world’s:1 rising:1 licensing:1 stockholder:1 reached:1 mark:1 singing:1 crisis:2 pharmaceutical:1 use:1 raise:1 would:2 pearl:1 one-day:1 support:1 two:3 strategy:1 their:1 much:1 rates:1 asset:1 statement:2 biggest:2 markets:2 deposits:2 more:1 firm:1 troubled:2 buy:4 offering:1 offer:4 successful:1 700:2 company:3 crack:1 but:3 gain:1 bidding:1 all-cash:1 prices:1 effort:1 analyst:1 those:1 financing:1 has:4 14:1 17:1 cash:1 signed:3 n't:4 record:1 below:1 sour:1 were:1 following:1 making:1 spotlight:2 bet:1 biotech:1 uncertainty:1 share:5 comfortable:1 10,000:1 financial:2 substantial:1 dropped:1 have:2 need:2 sounding:1 any:1 if:1 tumbled:2 drama:3 moves:1 goal:1 open:1 began:1 stake:2 1:4 other:1 pivotal:1 details:1 which:3 instead:1 subject:1 offered:1 stock:5 gaining:2 acquire:8 's:11 plans:1 may:1 after:3 said:3 plan:3 ownership:1 70:2 stocks:3 appear:2 billion:15 wreckage:2 guarantee:2 third:1 amid:3 futures:4 mortgages:1 severe:1 points:1 time:3 biotechnology:3 800:1 effects:1
stock_LLY r_up	prices:1 outlook:1 bill:2 deal:1 interventions:1 agreed:1 demand:1 700:1 focus:2 trade:1 four:1 10,000:1 6.5:3 session:1 trading:1 battered:1 years:1 plan:1 moves:1 worst:1 market:3 seemed:1 one:1 $:4 support:1 implosion:2 add:1 shares:3 mark:1 only:1 much:1 tumbling:2 those:1 which:1 biggest:2 get:1 has:1 bailout:2 over:2 stock:2 gaining:2 sink:2 ends:2 after:2 's:2 government:1 history:1 price:2 acquire:1 wave:1 drops:1 expected:1 nearly:1 anxiety:1 experiences:1 lows:2 significant:1 despite:2 active:1 kept:1 stocks:6 investor:1 declining:3 billion:2 weighed:1 include:1 off:2 maimed:2 crude:2 amid:1 uncertainty:3 work:1 see:1 plunging:1 below:1 points:3 time:1 banks:1 making:1 sell-offs:1 800:3 fell:1 first:1
stock_LLY r_down	150:1 note:1 ending:1 course:1 session:1 trading:3 have:1 if:1 pharmaceutical:1 said:1 $:3 would:1 merger:1 pay:1 negative:1 day:1 late:1 under:1 territory:1 flat:1 hover:1 around:1 completed:1 million:1 agreement:1 bullish:1 modest:1 fee:1 not:1 comeback:1 line:1 stocks:7 beginning:1 between:1 after:1 stage:1 reverse:1 companies:1 turn:2 while:1 afternoon:5 action:2 termination:1 climb:2 south:2
stock_LLY r_down	summer:1 major:1 term:1 deal:1 most:1 --:1 large:1 after:1 soon:1 anytime:1 n't:1 insured:1 likely:1 near:1 shareholder:1 unlikely:1 making:1 speculation:1 wo:1 acquirer:1 bought:1
stock_LLY r_down	futures:1 says:1 deal:1 globe:1 lack:1 financial:1 growth:1 another:1 sharp:1 hammer:1 uncertainties:1 system:1 concerns:1 markets:1 stock:1 's:2 around:1 stocks:1 day:1 faith:1 frozen:1 losses:1 credit:1 continue:1 faces:1 more:2 spotlight:2
stock_LLY r_down	sector:1 investors:1 global:1 mixed:3 one:1 session:1 trading:2 rally:3 bailout:2 weeks:1 ever:1 gains:1 rebound:1 after:1 early:1 action:2 part:1 scores:1 stocks:6 day:1 bank:2 rallied:1 most:1 afternoon:3 following:1 history:1 first:1
stock_LLY r_down	consumers:1 rewrite:1 federal:1 could:1 pushing:1 administration:1 states:1 rules:1 officials:1 array:1 changes:1 lawsuits:1 block:1
stock_LLY r_down	heart:3 have:2 determine:1 any:2 best:1 said:2 their:2 forces:1 status:2 's:1 clots:1 after:1 but:1 they:3 rare:1 received:2 protect:1 word:2 dangerous:1 medical:1 companies:1 drug:2 n't:2 stents:1 patients:1 experimental:2 treated:1 prasugrel:1 joining:1
stock_LLY r_up	ahead:3 investors:1 global:1 share:1 sales:3 batch:1 price:1 through:1 per:1 broader:3 cruise:2 's:1 stabilize:1 market:3 greater:1 sell:1 forced:1 confidence:1 $:3 positive:1 shares:2 finally:1 chairman:1 markets:1 sold:2 stock:1 week:1 even:1 co-founders:1 filings:2 government:1 involuntary:1 company:1 million:2 took:1 effect:1 director:1 regulatory:1 stocks:3 both:2 valued:2 last:1 showed:1 calls:1 average:1 according:1 directors:1 place:1 were:1 action:1 more:1 having:1 latest:1
stock_LLY r_down	proposed:1 being:1 developed:1 settlements:1 dollar:1 results:1 own:2 controversial:1 talks:2 its:3 osteoporosis:1 fronts:2 20:1 $:9 bipolar:1 increasingly:2 charge:4 potential:2 treatment:1 has:1 earnings:2 probe:2 obtain:1 five:1 updates:1 report:1 using:1 multiple:2 advanced:1 resolve:2 --:4 make:1 morning:1 settle:2 popular:1 quarter:2 disorder:1 right:1 financial:2 deal:1 crunch:1 some:1 past:3 schizophrenia:1 cost:1 result:2 year:1 discussions:2 close:2 said:4 adds:2 federal:1 decision:1 increase:1 outside:1 investigation:3 marketing:3 before:1 turmoil:2 led:1 sixth:1 pressure:2 add:1 members:1 article:1 antipsychotic:2 last:1 getting:2 months:1 allows:1 drug:4 display:1 credit:1 published:1 maker:1 software:1 already:2 slipped:1 into:3 expensive:3 industrials:1 additional:1 three:1 least:1 needed:1 treat:1 expected:1 probes:1 final:1 more:5 firm:1 ``:1 drugs:2 difficult:1 company:1 prescription:1 than:1 13:1 likely:2 n't:2 record:2 ongoing:2 franc:1 spotlight:2 acquisition:2 1.4:4 medication:2 investors:1 share:2 '':1 rat:1 against:1 have:1 sell:1 information:2 strength:1 scrutinized:1 pay:1 44:2 virtual:1 issuing:1 take:3 which:1 test:1 developers:1 stock:2 product:1 's:5 models:1 quote:1 bellwethers:1 after:1 outperformed:1 lab:1 recent:2 designed:1 coming:1 stocks:1 eighth:1 diabetes:1 billion:5 third:2 futures:1 1.29:2 practices:2 does:2 starting:1 review:1 effects:1
stock_LLY r_down	probe:1 focus:4 trade:3 session:3 including:1 controversial:1 aggressive:1 whose:3 $:4 rose:1 expectations:1 late:1 charge:1 treatment:1 has:1 might:1 them:1 big:1 125:1 downturn:1 dose:1 loss:1 companies:3 found:1 quarter:2 affordable:1 because:1 antibiotic:1 deal:1 see:2 trading:1 result:1 2.2:1 bacteria:1 said:1 shares:3 outside:2 drawn:1 available:1 marketing:1 million:2 upfront:1 active:3 declining:2 antipsychotic:1 study:1 drug:1 credit:1 maker:1 experimental:1 seeing:1 into:1 one:1 right:2 wider:1 market:1 become:1 third-quarter:1 treat:1 expected:2 diabetes:1 more:2 billion:1 but:1 biggest:2 known:1 165:1 line:1 posted:1 13:1 made:1 third:1 record:1 can:2 medication:1 sell:2 pay:2 make:1 topped:1 also:2 potential:1 fourth:1 stock:1 gaining:2 's:5 after:1 upon:1 stocks:2 recent:1 acquisitions:1 calls:1 infections:1 chief:1 biotechnology:1 2009:1 starting:1
stock_LLY r_up	global:1 adjusted:1 discovered:1 session:1 tablets:1 higher:2 settlement:2 fine:1 its:9 previous:1 litigation:2 25:1 group:2 $:5 application:1 disposal:1 seems:1 recommending:1 blog:1 economy:1 charge:3 treatment:1 must:1 advertising:1 gains:1 government:3 very:1 rebound:1 rise:1 focus:2 trading:1 nearly:1 fall:2 report:1 loss:9 --:3 companies:3 50:1 communications:2 settle:2 each:1 through:1 crude-oil:1 prasugrel:1 still:1 says:1 acquired:1 posts:1 energy:1 prediction:1 related:2 schizophrenia:1 actively:1 simmering:1 year:2 makers:1 special:1 85:1 regulator:1 said:3 tussle:1 bottom:1 profit:5 review:1 comments:1 forecast:1 simmer:2 navigating:1 sixth:1 net:2 weekly:1 announced:1 rundown:1 triples:2 scientific:1 business:2 whose:1 marketing:5 million:2 notable:1 following:1 regulators:1 tripled:2 although:1 offset:2 directions:1 approval:2 along:1 strong:2 beginning:1 declining:4 antipsychotic:2 reaction:1 almost:1 cautious:1 site:1 items:1 losses:1 according:1 drug:8 takeover:1 due:1 opinion:1 experimental:1 among:1 raised:1 benefited:1 previously:1 into:4 period:1 third-quarter:7 names:1 drove:1 market:3 conference:1 pharmaceutical:1 swings:2 much:1 jobless:1 their:2 monthly:1 positive:1 anti-clotting:1 two:2 adopted:1 next:1 backing:1 2:1 call:1 taken:1 9.6:2 panel:1 type:1 250,000:1 company’s:1 ``:1 recommends:1 received:1 company:2 466:1 defunct:1 but:2 hurt:1 biggest:4 gain:2 prices:2 analyst:1 those:1 posted:3 has:1 14:1 recession:4 while:2 were:1 squeezed:1 making:1 steep:1 firm:1 cents:2 lines:1 share:2 sales:6 '':1 unit:3 brutal:1 triple:1 seem:1 moves:1 proceeds:1 alive:1 again:3 different:1 compared:1 grant:1 rout:1 agency:1 fears:3 43:1 same:1 shares:1 also:1 other:1 earnings:1 outlook:1 swung:5 stock:4 gaining:4 independent:1 product:1 extended:1 's:23 intended:1 investigations:4 after:1 includes:1 fell:1 stocks:6 diabetes:2 ago:1 sectors:1 charges:3 futures:1 cover:2 sale:4 antidepressant:2 costs:2 2007:1 healthcare:2 far:1 claims:1 2008:1
stock_LLY r_down	sector:1 less:1 sell-off:1 global:1 through:1 shares:2 broader:4 fear:1 its:5 impact:1 rose:1 swoon:2 analyst:2 late:2 program:1 has:3 updated:1 gains:2 very:2 big:1 safe:2 early:1 now:1 areas:1 --:2 companies:2 've:1 stock:1 economically:1 worldwide:1 right:1 suspended:2 findings:1 energy:3 some:1 seesaw:2 economic:2 trading:5 year:1 further:2 morning:2 declined:1 said:2 hide:2 comments:2 health:1 told:1 we:1 pharmaceutical:1 seesaws:1 sparked:1 weak:1 water:2 put:1 declining:1 care:1 sending:1 industry:2 drug:3 place:2 afternoon:1 maker:2 experimental:2 within:1 another:2 throughout:1 market:4 pouring:2 heads:2 additional:1 hammered:3 ripples:1 clinical:3 treat:2 taken:1 markets:1 more:1 ``:1 health-care:1 company:1 's:1 prices:4 hold:2 than:1 account:1 mount:2 bellwether:1 recession:1 while:1 decided:1 plunges:1 soars:2 alongside:2 share:2 medical-technology:1 '':1 dropped:2 have:1 seen:1 partner:2 viewed:1 indexes:2 rally:4 tumbling:1 details:2 which:1 tumbles:2 several:1 economy:2 development:2 insulated:1 pain:2 price:1 stocks:5 data:1 recent:1 tracking:1 overnight:1 south:2 notion:2 profits:1
stock_LLY r_down	right:1 hoping:1 proposed:1 deaths:1 caused:1 businesses:1 fiduciary:1 injuries:1 pharmaceutical:1 sue:1 said:1 breached:1 consumers:1 merger:1 their:1 other:1 board:1 's:2 duties:1 complaint:1 recently:1 big:1 company:2 sharply:1 filed:1 class:1 industry:1 alleging:1 against:1 connection:1 action:1 curb:1 medicines:1
stock_LLY r_up	right:1 hoping:1 century:1 caused:1 focus:2 businesses:1 have:1 injuries:1 pharmaceutical:1 sue:1 $:2 deaths:1 able:1 been:1 other:1 big:1 sharply:1 70:2 than:2 case:2 medicines:1 companies:1 drug:3 curb:1 industry:1
stock_LLY r_down	lower:1 interest:1 rocket:2 move:1 soon:1 warms:1 rates:1 broader:3 further:1 hopes:1 rally:3 stocks:3 market:3
stock_LLY r_up	comment:1 major:1 they:1 campaign:1 do:1 doing:1 tax:2 according:1 another:1 alternative:1 crisis:1 conventional:1 majority:1 create:1 flying:1 their:1 earnings:1 lobbyists:1 reject:1 firms:1 holiday:2 congressional:1 multinational:1 activities:1 lobbying:1 jobs:1 government:1 familiar:1 little:1 wisdom:1 preparing:1 letter:1 such:1 proposal:1 people:1 bailouts:1 --:1 6th:1 solution:1 face:1 so:1 push:1 overseas:1 corporate:1 liquidity:1 20th:1 grounds:1
stock_LLY r_up	major:2 cancer:1 lobbying:2 broaden:1 tax:2 another:2 blockbuster:1 children:1 use:1 compared:1 disorders:1 application:1 review:1 priority:1 their:2 earnings:2 firms:2 holiday:2 dramatically:1 treatment:1 multinational:2 activities:2 combination:1 said:2 therapy:1 preparing:2 alone:1 accepted:1 supplemental:1 anxiety:1 cognitive:1 --:2 drug:1 either:1 behavioral:1 push:2 overseas:2 reduced:1 researchers:1
stock_LLY r_up	tumble:3 trade:1 news:1 due:1 shares:1 their:1 version:1 medicine:1 more:1 seeking:1 problems:1 delayed:2 regulatory:1 approval:1 stocks:3 data:1 diabetes:2 could:1 drug:2 while:1 mixed:3 filing:1
stock_LLY r_down	candidate:1 their:1 after:3 elected:1 slide:3 election:2 president:1 stocks:3 day:3
stock_LLY r_down	consider:2 do:1 warns:2 alongside:1 ``:1 crosshairs:2 '':1 ask:1 pricing:1 have:1 our:2 take:1 advertise:1 makers:2 conference:1 pharmaceutical:2 said:1 ads:2 keynote:1 should:2 seriously:1 program:1 speech:1 details:1 biotechnology:1 products:1 you:1 stock:1 then:1 head:2 used:1 's:5 business:1 government:2 cars:1 price:1 we:2 updates:1 meet:2 prices:2 yourselves:1 --:2 industry:2 up:2 drug:2 so:1 easing:2 challenge:2
stock_LLY r_up	acceleration:1 pharmaceutical:1 but:1 mid-sized:1 not:1 going:1 companies:2 cash:1 acquisitions:1 drug:1 say:1 're:1 expect:1 they:1 flush:1 small:1 shopping:1 executives:1
stock_LLY r_up	150:1 because:2 some:2 dose:2 selling:1 hypertension:1 slumped:2 's:4 its:3 concern:3 said:2 unable:2 million:1 much:1 due:2 shares:1 failed:2 version:1 treatment:3 premarket:1 has:1 ingredient:2 full:2 handle:2 after:1 part:1 uses:1 effects:2 active:2 potential:2 buying:1 $:2 38:1 rights:3 31:1 drug:2 flagship:1 trial:2 patients:2 were:2 biotechnology:3 oral:1 side:2
stock_LLY r_up	rose:1 fell:1 's:1
stock_LLY r_down	cancer-drug:1 strengthen:1 executive:1 its:1 market:1 said:1 attractive:1 pursuing:1 downturn:1 has:1 more:1 's:1 such:1 recent:1 acquisitions:1 pipeline:1 made:1 license:1 --:1 drug:1 deals:2 chief:1 maker:1
stock_LLY r_up	...:2 named:1 old:1 risk:1 company:1 45:1 years:1 also:1 chief:2 part:1 officer:1 holding:1 position:1 new:1
stock_LLY r_up	major:1 significantly:1 move:1 some:1 session:1 trading:1 home:1 close:1 makers:1 market:1 out:1 incredible:1 p.m.:1 1:1 best:1 closed:1 buys:1 expected:1 include:1 markets:1 gaining:2 's:6 holding:1 auto:1 nation:1 early:1 biggest:2 stocks:2 declining:2 like:1 well:1 sale:1 points:1 retailers:1 were:1 builders:1
stock_LLY r_down	use:1 pain:1 plans:1 medicine:1 next:1 application:2 resubmit:1 year:1 regulatory:1 approval:1 its:1
stock_LLY r_up	one:1 6.5:2 incremental:1 year:1 its:4 depression:1 complete:1 closer:1 ratings:2 use:1 cut:1 $:2 needed:1 bringing:1 next:1 1:2 application:1 citing:2 resubmit:1 treatment:1 which:1 medicine:1 closed:1 pending:1 more:1 's:6 plans:1 pharmaceutical:1 earlier:1 giant:1 early:1 lowered:1 approval:1 debt:1 data:1 billion:2 drug:1 credit:2 notch:1 maker:1 acquisition:2
stock_LLY r_down	soon:1 its:1 disappear:1 pharmaceutical:1 voluntary:1 spending:1 commercials:1 wo:1 expected:1 announce:1 has:1 week:1 drugs:1 but:1 probably:1 ads:1 restrictions:1 television:1 prescription:1 industry:1 anytime:1 n't:1 advertising:1
stock_LLY r_up	less:1 expects:2 month:1 held:1 6.5:3 including:1 follow:1 forecast:2 yet:1 giant:1 $:11 field:1 had:1 than:2 late:1 charge:2 potential:1 4:2 quarterly:1 has:1 take:1 updated:1 risk:1 fate:1 auto:1 rise:2 anticipated:1 early:1 cutting:2 updates:1 uncertain:1 now:1 loss:10 notable:1 --:2 damped:2 large:1 quarter:1 noted:2 related:1 competition:1 oil:1 trading:1 result:3 year:2 employment:1 adequately:1 out:2 said:9 adds:1 profit:3 miss:1 review:1 shares:2 its:6 version:1 closed:1 sixth:1 progress:2 net:7 after:1 jobs:2 exchange:1 weak:1 seventh:1 takeover:1 post:4 beginning:1 declining:2 faced:1 reaction:1 10th:1 last:1 industry:1 drug:2 bet:1 swing:1 maker:1 fourth-quarter:2 outlook:2 cancer:1 into:1 one:1 associated:2 throughout:1 open:1 follow-on:1 pharmaceutical:2 little:2 would:2 basis:1 due:1 production:1 rates:1 which:1 biggest:2 1.56:1 diabetes:1 markets:1 more:2 advance:2 drugs:1 company:2 but:5 expected:2 wiping:2 favorable:1 demand:1 analyst:1 decided:1 target:1 growth:4 making:1 drops:2 spotlight:2 acquisition:8 sees:3 share:3 sales:4 slowing:1 currency:1 full-year:4 biologics:2 have:1 moves:1 check:1 gains:1 blockbuster:1 'll:1 generic:1 detail:1 traders:1 also:2 causing:1 earnings:4 fourth:2 worsening:1 bailout:1 stock:3 gaining:2 picture:1 extended:1 's:4 plans:1 may:1 quote:1 price:1 earlier:3 factored:1 stocks:6 recent:2 billion:5 lower:1 charges:3 amid:1 futures:1 well:1 commodities:1 costs:6 '09:2 2008:8 2009:9 starting:2
stock_LLY r_up	biotech:1 $:1 cancer:1 drugs:1 pay:1 company:1 million:1 least:1 240:1
stock_LLY r_up	pharmaceutical:1 giant:1 's:2 payouts:1 trend:1 dividends:1 boosted:1 contractor:1 their:1 while:1 defense:1 drug:1 slashed:1 dividend:1 fellow:1 its:1 maker:1 affirmed:1
stock_LLY r_down	heart:1 raised:1 cancer:1 affects:1 move:1 assess:1 stroke:1 growth:1 including:1 questions:1 year:1 makers:1 said:1 group:1 trials:1 guidance:1 agency:1 two:1 recommending:1 better:1 application:1 attack:1 clinical:1 safety:1 treat:1 certain:1 document:1 type:1 pending:1 more:2 used:1 's:2 seeking:1 drugs:2 outlined:1 after:1 immediately:1 applications:1 such:1 approval:2 than:1 those:1 diabetes:2 target:1 effective:1 --:2 involved:1 well:1 disease:1 drug:2 patients:1 future:1 products:1 risks:1 were:1 colon:1 gene:1
stock_LLY r_down	obligations:1 move:1 reviewed:1 including:1 questions:1 during:1 cardiovascular:1 giant:1 27:1 granting:1 guidance:1 recommending:3 better:2 under:1 pending:1 exceptional:1 outlined:1 spell:1 immediately:1 --:2 specific:1 declared:2 heart-attack:1 year:1 subject:1 annually:1 said:3 affects:1 review:2 vaccines:2 safety:1 before:1 officially:1 marketing:1 active:1 approval:2 vaccine:1 panel:1 days:1 drug:3 opinion:1 undergo:1 options:1 raised:1 assess:2 viruses:1 intervention:1 use:1 positive:1 adopted:1 attack:1 clinical:2 more:3 drugs:2 than:1 those:1 regulator:1 patients:1 future:1 risks:2 were:1 following:1 heart:1 backing:1 pandemic:4 stroke:2 syndrome:1 trials:2 began:1 agency:1 application:1 potential:1 document:1 events:1 's:6 intended:1 generic-drug:1 may:1 after:1 treatments:1 prepared:1 applications:1 such:1 opportunity:1 diabetes:3 effective:1 well:1 time:1 2008:1 prevention:1
stock_LLY r_up	respond:1 heart:1 financial:2 less:1 half:1 site:1 agent:1 say:1 year:1 seem:1 its:2 posting:1 $:1 anticlotting:1 publish:1 1:1 start:1 version:1 more:1 disclose:1 begin:1 plans:1 normal:1 targeted:1 company:2 paid:1 tracking:1 5,000:1 doctors:2 ties:2 data:1 than:2 those:1 2009:1 medical:1 second:1 annually:1 became:1 gene:2 latest:1
stock_LLY r_up	heart:2 agency:1 help:1 proposed:1 advisory:1 30:1 blood-thinning:2 soon:1 years:1 cardiac:1 likely:1 act:1 another:1 's:2 face:1 wo:1 any:1 panel:2 considering:1 information:1 said:1 would:1 application:1 federal:1 decision:1 means:1 anti-clotting:1 three:1 least:1 approved:1 delay:1 may:2 3:3 medicine:1 new:1 struggling:1 layoffs:1 thousands:1 until:1 more:1 handing:1 used:1 pipelines:1 greater:1 slight:1 drugs:1 could:1 showing:1 after:1 scrutiny:1 regulators:3 recent:1 consolation:1 doctors:1 not:1 interfere:1 than:1 updating:1 review:1 factors:1 include:1 effective:1 developing:1 --:3 meeting:1 industry:1 yet:1 companies:1 label:1 drug:6 asked:1 n't:1 prior:1 patients:2 were:1 2008:1 studies:1 receive:1 prasugrel:2 genetic:1
stock_LLY r_down	dangerous:1 certain:1 effects:1 years:1 patient:1 hospitals:1 any:1 24:1 detect:1 20:1 22:1 three:1 approved:5 whether:1 treatment:1 test:1 new:2 struggling:1 layoffs:1 thousands:1 more:2 used:1 pipelines:1 greater:1 slight:1 drugs:3 2005:1 leukemia:1 scrutiny:1 helping:1 records:1 regulators:2 two:1 consolation:1 included:1 article:1 lymphoma:1 than:2 types:1 --:1 18:1 industry:1 drug:2 antidepressant:1 prior:1 2006:2 can:1 published:1 2008:2 side:1 joining:1
stock_LLY r_up	pact:1 said:1 's:1 pharmaceuticals:1 provide:1 company:1 manage:1 package:1 vaccines:1 most:1 services:1 transportation:1 entered:1 has:1 distribution:1
stock_LLY r_down	purchases:1 letters:1 significant:1 over:1 receipt:1 some:1 ninth:1 declined:2 '':1 resources:1 through:1 immediately:1 ready:1 patient:1 its:2 market:2 if:1 conference:1 n't:2 shareholders:1 said:2 antipsychotic:2 candidate:1 investor:1 make:2 submit:1 yet:1 application:2 does:1 safety:1 details:1 which:1 cash:1 leader:1 dividends:1 has:4 email:1 sent:1 disclosed:1 week:1 buybacks:1 ``:1 's:3 complete:2 long-acting:2 big:1 company:1 return:1 but:1 broadcast:1 plan:1 letter:3 news:1 beginning:1 response:2 acquisitions:1 received:2 according:1 drug:3 maker:2 regulator:1 ensure:1 analysts:1 share:1 2009:2 approve:3 asked:1 mean:1
stock_LLY r_up	investors:1 some:1 ``:2 according:1 '':2 email:1 shares:1 have:1 hit:1 plan:1 its:1 declined:1 regulator:1 submit:1 antipsychotic:1 long-acting:1 beginning:1 been:1 winning:1 delay:1 application:1 safety:1 patient:1 details:1 pretty:1 new:1 has:2 price:1 surprised:1 stock:1 week:1 deemed:1 analysts:1 's:2 complete:1 may:1 company:1 possible:1 market:1 updates:1 letter:1 regulatory:1 approval:1 exciting:1 bode:1 response:1 received:1 well:1 cash:1 drug:2 asked:1 takeout:1 ensure:1 sent:1 learn:1 growing:1 approve:1 maker:1 profits:1 first:1
stock_LLY r_down	sending:1 trying:1 fix:1 disease:1 long:1 smoke:1 suffered:1 has:1 problem:1 out:1
stock_LLY r_down	use:1 quarter:1 get:1 update:1 expects:1 label:1 treatment:1 during:1 first:1 its:1 decision:1 diabetes:1
stock_LLY r_down	heavy:1 bars:1 appeals:1 costly:1 unapproved:1 cancer:1 finalized:1 over:2 guidelines:1 nearing:1 improper:1 officials:1 rule:1 have:2 settlement:1 its:1 pharmaceutical:1 use:1 court:1 antipsychotic:1 would:1 federal:2 make:1 alleged:1 research:1 their:1 version:1 treatment:1 under:1 medicine:1 easier:1 them:1 urging:1 get:1 drugs:1 marketing:2 bid:1 but:1 questioning:1 tested:1 uses:1 not:1 promote:1 because:1 those:1 panel:1 articles:1 prosecutors:1 effective:1 --:2 clear:1 companies:1 drug:1 n't:2 generic:1 patients:1 maintain:1 ruling:1 organization:1 gene:1 tumors:1 came:1
stock_LLY r_up	sector:2 restore:1 violation:1 agreed:6 allegations:3 results:1 including:1 settlement:6 its:6 previous:1 announcement:1 $:21 had:2 suits:2 charge:3 promoting:2 criminal:1 over:3 do:2 whistleblower:1 background:1 advanced:1 drugmaker:1 brought:2 regarding:3 --:4 settle:3 worries:1 set:2 financial:1 deal:1 past:1 accused:1 plead:3 discussions:1 said:2 federal:7 sum:1 since:1 comments:1 agrees:1 enough:1 investigation:1 health:1 improperly:3 announced:1 marketing:7 million:1 pressure:1 beginning:1 antipsychotic:7 settling:2 faith:1 prosecutors:5 guilty:4 drug:9 amount:1 traded:1 maker:1 into:1 one:1 improper:1 reached:1 throughout:1 jobless:2 lawsuits:2 long-awaited:3 alleged:1 been:1 treat:2 statement:1 expected:2 promotions:1 ``:1 cases:1 case:1 has:3 n't:2 record:1 while:1 9th:1 were:2 spotlight:2 1.4:5 '':1 blockbuster:4 pay:9 aside:2 potential:1 details:2 tech:1 stock:1 illegally:1 's:1 wasn’t:1 off-label:1 approved:2 billion:10 lower:1 resolution:1 futures:1 so:2 claims:2 800:1 corporate:1
stock_LLY r_down	among:1 outlook:1 force:1 reduce:1 sales:4 years:1 likely:1 including:1 slashing:1 another:1 news:1 its:1 market:1 pharmaceutical:1 cut:1 20:1 according:1 board:1 forces:1 several:1 across:1 giants:1 's:2 apparent:1 weak:1 but:1 one-third:1 possibly:1 job:1 plan:1 article:1 2,400:1 bleak:1 recent:1 positions:1 up:1 drug:2 reports:1 remain:1 costs:1 so:1 published:1
stock_LLY r_up	bets:1 handily:1 though:1 beat:1 energy:1 health-care:1 overall:1 hurt:1 few:2 returns:1 retailers:1 our:1 discount:1 stocks:1 their:1
stock_LLY r_down	help:1 just:1 less:2 domestic:1 results:1 questions:1 its:4 cell:2 $:2 entire:1 revenue:1 treatment:1 has:1 2011:3 pending:1 government:1 bid:2 conduct:1 worst:1 report:1 bigger:1 60:2 --:2 busiest:1 quarter-century:1 cholesterol:1 quarter:2 human:1 deal:1 feeling:1 competition:1 rate:1 pain:1 arm:1 best:2 even:2 gross:1 clearing:1 research:1 vaccines:1 between:1 new:1 expiration:1 ability:2 stem:2 reported:2 beginning:1 appears:2 choppy:2 could:1 annual:1 drug:1 credit:2 range:1 journey:1 argue:1 first:2 fourth-quarter:2 raised:1 secure:2 cancer:1 presence:1 lending:1 number:1 down:1 lung:1 market:2 use:2 sheet:2 needed:2 remains:2 mounting:1 long:1 their:1 much:1 treat:1 interest:1 expected:1 type:1 today:2 more:1 field:1 posting:1 drugs:1 season:1 company:2 differences:1 benchmark:1 but:2 than:1 wide:1 financing:2 made:1 whether:2 meeting:1 zero:1 n't:4 near:1 represents:1 500:1 high-growth:1 balance:2 way:1 reviewing:1 have:2 blockbuster:1 5.4:1 trial:1 generic:1 application:1 potential:1 earnings:1 which:2 week:1 product:2 's:14 after:1 looming:1 levels:1 billion-plus:2 especially:1 third:1 programs:1 clear:2 patent:1 2001:2 components:1 spend:1
stock_LLY r_up	billion:1 natural:1 $:5 federal:1 pay:1 agreed:1 alleged:1 its:1 industry:1 settle:1 investigation:1 mature:1 marketing:1 2.3:5 says:1 off-label:1 into:1 conclusion:1
stock_LLY r_up	fourth-quarter:2 cancer:1 revenue:2 health-care:1 influence:1 sales:3 agent:2 makers:1 weighed:2 growth:2 thanks:1 questions:1 swung:3 year-earlier:2 its:1 down:2 swings:2 antipsychotic:2 profit:5 rose:2 stake:1 anticlotting:2 4:2 comments:1 strategy:1 access:1 drugs:1 details:1 fourth:3 expected:1 performance:1 has:1 15th:1 stock:1 expand:1 product:1 's:2 rules:1 price:1 sparked:1 seventh:1 one-time:1 helped:2 updates:1 new:1 beginning:2 change:1 loss:2 charges:2 sale:1 drug:4 while:2 costs:1 gain:1 growing:1 quarter:3 maker:2 acquisition:1 nearly:2
stock_LLY r_up	case:1 week:1 use:1 set:1 's:3 antipsychotic:1 trial:1 federal:1 caused:1 lawsuits:1 alleging:1 two:1 dismissed:1 one:1 personal:1 2:2 including:1 judge:1 has:1 next:1 injuries:1
stock_LLY r_down	saying:2 illustrates:1 focus:6 quarters:1 6.5:1 session:1 including:1 shares:1 year-earlier:1 its:5 whose:1 $:15 surprises:2 state:1 should:2 charge:3 advisories:2 treatment:1 400:3 hit:1 watching:1 early:1 decide:1 report:1 trade:1 loss:6 1.07:1 --:2 warned:1 companies:3 did:1 settle:1 economy:1 sign:1 see:2 economic:2 animal-health:1 year:1 's:1 thinks:1 said:1 remain:1 legal:1 enough:1 asking:1 net:4 pinched:1 after:1 business:1 million:2 weak:1 reported:1 takeover:1 address:1 active:1 news:1 panel:1 suggested:1 acquiring:1 package:1 drug:2 products:1 planned:1 rose:1 insufficient:1 maker:3 fourth-quarter:3 own:1 point:3 likes:1 market:2 millions:1 decline:1 swings:2 would:1 removing:1 question:1 antipsychotic:1 start:3 expected:1 meeting:1 more:1 flat:1 ``:1 drugs:1 memo:1 part:1 investigation:1 known:1 90:1 removed:1 whether:3 rival:1 n't:1 while:1 future:1 were:1 impotence:1 acquisition:2 marketplace:1 weaker:3 investors:1 cents:2 share:2 sales:1 evidence:1 '':1 examine:1 experts:1 reports:2 have:1 swung:3 sell:1 documents:1 weakened:1 agency:1 pills:1 flood:1 earnings:7 income:1 stimulus:1 company:1 stock:2 used:1 pain:1 may:1 approves:1 earlier:1 prepared:1 compared:1 stocks:2 data:2 78:1 billion:5 purchase:1 booked:2 database:1 charges:3 medical:1 futures:2 roughly:1 2008:1 latest:1 corporate:1 roundup:1 justify:1
stock_LLY r_down	help:1 proposed:5 unemployment:1 being:4 developed:4 over:1 executive:2 month:1 divestitures:1 comments:1 settlement:1 fine:1 its:4 succeeding:1 impact:1 giant:1 $:7 23:1 should:10 investigation:1 questioned:1 reviewers:4 criminal:3 take:1 do:1 them:1 very:2 auto:1 rise:1 five:1 they:1 not:1 world:1 grim:1 drugmaker:1 outweigh:1 --:6 companies:1 identified:1 did:1 verdict:1 retailers:1 popular:1 dour:1 deal:1 bleeding:4 declines:1 some:1 challenges:1 carry:5 rate:1 economic:1 pain:1 makers:1 said:6 lead:1 decision:1 since:1 anticlotting:1 shares:1 enough:1 bracing:1 safety:1 appointed:1 announced:1 business:1 wo:1 marketing:2 million:3 regulators:1 offset:1 dividend:1 100:1 panel:2 essentially:1 benefits:1 could:1 drug:6 connection:1 products:1 approve:4 comment:1 major:1 tough:4 cancer:4 civil:1 into:2 address:1 8217:2 one:1 60:1 vote:2 market:3 has:2 given:1 additional:2 analyst:1 pharmaceuticals:1 illegal:1 anti-clotting:3 antipsychotic:1 their:1 indicators:1 especially:1 final:1 more:1 billion:2 formally:1 drugs:4 company:2 but:4 site:2 expected:1 part:1 former:1 known:1 prescription:1 removed:1 than:2 posted:2 divisions:2 12:1 join:1 14:1 16:1 require:1 work:1 finances:1 n't:3 risks:6 were:2 medical:5 acquisition:1 ordered:1 investors:1 sales:1 experts:1 have:1 close:1 blockbuster:1 worry:1 if:1 narrowly:2 information:1 different:3 pay:2 make:2 agency:6 s:2 pills:1 highlighted:1 recommended:1 concerns:1 split:1 investigations:1 big:1 week:2 's:11 warnings:4 earlier:1 includes:1 most:1 plan:1 payment:1 ago:1 off:4 assets:1 antitrust:1 halve:1 clear:1 well:1 roughly:1 chief:1 pulled:1 left:1
stock_LLY r_up	set:1 sales:1 valuable:2 market:1 competitor:1 $:1 would:1 decision:2 marketed:1 anticlotting:2 should:1 may:1 potentially:2 multibillion-dollar:1 recommend:1 expected:1 new:3 sway:1 pill:3 more:1 selling:1 's:3 7:1 government:2 drugs:2 after:1 but:2 6,000:2 approaches:2 world:1 than:1 panel:3 billion:1 --:1 dangerous:2 signal:2 drug:1 whether:1 which:1 2007:1 approve:1 called:1 prasugrel:1
stock_LLY r_up	drop:1 investors:2 heavily:1 being:1 developed:1 cuts:1 some:3 sales:2 industry:1 down:1 slates:2 taxes:2 have:1 year:1 forecast:1 economist:2 dueling:2 has:2 unanimously:1 proposed:1 her:2 activism:2 agency:1 anticlotting:1 long:1 any:2 makers:1 bleeding:1 recommended:1 other:1 steep:1 closed:1 auto:2 expected:1 new:1 weeks:1 prominent:2 supporting:2 study:2 more:2 vehicle:1 campaign:2 earlier:1 's:2 slash:2 than:2 warnings:1 season:2 continues:1 v.:2 profits:2 eight:1 proxy:2 former:2 weigh:1 active:4 news:1 multinationals:2 investor:2 killed:2 production:1 panel:1 plants:1 short:2 name:2 adviser:2 --:3 fallen:1 could:2 30:1 drug:1 foreign:2 recession:2 indication:2 risks:1 were:2 fleet:1 feeling:2 approve:1 think:2 prasugrel:1 proposal:2
stock_LLY r_down	sticking:1 unanimously:2 emerging:1 proposed:2 can:1 bleeding:4 sepsis:2 site:1 '':1 together:1 follow:1 further:1 sidelines:1 panel:2 might:2 huge:1 death:2 developed:2 working:1 sit:1 review:2 agency:3 anticlotting:2 patients:1 increase:2 being:2 recommended:2 safety:2 treat:2 statement:1 communication:1 posted:1 meeting:1 events:1 details:1 picture:1 ``:2 used:2 's:7 risk:2 form:1 warnings:1 strokes:1 evaluate:1 clots:1 after:2 clearer:1 acquisitions:1 early:1 said:1 designed:1 which:2 major:1 recent:2 suggested:2 received:1 conducting:2 cause:1 lead:1 pursuing:1 --:3 dangerous:1 could:2 companies:1 drug:7 keep:1 heart:1 attacks:1 severe:2 risks:1 serious:3 approve:2 study:2 prasugrel:2 blood:2
stock_LLY r_up	found:1 made:2 would:1 cancer:3 people:1 drugs:1 study:1 help:1 two:1 thought:1 attack:1 worse:1 colon:1 newer:1 combining:1 miserable:1 patients:1 advanced:1 more:2
stock_LLY r_down	strengthening:1 600:1 deal:1 presence:1 certain:1 agreed:1 within:1 related:1 achieves:1 have:1 year:1 close:1 its:1 after:1 pharmaceutical:1 said:2 $:5 candidate:1 giving:1 pay:2 sum:1 which:1 expected:1 has:1 disclose:1 million:3 's:2 300:1 company:1 acquire:1 upon:1 pipeline:1 unanimously:1 if:1 background:1 doctors:1 regulatory:1 immediately:1 approval:1 approved:1 bigger:1 additional:1 900:1 transaction:1 boards:1 publicly:1 up:2 drug:2 payments:1 milestones:1 become:1 closing:2 2009:1 makes:1 maker:1 latest:1
stock_LLY r_down	s:2 8217:2
stock_LLY r_up	financial:1 them:1 '':1 good:1 have:1 watched:1 still:1 monitors:1 relationships:1 story:1 surgeons:1 p.m.:1 outside:1 version:1 expected:1 ``:1 adieu:1 bid:1 corrected:1 but:1 soon:1 orthopedics:1 follows:1 could:1 companies:1 continue:1 ensure:1 behavior:1 published:1
stock_LLY r_down	set:1 rights:1 rival:1 global:1 anticlotting:1 drug:1 medicine:1 hopes:1 announce:1 experimental:1
stock_LLY r_up	heart:2 less:1 allege:1 its:1 unit:1 improperly:1 information:1 said:1 additional:1 lawsuits:1 two:1 treat:1 has:1 heart-failure:1 patients:2 whistleblower:1 but:1 failure:2 approved:1 aggressively:2 prosecutors:1 --:1 alleging:1 joined:1 drug:3 severe:2 2001:1 promoted:2
stock_LLY r_down	19:1 sepsis:1 settlements:2 number:1 setback:1 high:1 bring:1 rate:1 doubled:1 another:1 aggressive:1 makers:1 market:2 encouraged:1 litigation:1 these:1 copycat:1 said:1 patent:1 trials:1 there:1 its:2 increase:1 their:4 clinical:1 potentially:1 new:1 has:2 more:1 development:1 spiked:1 them:1 good:1 get:1 debate:1 but:1 suffering:1 lucrative:1 related:1 coming:1 amp:2 despite:1 2008:1 advanced:1 stage:1 challenges:2 branded:1 success:2 versions:1 --:2 involved:1 companies:3 drug:4 enjoying:1 benefit:1 continue:1 products:1 whether:1 push:1 efforts:2 discontinued:1 generic:3
stock_LLY r_down	advisory:1 said:1 weighing:1 leading:1 s:2 barring:1 8217:2 made:1 cardiologist:1 drug:1 panel:1 meeting:1 potential:1 mistake:1
stock_LLY r_up	scheduled:1 all:1 everyone:1 besides:1 companies:3 national:1 health-care:1 ``:4 product:1 mistake:1 cardiologist:2 names:1 have:1 year:1 need:1 controversial:1 '':4 said:1 end:1 pharma:1 federal:1 decent:1 anti-clotting:1 field:1 much:2 candidates:1 pretty:1 money:1 has:1 leader:1 development:1 prized:1 which:1 offer:1 may:1 big:2 recommend:1 else:1 regulators:1 sheets:1 not:1 news:1 approval:1 those:1 panel:1 desperately:1 financing:1 made:1 like:1 amp:2 --:2 biotechs:1 could:1 well:1 up:2 drug:2 whether:1 bad:1 leading:1 biotechnology:2 participate:1 balance:1 partnerships:1
stock_LLY r_down	detailed:1 founder:1 sentence:1 focus:2 60:1 accused:1 year:1 probation:1 children:1 improperly:1 said:1 $:2 granted:1 long:1 outside:1 provides:1 prison:2 he:1 strength:1 higher:3 his:3 led:1 plans:1 advance:1 marketing:1 completed:1 free:1 released:1 lift:1 antidepressants:1 judge:2 stocks:1 ruled:1 restrictions:1 last:2 --:1 could:1 months:1 request:1 officer:1 banks:1 served:1 notifies:1 order:1 5,000:2 travel:3
stock_LLY r_down	's:1 raise:1 would:1 business:1 shift:1 subsidies:1 budget:1 taxes:1 nation:1 increase:1 regulation:1 dramatic:1 capital:1 ax:1 toward:1 corporate:1 view:1
stock_LLY r_down	point:1 some:1 sales:1 8217:2 one:1 its:1 even:1 documents:1 show:1 had:1 cause:1 tell:1 though:1 psychiatric:1 link:1 doctors:1 such:1 diabetes:1 physician:1 did:1 drug:1 n't:1 s:2 individuals:1
stock_LLY r_down	s:2 8217:2
stock_LLY r_down	all:1 point:1 moved:1 one:1 broader:2 follow:1 its:1 market:2 pharmaceutical:1 since:1 negative:1 makers:1 delay:2 state:1 lured:1 tumbles:2 's:1 economy:1 lowest:1 hit:1 retrench:2 rebound:1 after:1 early:1 somewhat:1 stocks:4 day:1 reaction:1 1997:1 losses:1 drug:2 testimony:1 were:1 higher:1 south:1
stock_LLY r_up	body:1 named:1 committee:2 move:1 8217:2 disappointing:1 his:1 broader:3 rally:2 market:3 ground:1 giant:1 two:1 strategy:1 details:1 executive:2 newly:1 several:1 duties:1 more:2 week:1 ``:1 formed:1 gains:1 sessions:1 company:2 earlier:1 falls:2 promoted:1 president:1 stocks:3 him:1 '':1 --:1 amid:1 chairman:1 board:1 drug:1 s:2 allow:1 time:1 following:1 senior:1 higher:1 changes:1 spend:1
stock_LLY r_down	retracts:1 sales:1 warns:1 expects:2 quarters:1 '':2 rate:1 good:1 trading:2 elevated:1 broader:2 year:1 next:1 investment:1 declined:1 bankruptcy:2 pharmaceutical:1 fails:1 said:3 $:1 million:3 few:1 profit:2 rose:1 detail:1 comments:1 grow:1 failed:1 market:2 new:3 net:1 2007:1 low:1 ``:2 after:2 company:3 measures:2 possible:2 but:1 results:1 driven:1 reported:1 rise:1 fell:1 announce:2 background:1 fall:3 rollout:1 28.2:1 stocks:4 analyst:1 drugmaker:1 lower-than-expected:1 last:1 products:1 launch:1 stimulus:2 warned:1 double-digit:1 drug:1 --:1 range:1 continue:2 '08:2 afternoon:2 amid:1 through:1 2008:1 2009:4 33:2
stock_LLY r_up	executive:1 demand:1 drop:1 's:2 business:1 revenue:1 --:1 automotive:1 industry:1 despite:1 consumer:1 company:1 chief:1 said:1 cars:1 advertising:1 rose:1 2008:3 steep:1 its:1
stock_LLY r_down	shed:1 tap:1 health-care:1 according:1 have:1 year:1 plan:1 piling:1 pharmaceutical:2 said:2 $:7 million:2 reform:1 ways:1 morning:1 costs:1 take:1 year-ago:1 9:1 performance:1 markets:1 capital:1 expiring:1 surges:2 made:1 bonus:2 company:2 pushing:1 efficiency:1 were:1 levels:1 megamergers:1 issuance:3 they:1 spree:1 month:1 potential:1 salary:1 received:2 amid:1 look:1 pressure:1 boost:1 industry:1 1.34:1 companies:2 up:2 drug:3 times:1 part:1 patents:1 healthcare:1 under:1 2008:5 traded:1 filing:1 acquisition:1 bond:3
stock_LLY r_up	seven:1 smaller:1 broader:3 investors:1 less:1 30s:1 turned:1 site:1 replace:1 questions:1 single:1 embrace:1 dropped:1 have:2 during:1 rally:3 next:1 makers:1 market:3 1:1 shareholders:1 $:3 profit:1 treat:1 review:1 drive:1 proposed:1 two:3 hedge-fund:1 fates:1 their:1 bailout:1 board:1 stepped:1 has:1 meeting:1 company:1 discuss:1 stock:1 notice:1 's:7 government:1 drugs:1 funds:1 price:1 landscape:1 consolidation:1 campaigns:1 drug:1 2:2 key:1 news:1 injection:1 stocks:3 recipient:1 than:1 raising:1 panel:1 digits:1 posted:1 --:2 industry:1 months:2 companies:1 up:1 begun:1 month:1 diabetes:1 47:2 tablets:1 2009:1 first:1
stock_LLY r_up	biotech:1 right:1 's:1 ability:1 --:1 demonstrates:1 price:1 tag:1 assets:1 leverage:1 downtrodden:1 buyer:1 especially:1 otherwise:1 market:1 higher:1
stock_LLY r_up	biotech:2 right:1 prompt:1 hoping:1 investors:1 can:1 remaking:1 insight:1 downplays:1 sales:1 competition:1 up:1 disappointing:1 buyer:1 likely:1 tag:1 hypertension:1 drug:3 seen:1 need:1 recently:1 especially:1 face:1 its:3 market:3 before:1 even:1 confidence:1 compared:1 downtrodden:1 leverage:1 remains:1 demonstrates:1 higher:1 slapped:1 accelerate:1 time:1 deal:1 additional:1 relatively:1 boost:1 pill:1 more:1 acquisitions:1 continues:1 's:7 ability:1 hefty:1 price:1 after:1 but:1 otherwise:1 often:1 domination:1 wrist:1 effects:1 if:1 others:1 known:1 article:1 valuation:1 condition:1 diabetes:1 treating:2 pancreatic:1 fatal:1 rare:1 assets:1 getting:1 --:2 industry:1 launch:1 itself:1 heat:1 analysis:1 side:1 large:1 regaining:1 risks:1 published:2 health-care:1 stock:1 changes:1 maker:2 battered:1
stock_LLY r_up	sector:3 biotech:2 version:1 1.2:1 can:1 into:2 move:2 wrist:1 sales:1 0.7:1 slapped:1 disappointing:1 regulatory:1 hypertension:2 drug:2 year:1 edged:1 side:1 its:2 market:2 comments:1 compared:1 plays:2 positive:2 domination:1 while:1 shares:2 winning:1 accelerate:1 their:2 much:1 recently:1 territory:2 0.3:1 higher:2 gaining:1 product:1 testing:1 's:8 gains:1 hoping:1 end:1 inhaled:1 delayed:1 early:1 extending:1 modest:1 fell:1 wake:1 effects:1 others:1 remarks:2 approval:1 article:1 stocks:2 appears:1 advanced:1 treating:1 10:1 made:1 off:2 last:1 launch:1 --:1 broad-based:2 could:1 later:1 up:1 outpace:1 pill:1 recession:1 more:1 chief:3 four-session:1 week:1 streak:1 allow:1 rose:1 action:1 known:1 drugmakers:1 makes:1 maker:1 paced:1 published:1
stock_LLY r_up	streak:1 1.5:1 0.2:1 moved:1 0.4:1 trading:1 year:1 end:1 $:2 rose:1 chief:1 comments:1 winning:1 3:2 500:2 higher:1 week:1 edged:1 gains:2 early:1 extending:1 four-session:1 wake:1 stocks:1 sides:1 advanced:1 both:1 made:2 last:1 could:1 later:1 up:1 recession:1 while:1
stock_LLY r_up	stocks:3 ahead:1 76:2 biotechs:1 make:1 8217:2 economy:1 renewed:1 trading:2 market:1 broader:1 declines:1 mixed:3 strength:1 moves:1 meeting:1 showing:1 midday:3 conclusion:1
stock_LLY r_down	institutional:1 mainly:1 resistance:2 years:1 four:2 brain:1 including:1 its:2 giant:2 asthma:1 $:1 4:4 fatal:1 diseases:1 combination:2 focus:2 press:1 condition:1 --:2 list:2 identified:1 calling:2 yields:1 release:1 flagged:1 says:2 companies:4 elderly:1 schizophrenia:1 thinks:1 out:3 research:2 version:1 provider:1 public:2 put:1 appears:1 improve:2 advance:1 acquiring:1 ahead:1 many:1 could:2 drug:2 range:1 a.m.:1 published:1 efforts:1 changes:2 experimental:1 one:1 would:1 area:1 three:1 governance:2 returns:2 dozens:1 treatment:1 ``:2 drugs:1 corrected:1 strikes:1 167:1 he:1 target:1 below:1 more:1 called:1 medical-technology:1 '':2 if:1 health-related:1 also:1 other:1 largest:2 performance:2 poor:2 's:5 most:1 important:1 shareholder:1 billion:1 land:1 assets:1 proud:1 disease:1 pension:2 latest:1
stock_LLY r_up	among:1 version:1 mainly:2 elderly:2 years:2 brain:2 schizophrenia:2 broader:2 amp:2 thinks:2 market:2 ground:1 has:1 said:1 asthma:2 would:2 area:2 generic:1 research:4 fatal:2 winners:1 treatment:2 biggest:1 dozens:2 final:1 more:2 's:11 diseases:2 received:1 drugs:2 strikes:2 falls:2 most:2 important:2 if:2 gain:3 article:1 approval:1 stocks:3 condition:2 he:2 advance:2 land:2 acquiring:2 target:2 ahead:2 --:5 many:2 proud:2 disease:2 range:2 yields:2 published:1 efforts:2 experimental:2
stock_LLY r_up	join:2 help:1 government:1 have:1 reacts:1 debts:1 system:1 financial:1 stifled:1 plan:1 broader:3 toxic:1 rally:3 rid:1 stocks:3 's:1 lending:1 market:3
stock_LLY r_down	gaining:2 moves:1 's:2 banking:1 include:1 trading:1 significant:1 biggest:2 making:1 stocks:3 declining:2
stock_LLY r_up	gaining:2 among:1 moves:1 's:3 lead:2 biotech:2 north:2 notable:1 shares:2 front:1 market:1 pack:1 those:1 were:1 biggest:2 making:1 advance:1 stocks:3 declining:2 stock:1
stock_LLY r_down	heart:1 sales:1 billions:2 jump:1 see:1 have:1 if:1 asthma:1 jobless:1 would:1 federal:1 anniversary:1 next:1 better:1 their:1 other:1 treat:1 which:1 under:1 expected:1 new:1 out:1 conditions:1 events:1 summit:1 's:1 attend:1 government:2 drugs:1 arthritis:1 20:1 cutting:1 they:1 progress:1 report:1 8.5:1 debt:1 loans:1 than:1 received:1 --:1 dollars:2 register:1 proposals:1 up:1 heads:1 costs:1 addition:1 're:1 overseas:1 rate:1 options:1
stock_LLY r_down	sector:1 all:1 could:2 eventually:1 trend:3 move:1 discover:1 hearing:1 include:1 signed:1 broader:1 market:1 bankruptcy:1 result:1 respective:1 said:2 develop:1 $:2 300:1 shares:2 looking:1 their:1 much:1 treat:1 which:1 cardiovascular:1 new:1 developers:1 higher:1 gaining:1 billion:1 million:1 's:1 filings:1 drugs:1 auto:1 after:1 break:2 fell:1 plan:1 key:1 milestone:1 regulatory:1 news:1 now:1 surged:1 potential:1 diabetes:1 acquisitions:1 stocks:1 has:2 15:1 ahead:1 --:1 industry:1 up:1 drug:3 pact:1 products:1 payments:1 downward:2 drugmakers:2 maker:1 diseases:1
stock_LLY r_up	sector:2 shot:1 just:1 being:1 developed:2 over:1 raised:1 trade:1 session:1 shares:4 high-profile:1 its:4 previous:1 thyroid:1 whose:1 proposed:1 candidate:2 title:1 thinking:1 much:1 sugar:1 interested:1 cardiologists:1 has:1 presentation:2 pill:1 long-acting:1 big:1 results:1 early:1 2:1 therapy:1 they:1 during:1 now:1 advanced:1 loss:1 17:1 --:3 companies:1 $:1 superiority:1 medications:1 each:1 small:1 two:2 weight:1 positioned:1 up:4 see:1 trading:1 edged:1 event:1 said:1 lead:2 comments:1 version:1 new:1 cardiovascular:1 ends:1 recently:1 cholesterol:1 forgive:1 reported:1 active:1 declining:2 takes:1 hearing:1 benefits:1 ahead:1 study:4 climbed:1 drug:6 trial:2 leading:1 studies:2 seeing:1 major:1 cancer:1 number:1 one:2 60:1 diabetics:1 been:1 conference:1 additional:1 positive:2 three:1 least:1 traction:1 clinical:3 low:1 biggest:2 type:2 more:3 suggested:1 ``:1 drugs:1 company:1 but:1 released:1 controlling:1 gain:1 doctors:1 surged:1 than:2 shoot:1 helped:1 12:1 word:1 showed:3 rate:1 patients:1 can:1 were:1 0.9:1 heart:2 gathering:1 moved:1 sales:1 0.7:1 '':1 have:1 partner:1 blockbuster:1 saw:1 information:1 different:1 concerns:1 which:1 instead:1 gaining:2 product:1 's:6 after:1 levels:1 eight:1 blood:1 stocks:4 data:1 diabetes:6 acquisitions:1 effective:1 oral:1 points:1 starting:1
stock_LLY r_up	sector:1 glucose:1 says:1 version:1 trend:2 control:1 over:1 manage:1 trading:1 doses:1 weekly:1 its:1 best:1 before:1 superior:1 medications:2 score:1 two:2 comments:1 class:1 much:1 diabetes:3 red:1 afternoon:1 's:3 gains:2 company:1 after:1 early:1 reported:1 modest:1 compared:1 therapy:1 languishes:1 bulk:1 surged:1 potential:1 additional:1 settling:1 buck:2 has:1 showed:1 19:1 rival:1 study:1 maximum:1 drug:2 --:1 analysts:1 injectable:2 downward:2 more:1 oral:2 once:1
stock_LLY r_down	seeing:1 advisory:1 trade:1 session:1 trading:1 raises:1 whose:1 two:1 shares:1 late:1 biggest:2 diabetes:1 red:1 gaining:2 hurdles:2 's:2 drugs:1 after:1 flag:1 key:1 active:1 stocks:5 declining:2 panel:1 companies:1 drug:2 morning:2 slide:1 weigh:2
stock_LLY r_down	risk:1 help:1 investors:1 doing:1 connection:1 churning:1 health-care:1 share:1 disease:1 '':1 n't:5 1.7:1 rule:1 have:1 year:1 seen:1 still:1 makers:1 market:2 out:2 considering:1 large:1 cancer:1 cut:1 competitor:1 $:2 trials:1 biosimilars:1 contributed:1 two:1 research:1 their:1 outside:2 clinical:1 which:1 under:1 policy:1 new:1 concern:1 into:1 announced:1 week:1 exploring:1 ``:1 million:1 's:2 plans:1 get:1 drugs:1 company:1 325:1 kind:1 but:1 treatments:1 director:1 pressure:1 said:2 value:1 losing:1 future:1 potential:1 diabetes:1 billion:1 conglomerate:1 financing:1 last:2 fund:1 receive:1 companies:1 up:1 drug:2 deals:1 --:2 while:1 costs:1 so:1 does:2 thyroid:1 did:1 efforts:1 similar:1 its:1 experimental:1
stock_LLY r_up	major:1 results:1 economic:1 blockbuster:1 seek:1 patent:1 potential:1 which:1 expected:1 announced:1 giants:1 turmoil:1 increased:1 undergoing:1 government:1 drugs:1 consolidation:1 looming:1 wave:1 pressure:1 prices:1 during:1 come:1 lower:1 amid:1 industry:2 counter:1 drug:1 deals:2 expiration:1 mixed:1 quarter:1 trio:1 first:1
stock_LLY r_up	they:1 back:1 down:1 prices:1 say:1 economic:1 expect:1 flush:1 midsize:1 hospitals:1 pharmaceutical:1 rumors:1 going:1 health:1 board:1 care:1 sent:1 uptick:1 shopping:1 slump:1 but:1 pressure:1 step:1 demanding:1 letter:1 despite:1 not:1 raising:1 he:1 acquisitions:1 companies:3 cash:1 drug:1 costs:1 're:1 small:1 rein:1 executives:1
stock_LLY r_up	consulting:1 food:1 travel:1 compensation:1 expenses:1 gifts:1 state:1 speaker:1 fees:1 including:1
stock_LLY r_up	cancer:1 sales:3 trade:1 active:1 see:1 session:1 lung:1 first-quarter:1 its:2 out:1 whose:1 due:1 shares:1 rolls:1 earnings:3 expected:4 higher:3 's:1 focus:2 early:1 part:1 treatment:1 report:3 post:1 strong:1 companies:1 antidepressant:1 growth:1
stock_LLY r_down	less:1 issued:1 over:3 shaky:1 dollar:1 results:1 month:1 prices:1 paper:1 looks:1 broader:1 its:5 impact:1 busy:1 23:4 rose:2 headed:1 institution:1 better:1 other:1 quarterly:1 lending:1 gains:1 focus:2 far:1 rise:2 anticipated:1 fall:2 not:1 amp:1 bit:1 investor:1 bank:1 drugmaker:1 like:1 drop:2 morning:1 worries:1 finishing:1 stock:5 better-than-expected:1 says:1 prompted:1 deal:1 back:1 competition:1 result:3 table:2 first-quarter:1 margins:1 out:1 flee:2 gross:1 said:1 unsettling:1 profit:2 opening:1 forecast:3 increase:1 activist:1 various:1 consecutive:1 net:5 announced:1 earlier:1 terms:1 exchange:1 sixth:1 reacts:1 maintains:2 continuing:1 reported:1 tripled:1 ratios:1 others:1 news:1 futures:4 suggested:1 engage:1 last:2 credit-card:1 taking:2 losses:1 flurry:2 reports:2 foreign:1 credit:1 figures:2 mixed:1 first:1 major:1 benefited:1 revenue:4 into:3 negative:2 down:1 least:1 another:1 financial:2 actually:1 market:2 use:1 system:1 been:2 few:1 territory:2 markets:1 500:1 more:2 buy:1 releases:1 becomes:1 company:2 but:5 kicks:1 than:2 posted:1 10:1 look:1 bits:1 while:1 future:1 ongoing:1 were:2 acquisition:1 bell:1 months:1 slip:1 investors:1 sales:2 warning:1 dropped:1 have:3 increased:1 run-up:2 generic:1 able:1 traders:2 concerns:1 earnings:4 income:3 stepped:1 worsening:1 higher:1 week:3 's:6 charge-offs:1 after:6 react:1 most:1 quarter:1 stocks:3 acquisitions:1 purchase:1 lower:2 off:3 assets:1 third:1 amid:1 many:1 stronger:1 maintain:1 profits:2 banks:1 2008:1 2009:1 came:1
stock_LLY r_up	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_LLY r_up	8220:2 because:1 years:1 market:1 conference:1 pharmaceutical:1 said:1 research:1 few:1 call:1 which:1 shared:1 economy:1 firm:1 8221:2 's:1 execs:1 than:1 thoughts:1 word:1 influential:1 could:1 50:1 contract:1 analysts:1 deterioration:1 time:1 more:2 video-on-demand:1 first:1
stock_LLY r_up	force:2 version:1 heavily:1 reduce:1 sales:2 drug:2 partner:1 further:1 blockbuster:1 its:2 lean:1 application:1 potential:1 treatment:2 new:1 more:1 200:2 's:1 plans:1 marketing:1 company:1 diabetes:2 submitted:1 35:1
stock_LLY r_down	medication:1 they:1 long-acting:1 new:1 their:1 approval:1 have:1 filed:1 regulatory:1 rally:3 news:1 filing:2 diabetes:1
stock_LLY r_up	heart:1 says:1 risk:1 study:1 medicine:1 anticlotting:1 attack:1 pills:1 popular:1 increases:1 mixing:1 new:1 heartburn:1 |:1
stock_LLY r_down	heart:2 medication:1 says:2 sign:1 trade:1 aiding:1 blockbuster:1 its:2 shown:2 rivals:1 generic:1 mounting:1 shares:1 better:3 pressures:1 earnings:1 more:1 branded:1 pill:1 shows:1 's:2 gains:2 company:1 rise:1 gain:1 competing:1 report:1 news:1 worked:1 stocks:3 than:4 prospects:1 effective:1 study:2 latest:1 drug:4 morning:1 trial:2 mixed:3 better-than-expected:1 late-stage:1
stock_LLY r_down	ultimately:1 said:1 industry:1 drug:1 speech:1 plan:1 innovation:1 before:1 could:1 he:1
stock_LLY r_up	slowing:1 growth:1 have:1 children:1 out:1 shareholders:1 advisers:1 support:1 fight:1 state:1 board:1 between:1 nominees:1 more:1 's:3 prescriptions:1 agencies:1 scrutiny:1 usage:1 part:1 proxy:1 come:1 drug:1 intensify:1 maker:1
stock_LLY r_up	disclosure:1 already:1 show:1 elderly:1 children:1 say:1 against:1 unapproved:1 further:1 go:1 lawyers:1 its:1 out:2 documents:2 antipsychotic:1 lawsuits:1 makers:1 promoting:1 's:4 plaintiff:1 uses:1 plan:1 they:1 doctors:1 front:1 attorneys:1 discussed:1 drug:4 compensation:1 continue:1 release:1 promotion:1 trickle:1 maker:1 executives:1
stock_LLY r_down	prevent:1 help:1 health-care:1 '':1 cuts:1 overhaul:1 system:1 controls:1 wo:1 main:1 ``:1 's:2 drugs:1 price:1 prices:1 aiming:1 effort:1 case:1 prescription:1 makes:1 industry:1 n't:2 problem:1 executives:1 steep:1 joining:1
stock_LLY r_up	says:1 driving:1 large:1 part:1 write-downs:1 upbeat:1 data:1
stock_LLY r_down	recess:1 certain:1 dose:1 animal-health:1 seats:1 should:1 open:1 its:3 before:1 sell:1 member:1 said:3 prasugrel:1 $:1 doctor:1 avoid:1 anti-clotting:1 two:1 41:1 looking:1 re-elected:1 won:1 board:3 which:1 order:1 meeting:1 gave:1 fight:1 's:3 any:1 stop:1 company:1 were:1 problems:1 early:1 takeover:1 no:1 key:1 review:1 chairman:1 investor:2 than:1 he:1 billion:1 lower:1 amid:1 assets:1 antitrust:1 involved:1 study:1 annual:1 drug:2 called:1 n't:1 indication:1 planned:1 defeat:1 following:1 more:1 studies:1 maker:1 acquisition:1 proxy:2
stock_LLY r_down	faced:1 pharmaceutical:1 generic:1 bar:1 drugs:1 --:1 legislation:1 support:1 settlements:1 grilling:1 delay:1 patent:1 lawmakers:1
stock_LLY r_up	all:1 adults:3 proposed:1 being:1 ages:1 ninth:1 '':2 schizophrenia:4 carry:3 children:6 staff:2 considering:1 information:1 use:1 said:3 additional:1 disorders:3 agency:1 they:1 three:3 bipolar:5 treat:5 ``:2 's:7 drugs:3 but:3 applications:1 significant:3 approved:3 treating:3 10:1 17:1 effective:3 considered:1 disorder:5 --:2 indication:1 risks:3 were:3 adolescents:4
stock_LLY r_down	proposed:1 show:1 session:3 7.6:1 whose:3 21:1 better:1 97:1 has:1 combination:1 showing:1 lost:5 --:2 follows:1 companies:3 14.8:1 fewer:1 sliding:1 higher:1 weight:1 second:1 actively:3 trading:3 makers:1 even:1 shares:3 p.m.:1 looking:1 version:2 correct:1 available:1 jobs:1 article:1 100:1 last:1 study:2 annual:1 according:1 drug:4 fell:6 published:2 traded:1 first:1 point:1 period:1 down:1 reducing:1 conference:1 story:1 been:1 too:1 diabetes:4 500:4 glucose:1 ``:1 released:2 finished:1 controlling:1 prices:1 than:1 those:1 patients:2 were:3 taking:2 1.4:2 1.6:1 months:1 1.3:3 '':1 dropped:2 rally:1 sharp:1 any:1 compared:1 recovery:1 traders:1 also:1 economy:1 9:1 stock:1 week:1 closer:1 's:9 levels:1 eight:1 blood:1 70:1 stocks:4 data:1 recent:1 lower:1 off:1 older:2 futures:3 points:6 latest:1
stock_LLY r_down	proposed:2 filed:2 allegations:2 results:1 ended:1 session:1 its:1 whose:1 opportunities:2 better:2 treatment:2 has:1 complaint:2 amended:2 seeking:2 wave:1 suffering:1 every:1 nearly:1 affect:2 now:2 loss:1 --:3 medicines:1 companies:1 after-hours:1 weight:1 actively:1 trading:1 measure:1 substantially:2 federal:2 shares:1 7:1 new:1 journal:2 lawsuit:2 improve:1 gained:1 advance:2 study:1 according:2 drug:1 fell:1 published:2 mixed:1 comment:1 point:2 within:2 millions:1 conference:1 proceed:2 data:1 been:1 2:3 alleges:1 type:1 500:1 glucose:2 successful:1 company:4 but:1 controlling:2 doctors:1 promote:1 showed:1 patients:2 nine:2 policies:2 promising:2 plaintiffs:2 employees:2 control:1 equal:2 dropped:1 allege:1 denying:2 compared:2 against:4 pay:2 class-action:2 1:2 drugs:2 status:2 's:9 most:1 levels:1 blood:2 stocks:1 weekend:2 class:1 diabetes:6 medical:2 points:1 opportunity:2
stock_LLY r_up	biotech:1 plus:1 adults:1 betting:1 both:1 ages:2 '':1 schizophrenia:3 growth:1 fewer:1 appealing:1 tend:1 children:1 market:1 parent:1 said:1 $:1 make:1 due:1 forecast:1 targets:1 few:1 bipolar:2 2:1 treat:3 basic:1 expected:1 new:3 effectiveness:1 markets:1 into:1 more:1 criteria:1 ``:1 's:4 than:2 seeking:1 approvals:1 company:1 safe:1 expansion:1 its:1 takeover:1 uses:1 nowhere:1 regulatory:2 approval:1 approved:1 panel:1 billion:1 10:1 13:1 made:1 17:2 effective:1 --:1 adolescents:2 annual:1 companies:1 drive:1 drug:2 antidepressant:1 near:1 future:2 2006:1 meet:1 skepticism:1 clearance:1 disorder:2 maker:1 peak:1
stock_LLY r_up	biotech:1 shot:1 committee:1 advisory:1 actions:1 backed:1 schizophrenia:1 broader:1 positive:1 market:1 use:1 group:1 $:1 candidate:1 leading:1 charge:1 shares:1 its:1 also:1 3:1 2:1 various:1 treat:1 clinical:1 more:1 's:4 gains:1 company:1 took:1 early:1 reported:1 nearly:1 known:1 20:1 stocks:1 data:1 than:1 advanced:1 panel:1 rallied:1 lupus:1 made:1 bipolar:1 disorder:1 climbed:1 children:1 up:1 drug:1 equities:1 adolescents:1
stock_LLY r_down	early:1 lupus:1 group:1 stands:1 candidate:1 advance:1 positive:1 drug:3 data:1 leads:2 biotech:1 pack:1 therapy:1 rallying:1 rally:2 stocks:3 out:1 stage:1
stock_LLY r_down	move:1 shares:1 broader:1 children:3 osteoporosis:1 death:3 $:3 should:2 premarket:1 include:1 collaborate:1 around:1 showing:2 stop:2 despite:2 world:1 association:1 --:1 medicines:1 companies:1 continue:1 found:1 disorder:1 people:1 discover:1 officials:1 trading:1 said:3 ways:1 comments:1 looking:1 enough:1 deficit:1 between:1 new:1 boost:1 attention:1 recently:1 decline:1 million:2 blockbusters:1 27:1 members:1 many:1 taking:3 30:1 funded:1 drug:1 comes:1 cancer:1 down:1 market:1 pharmaceutical:1 use:1 holdings:1 there:1 their:3 treat:3 recommends:1 pipelines:1 drugs:5 released:2 effort:1 former:1 11:1 versions:1 dangerous:1 n't:5 were:1 study:4 associated:2 1.2:1 health-care:1 evidence:1 sudden:3 have:1 partly:1 generic:1 take:1 which:2 's:2 may:2 medications:1 portal:1 such:1 diabetes:1 especially:1 amid:1 disease:1 researchers:1
stock_LLY r_up	physicians:1 all:1 's:2 $:3 get:1 company:1 reporting:1 start:1 5,000:1 payments:1 year:1 800,000:2 more:1
stock_LLY r_down	them:1 often:1 get:1 always:1 won’t:1 companies:1 ideas:1 up:1 try:1 only:1 anywhere:1 too:1 they:2 new:1 come:1 look:2
stock_LLY r_up	seniors:1 help:1 exposed:1 stronger:1 over:1 share:1 relative:1 year:1 need:1 market:1 pay:1 had:1 their:1 low:1 expected:1 dominate:1 shows:1 earnings:1 week:1 offering:1 far:1 dividends:1 free:2 most:1 but:1 prices:1 stocks:1 than:1 pact:1 past:1 industry:1 debut:1 flow:1 cash:2 decent:1 more:1
stock_LLY r_down	session:2 point:1 out:1 concern:1 trade:1 actively:2 trading:1 dropped:1 have:1 been:1 withdrawn:1 market:1 ground:1 whose:1 respective:1 painkiller:1 shares:1 1:1 their:1 recommended:1 points:5 safety:1 4:1 closed:1 9:1 main:1 500:2 's:1 lose:1 worries:2 regular:1 2:1 stocks:4 concerns:1 gained:2 lower:2 lost:2 amid:1 medical:1 companies:1 50:1 34:1 regulator:1 patients:1 fell:1 products:1 insulin:1 were:2 mixed:3 drugmakers:1 traded:1
stock_LLY r_down	use:1 just:1 cancer:1 drugs:1 into:1 months:1 question:1 called:1 prolong:1 patients:1 lives:1 published:1 article:1 widespread:1 weeks:1 expensive:1
stock_LLY r_down	limited:1 benefits:1 $:1 drugs:1 developed:1 study:1 should:1 n't:1 say:1 cost:1 they:1 authors:1 new:1 more:1 20,000:1 than:1 if:1
stock_LLY r_down	billion:1 1.5:1 's:5 $:1 rights:1 drugs:1 seems:1 could:1 share:1 considering:1 amount:1 experimental:1 reasonable:1 big:1 small:1 payoff:1 bet:1 relatively:1
stock_LLY r_down	stock:1 prospect:1 major:1 weaker:1 cancer:3 caused:1 health-care:1 results:1 competition:1 years:1 four:1 economic:1 lung:3 result:1 year:1 rounds:1 market:2 pharmaceutical:1 woes:1 also:1 generic:1 six:1 due:1 approved:2 contract:1 spread:1 treatment:3 maintenance:2 under:1 expected:1 new:1 has:2 shrink:1 more:1 cutbacks:1 then:1 's:1 than:1 manufacturers:1 drugs:1 stop:1 company:1 continuing:1 expects:1 pressure:2 because:1 chemotherapy:1 prices:1 post:1 bringing:1 second-quarter:1 advanced:3 parts:1 whose:1 difficulty:1 --:1 tumors:1 uncertainty:1 companies:1 50:1 drug:2 other:1 patients:2 body:1 stopped:1 either:1 time:1 growing:1 first:3 treated:1 reform:1 pricing:1
stock_LLY r_down	contains:1 late-trading:1 removed:2 results:1 trade:2 carry:2 second:1 warning:2 operator:1 's:2 its:1 fifth:1 boxed:2 information:1 said:3 developed:1 raise:1 would:3 stronger:1 ingredient:1 agency:2 had:1 been:1 pills:2 late:2 risk:2 take:1 which:1 under:1 expected:1 additional:1 more:1 fatal:1 public:1 stock:2 rejected:2 pain:2 plans:1 offering:1 company:1 undisclosed:1 but:2 market:3 gain:2 known:2 month:1 active:1 than:2 common:1 has:1 calls:2 restaurant:1 movers:1 study:1 launch:1 posts:1 cash:1 years:1 --:2 amount:1 products:2 analysts:1 were:1 action:1 biotechnology:1 toughest:2 discussing:2 require:2 50:1
stock_LLY r_down	agreed:1 results:2 quotes:1 session:3 6.1:1 its:1 traders:2 giant:2 $:2 22:1 rose:5 equity:1 details:1 then:1 returned:1 advantage:1 get:2 updates:1 they:1 report:2 21.50:1 continued:2 day:2 offerings:1 lost:2 aluminum:2 --:1 companies:4 after-hours:3 stock:4 see:2 actively:3 trading:4 2.3:1 edged:1 2.7:1 declined:1 out:2 said:2 review:1 near:2 shares:5 looking:1 1.75:1 3:2 jobs:2 whose:3 drug:1 100:2 rut:2 gained:1 last:2 launch:1 35:1 prior:2 fell:3 slightly:1 point:1 down:1 reached:2 market:2 their:1 much:1 diabetes:1 markets:1 9.1:1 500:5 more:1 lowest:2 offering:1 but:1 wake:2 lows:2 11:1 12:1 16:1 up:2 while:1 economic:2 can:2 were:5 closing:1 885:1 1.9:1 two-month:2 disappointing:2 dropped:2 blockbuster:1 if:2 5.1:1 4.1:1 1:1 application:1 potential:1 take:1 higher:2 week:2 added:1 's:7 price:1 await:2 levels:2 stocks:5 recent:2 2:1 lower:1 futures:7 jitters:2 points:11 favorable:1
stock_LLY r_up	comment:1 thinner:1 shot:1 bleeding:2 blood-thinning:3 warning:2 carry:2 blockbuster:1 its:5 long-awaited:3 comments:1 label:2 marks:1 fatal:2 cause:2 can:2 's:4 becoming:1 blood:1 significant:2 doctors:2 strong:2 beginning:1 approved:3 has:1 6th:1 sometimes:2 drug:6 spokeswoman:1 while:1 prescribing:2 victory:3 time:1 first:1 executives:1
stock_LLY r_down	prescribing:1 's:4 bleeding:1 long-awaited:1 doctors:1 blood-thinning:1 label:1 drug:2 its:2 sometimes:1 fatal:1 warning:1 victory:1 significant:1 published:1 carry:1 article:1 strong:1 cause:1 approved:1 can:1
stock_LLY r_down	extend:1 product:1 says:1 showed:1 lead:2 certain:1 study:1 help:1 drug:2 patients:1 clinical:1 lives:1 can:1 lung:1 stocks:2 its:1 cancer:1 higher:2
stock_LLY r_up	says:1 's:2 help:1 gold:1 18:3 delays:1 filing:1 anti-clotting:1 drug:2 standard:1 current:1 companies:1 cost:1 could:1 disclosed:1 new:1 than:1 more:1
stock_LLY r_up	aided:1 prevent:1 gold:1 revenue:1 companies:1 betting:1 cost:1 's:3 touting:1 its:1 current:1 22:1 large:1 anti-clotting:1 than:2 increase:1 can:1 clinical:1 disclosed:1 new:1 insurers:1 premium:1 stock:1 product:1 multiple:1 ability:1 reaction:1 boosted:1 price:3 standard:1 updates:1 they:1 analyst:1 10:1 attacks:1 18:3 sclerosis:1 drug:2 heart:1 trial:1 patients:1 greatly:1 more:2 justify:1
stock_LLY r_down	prospect:1 some:1 buy:1 dilemma:1 investors:1 reform:1 companies:1 into:1 health-care:3 political:1 due:1 creates:1 concerns:1 operating:2 strong:1 growing:1 table:2 stocks:3
stock_LLY r_up	gained:1 whose:1 1.6:1 gene:1 1.1:1 1.2:1 wo:1 rose:2 medicines:1 climbed:1 companies:1 shares:1 n't:1 these:1 benefit:1 actively:1 trading:1 after-hours:1 stocks:1 500:1 session:1
stock_LLY r_up	upgrade:1 futures:6 office:1 up:2 lobbying:2 marginal:1 0.3:1 health-care:1 focus:2 trade:1 past:1 see:1 session:1 economy:2 's:3 message:2 awaiting:1 market:2 2.4:1 take:1 whose:1 6.5:1 overhaul:1 would:1 fell:1 rose:3 point:3 three:1 shares:1 quickly:2 increase:1 1:1 only:3 earnings:2 time:1 expected:1 curtain:1 struggling:1 curtail:1 warrant:2 applications:1 500:2 stock:2 head:1 move:2 edged:2 gains:2 enough:2 post:1 digesting:2 after:2 problems:1 but:2 choice:1 reported:1 host:2 inflation:2 moving:2 key:2 despite:1 active:1 budget:1 100:2 half:1 bank:2 recent:2 agency:1 organizations:1 lower:1 central:2 policy:2 industry:1 months:1 companies:2 drive:1 reports:2 34:1 patent:1 points:3 activity:1 tighter:2 were:1 higher:1 slightly:1 added:1
stock_LLY r_down	sector:3 operations:1 oncology:1 able:1 results:7 patent:1 including:2 seller:1 its:8 row:3 group:1 21:3 rose:2 had:1 outside:2 analyst:1 add:1 outlooks:1 treatment:2 has:2 drug:7 details:1 giants:1 hurting:1 gains:4 meanwhile:2 wave:3 early:1 updates:2 second-half:1 chips:3 bank:4 loss:1 like:1 drop:1 companies:2 morning:1 facing:1 raised:2 stock:7 cost-cutting:1 smaller:3 financial:2 posts:2 some:1 competition:2 trends:1 growth:1 trading:1 3.1:1 pain:2 margins:1 makers:2 declined:1 blue:3 reducing:1 lead:2 federal:1 shares:1 forecast:3 state:1 closed:1 between:1 new:1 poorly:2 numerous:1 available:1 marketing:1 continuing:1 bringing:1 reported:2 offset:1 news:1 100:1 $:4 faced:1 received:2 quarter:1 improved:1 launch:1 32:1 reports:2 costs:1 analysts:1 mixed:1 efforts:1 traded:2 comment:1 outlook:2 cancer:2 revenue:3 into:1 expectations:1 down:1 63:1 raises:3 narrowed:1 throughout:1 market:1 combines:1 off-label:1 8.4:1 positive:1 top:3 anti-clotting:1 negative:2 been:1 their:2 rates:1 biggest:1 territory:1 500:2 4:1 north:2 drugs:5 company:1 hurt:1 volume:1 favorable:1 prices:2 second-quarter:7 made:1 target:1 19:3 rival:4 edged:1 while:4 were:2 following:1 biotech:1 seven:3 weaker:1 challenging:1 1.2:1 share:1 sales:10 helped:2 currency:2 full-year:1 caution:3 dropped:3 sells:1 saw:1 increased:3 generic:2 generally:3 topped:1 also:1 other:1 earnings:7 which:1 several:1 higher:8 all:1 's:13 investigations:1 boosted:2 after:6 expirations:1 greeted:3 most:1 fell:4 uses:1 stocks:4 4.25:1 soared:1 diabetes:1 lower:6 amid:1 futures:11 steady:1 antidepressant:2 profit:7 points:5 time:1 2009:4 profits:2 latest:2
stock_LLY r_up	less:1 teetering:1 agreed:1 cuts:3 unfavorable:1 find:1 24:1 giant:1 $:5 continued:2 had:1 expectations:2 institution:1 late:1 treatment:1 details:1 increased:1 cheaper:1 know:1 background:1 bringing:1 impressive:1 --:2 companies:1 large:1 banking:1 each:1 higher:3 financial:1 deal:1 headwinds:1 competition:1 cost:3 second-quarter:2 2.1:1 makers:2 2.4:1 said:1 announces:1 exceeding:2 havoc:1 brink:1 access:1 never:1 weak:1 hours:1 reported:3 appears:1 faced:1 could:1 drug:2 products:2 context:1 makes:1 maker:1 comment:1 cancer:1 seems:1 rising:2 another:1 total:1 additional:1 top:3 system:1 quickly:1 their:1 rates:1 stock:1 more:1 buy:1 drugs:2 wake:1 prices:1 than:1 stabilized:1 16:1 cash:1 promising:1 toward:1 industry:2 acquisition:1 streak:2 give:1 share:1 sales:3 helped:3 itself:1 have:1 partner:1 information:1 recovery:1 generic:1 pay:1 earnings:3 you:1 economy:2 's:2 though:1 billion:2 purchase:1 transaction:1 roughly:1 savvy:1 its:1 profits:1
stock_LLY r_up	strengthened:1 unexpected:1 cancer:1 betting:1 bound:1 plummeting:1 unexpectedly:1 manager:1 send:1 have:1 year:2 portfolio:1 its:1 market:1 pharmaceutical:1 group:1 their:2 advisers:1 top:1 shares:3 pharmaceuticals:1 multibillion-dollar:1 reject:1 new:1 's:7 fourth:1 drugs:1 after:4 slump:2 landing:1 chemicals:1 introduce:1 mandate:1 authorities:1 approval:1 rejection:2 like:1 these:1 positions:1 industry:1 drop:1 companies:2 according:1 drug:2 benefit:1
stock_LLY r_up	``:1 's:3 23:1 follows:1 noon:1 corrected:1 drug:1 '':1 trial:1 version:1 published:1 phase:1 eighth:1 experimental:1
stock_LLY r_down	executive:1 results:1 helm:1 its:6 grappling:1 giant:1 $:1 bringing:1 expectations:1 analyst:1 lender:1 only:1 treatment:1 hit:1 beat:1 continues:1 updates:1 background:1 continued:1 secondary:1 progressive:1 excluding:1 --:4 did:1 activity:1 quarter:1 growth:1 trading:1 year:1 2.3:3 multiple:2 85:2 said:1 adds:3 lead:2 banking:1 profit:2 integration:1 comments:1 3:2 new:1 reported:2 succeed:1 last:1 pressure:1 items:1 study:1 drug:4 trial:1 context:1 discontinued:2 comment:2 revenue:2 primary:1 down:1 foreign-exchange:1 two-year:1 start:1 clinical:2 6:1 expected:1 plunge:1 company:2 former:1 second-quarter:1 endpoint:1 showed:1 plunged:1 n't:1 patients:1 were:1 meet:1 acquisition:1 biotech:2 delaying:1 share:1 sales:1 weighed:1 dropped:1 blockbuster:1 strength:1 generic:1 trials:2 detail:1 chairman:2 tapped:1 experienced:1 's:3 price:1 after:2 billion:1 stock-price:1 mortgage:1 sclerosis:2 disease:1 time:1 fresh:1 2009:2 effects:1
stock_LLY r_down	giant:1 valued:1 's:1 $:1 million:1 facilities:1 --:1 agreed:1 acquire:1 some:1 analysis:1 provide:1 contract:1 145:1 drug:1 under:1 services:1 genomic:1 related:1 five-year:1
stock_LLY r_up	proposed:1 '':1 schizophrenia:1 unanimously:1 would:1 bipolar:2 treat:1 statement:1 under:1 brand:1 ``:1 fourth:1 sold:1 safe:1 said:1 background:1 backed:1 beginning:1 panel:2 treating:1 name:1 effective:1 --:1 drug:1 which:1 disorder:2
stock_LLY r_down	all:1 civil:1 demand:1 attorney:1 general:1 '':1 itself:1 pricing:1 total:1 its:1 information:1 documents:2 20:1 $:1 disclosed:1 has:2 more:1 requested:1 ``:1 's:2 seeking:1 marketing:1 million:1 said:2 doctors:1 regulatory:1 than:1 posted:1 received:1 2009:1 rights:1 drug:2 maker:1 2000:1 payments:1 quarter:1 cooperating:1 filing:1 came:1 first:1
stock_LLY r_up	pouring:1 all:1 money:1 into:1 drug:1 doctors:1 insurers:1 makers:1
stock_LLY r_up	buyouts:1 said:1 's:1 ahead:1 offering:1 reduce:1 sales:2 restructuring:1 planned:1 force:1 effort:1 maker:1
stock_LLY r_down	transit:1 number:1 conference:1 pharmaceutical:2 sue:1 said:1 patent:1 positive:1 since:1 had:1 call:1 treatment:1 has:1 markets:1 giants:1 's:3 plans:1 drugs:1 company:1 stop:1 use:1 allowing:1 report:1 second-quarter:1 diabetes:1 developing:1 --:1 countries:1 generic:1 reception:1 following:1 launched:1 laws:1
stock_LLY r_down	lower:1 territory:1 join:1 lead:2 get:1 negative:1 drug:2 shares:1 market:1 broader:1 downgrade:1 stocks:3 dragged:1 south:2
stock_LLY r_down	division:1 sales:1 but:1 disappointing:1 reported:1 growth:1 half:1 resilient:1 eacute:3 its:1 first:1
stock_LLY r_up	pharmaceutical:1 all:1 30:1 off:1 almost:1 sold:1 health-care:1 investments:1 ended:1 biotechnology:1 quarter:1 its:1
stock_LLY r_down	often:1 valuable:1 wrong:1 too:1 tactic:1 pursuing:1 waste:1 resources:1
stock_LLY r_up	focus:2 ask:1 see:1 trading:1 want:1 osteoporosis:1 said:1 missed:1 awkward:1 trials:1 review:1 submit:1 clinical:1 expected:1 several:1 efficacy:1 wo:1 after:1 but:1 if:2 know:1 key:1 active:1 stocks:1 those:1 many:1 drug:1 n't:1 patients:1 can:1 endpoints:1
stock_LLY r_up	actively:1 whose:1 's:1 8.4:1 lost:1 fell:1 companies:1 37:1 declined:1 shares:1 points:3 3.8:1 dropped:1 trading:1 stocks:1 500:1
stock_LLY r_up	smaller:1 pointing:1 tumble:1 missed:1 secondary:1 trade:1 endpoints:1 actively:1 dropped:1 another:1 year:1 68:1 sharp:1 swung:1 its:1 osteoporosis:1 result:1 index:2 said:1 higher:2 8.4:1 lead:3 profit:1 continued:1 review:1 six:1 shares:3 than:1 business:1 their:1 add:1 biggest:1 surprise:1 weeks:1 posted:1 500:1 stock:1 available:1 fiscal:1 efficacy:1 earlier:1 's:1 string:1 first-quarter:1 opening:1 wo:1 rebound:1 after:1 improve:1 several:1 expected:1 modest:1 fell:3 submit:1 key:1 compound:1 prices:1 100:1 stocks:4 data:1 day:1 advanced:1 recent:1 session:1 lower:2 retail:1 15:1 whose:1 showed:1 charges:1 taking:2 futures:2 companies:1 drug:3 drugmaker:1 n't:3 trial:1 while:1 points:3 expenses:1 afternoon:1 -2:2 following:1 drops:1 latest:1
stock_LLY r_up	attorney:1 consider:1 agreed:1 general:1 accused:1 depression:1 improperly:1 said:1 $:3 pay:1 should:1 promoting:1 which:1 before:1 has:1 antidepressants:1 's:1 million:1 suffering:1 therapy:1 report:1 lawsuit:1 women:1 taking:1 settle:1 22.5:1 maker:1
stock_LLY r_up	point:1 session:2 trading:2 4.5:1 whose:2 actively:2 4.3:1 rose:2 shares:2 7:1 9:1 500:2 higher:2 's:2 increased:2 stocks:2 gained:2 57:1 companies:2 36:1 points:5 traded:2
stock_LLY r_up	comment:1 cents:2 high:1 trading:1 year-to-date:1 have:2 67:1 68:2 its:1 market:1 unusual:1 said:2 20:1 $:1 driving:1 shares:1 52-week:1 low:1 statement:1 policy:1 higher:1 sure:1 closed:1 normal:1 company:1 activity:1 but:1 volume:1 tripled:1 nearly:2 they:2 70:2 not:1 than:1 soared:1 11:1 past:1 12:1 --:1 months:1 up:1 daily:1 times:1 n't:1 more:1 were:2 fresh:1 stock:1
stock_LLY r_down	letters:1 session:1 being:1 '':1 actively:1 trading:1 lawyers:1 even:1 whose:1 shareholders:1 23:1 rose:1 shares:1 access:1 complex:1 arcane:1 judging:1 affecting:1 5:1 proposal:1 public:1 sent:1 higher:1 ``:1 's:3 proxy:1 2:1 stocks:1 change:1 gained:1 topic:1 traded:1 climbed:1 companies:2 rule:1 regulator:1 points:3 500:1 corporate:1 playing:1
stock_LLY r_up	``:1 follows:1 corrected:1 drug:1 p.m.:1 '':1 version:1 treat:1 published:1 approved:1 short-term:1
stock_LLY r_down	says:1 led:1 $:2 offering:1 spending:1 discounted:1 companies:1 off:1 new:1 20:2 --:2 growth:1 fending:1 '09:1 generics:1 half:1 report:1 during:1 co-pays:1 first:1
stock_LLY r_down	pills:1 do:2 thinner:1 risk:1 working:1 heart:1 --:1 heartburn:1 according:1 keep:1 n't:4 drugs:1 patients:1 blood:1 attack:1 new:1 put:1 such:1 higher:1 study:1 take:1
stock_LLY r_down	over:1 biotech:1 deal:1 agreed:1 soon:1 '':1 tender:1 drug:1 talks:2 exclusivity:1 moves:1 2.6:1 market:2 if:1 pharmaceutical:3 medications:2 end:1 $:1 matter:2 generic:1 improvement:1 finally:1 version:1 forward:1 stage:2 correct:1 ``:1 buy:3 's:2 plans:1 familiar:2 seventh:1 said:3 biologic:2 coming:2 come:1 potential:1 endless:1 billion:1 has:1 versions:2 --:2 follows:1 could:1 launch:1 start-up:1 days:1 biologics:1 final:2 person:2 amount:1 maker:3 allow:1 time:1 industry:1
stock_LLY r_up	help:2 reductions:1 focus:1 setback:2 years:1 four:1 cuts:2 speed:1 its:13 fifth:1 staff:1 cut:4 20:2 pharma:2 candidate:1 5,500:7 analyst:1 has:2 2010:1 staffing:1 updated:1 multibillion-dollar:1 big:2 sellers:1 next:1 5,000:3 nearly:4 half:1 2:6 continued:1 loss:1 companies:2 slide:1 become:1 difficult:1 heavy:2 preceded:1 force:3 exposed:1 series:1 reduce:2 competition:3 challenges:1 see:1 growth:1 pain:2 best:2 out:1 said:3 bottom:1 shares:1 research:1 current:1 decade:2 innovation:1 probably:1 announced:1 creating:1 jobs:3 ability:1 business:1 sixth:1 job:1 protection:1 operating:2 key:1 found:2 news:1 come:1 $:9 advance:2 patent:3 ahead:5 standalone:1 many:1 employees:3 losses:2 restructuring:1 drug:4 keep:1 trial:1 products:1 long-term:1 efforts:2 suitable:1 maker:1 revenue:1 into:1 revamp:3 two:1 down:1 reducing:1 pharmaceutical:1 eye:1 prepare:1 due:1 long:1 mark:1 confident:1 returns:1 clinical:1 way:1 expected:1 more:2 ``:1 elsewhere:1 reaction:1 drugs:2 some:1 company:1 slides:2 part:1 gain:1 line:1 effort:1 than:1 14:4 work:3 up:2 recession:1 remain:1 future:1 2013:1 headache:1 could:1 challenging:2 days:1 '':1 our:1 end:1 migraine:1 detail:1 1:1 which:3 becomes:1 units:1 ensure:1 several:1 brace:2 stock:1 development:1 's:3 plans:5 generic-drug:1 though:1 price:1 workforce:1 whittle:1 plan:1 stocks:3 eighth:1 structure:3 billion:1 short:1 industry:1 medical:1 face:2 generic:3 shore:1 costs:1 relief:2
stock_LLY r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_LLY r_up	year-end:1 have:1 number:1 quarters:1 down:1 reviewing:1 want:1 year:2 apply:1 during:2 targets:1 slow:1 agency:1 three:1 rushing:1 other:2 rates:1 crack:1 new:2 might:1 final:1 higher:1 lowest:1 them:1 's:1 any:1 drugs:1 applications:2 compared:1 regulatory:1 approval:2 than:1 made:1 --:1 months:1 companies:1 according:1 drug:1 these:1 receives:1 time:1 meet:1 first:1
stock_LLY r_down	among:1 oncology:1 trump:1 cancer:1 independent:1 provision:1 all:1 rate:1 colon:1 unless:1 beyond:1 its:1 conference:1 pharmaceutical:1 $:2 would:1 federal:1 data:1 state:2 disclosure:1 survival:1 division:1 's:5 company:1 reporting:1 key:1 law:1 weekend:1 10:2 --:1 requires:1 study:1 drug:1 patients:1 learn:1 starting:1 laws:1
stock_LLY r_up	examines:1 six:1 possible:1 potential:1 acquirers:1 targets:1
stock_LLY r_up	exclusive:1 cancer:1 acquired:1 certain:1 additional:1 reinforce:1 lung:1 aimed:1 our:1 progress:2 painkillers:1 said:4 $:1 candidate:1 pay:2 plans:2 anti-clotting:2 patients:1 analyst:2 2:1 health:2 details:1 new:2 has:1 sluggish:2 worldwide:1 ``:1 lived:1 's:8 finance:2 million:1 convincing:2 but:2 compared:1 five:1 effects:1 upfront:1 volumes:1 data:1 payment:1 advanced:1 appear:2 treating:1 reimbursement:1 placebo:1 prescription:1 showed:1 rights:1 late-stage:1 study:1 months:1 drug:6 maker:2 chief:2 9th:1 taking:1 making:2 view:1 side:1 latest:1
stock_LLY r_down	among:1 proved:1 significant:1 cancer:7 previously:1 results:1 according:1 rate:1 lived:4 colon:5 their:1 its:1 seemed:1 conference:1 pharmaceutical:3 compared:3 three:1 no:1 rose:1 detail:1 shares:3 improvement:1 failed:1 added:2 rates:2 details:1 which:1 chemotherapy:4 receiving:1 company:4 sent:1 shows:1 independent:3 earlier:1 's:2 said:1 survival:2 after:2 overall:1 treatments:1 standard:1 fell:1 whether:1 key:1 half:1 alone:1 one:1 data:2 day:1 those:1 improve:1 received:1 longer:3 showed:4 --:3 study:6 months:4 median:1 up:1 drug:3 n't:1 trial:1 patients:6 3.5:1 treatment:1 afternoon:1 rollercoaster:1 published:1 17:1 two:1
stock_LLY r_down	over:1 focus:2 rate:2 's:2 before:2 strength:1 patent:1 version:1 call:3 policy:1 dispute:3 interest-rate:1 modestly:1 used:1 led:1 company:1 rise:1 bone-drug:2 stocks:3 women:1 ahead:1 wins:3 up:2 drug:1 generic:1 banks:1 round:3 bone:1
stock_LLY r_down	control:1 pharmaceutical:1 shown:1 said:1 's:2 blood:1 efficient:1 sugar:1 company:1 drug:2 than:1 patients:1 clinical:1 been:1 diabetes:1 competing:1 improving:1 study:1 has:1 its:1 more:1
stock_LLY r_down	million:1 $:1 have:1 four-year:1 been:1 patients:1 cooperation:1 100:1 now:1 exercise:1 first:1
stock_LLY r_up	major:1 stake:1 proposed:1 companies:1 some:1 up:1 challenges:1 cutting:1 including:1 now:1 pipelines:1 makers:1 plans:1 pharmaceutical:1 given:1 fee:1 patent:2 holds:1 administration:1 also:1 5.1:1 costs:1 health:1 developer:1 increasing:1 supports:1 price:1 deals:1 earlier:1 's:1 expirations:1 government:1 big:1 atop:1 promising:1 weak:1 pressure:1 said:1 megamergers:1 quarters:1 response:1 buying:1 insurers:1 15:1 --:1 confront:1 bill:1 list:1 roughly:1 drug:3 facing:1 players:1 competitors:1 continue:1 hike:1 landmark:1 reigns:1 skepticism:1 changes:1 payoffs:1
stock_LLY r_up	major:2 proposed:1 process:1 administration:1 50:1 '':2 bring:1 likely:1 file:1 moves:1 clearly:1 if:1 fee:1 end:1 would:1 patent:2 support:1 legislation:2 compromise:1 details:1 which:1 forward:1 proposal:1 supports:1 ``:2 ball:1 's:1 said:2 letter:1 years:1 approved:1 15:1 --:1 hike:1 bill:1 roughly:1 landmark:1 changes:2 wrote:1 first:2
stock_LLY r_up	has:1 antipsychotic:1 tentative:1 improperly:1 caused:1 alleged:1 drug:1 state:1 which:1 promoted:1 reached:1 settlement:1 lawsuit:1 maker:1 diabetes:1
stock_LLY r_up	gained:1 whose:1 's:1 increased:1 session:1 rose:1 companies:1 shares:1 41:1 points:3 trading:1 actively:1 7:2 stocks:1 traded:1 500:1 higher:1
stock_LLY r_down	actively:1 whose:1 4.7:1 's:1 increased:1 mostly:1 point:1 fell:1 rose:1 companies:1 shares:1 after-hour:1 1:3 0.1:1 finished:1 points:2 trading:1 session:1 stocks:1 500:1 higher:1
stock_LLY r_up	saying:1 agreed:1 some:1 focus:1 quarters:1 decided:1 its:1 sell:1 ingredients:1 rather:1 surprises:2 advisories:2 earnings:1 cost-cutting:1 plant:1 expirations:1 drugs:1 goals:1 coming:1 than:1 change:1 roundup:1 purchase:1 amid:1 companies:1 reports:1 patent:1 future:1 biotechnology:1 corporate:1 latest:1
stock_LLY r_up	guidelines:1 familiar:1 lack:1 evidence:1 find:1 head-to-head:1
stock_LLY r_down	disclose:1 became:1 company:1 some:1 focus:2 shares:1 trade:1 active:1 see:1 session:1 drug:1 doctors:1 expected:1 payments:1 its:1 maker:1 those:1 latest:1
stock_LLY r_down	saying:1 emerging:1 developed:1 settlements:1 results:3 quarters:1 shares:1 cuts:1 years:1 year-earlier:3 its:9 issues:1 adding:1 $:1 surprises:2 revenue:1 had:2 than:1 advisories:2 black:1 treatment:1 premarket:1 enjoying:1 details:2 increased:2 continues:2 wave:2 early:1 increases:1 cutting:1 updates:1 background:1 focus:2 not:1 trade:1 day:2 retreat:1 lost:1 companies:1 lose:2 economy:2 successful:1 set:2 financial:2 trend:1 declines:2 competition:1 challenges:2 second:2 year:2 2.3:1 star:1 depression:1 said:1 profit:7 rose:1 legal:3 forecast:5 enough:1 new:1 jobs:1 risen:1 rolled:1 million:1 seventh:1 tripled:1 offset:1 come:2 antipsychotic:1 roundup:1 reaction:1 quarter:2 improved:2 recovering:1 drug:3 protection:1 graph:1 long-term:2 maker:2 comment:1 outlook:2 point:1 period:2 down:3 raises:2 throughout:1 swings:3 arsenal:1 best-selling:1 third-quarter:3 biggest:3 assessment:2 more:1 both:1 drugs:5 company:2 but:3 hurt:1 slides:2 lows:1 last:1 analyst:1 markets:2 straight:2 while:3 future:1 were:1 plunges:2 spotlight:1 sales:4 weighed:2 full-year:1 reports:1 have:2 swung:3 saw:1 returned:1 4.6:1 patent:1 other:1 lifts:1 earnings:4 fourth:1 several:1 roll:1 stock:3 topping:1 's:5 may:1 price:1 after:4 forecasts:1 most:3 coming:1 stocks:2 lower:2 third:1 charges:3 futures:2 stronger:1 face:2 generic:1 costs:1 2009:1 corporate:1 latest:2
stock_LLY r_up	million:1 giant:1 said:1 's:2 target:1 cancer:1 launch:1 price:1 work:1 estimates:1 $:1 drug:2 research:1 fund:1 venture-capital:1 closely:1 cuts:1 250:1 health-care:1 maker:1 more:1
stock_LLY r_up	says:1 weight:1 people:1 causes:1 dysfunction:1 said:1 generic:1 positive:1 adopted:1 treatment:1 has:1 's:1 psychiatrist:1 drugs:1 erectile:1 link:1 gain:1 --:1 could:1 ratiopharm:2 n't:1 opinion:1 taking:1
stock_LLY r_down	just:1 caused:1 children:1 medications:1 much:1 take:1 widely:1 new:1 weeks:1 used:1 's:3 drugs:1 after:1 average:1 gain:1 11:1 pounds:1 19:1 youths:1 according:1 deals:1 published:1 study:1
stock_LLY r_up	comment:1 seven:2 into:1 results:2 third-quarter:1 '':1 schizophrenia:1 reached:1 its:2 late:2 said:3 additional:2 analyst:1 profit:1 trials:2 detail:1 sugar:2 better:2 investigation:1 520:1 way:2 marks:2 net:1 diabetes:2 company:1 lowering:2 ``:1 rise:1 's:3 which:2 marketing:1 sold:2 million:1 possible:2 agreement:1 step:2 blood:2 approval:2 worked:2 than:2 stage:2 posted:1 has:3 22:1 --:2 rival:2 study:4 according:2 drug:8 $:1 settle:1 principle:1 underway:2 small:2 maker:1 experimental:2
stock_LLY r_down	over:2 fear:1 its:5 inquiries:1 $:3 candidate:1 23:1 whistle-blower:1 had:1 suits:1 production:1 disclosed:1 has:1 physicians:1 them:1 gains:2 government:1 psychiatric:1 early:1 day:3 drugmaker:1 --:1 settle:2 though:1 related:4 second:3 result:1 year:1 2.3:1 aggressive:1 said:2 federal:1 selected:1 shares:1 520:1 announced:2 marketing:5 million:1 agreement:1 here:2 reason:1 antipsychotic:1 received:1 industry:1 days:1 drug:4 turn:1 climb:1 maker:1 seems:1 into:1 one:2 likes:1 reached:1 pharmaceutical:1 story:3 stocks:3 would:1 positive:1 lawsuits:1 there:1 two:2 clinical:2 wrongdoing:1 stage:1 more:1 ``:1 mostly:1 drugs:1 company:1 than:1 case:1 these:1 three:1 called:1 1.4:1 painkiller:1 sales:1 evidence:1 '':1 slip:3 tam:1 blockbuster:1 documents:1 no:1 pay:1 seeking:1 also:1 other:1 's:3 investigations:2 paid:1 most:1 involving:1 authorities:1 off-label:1 data:1 promotion:1 diabetes:1 billion:2 charges:1 sale:1 practices:1 subpoena:1 trials:1 filing:1
stock_LLY r_down	comment:1 force:1 version:2 amid:2 series:1 cuts:1 reduce:1 40,000:2 '':2 reports:2 year:2 meltdown:1 throughout:1 news:1 makers:1 kidney:3 again:1 mutual:1 said:2 its:1 symbol:1 may:2 headlines:1 much:1 details:1 7:1 money:1 medicine:2 new:3 diabetes:2 issue:1 correct:2 announced:1 treatment:2 ``:2 his:1 's:5 stance:1 prevented:1 big:1 company:1 problems:2 story:1 fund:1 job:1 made:2 plan:1 scope:1 losing:1 during:1 ticker:1 approved:2 he:1 cautious:2 last:1 name:1 --:2 follows:2 work:1 label:2 drug:1 bad:1 p.m.:1 published:1 first:1 cause:2 latest:1
stock_LLY r_up	billion:1 's:4 $:1 industry:1 drug:1 its:1 1:1 into:1 plan:1 example:1 push:1 latest:1 spend:1 expand:1 center:1
stock_LLY r_up	says:1 help:1 cancer:2 some:1 sales:1 open:1 initial:1 remain:1 failed:1 treatment:1 boost:1 company:1 's:5 survival:1 overall:1 but:1 believe:1 data:1 former:1 advanced:1 improve:1 16,000:2 --:1 could:1 headquarters:1 drug:1 patients:1 study:1
stock_LLY r_up	'':2 cost:1 long:2 68:1 close:1 makers:1 issues:2 said:2 20:1 $:1 six:1 sites:1 post-merger:1 research:1 take:2 6:2 explains:1 ``:2 plans:1 digesting:1 company:1 consolidation:1 cutting:1 billion:1 resolve:2 rival:1 drug:1 takeover:1 time:2 its:3 round:1 latest:1
stock_LLY r_down	information:1 all:1 ads:1 --:1 ca:1 agency:1 expect:1 drug:1 sites:1 n't:1 risk:1 other:1 experts:1 advertising:1 specialists:1 present:1 told:1
stock_LLY r_up	interests:1 named:2 operation:1 resigned:1 technology:1 its:1 quit:1 said:2 lead:1 retiring:1 been:1 research:3 other:1 statement:1 has:3 announced:1 discovery:1 development:1 head:2 's:3 separate:1 former:1 successor:1 --:1 rival:1 joined:1 drug:1 pursue:1 science:1 maker:1
stock_LLY r_up	previously:1 owned:1 selling:1 investment:2 filings:1 investor:2 stake:1 which:1 new:3 his:2 interest:1 company:1 reporting:1 reported:2 regulatory:2 article:1 continued:1 he:1 --:2 30:3 companies:1 according:1 drug:1 while:1 published:1 biotechnology:1 filing:1 stakes:2
stock_LLY r_up	company’s:1 broader:2 positive:1 study:1 but:1 shares:1 jump:1 drug:1 clinical:1 market:2 slip:1 new:1 follow:2 stocks:3 south:2
stock_LLY r_down	executive:1 purposes:1 years:1 his:2 enhanced:1 technology:1 retirement:1 $:3 service:1 severance:1 retiring:1 benefit:2 research:1 2:1 disclosed:1 retire:1 's:1 company:1 million:1 early:1 said:1 despite:1 regulatory:1 president:1 payment:1 additional:1 10:1 benefits:1 full:1 vice:1 receive:2 science:1 eligible:1 cash:1 drug:1 filing:1 credit:1 chief:1 pension:3 maker:1
stock_LLY r_up	1,000:1 civil:1 health-care:2 's:2 fraud:1 makers:1 feared:1 pharmaceutical:1 overhaul:1 $:2 has:1 partly:1 rose:1 comfort:1 had:1 due:1 been:1 your:1 52-week:1 2:2 increasing:1 pending:1 executive:1 hit:1 wo:1 highs:1 involving:1 nearly:1 cases:1 stocks:1 investor:1 reading:1 drug:1 n't:1 compensation:1 afternoon:1
stock_LLY r_down	sector:1 gains:2 lost:1 rattle:2 showing:1 concern:1 drug:3 credit:1 jitters:2 trading:1 stock:1 broader:1 investors:1 stocks:2 crisis:1 market:1 ground:1
stock_LLY r_up	extended:2 's:2 --:2 collaboration:2 agreement:1 drug:1 years:1 said:2 5:2 drug-discovery:1 five:1 has:2 its:2 unit:2 discovery:1
stock_LLY r_up	comment:3 primary:3 endpoints:3 said:7 analyst:2 better:4 comparing:3 clinical:4 treatment:4 under:4 type:4 development:4 's:6 company:3 met:3 2:3 than:4 diabetes:7 treating:4 works:4 --:4 study:4 according:4 drug:6 patients:3 placebo:3 studies:3 taking:3 experimental:4
stock_LLY r_up	clamp:1 already:1 associated:1 weight:3 reviewers:1 push:1 teenagers:2 effects:1 companies:1 down:1 schizophrenia:1 its:1 impact:1 specific:1 use:1 said:4 antipsychotic:2 tablet:1 review:1 agency:2 two:1 should:1 also:1 bipolar:1 other:1 take:1 which:1 conduct:1 additional:1 include:1 more:2 wants:1 continues:1 's:4 risk:1 form:1 warnings:1 drugs:5 between:1 effect:1 but:1 warn:1 manic:1 increases:1 relationship:1 know:1 doctors:1 device:1 approved:2 diabetes:1 treating:1 younger:1 kids:1 look:1 --:1 medical:1 children:1 episodes:1 drug:2 n't:1 patients:1 common:1 mixed:1 disorder:1 side:2 gain:3
stock_LLY r_down	climbed:1 just:1 cancer:1 higher:1 22:1 years:1 rate:1 dropped:1 year:1 11,000:1 jobs:1 index:1 $:2 4.3:1 rose:1 there:1 two:1 next:1 smallest:1 rates:1 chairman:1 interest:1 6:1 speech:1 destruction:1 sent:1 stock:1 ceiling:1 added:1 's:1 closed:1 drugs:1 price:1 after:1 payroll:1 nonfarm:1 job:1 fell:2 nearly:1 news:1 100:1 stocks:1 raise:1 lower:1 38:1 lost:1 ahead:1 --:1 could:1 futures:3 21:1 points:6 500:2 were:1 30,000:2
stock_LLY r_down	bounce:2 years:1 likely:1 have:2 year:1 go:1 decline:1 now:1 end:1 would:1 rebounded:1 generally:1 been:1 their:1 only:1 interested:1 between:1 you:1 several:1 2010:2 modestly:1 lows:1 stocks:3 lower:1 many:1 list:1 can:2
stock_LLY r_up	all:1 being:2 over:1 labels:2 children:2 cardiovascular:1 impact:2 caveats:1 antipsychotic:2 going:1 board:1 violations:1 has:3 ...:1 payouts:1 big:1 possible:1 psychiatric:1 increases:1 effects:1 they:2 hedge:1 like:1 --:2 signal:1 companies:2 yield:1 deals:1 payments:1 cholesterol:1 side:1 glucose:1 weight:2 said:3 lead:1 2.39:1 its:1 activist:1 cause:1 can:2 disclose:1 dividends:1 pressure:1 dividend:2 beginning:1 could:3 drug:1 products:1 published:1 changes:1 asked:1 blood:2 among:1 named:1 article:1 considering:2 top:2 today:1 more:1 firm:1 manufacturers:2 drugs:3 warn:2 fund:1 gain:2 insider-trading:1 institution:1 official:2 up:1 n't:1 500:1 piece:1 biotech:1 strengthening:2 adults:2 division:1 ai:1 health-care:1 examined:1 have:1 information:1 compared:2 pay:1 agency:3 concerns:2 which:2 docs:1 nice:1 independent:1 's:2 after:1 problems:1 director:2 levels:1 72:1 device:1 such:1 data:1 diabetes:3 amid:2 average:1 stronger:2 points:1 time:1 push:1 usual:1 latest:1
stock_LLY r_down	saying:1 show:1 probe:1 trade:1 session:4 7.4:1 issues:1 weekly:1 whose:5 upgrade:1 rose:10 better:1 advisories:2 4:1 8:1 has:1 2010:4 2013:2 global:1 increased:2 continues:2 possible:1 after-hour:1 early:1 fall:1 anticipates:2 quarters:1 advanced:1 medicines:2 51:1 deals:1 6.4:1 stock:1 financial:2 broader:1 deal:2 companies:6 7.1:1 actively:4 trading:5 year:4 81:1 index:1 said:1 blue-chip:1 shares:6 forecast:3 future:1 various:2 7:1 new:2 across:1 component:1 active:1 news:1 100:1 declining:2 gained:2 ahead:1 most:1 could:1 climbed:2 reports:1 surprises:2 mixed:1 climb:3 traded:3 patents:2 seeing:1 economists:1 into:1 66:1 69:1 buoyed:1 decline:1 confidence:1 jobless:1 detailing:2 two:2 been:1 next:2 insider:1 growth:2 biggest:2 markets:1 500:4 more:2 roundup:1 ``:1 8.25:1 part:1 11:2 '':1 13:1 grew:1 14:1 launch:2 up:2 while:3 economic:1 expiration:2 growing:1 investigating:1 moved:2 helped:1 drug:2 5.1:1 agency:1 40:1 regions:1 earnings:1 several:1 higher:3 gaining:2 added:1 's:6 plans:2 after:1 looming:2 falls:2 action:1 75:1 stocks:10 data:1 starting:2 futures:3 points:18 claims:1 corporate:1 latest:1
stock_LLY r_down	outlook:1 own:1 just:1 ...:1 cents:1 share:1 down:1 trading:1 year:1 still:1 its:1 rely:1 $:1 lackluster:1 per:1 next:1 1:1 earnings:1 which:1 presentation:1 company:2 today:1 fairly:1 ``:2 plans:1 drugs:1 estimates:1 offered:1 midpoint:1 yesterday:1 investor:1 day:1 '':2 pipeline:1 off:1 meeting:1 37:1 forecast:1 morning:1 n't:2 sour:1 following:1 experimental:1
stock_LLY r_up	's:1 antipsychotic:1 docs:1 long-acting:1 becomes:1 approved:1 list:1 drug:1 maker:1 version:1 pays:1 blockbuster:1 its:1 today:1 latest:2
stock_LLY r_down	comment:1 raised:1 deal:1 backers:1 agreed:1 executive:1 share:1 major:1 into:1 partner:1 pharmaceutical:1 said:2 based:1 pharma:1 merger:1 leading:1 make:1 interference:2 attractive:1 platform:1 interested:1 details:1 which:1 big:1 fledgling:1 company:2 build:1 supported:1 's:2 some:1 bid:1 million:1 delivery:1 part:1 peer:1 technologies:2 combined:1 getting:1 --:1 science:1 medicines:1 companies:1 sale:1 merge:1 position:1 more:1 experimental:1
stock_LLY r_up	control:1 smaller:1 front-runner:1 presence:1 executive:1 some:1 results:1 one:1 '':1 likely:1 because:1 cementing:1 further:1 technology:1 its:2 n't:1 said:1 addition:1 quality:1 make:1 outstanding:1 increase:1 responsibilities:2 interested:1 role:1 under:1 new:1 include:1 more:1 ``:1 his:3 's:1 information:1 company:1 peers:1 here:1 pressure:1 leadership:1 but:1 during:1 strong:1 day:1 like:1 pipeline:1 has:1 acquiring:1 assets:1 --:1 expanded:1 drug:1 deals:1 career:1 chief:1 place:1 become:1 maker:1 pack:1
stock_LLY r_up	over:1 executive:1 trade:1 ended:1 interim:1 higher:2 broader:1 its:2 whose:2 27:1 $:5 rose:6 improvement:1 permanent:1 board:1 policy:1 has:1 ...:1 rise:1 therapy:1 front:1 world:1 bank:1 companies:2 morning:1 session:2 therapies:1 economy:1 heading:1 replacement:1 6.1:1 deal:3 some:1 actively:2 trading:1 87:1 special:1 lead:1 selected:1 shares:3 announced:1 slight:1 million:1 broker:1 possibility:1 monetary:1 news:1 100:1 strong:1 gained:3 last:1 receive:1 climbed:2 drug:1 climb:3 maker:1 carry:1 market:1 expected:1 markets:1 500:4 north:1 soar:1 company:2 seeks:1 99:1 stem-cell:1 hurt:1 90:1 11:1 10:1 13:1 19:1 work:1 up:3 signed:1 were:2 following:1 detailed:1 weaker:2 autoimmune:1 soars:2 cents:1 moved:1 0.4:1 high:1 reports:1 develop:1 retiring:1 43:1 41:1 1:1 concerns:1 5:3 chairman:1 online:1 9:1 stock:1 week:1 independent:1 product:1 continues:1 's:4 though:1 after:3 director:1 end:1 stocks:6 tighter:1 programs:1 futures:3 disease:1 chief:1 points:9 liquidity:1
stock_LLY r_down	saying:1 higher:1 executive:1 we:1 quarters:1 down:1 earnings:1 trading:1 reports:1 have:1 year:1 research:1 makers:1 85:1 whose:1 gradually:1 said:1 20:1 $:1 illegal:1 question:1 been:1 investment:1 preventing:1 their:1 advisories:2 economy:1 closed:1 late:1 expected:1 12:1 grew:1 ever:1 gained:1 fines:1 more:1 development:1 roundup:1 ``:1 's:2 rose:1 government:1 drugs:1 big:1 rebound:1 points:3 26:1 but:1 next:1 fell:1 active:1 future:1 than:1 billion:1 '':1 stocks:1 made:1 corporate:1 companies:2 up:1 drug:1 've:1 sensitive:1 chief:1 improves:1 500:1 shares:1 surprises:2 promotion:1 2009:1 slightly:1 latest:1
stock_LLY r_down	0.8:1 deal:3 cents:1 agreed:1 dollar:1 competitive:1 highly:1 result:1 83:1 tender:1 statin:1 pills:1 sell:2 giant:1 said:1 terms:1 21:1 puts:1 pay:1 sum:1 stake:1 had:1 off:1 shares:1 arm:1 field:1 treatment:1 which:1 completed:1 firm:1 ...:1 selling:1 's:4 food:1 company:1 after:1 undisclosed:1 took:1 jointly:1 public:1 baby:1 world:1 best-selling:1 $:1 prescription:1 statins:1 drug:1 maker:1 cholesterol:1 its:1 playing:1
stock_LLY r_up	videogame:1 tough:1 bottom:1 fishers:1 wary:1 but:1 times:1 should:1 has:1 fallen:1 maker:1
stock_LLY r_up	feedback:1 within:1 '':1 its:2 pharmaceutical:1 said:1 version:1 treatment:2 fourth:1 expected:1 weeks:1 formal:1 correct:1 ``:1 's:2 company:1 commercial:1 joint:1 worked:1 diabetes:1 regarding:1 launch:1 follows:1 exiting:1 venture:1
stock_LLY r_down	pharmaceutical:1 magnate:1 prolific:1 surviving:1 age:1 last:1 94:3 died:1
stock_LLY r_up	physicians:1 serving:1 's:1 boards:1 wo:1 n't:1 receive:1 allowed:1 corporate:1 stock:1
stock_LLY r_down	comment:1 advisory:1 another:1 rated:2 less:2 results:2 depressed:6 see:2 fibromyalgia:1 determine:2 wider:1 pain:3 depression:3 if:2 little:2 medications:2 group:2 treat:2 no:2 six:2 benefit:4 symptoms:2 also:1 treatment:2 which:2 new:2 has:1 meeting:1 patients:2 combined:2 product:1 's:1 severely:2 very:2 company:1 seventh:1 use:2 released:2 involving:3 doctors:2 approval:1 nerve:1 approved:1 those:2 panel:1 severe:4 chronic:1 most:2 --:3 disorder:1 seeking:1 according:2 analysis:2 antidepressant:3 canceled:1 receive:2 while:2 person:2 mildly:2 studies:2 researchers:2
stock_LLY r_up	biotech:1 doing:1 25:3 26:3 compared:1 pharma:1 area:1 agency:1 also:1 outside:1 call:1 too:1 expected:1 new:1 trend:1 several:2 store:1 more:1 may:1 business:1 though:1 drugs:3 reach:1 early:1 regulators:1 key:1 approved:3 shelves:1 --:1 medicines:1 companies:1 n't:1 did:1 were:1 2008:5 2009:6
stock_LLY r_down	little:1 's:1 longer:1 no:1 scrappy:1 manufacturers:1 think:1 competitors:1 generics:1 big:1 heels:1 correct:1 pharma:1
stock_LLY r_down	raised:1 expects:1 facilities:1 accelerate:1 prostate-cancer:1 partner:1 its:2 completion:1 given:1 said:1 leverage:1 comments:1 treatment:1 finding:1 has:1 conference:1 's:2 marketing:1 article:1 manufacturing:1 roundup:1 --:1 cash:2 came:1 published:1 quick:1 experimental:1
stock_LLY r_down	serving:1 antipsychotics:1 sales:1 one:1 '':1 nursing-home:1 millions:1 story:1 alleged:1 long:1 increase:1 largest:1 patients:1 ``:1 paid:1 homes:1 getting:1 nursing:1 dollars:1 thorny:1 kickbacks:1 pharmacies:1
stock_LLY r_up	converging:1 fourth-quarter:1 because:1 deal:1 process:1 laying:1 some:1 results:1 sign:1 see:1 have:2 soon:1 makers:1 market:1 streamlining:1 pharma:1 merger-related:1 also:1 patent:1 began:1 improvement:1 their:1 generics:1 thousands:1 economy:1 giants:1 's:1 big:1 continues:1 notable:1 expiry:1 most:1 demand:1 off:1 improved:1 cost-cutting:1 could:1 companies:1 up:1 drug:1 generic:1 competitors:1 products:1 socked:1 pick:1 shops:1 workers:1 talk:1 latest:1
stock_LLY r_down	sector:2 fourth-quarter:1 gaining:1 deal:1 voters:1 developed:1 half:1 some:1 results:1 seat:1 high:1 see:1 election:2 have:3 approval:1 rally:1 should:1 soon:1 makers:2 market:1 fill:1 even:1 pharmaceutical:1 said:1 also:1 patent:1 large:1 began:1 there:1 shares:1 improvement:1 their:1 2:1 treatment:1 insurance:1 type:1 2010:1 economy:1 giants:1 after:1 's:3 plans:1 company:1 continues:1 notable:1 expiry:1 most:1 cut:1 decide:1 demand:1 hopes:1 article:1 boosts:2 diabetes:1 improved:1 world:1 launch:1 many:1 could:1 companies:2 up:1 drug:2 other:1 generic:1 competitors:1 products:1 socked:1 back:1 pick:1 health-care:2 first:1 workers:1 talk:1 published:1
stock_LLY r_down	restrictions:1 plans:1 drop:2 administration:1 slides:1 banks:1 tighter:1 broader:3 push:1 news:1 stocks:2 market:3
stock_LLY r_up	actively:1 trading:1 whose:1 rose:1 shares:1 5:1 between:1 9:1 500:1 higher:1 increased:1 scrutiny:1 doctors:1 ties:1 stocks:1 gained:1 39:1 industry:1 companies:1 drug:1 points:3 were:1
stock_LLY r_up	agreed:1 epilepsy:1 allegations:1 expects:2 swells:1 shares:2 fine:1 its:3 thyroid:2 whose:2 $:2 rose:1 treatment:2 under:2 struck:1 has:3 increased:1 introduce:2 regarding:1 resolve:1 --:4 companies:2 after-hours:1 stock:1 investigators:1 competition:2 actively:2 trading:2 declined:1 said:7 opened:1 review:2 comments:2 version:2 7:1 new:2 sold:2 million:1 agreement:1 provides:2 plea:1 approval:4 gained:1 pipeline:1 weeks:2 drug:9 promotion:1 traded:2 comment:1 key:1 slipped:1 into:1 within:2 down:1 68:1 market:4 pharmaceutical:2 cancer:2 185:1 500:2 closed:1 firm:1 company:5 but:2 sharply:1 prices:1 subsidiary:1 analyst:1 insights:2 13:1 criminal:1 regulator:2 give:2 warning:2 around:1 4.6:1 things:1 agency:2 detail:1 also:2 5:1 2.5:2 rallies:2 higher:3 's:10 capitalization:1 may:2 after:3 fell:1 authorities:1 stocks:2 approved:3 diabetes:7 billion:1 well:1 points:6 pay:1 clears:2 fresh:1 requires:2
stock_LLY r_up	has:1 stocks:1 's:1 nod:2 shares:1 edge:1 gain:3 diabetes:1 new:1 news:1 drugmakers:2 medication:1 approved:1 higher:1
stock_LLY r_down	being:1 executive:1 expects:2 nominated:2 years:2 leads:2 held:2 session:3 deadline:1 per:1 broader:1 cuts:1 battle:2 year-earlier:4 its:6 whose:3 uneven:1 $:7 rose:1 29:1 multiyear:1 better:1 multi-year:1 charge:1 concerns:1 board:3 quarterly:1 8,000:2 has:2 thousands:1 2010:2 earnings:1 ...:1 updated:1 his:2 hit:2 gains:3 slate:1 results:4 early:2 increases:1 updates:1 background:1 fall:1 trade:1 replace:1 investor:1 day:1 minute:2 14:2 loss:3 lost:3 excluding:1 --:2 companies:3 slide:1 night:1 quarter:3 thanks:1 because:1 mental:3 ten:1 seats:1 estimates:2 back:2 competition:1 past:1 second:1 actively:2 trading:3 year:3 2.2:1 margins:1 3.8:1 gross:1 said:4 profit:11 contributed:1 while:5 shares:5 3:1 activist:2 sixth:1 falling:1 leader:1 announced:1 business:3 nature:1 hefty:1 million:2 focus:2 reported:1 shifting:1 address:1 active:1 beginning:2 pipeline:2 last:5 split-off:1 prior-year:1 annual:2 36:1 drug:6 products:1 launched:1 positive:1 usually:2 traded:2 maker:2 south:2 comment:1 fourth-quarter:8 tone:1 revenue:7 previously:1 wave:1 others:1 splitting:2 period:1 increased:1 two:2 down:2 simply:1 notify:1 winning:1 quality:1 market:1 decline:2 swings:1 additional:1 analyst:1 8.9:1 best-selling:1 top:1 three:1 tiny:1 expected:2 upbeat:1 meeting:2 until:2 500:2 ``:1 enough:1 drugs:1 some:2 company:9 booked:1 but:1 hurt:2 markets:1 taken:1 prices:2 improved:1 despite:1 than:1 posted:3 '':1 15:1 succeeded:1 nominate:3 see:1 n't:1 below:1 growth:1 baby-formula:3 9th:1 were:1 acquisition:4 1.5:2 biotech:2 slid:2 illness:3 have:1 cents:1 share:1 sales:6 weighed:3 dropped:2 world-wide:1 swung:4 rekindling:2 huge:3 generic:1 47:1 highlighted:1 also:1 intends:1 points:3 5:1 details:2 fourth:1 commentary:1 stock:3 analysts:1 's:15 plans:1 after:6 upon:2 treatments:3 expirations:1 prepared:1 fueled:3 fell:3 coming:1 assessed:1 stocks:6 recent:3 billion:2 purchase:1 lower:2 short:1 off:2 third:1 charges:4 futures:1 well:1 deal:1 patent:1 directors:5 costs:1 does:1 2008:2
stock_LLY r_down	saying:1 epilepsy:1 allegations:1 quarters:1 improper:1 drug:1 still:1 its:1 surprises:2 practices:1 advisories:2 earnings:1 big:1 criminal:1 's:2 string:1 marketing:1 showing:1 agreement:1 involving:1 cases:1 future:1 roundup:1 companies:1 reports:1 settle:1 problem:1 corporate:1 latest:2
stock_LLY r_up	among:1 old:1 leaders:1 soon:1 years:1 likely:1 65:1 year:1 mandatory:1 pharmaceutical:1 retirement:1 there:1 age:1 2011:1 announced:1 more:1 his:1 's:1 reaching:1 could:1 continues:1 replacement:1 change:1 recent:1 industry:1 drug:2 turn:1 turnover:1 changes:1 maker:2 generational:1
stock_LLY r_down	financial:1 deal:1 over:2 some:2 promotional:2 its:1 giant:1 said:1 $:1 also:1 spending:1 comments:1 targets:1 spokesman:1 their:2 3:1 much:1 lowered:1 has:2 2012:1 plans:1 drugs:2 material:2 cut:1 billion:1 --:2 warned:2 drug:1 misleading:2
stock_LLY r_down	comment:1 --:2 warned:2 over:2 material:2 some:2 comments:1 promotional:2 spokesman:1 their:2 misleading:2 drugs:2 has:2
stock_LLY r_up	sector:1 giants:1 interest:1 animal-health:2 appeared:1 filed:1 2nd:1 down:1 pair:1 businesses:1 analysis:3 want:1 year:3 path:1 rekindle:2 even:2 said:1 $:2 would:2 valuation:1 guidance:1 partnership:2 microscope:1 heading:1 increasingly:1 details:1 statement:1 under:2 expected:2 new:1 more:1 venture:2 method:1 higher:1 weeks:2 activists:1 's:8 calculations:1 coming:3 adjusting:1 million:2 drug:3 have:1 shareholder:1 proxy:1 decide:2 preliminary:1 regulatory:1 using:1 article:1 sign:1 beginning:1 than:3 bigger:2 received:2 valued:2 last:2 like:1 joint:2 package:4 --:1 industry:1 30:1 companies:1 according:2 value:1 filing:1 traditional:1 maturity:1 compensation:4 undone:1 '08:4 whether:2 act:1 2008:1 2009:7 maker:2 published:1
stock_LLY r_up	pact:2 billion:1 license:1 $:3 deal:1 royalties:1 pay:1 treat:1 up:1 drug:3 arthritis:1 bln:2 used:1 reaches:1 ink:2 rheumatoid:1 1.25:3 before:1
stock_LLY r_down	have:1 cancer:1 people:1 encourages:1 caused:1 agreed:1 high:1 clear:1 learning:1 approval:1 's:1 250:1 blockbuster:1 its:1 if:1 pharmaceutical:1 $:3 application:1 pay:1 conduct:1 next:1 failed:1 another:1 clinical:1 study:1 take:1 accusations:1 between:1 test:1 has:1 week:1 after:2 jury:1 which:1 form:1 marketing:1 million:1 warn:1 pressure:1 running:1 properly:1 hear:1 blood:1 ties:1 approved:1 gain:1 antipsychotic:1 television:1 treats:1 --:2 industry:1 companies:1 sale:1 drug:3 became:1 risks:1 diabetes:1 investigating:1 pulled:1 maker:1 experimental:1 first:1
stock_LLY r_up	sector:1 help:1 move:1 four:1 including:1 its:4 antipsychotic:2 sugar:1 other:1 treatment:1 version:1 has:2 eventually:1 his:2 increased:1 early:2 continued:2 --:3 conditions:1 companies:1 reasonable:2 follows:1 businesses:1 disorder:1 attorney:1 often:1 related:1 global:1 comments:1 state:1 activist:1 between:2 racing:1 correct:1 exercise:1 told:2 opening:1 diagnosis:1 extreme:1 taking:1 according:2 trial:2 diagnosed:1 published:1 comment:1 manage:1 down:2 61:1 throughout:1 mental:1 quit:1 use:2 management:1 jurors:1 leading:1 brewer:1 question:1 been:1 their:1 beer:2 board:1 ``:3 himself:1 becomes:1 company:2 but:3 aware:2 link:2 natural:1 he:3 target:1 publicly:2 nominate:1 site:1 biotech:1 ad:1 division:1 ran:1 turned:1 head:1 evidence:2 '':3 pushed:1 risk:2 marking:1 documents:2 court:1 began:3 also:2 client:1 arguments:1 which:1 test:1 play:2 added:1 's:9 plans:1 separate:1 after:2 needs:1 blood:1 diabetes:5 stress:1 kept:1 clear:1 sale:1 directors:1 2001:1 2004:1 wine:1 veteran:1 latest:1
stock_LLY r_down	help:1 caused:1 four:1 attempts:1 including:1 shares:1 follow:2 its:2 setbacks:1 batches:1 investor:1 fix:4 should:1 investigation:1 board:2 include:1 ingredient:2 his:2 which:1 during:1 procedures:2 day:1 processes:1 --:3 warned:2 did:3 investigate:1 shortage:1 quarter:1 some:1 officials:1 adequately:1 said:3 adds:1 federal:1 comments:1 activist:2 medicine:1 million:1 pharmaceutical:1 pushing:1 broken:1 tripled:1 regulatory:1 manufacturing:4 could:1 compliance:1 foreign:1 products:1 share:1 comes:1 into:1 active:1 bribery:1 determine:1 ailing:1 market:1 decline:1 holdings:1 top:1 disclosed:1 ``:4 himself:2 drugs:2 influence:1 company:8 released:1 valuation:1 than:1 he:3 has:1 announcing:1 whether:1 nominate:2 expanded:1 aims:3 n't:3 substantial:1 ongoing:1 making:2 more:1 biotech:2 1.8:1 '':4 good:2 have:1 recover:1 confirmed:1 ingredients:1 make:1 stake:1 4.8:1 fourth:1 plant:2 used:2 's:5 plans:3 price:1 after:1 produce:2 letter:2 law:1 diabetes:1 attempt:1 sale:3 directors:2
stock_LLY r_up	good:1 's:1 almost:1 company:1 after:1 year:1 but:1 pricey:1 looks:1 online:1 last:1 empire:1 doubling:1
stock_LLY r_down	information:1 antipsychotics:1 government:1 marketing:1 probe:1 continuing:1 sales:1 has:1 asked:1 more:1
stock_LLY r_up	comment:1 antipsychotics:1 civil:1 probe:1 sales:1 '':1 declined:1 information:2 additional:1 demands:1 spokesman:1 disclosed:1 details:1 has:1 more:2 disclose:1 ``:1 government:2 marketing:1 company:1 continuing:1 immediate:1 regulatory:1 article:1 did:1 seeking:1 asked:1 n't:1 published:1 served:1 filing:1
stock_LLY r_down	control:1 exclusive:1 weight:1 acquired:1 series:1 including:1 have:2 said:1 develop:1 $:1 pay:1 sugar:1 1:1 potential:1 potentially:1 which:1 has:1 worldwide:1 company:1 million:1 blood:1 upfront:1 loss:1 showed:1 rights:2 benefit:1 other:1 effects:1
stock_LLY r_up	can’t:1 performer:2 read:1 advice:2 free:3 top-performing:1 offers:2 can:1 letter:1 you:2
stock_LLY r_down	feed:1 deal:1 agreed:1 some:1 animal-health:1 year:1 vaccines:1 details:1 which:1 include:1 disclosed:1 's:2 acquire:1 part:1 has:1 last:1 rights:1 --:1 n't:1 products:2 acquisition:1 were:1 divest:1 asked:1 additives:1
stock_LLY r_up	week:1 anticipation:1 --:1 sold:1 crucial:1 drug:1 years:1 long-acting:1 version:1 faces:1 approval:1 decision:1 diabetes:1
stock_LLY r_up	medication:2 ordered:1 some:2 warning:4 through:1 says:1 risk:1 information:1 additional:1 top:1 marketed:1 anti-clotting:2 label:1 does:2 toughest:1 product:1 added:1 's:2 boxed:2 sixth:1 most:1 doctors:2 appears:1 --:1 work:2 well:2 drug:1 n't:2 patients:2 10th:1
stock_LLY r_up	sector:2 rating:2 over:1 global:1 dollar:2 focus:2 through:1 shares:3 broader:1 its:2 whose:3 26:1 upgrade:1 $:1 23:1 rose:1 issuing:1 equity:1 8:1 main:1 take:1 'trash:2 long-acting:2 worst:2 bit:1 level:1 --:2 12th:1 countries:1 companies:3 each:1 worries:1 including:2 economy:1 because:2 financial:1 declines:1 energy:3 actively:3 trading:5 measure:2 close:2 2.1:2 2.7:1 declined:1 said:2 blue-chip:1 below:1 comments:1 label:2 version:2 7:2 denied:2 warned:2 sliding:1 led:2 sixth:1 sold:2 drug:4 approval:2 manufacturing:1 declining:1 gained:1 crude-oil:2 30:1 reports:2 credit:3 traded:2 first:1 note:2 slipped:1 into:1 down:4 double-dip:3 sounds:1 market:1 their:1 legislation:1 process:1 dropping:1 expected:1 diabetes:2 500:3 more:2 premier:3 mostly:1 company:1 hurt:2 cautious:1 prices:3 potential:1 10:1 12:1 17:1 edged:1 up:1 nations:3 recession:3 while:1 risks:5 were:2 following:2 slid:3 performer:2 1.3:1 0.1:1 0.2:1 0.5:1 site:2 helped:1 warning:2 dropped:2 have:2 rally:3 technology:2 weaken:3 grown:2 information:3 needs:2 5.3:1 48:1 agency:4 40:1 1:1 also:1 concerns:1 details:2 stock:5 product:2 oil:1 's:11 ratings:2 may:2 after:2 fell:7 plan:2 stocks:10 recent:2 lower:5 off:1 weakened:2 third:1 futures:6 commodities:1 points:13 components:2 dragged:1
stock_LLY r_up	sector:3 limited:1 managed:2 over:2 ending:1 four:2 ended:1 session:1 comments:1 partial:2 aggressive:1 its:3 before:1 whose:1 giant:1 police:1 $:4 fifth-straight:2 rose:1 explain:2 has:1 worth:1 nervousness:1 gains:1 far:1 rise:2 possible:1 increases:1 day:1 retreat:1 countries:2 --:2 companies:4 large:1 after-hours:1 worries:1 late-day:2 financial:2 often:2 strongest:1 cost:2 trading:1 pricing:1 's:2 80:1 out:1 index:1 said:1 consumer-staples:1 blue-chip:2 shares:4 state:1 predicting:1 led:2 million:1 component:1 comeback:2 gained:1 advance:1 2.8:1 against:1 times:2 mixed:1 retail:1 traded:1 upgraded:1 one:1 pharmaceutical:2 negative:1 their:2 much:1 biggest:1 territory:1 500:1 more:3 interest-rate:1 buy:1 drugs:3 reversed:1 benchmark:2 but:1 gain:3 five-day:1 hold:1 than:2 10:1 stolen:1 17:1 up:4 below:1 actively:1 were:1 history:1 0.8:1 slid:1 0.1:1 0.2:1 helped:4 pressing:2 pulling:1 rally:1 5.5:1 make:2 other:2 warehouse:1 higher:1 oil:1 edged:2 after:1 thefts:1 most:1 75:1 such:2 stocks:6 weekend:1 why:2 points:3 rallying:1 barrel:1 backdrop:1
stock_LLY r_up	drugs:1 pharmaceutical:1 such:1 cost:1 often:1 --:1 explain:1 companies:1 times:1 four:1 their:1 pressing:1 published:1 article:1 why:1 more:1
stock_LLY r_up	among:1 focus:2 trade:1 see:1 session:1 including:1 antidepressants:1 pharmaceutical:1 confirmed:1 antipsychotic:1 shares:1 expected:1 ever:1 's:1 drugs:1 biggest:1 active:1 during:1 one:1 weekend:1 those:1 stolen:1 --:1 well:1 afternoon:1 were:1
stock_LLY r_up	operations:1 biotech:1 right:1 nursing:1 toss:1 into:1 fall:2 down:1 say:1 smaller:1 out:1 65:1 sense:1 vote:2 home:1 still:1 thinks:1 second:1 even:1 he:1 said:2 court:1 $:1 would:1 carriers:1 federal:1 get:1 two:1 comments:1 fight:1 member:1 needed:1 activist:1 health:2 board:2 which:1 ruling:1 biggest:1 insurers:3 company:2 red:1 more:2 direction:1 his:1 's:1 reaching:1 operators:1 after:3 agreement:1 interview:2 shareholder:1 gain:2 sharply:1 coming:1 change:1 care:1 million:1 third:1 --:2 split:1 could:2 drop:1 up:1 appeals:1 patent:1 while:2 decided:1 indication:1 analysts:1 time:1 mixed:1 moving:1 dispute:1 makes:1 order:1 road:1 proxy:1
stock_LLY r_up	heart:1 scrambling:1 thinner:1 figure:1 may:1 warned:1 blood:1 after:1 drug:1 should:1 patients:1 continue:1 everyone:1 take:1 which:1 doctors:1 not:1 work:1 out:1
stock_LLY r_down	acquisitions:1 weighing:1 reform:2 local:1 company:1 health-care:1 but:1 eyeing:1 presence:1 also:1 only:1 potential:1 here:1 not:1 turning:1 efforts:1 's:3 debate:1 expand:1 he:1
stock_LLY r_down	heart:1 illegally:1 lead:1 people:1 attacks:1 ingredients:1 two:1 contained:1 weight-loss:1 products:1 can:1 importing:1 charged:1 counterfeit:1
stock_LLY r_up	presence:1 paid:1 some:1 eyeing:1 officials:1 further:1 turning:1 debate:1 speak:1 considering:1 adds:1 reform:2 travel:1 detail:1 looking:1 also:1 only:1 potential:1 health:1 way:1 capital:1 interview:1 care:1 's:1 price:1 told:1 weighing:1 plans:1 government:1 drugs:1 company:1 but:1 curbing:1 here:2 not:1 changing:1 expand:1 he:1 acquisitions:2 --:2 efforts:1
stock_LLY r_up	said:1 last:1 $:3 medicines:1 4,500:1 half:1 million:1 year:1 treatments:1 paid:1 its:1 second:1 35:3 promote:1 doctors:1 during:1 work:1 hospitals:1 study:1
stock_LLY r_down	short:2 provide:1 0.3:2 contractor:1 high:2 all-time:2 defense:1 lift:1 close:2 stocks:3 markets:1 oil-related:1
stock_LLY r_up	development:1 professionals:1 health-care:1 $:3 matters:1 4,500:1 marketing:1 million:1 35:1 drug:1 second:1 other:1 paid:1 half:1 during:1 drugs:1 2009:3 new:1 maker:1
stock_LLY r_up	cancer:2 coming:1 competition:1 replace:1 lung:1 bloodletting:1 needs:1 blockbuster:1 court:1 patent:2 guidance:1 cell:1 drugs:1 upheld:1 treatment:1 draft:1 medicine:1 probably:1 has:1 until:1 more:1 's:3 maintenance:1 wo:2 use:2 validity:1 protection:1 compound:1 cleared:1 maintaining:1 off:1 --:1 drug:2 face:1 n't:2 federal:1 patients:1 published:1 making:1 first:1 institute:1 generic:1
stock_LLY r_up	because:1 coverage:2 investors:1 revenue:1 within:1 health-care:1 some:1 results:1 submitted:1 ready:1 recently:1 exclusivity:1 longer:1 makers:1 market:1 looking:1 prescription-drug:1 overhaul:1 mood:1 bullish:1 application:1 provide:1 patients:1 long:1 its:1 increase:1 also:1 treat:1 new:1 more:1 several:1 's:1 company:1 treatment:1 deals:1 ensure:1 first-quarter:1 gains:1 drugs:1 big:1 sold:1 continues:1 diagnostics:1 biologic:1 healing:1 significant:1 demand:1 post:1 addiction:1 supplemental:1 he:1 has:1 improved:1 look:1 --:1 amid:1 no:1 companies:1 drug:2 large:1 cast:1 while:1 signed:1 allow:1 many:1 expand:1 aid:1 climb:1 economy:1 mergers:1
stock_LLY r_up	sector:1 saying:1 cheap:1 results:4 actions:1 quarters:1 session:1 looks:1 operations:1 still:1 its:6 fifth:1 whose:2 some:1 cut:1 overhaul:5 $:10 also:2 products:1 disappointed:1 guidance:1 point:1 had:1 expectations:2 than:1 failed:1 add:2 resubmit:1 board:1 fade:2 under:1 posted:1 might:1 2010:2 earnings:6 makes:1 his:1 hit:1 gains:3 get:2 allegations:1 focus:1 early:1 cutting:2 updates:2 background:2 progress:2 trade:1 multiple:1 bank:2 loss:3 issues:1 necessary:1 prescription:1 excluding:1 covering:1 --:3 conditions:1 future:1 shock:3 companies:4 yield:1 continue:3 predicted:2 allegation:2 activity:1 popular:1 volcano:1 aftermath:1 higher:5 mergers:1 week:1 requirement:1 drop:2 financial:4 continued:2 reduce:2 related:5 see:2 3.5:1 trading:4 after-hours:1 year:1 close:1 80:1 makers:2 mid-cap:1 points:3 gross:1 federal:1 said:3 3rd:1 reform:2 profit:6 56:1 review:2 shares:4 rival:2 35:1 version:2 health:3 eliminate:1 new:4 firms:1 boost:2 supporting:1 recently:3 prescriptions:1 taxing:1 jumps:2 million:9 combines:1 rebates:3 reported:4 recent:1 offset:1 regulatory:2 dividend:1 anticipated:1 revenues:1 first-quarter:9 manufacturer:1 gained:1 reaction:1 quarter:1 last:1 dietary:1 many:1 annual:1 has:1 days:1 drug:12 follows:1 turn:2 fell:4 a.m.:1 afternoon:2 rose:2 changes:1 maker:7 surprises:2 comment:1 among:3 volcanic:2 slipped:1 revenue:9 within:1 number:1 because:1 been:2 news:1 narrowed:3 throughout:3 shrinking:1 crisis:3 market:1 cost:1 decline:3 shareholders:2 law:1 additional:1 would:1 remains:1 1.3:1 due:4 least:1 hitting:1 advisories:2 program:2 -2:2 low:1 passed:2 expected:2 upshot:1 proposal:1 care:1 meeting:1 500:1 treatment:2 slips:2 roundup:1 ``:2 mostly:1 received:1 drugs:1 700:2 company:7 400:3 benchmark:1 requires:2 but:2 1.9:1 lowered:3 gain:1 aviation:3 given:1 pain:1 analyst:1 must:1 plants:1 handily:1 fraud:4 17:2 2011:2 require:1 bill:1 up:1 flagship:2 while:2 actively:2 were:1 following:1 making:2 drops:2 similar:1 spotlight:2 published:1 supplement:1 1.5:1 30:1 tap:1 600:2 impacts:2 outstanding:1 cents:2 certain:2 subsidies:1 health-care:6 share:2 sales:1 '':2 warning:1 dropped:2 have:1 partner:1 mover:1 story:1 sells:2 streamlining:1 5.4:1 author:1 pay:2 government:3 fears:2 topped:1 indexes:1 note:1 application:1 other:3 5:18 details:3 which:4 acetaminophen:1 estimates:1 more:1 several:1 events:1 stock:9 poor:2 topping:1 analysts:4 's:17 plans:1 reverberates:2 corrected:1 price:2 measures:2 disclosed:1 forecasts:3 announcements:1 jumping:1 shareholder:1 allowing:1 letter:1 waves:3 included:2 such:1 stocks:5 grave:1 diabetes:3 lower:5 short:1 off:1 margins:1 charges:6 approve:1 futures:6 metal:1 reports:1 directors:1 costs:8 350:2 weigh:2 voting:1 corporate:2 retirees:1 latest:2
stock_LLY r_down	cancer-drug:1 financial:1 help:1 revenue:2 cents:2 health-care:2 reduce:3 sales:3 price:1 trends:1 4:1 favorable:1 year:1 first-quarter:2 settlement:2 expects:2 its:3 full-year:1 out:1 impact:1 giant:2 said:3 recently:2 $:4 would:1 49:3 profit:5 rose:2 bite:1 legislation:1 29:7 next:1 increase:2 also:1 add:1 health:1 take:1 400:2 quarterly:1 new:3 's:1 2010:2 500:2 dispute:2 jobs:1 drugs:2 earnings:3 company:3 million:4 background:1 citing:1 but:2 results:1 cut:2 383:1 push:3 newer:1 throughout:1 overhaul:3 details:1 vaccine:1 10:2 reported:2 reform:1 up:3 patent:2 while:1 lowered:1 products:1 forecast:1 growing:1 share:2 quarter:1 stock:1 updates:1 first:1
stock_LLY r_down	comment:1 biotech:1 outlook:1 methods:1 investors:1 summer:1 agreed:1 collaboration:2 see:1 extended:1 another:2 year:2 research:1 targets:1 said:2 develop:1 deal:1 trials:1 interference:1 been:1 should:1 returns:1 significant:1 violations:1 has:1 2010:1 body:1 ``:1 buy:1 's:2 extend:1 drugs:1 company:1 expires:1 but:1 delivering:1 fell:1 background:1 based:1 likelihood:1 analyst:1 raising:1 antipsychotic:1 '':1 short:1 extension:1 healthy:1 warned:1 second:1 drug:2 --:1 pediatric:1 involved:1 dip:1 maker:1
stock_LLY r_up	health-care:1 we:1 defended:1 '':1 have:1 recently:1 perfect:1 said:1 overhaul:1 would:1 support:1 legislation:1 written:1 ``:1 's:2 though:1 he:1 bill:1 drug:1 n't:2 chief:1 maker:1
stock_LLY r_down	people:1 agreed:1 allegations:3 sales:1 helped:1 diabetes:1 settlement:1 its:1 market:1 improperly:2 said:1 $:2 no:1 pay:2 priority:1 520:2 treatment:1 which:1 familiar:1 expected:1 announce:1 main:1 2010:1 week:1 blowing:1 's:1 government:1 successful:1 marketing:1 company:2 million:2 whistle:1 representative:1 new:1 former:1 antipsychotic:2 resolve:2 especially:1 stranger:1 --:2 according:1 drug:1 large:1 matter:1 investigate:1 practices:1 illegal:1 promoted:2 maker:1
stock_LLY r_down	flu:1 allegations:1 sales:1 helped:1 cites:1 no:1 rose:1 earnings:1 marketing:1 blowing:1 's:1 government:1 season:1 company:1 whistle:1 representative:1 former:1 stranger:1 51:1 drug:1 n't:2 investigate:1 practices:1 illegal:1 quarter:1 maker:1 first:1
stock_LLY r_up	because:1 help:1 family:1 some:1 expects:1 likely:1 rising:1 periods:1 exclusivity:1 seller:1 insurance:2 market:1 decline:1 26:1 said:1 22:1 reform:2 profit:1 top:1 legislation:1 while:1 its:2 may:1 call:1 earnings:1 include:1 told:1 's:1 diseases:1 extend:1 drugs:3 measures:1 but:1 sales:4 reported:1 were:1 newer:1 coverage:1 reporters:1 rare:1 age:1 former:1 raising:1 also:1 lower:1 benefits:1 longer:1 --:1 medicines:1 no:1 see:1 drug:1 cushioned:1 their:1 patent:1 benefit:1 protected:1 extensions:1 can:1 healthcare:2 adolescents:1 maker:1
stock_LLY r_down	style:1 widows:1 just:1 investors:1 orphans:1 back:1 juice:2 returns:2 coming:1 not:1 dividend:2 more:1 they’re:1 any:1 best:2 strategies:2
stock_LLY r_up	major:1 investors:1 sales:1 socks:1 year:1 's:2 saw:1 quieter:1 group:1 top:1 earnings:1 largest:1 expected:1 party:1 shows:1 terms:1 may:1 company:1 reshuffle:1 15:1 most:1 world:1 bit:1 data:1 grow:1 nor:1 recent:1 knock:1 off:1 --:1 industry:1 drug:1 players:1 2009:3 mergers:1
stock_LLY r_down	medication:2 almost:1 setback:2 trading:2 80:1 shooting:1 its:4 ground:1 $:2 shares:2 1.39:1 rallies:2 9:1 new:2 stock:2 gaining:1 rebound:2 after:2 early:2 75:1 regulatory:2 rebounds:2 day:2 12:1 plunged:2 up:2 were:2 following:2 serious:1
stock_LLY r_up	positive:1 arthritis:1 data:1 trial:1 rheumatoid:1 cites:1
stock_LLY r_down	n't:1 blew:1 tactics:1 do:1 did:1 money:1 companies:1 sales:1 drug:1 according:1 improper:1 whistle:1 're:2 survey:1 actions:1 they:2 published:1 believed:1 suffered:1 their:1
stock_LLY r_down	'':1 ``:1 $:1 sentiment:1 whistleblowers:1 had:1 million:1 median:1 been:1 n't:2 personal:1 3:1 cost:1 not:1 reward:1 worth:1 payoff:1
stock_LLY r_up	cancer-drug:1 large-cap:1 pays:1 '':1 say:1 expertise:1 apply:1 its:2 bitten:1 $:1 clearly:1 pharmaceuticals:3 does:1 run:1 4:1 which:1 has:3 launching:1 too:1 rallied:1 ``:1 buy:1 star:2 offer:1 far:1 after:2 takeover:1 struggle:1 snapped:1 off:1 now:1 diabetes:1 billion:1 advance:1 attempt:1 hostile:2 stodgy:2 shy:1 failing:1 up:1 n't:1 twice:1 amid:2 maker:1 once:1
stock_LLY r_down	firm:1 's:2 side:1 gadfly:1 drug-pricing:1 became:1 unlikely:1 research:1 investment-banking:1 analyst:1 issues:1 joining:1
stock_LLY r_down	investors:1 issued:1 agreed:1 strategic:1 have:1 participate:1 250:1 25:1 20:1 $:4 contributed:1 also:1 state:2 potential:1 capital:1 has:3 government:2 million:2 fund:2 press:1 unnamed:1 raise:1 --:1 according:1 up:1 while:1 venture:1 release:1
stock_LLY r_down	rating:1 outlook:1 raise:1 unnamed:1 contributed:1 agreed:1 health-care:1 sales:1 strategic:1 '':1 press:1 investors:1 article:1 250:1 its:1 25:1 cut:1 overhaul:1 $:4 patent:1 anticlotting:1 negative:1 uptake:1 also:2 state:2 potential:1 capital:1 new:1 has:3 2011:1 ``:1 million:2 's:5 expirations:1 mostly:1 government:2 published:1 20:1 fund:2 said:1 issued:1 coming:1 participate:1 president:1 strong:1 he:1 building:1 high:1 have:1 vice:1 --:1 slow:1 up:1 drug:1 credit:1 while:1 costs:1 venture:1 steadily:1 release:1 according:1 starting:1 noted:1
stock_LLY r_down	just:1 heavily:1 '':1 growth:2 human:1 children:1 really:1 synthetic:1 index:1 said:1 disorders:1 two:1 find:1 few:1 other:1 dominated:1 treatment:1 themselves:1 markets:1 stock:1 bets:1 ``:1 hormone:1 's:3 option:1 form:1 big:2 health-cost:1 approved:1 buying:1 countries:1 --:1 taking:1 companies:1 regulator:1 those:1 banks:1
stock_LLY r_down	executive:2 head:1 '':2 11th:1 throughout:1 its:1 heads:1 short-lived:1 two:1 research:2 version:1 capital:1 correct:1 stock:1 ``:2 pipelines:1 experiment:1 company:1 hired:1 updates:1 background:1 prices:1 using:1 scrapped:1 beginning:1 efforts:1 name:1 follows:1 official:1 drug:1 while:1 a.m.:2 rival:1 senior:1 changes:1 having:1
stock_LLY r_down	week:1 peek:1 draw:1 's:2 business:1 may:1 conditions:1 into:2 global:1 influence:1 sale:1 offers:1 including:1 mergers:1 country:1 technology:1 setting:1 over:1 structure:1
stock_LLY r_down	gone:1 summer:1 up:1 most:1 2:2 5:2 have:1 stocks:1 historically:1
stock_LLY r_up	seeing:1 said:1 look:1 remains:1 continues:1 flow:1 opportunities:1 deals:1 merger:1 potential:1 drug:1 although:1 pursuing:1 maker:1 acquisition:1 increased:1
stock_LLY r_down	crushing:1 sampling:1 value:1 jobs:1 2.7:1 trade:1 risk:1 out:3 one:1 pharmaceutical:1 documents:1 group:1 $:3 drug-company:1 handed:1 research:1 3:1 viewed:1 samples:2 gave:2 fiscal:1 head:1 's:4 plans:1 million:2 free:1 most:1 240:1 doctors:1 prices:1 squeeze:1 data:1 billion:2 valued:1 sectors:1 --:2 country:2 medicines:1 according:3 drug:2 while:1 2007:2 vibrant:1 push:1 first:1
stock_LLY r_up	among:1 emerging:1 daunting:1 they:1 cancer:5 up:1 expanding:1 over:2 sales:1 strategic:1 continues:1 colon:4 skin:1 fail:2 its:2 out:1 group:4 weekend:2 marketed:2 ovarian:1 including:1 next:1 clinical:2 potentially:1 treat:2 certain:4 finding:2 5:2 markets:1 war:1 added:2 's:2 plans:1 extend:2 drugs:3 advances:1 survival:2 published:1 notable:1 treatments:3 but:1 reported:1 involving:2 five:1 lung:1 chemotherapy:4 article:1 background:1 years:1 data:1 approved:2 after:2 acquisitions:1 throw:1 surprising:2 showed:2 --:3 double:1 study:2 obstacles:1 companies:1 disease:1 drug:2 n't:2 did:2 patients:4 cancers:1 were:1 making:1 promotion:1 called:2 researchers:2
stock_LLY r_up	because:1 investors:1 trend:1 issued:1 say:1 set:1 shares:1 have:1 year:1 its:2 rose:1 been:1 should:1 positive:1 which:1 taken:1 new:1 darling:1 has:2 wide:1 giants:1 play:1 's:2 views:1 drugs:1 after:1 outperformed:1 pipeline:1 key:1 midst:1 role:1 both:1 peers:1 developing:1 --:3 medicines:1 battling:1 companies:1 disease:1 continue:1 analysts:2 healthcare:1 margin:1 looks:1
stock_LLY r_up	background:1 less:1 over:1 executive:1 ended:1 session:3 skin:1 its:1 cardiovascular:1 impact:1 whose:3 20:1 rose:2 late:1 potential:1 4:1 8:1 gains:1 contracts:1 showing:1 possible:1 reversal:1 lost:1 --:1 follows:1 companies:3 traders:1 stock:1 bond:1 reactions:1 some:1 back:2 actively:3 trading:3 's:4 2.6:1 declined:2 2.4:1 said:3 adds:1 patients:3 shares:3 3:1 version:1 safety:2 closed:1 medicine:2 new:2 correct:1 patient:1 weak:1 key:2 offset:1 regulatory:1 100:1 gained:3 recovered:1 ahead:1 launch:1 auction:1 study:1 months:1 drug:2 mixed:1 traded:1 options:1 first:1 comment:1 point:1 appeared:1 complications:1 symptoms:2 '':2 next:1 start:1 2:1 expected:1 meeting:1 500:4 ``:2 deeper:2 mostly:1 successful:1 but:1 those:1 soothe:1 look:1 16:1 18:1 require:2 up:1 while:1 economic:1 ongoing:1 expiration:1 were:3 procedure:1 mistake:1 1.5:1 proved:1 1.2:1 0.5:1 helped:2 reports:1 technology:1 monitoring:2 billion-dollar:1 1:1 also:1 concerns:3 details:1 which:2 brace:1 higher:2 week:1 edged:1 much:1 fell:7 frequently:1 stocks:4 response:2 diabetes:1 lower:2 slightly:1 futures:2 without:1 points:10 push:2 filing:1
stock_LLY r_down	cancer:1 global:1 lung:1 its:1 partners:1 co-branded:1 recommended:1 other:1 treatment:1 maintenance:1 under:1 test:1 include:1 common:1 strips:1 's:8 which:1 form:1 big:1 stable:1 most:1 regulators:1 moving:1 changing:1 diabetes:1 --:1 disease:1 products:1 insulin:2 meters:1 glucose:1 maker:1
stock_LLY r_up	biotech:1 interest:1 health-care:1 matter:1 sales:1 strips:1 ending:1 decided:1 meters:1 controversial:1 such:1 still:1 its:2 products:1 pharmaceutical:1 giant:1 said:1 proceed:1 area:1 diabetes:1 sale:1 had:1 stable:1 children:1 1:1 bipolar:2 clinical:1 details:1 fourth:1 which:2 test:1 drawn:1 has:2 auction:1 glucose:1 pursue:1 global:1 's:3 plans:1 big:1 partners:1 familiar:1 company:1 handful:1 reason:1 moving:1 not:1 approval:1 maker:1 beginning:1 antipsychotic:1 billion:1 changing:1 include:1 co-branded:1 --:1 according:1 study:1 early-stage:1 up:1 drug:3 $:1 spokeswoman:1 trial:1 person:1 heavyweights:1 insulin:2 pediatric:1 under:1 2009:1 disorder:1 other:1 late-stage:1
stock_LLY r_down	spokeswoman:1 distribute:1 sales:1 regulatory:1 decided:2 controversial:2 approval:2 still:1 its:2 pharmaceutical:1 giant:1 said:3 asthma:1 proceed:2 area:2 secured:1 had:1 children:2 1:1 bipolar:3 clinical:2 treatment:1 which:1 has:2 pursue:1 plans:1 company:1 not:2 article:1 promote:1 antipsychotic:2 billion:1 --:2 country:1 drug:5 $:1 separately:1 trial:2 products:1 pediatric:1 published:1 2009:1 disorder:2 late-stage:2
stock_LLY r_down	ago:1 only:1 pharma:1 giving:1 medical:1 year:1 companies:1 effect:1 gifts:1 most:1 state:1 banning:1 doctors:1 device:1 went:1 law:1 into:1
stock_LLY r_up	positive:1 over:1 weekend:1 gain:3 unveiled:1 meeting:1 studies:3 diabetes:2
stock_LLY r_down	among:1 pressured:1 --:1 weak:1 health-care:1 companies:1 rate:1 pricing:1 pressures:1 macroeconomic:1 conditions:1 trading:1 midday:1 were:1 worries:1 stocks:1 continued:1 500:1 weakest:1
stock_LLY r_up	sector:1 enter:1 over:2 held:1 giant:3 terms:1 rose:1 had:1 disclosed:1 them:1 gains:3 portfolios:1 1.8:1 early:1 game:2 nearly:1 closely:1 day:1 like:2 --:1 drop:4 companies:1 deals:1 slide:1 small:1 worries:2 shed:1 set:1 deal:1 declines:1 some:1 slowdown:2 jump:1 rate:1 economic:2 trading:3 year:2 edged:1 2.1:1 makers:1 declined:1 said:3 recently:1 entertainment:2 factory:3 looking:1 between:1 boost:1 red:1 bought:2 jobs:3 weak:1 popular:2 expire:1 focused:1 post:1 strong:1 nonfarm:1 losses:1 drug:1 maker:2 patents:1 first:2 slipped:1 into:1 down:1 licensing:1 jobless:1 monthly:1 their:3 much:1 biggest:1 9.5:1 buy:1 deeper:1 drugs:1 0.5:1 company:1 acquire:1 but:1 91:1 payrolls:1 94:1 made:1 14:1 showed:1 developing:1 up:1 devices:2 n't:1 while:1 were:1 led:1 0.9:3 1.5:1 1.6:1 months:1 measure:4 moved:1 disappointing:1 dropped:5 have:1 moves:1 orders:2 diseases:1 4.5:1 blockbuster:1 recovery:2 49:1 also:1 5:1 2.5:1 economy:1 week:1 's:6 track:1 after:3 treatments:1 fueled:2 fell:3 stocks:4 data:3 recent:2 lower:1 mobile:2 points:4 tech:1 time:2 decliners:2 having:1 came:2
stock_LLY r_up	premium:1 bets:1 waste:1 's:3 diseases:1 developing:1 drugs:2 medical:1 soon:1 patent:1 increases:1 protection:1 eight:1 expire:1 focusing:1 new:1 regulators:1 reducing:1 health:1 insurance:1 more:1
stock_LLY r_up	's:1 diseases:1 developing:1 drugs:2 soon:1 patent:1 protection:1 eight:1 expire:1 focusing:1 new:1 more:1
stock_LLY r_down	improve:1 's:2 publicly:1 marketing:1 becoming:1 time:1 drug:1 payments:1 try:1 surrounding:1 practices:1 disclosed:1 transparency:1 doctors:1 latest:1 its:1 maker:1 first:1
stock_LLY r_up	smaller:1 revenue:1 some:1 sales:1 rising:1 have:1 seen:1 blockbuster:1 injection:1 looking:1 productivity:2 patent:1 least:1 research:1 better:1 their:2 grapple:1 earnings:1 expected:1 has:1 boost:1 economy:1 giants:1 pipelines:1 expirations:1 mostly:1 drugs:1 big:1 wringing:1 continuing:1 back:1 low:1 demand:1 post:1 come:1 second-quarter:1 buying:1 acquisitions:1 improved:1 amid:1 industry:1 companies:2 up:1 flagship:1 ways:1 benefit:1 either:1 gotten:1 mergers:1
stock_LLY r_up	all:1 says:1 show:1 may:1 earnings:1 strong:1
stock_LLY r_up	outlook:1 leads:1 its:2 issues:1 weekly:1 setbacks:1 $:2 hunting:1 rose:2 delays:1 expectations:1 second-quarter:1 better:1 4:1 has:1 2011:1 2010:2 pending:1 expirations:1 bonds:1 rise:1 results:1 early:1 now:1 bank:1 medicines:1 yields:1 activity:1 higher:1 financial:1 estimates:1 challenges:1 economic:1 trading:2 said:1 blue-chip:1 forecast:2 beating:1 cost-cutting:1 approvals:1 swift:1 faced:1 unresolved:1 taking:1 drug:2 afternoon:2 dents:1 efforts:1 slightly:1 maker:1 raised:1 revenue:1 into:1 number:1 jobless:1 negative:1 been:1 north:1 offer:1 company:2 but:1 lowered:1 gain:2 hopes:1 than:1 those:1 account:1 16:3 momentum:1 were:1 cents:1 share:1 sales:1 rally:2 gains:1 ratings:1 end:1 recovery:1 patent:2 also:2 earnings:4 which:1 income:1 analysts:1 's:3 though:1 after:1 driven:1 stocks:2 data:3 recent:2 surprising:1 reignite:1 well:1 claims:1 starting:1 latest:2
stock_LLY r_up	all:2 results:1 years:1 four:2 session:2 shares:1 its:10 previous:3 25:6 cut:2 21:1 zone:1 rose:5 had:2 expectations:3 failed:2 concerns:2 continued:2 suite:2 has:1 2010:10 expirations:1 combination:2 meanwhile:1 beat:1 increases:2 background:1 despite:3 month:1 disappointed:2 gloom:2 --:2 follows:1 posts:2 fewer:1 testimony:2 erodes:1 stock:3 better-than-expected:2 shedding:2 because:1 estimates:2 competition:1 second:3 economic:4 pricing:2 year:2 revises:1 3.8:1 mood:1 lead:1 profit:7 comments:2 forecast:1 increase:2 pressures:2 version:1 closed:1 net:3 ground:2 announced:1 core:2 after:1 dropped:2 reported:3 108:1 offset:2 losing:2 100:2 strong:2 beginning:2 abroad:2 gained:2 quarter:1 30:2 drug:3 a.m.:1 faces:1 slightly:1 maker:5 raised:1 industrial:1 followed:2 revenue:2 throughout:1 decline:1 swift:2 due:1 per-share:1 grow:2 growth:3 euro:1 markets:1 500:2 ``:3 drugs:3 company:4 corrected:1 but:5 demand:2 hopes:2 surged:2 second-quarter:4 posted:1 '':2 handily:1 uncertain:2 showed:1 16:12 depressed:1 up:1 89:1 unusually:2 closing:1 acquisition:1 numbers:1 losses:2 1.1:2 outstanding:1 share:1 sales:7 reignited:2 expenses:1 helped:2 full-year:1 periods:1 orders:1 relatively:1 recovery:2 5.7:3 generic:1 detail:1 also:2 lifts:2 earnings:3 which:1 income:1 outlook:5 reversed:1 higher:2 added:1 's:7 though:1 price:4 published:1 treatments:4 fueled:1 4th:1 coming:1 data:3 eighth:1 recent:1 rallied:2 lower:1 chalks:1 futures:6 patent:1 points:8 components:2 time:2 meet:2
stock_LLY r_up	biotech:1 proved:1 investors:1 share-price:1 best:1 takeovers:2 their:1 stock:1 terms:1 gains:1 roster:2 price:1 pharma-biotech:1 haven:1 tags:1 recent:1 --:1 windfall:1 t:1 worst:1 eye-popping:1 shows:1
stock_LLY r_up	represent:1 emerging:1 background:1 partnership:2 share:1 focus:1 talks:1 rushing:1 market:3 if:1 huge:1 said:1 adds:1 would:1 positive:1 outside:1 should:1 vaccines:1 only:1 other:1 potentially:1 details:1 which:1 new:1 markets:1 stock:1 do:1 's:4 drugs:1 updates:1 significant:1 prices:1 such:1 data:1 companies:1 drug:1 patients:1 venture:1 growing:1 grab:1 first:1
stock_LLY r_down	appeals:3 challenged:2 competition:1 because:1 year:1 generic:1 court:3 additional:1 federal:5 decision:1 had:3 detail:1 anti-cancer:3 late:1 way:1 ruled:3 issue:1 may:1 earlier:1 said:1 expired:1 manufacturer:2 case:1 made:1 --:2 clear:1 drug:5 patent:9 ruling:4 claims:1 2009:2 affirmed:2
stock_LLY r_down	cut:2 countries:2 pinch:2 medicines:2 including:2 they:2 pay:2 prices:2 feeling:2 makers:2
stock_LLY r_up	received:1 said:1 letters:1 activities:1 government:1 federal:1 seeking:1 bribery:1 drug:1 its:1 countries:1 information:1 connection:1 foreign:1 has:1 maker:1 law:1
stock_LLY r_up	's:3 stranger:1 show:2 executive:1 departures:1 fells:2 no:1 suite:1 world:1 corporate:1 latest:2
stock_LLY r_down	lowers:2 outlook:2 says:1 revenue:1 sales:2 related:1 trading:1 result:1 year:1 its:2 patent:3 forecast:1 2:1 deficit:1 has:1 more:1 lowering:1 full:1 company:1 attention:1 fall:1 than:1 case:2 lost:1 drug:1 loses:2 ruling:1 after-hours:1
stock_LLY r_down	saying:1 major:1 late-trading:1 surprises:2 ground:1 certain:1 into:1 year:1 back:1 slowing:1 quarters:1 down:2 session:3 trading:2 3.3:2 during:1 capping:1 seen:1 rough:1 find:1 declined:1 3.9:1 4.4:1 renewed:1 rose:1 while:1 shares:4 indexes:1 late:2 advisories:2 royalty:1 points:5 growth:1 earnings:1 closed:1 ruling:2 has:1 might:1 9.1:1 500:2 higher:2 week:1 roundup:1 after:2 's:1 mostly:1 whose:2 signs:1 company:1 rallies:2 discontinue:1 red:1 fell:2 fall:1 trade:2 news:1 buyout:2 stocks:2 gained:1 loss:1 lower:1 17:2 lost:1 corporate:1 future:1 drop:1 companies:3 up:2 reports:1 slide:2 actively:2 economic:1 payments:1 after-hours:1 small:1 traded:1 latest:1
stock_LLY r_down	caused:1 mainly:1 focus:1 brain:1 session:3 shares:3 skin:1 whose:3 giant:1 slow:1 $:2 rose:4 had:2 analyst:1 charge:1 production:1 treatment:4 premarket:1 8:1 include:1 gave:1 updated:1 risk:1 seeking:1 advances:1 bid:1 possible:1 condition:1 chronic:2 55:1 underscores:1 --:2 retailers:1 after-hours:1 did:1 stock:3 round:1 bleeding:1 companies:3 elderly:1 past:1 actively:3 trading:3 result:1 year:1 pain:3 2.1:1 even:1 said:4 capacity:1 decision:1 comments:1 outside:1 safety:1 new:1 conditions:2 after:3 led:1 risen:1 given:1 difficulty:1 reason:1 takeover:1 key:1 ask:1 news:1 strong:1 beginning:1 panel:1 gained:1 reaction:1 quarter:1 climbed:1 drug:2 fell:1 mixed:1 studies:2 experimental:1 late-stage:1 fertilizer:1 industrial:1 cancer:1 encouraging:1 61:1 rising:3 approval:1 should:1 use:1 investors:1 8.7:1 utilization:1 two:1 expected:1 500:3 company:1 strikes:1 liver:1 2.16:1 than:1 has:1 third:1 showed:3 16:1 whether:1 expanded:1 up:4 halt:1 n't:1 patients:2 economic:1 risks:1 stages:1 spotlight:2 1.5:2 slid:1 rebuffed:1 associated:1 1.2:1 1.3:2 1.9:1 experts:1 reports:2 have:1 close:1 technology:1 increased:1 rather:1 damage:1 1:1 materials:1 earnings:2 higher:3 development:3 such:1 's:15 may:1 price:1 earlier:1 treatments:1 halted:2 4th:1 coming:1 improving:1 climbing:3 stocks:4 data:2 concerns:1 billion:1 effective:1 amid:1 medical:1 futures:1 disease:4 antidepressant:1 points:4 traded:3 components:1 corporate:1 latest:1
stock_LLY r_up	comment:1 advisory:1 raised:1 engagement:1 suitors:1 proposed:1 fall:1 halting:1 likely:1 including:1 concerns:1 company:1 news:1 pain:1 out:1 committees:1 potential:1 additional:1 candidate:1 rather:1 review:1 there:1 treatment:1 shares:1 indexes:2 drugs:1 other:1 safety:2 treat:3 which:1 under:1 drawn:1 meeting:1 brand:1 more:1 development:1 product:1 rise:2 's:6 may:1 sold:1 arthritis:1 joint:1 abuse:1 pursuit:1 background:1 wedding:1 misuse:1 during:1 than:1 develop:1 fibromyalgia:1 name:1 --:2 shotgun:1 disease:2 drug:5 slide:2 so:1 faces:1 difficult:1 disorder:1 maker:1 late-stage:1
stock_LLY r_down	comment:1 advisory:2 nerve:1 caused:1 back:1 chronic:3 knee:1 its:2 depression:1 narrowly:2 use:2 fibromyalgia:1 treatment:3 treat:1 product:1 pain:6 seeking:1 backed:2 such:1 approval:1 effort:2 approved:1 expand:2 panel:2 lower:1 anxiety:1 last:1 --:2 antidepressant:2
stock_LLY r_down	set:1 consider:2 proposed:1 dividend-paying:2 junk:1 competition:1 years:1 '':1 names:1 have:2 partly:1 linked:1 high-risk:1 busy:1 investors:1 woes:1 patent:1 offer:1 been:1 next:1 few:1 citing:1 concerns:1 safety:2 treat:1 biggest:1 so:1 you:1 bored:1 frustrated:1 more:1 development:1 paying:1 ``:1 pain:1 roster:2 far:1 dividends:1 stop:1 's:4 rejected:1 sellers:1 depths:1 pools:1 flown:1 recent:1 demand:1 strategists:1 stocks:2 downgraded:1 panel:1 abused:1 both:1 notch:1 fibromyalgia:1 healthy:1 egg:1 could:1 well:1 disease:1 drug:3 face:1 leave:1 generic:1 yields:2 can:1 recall:1 plumbing:1 misused:1 stock:1 disorder:1 maker:1 bond:1
stock_LLY r_up	used:1 associated:1 plans:1 combat:1 also:1 --:1 could:1 severe:1 drug:1 often:1 whether:1 see:1 test:1 obesity:1 its:1 condition:1 diabetes:2
stock_LLY r_up	sector:1 pharmaceutical:1 patent:1 's:3 ahead:1 tougher:1 healthy:1 months:1 companies:1 regulation:1 face:1 may:1 second:1 itself:1 health:1 reforms:1 trouble:1 quarter:1 find:1 care:1
stock_LLY r_down	development:2 all:1 own:2 revamp:2 month:1 individual:1 trading:1 controversial:1 cuts:2 strategy:1 its:4 unit:1 string:2 setbacks:2 stocks:1 jumped:1 though:1 outpacing:1 research:2 fire:2 health:2 under:2 include:2 gains:1 cost-cutting:2 's:1 around:2 business:2 exchange:1 may:2 funds:1 were:1 volume:1 efficiency:2 job:2 plan:2 reforms:2 world:2 austerity:2 come:2 care:2 has:2 last:1 programs:2 --:2 amid:2 exchange-traded:1 rival:1 quarter:1 traded:1 options:2 launched:2
stock_LLY r_up	emerging:1 help:1 declines:1 into:1 sales:1 further:1 its:2 said:1 pharmaceuticals:1 patent:1 mix:1 intends:1 program:1 health:1 screening:1 animal:1 interview:1 has:1 markets:1 product:1 's:2 critics:1 drugs:1 funds:1 company:1 looming:1 diversifying:1 protection:1 key:1 offset:1 losing:1 expand:1 --:1 invest:1 keep:1 venture:1
stock_LLY r_up	litigation:1 appeals:1 court:1 antipsychotic:1 certification:1 federal:1 over:1 against:1 its:1 drug:1 class:1 out:1
stock_LLY r_up	because:1 shoes:2 two-day:1 over:1 health-care:1 mission:2 past:1 session:1 have:1 year:1 owner:1 beyond:2 its:1 court:1 ads:1 spending:1 workers:1 been:1 goes:2 grand:2 gets:1 math:1 customers:1 selling:2 's:5 drugs:1 keeping:1 happier:1 happening:1 victory:1 learn:1 changes:1
stock_LLY r_up	control:1 strengthened:1 unclear:1 weight:1 series:1 blood:1 focus:1 effects:1 including:1 been:2 have:2 year:1 its:2 shown:1 said:2 adds:1 relationship:1 lead:3 develop:1 had:2 comments:1 sugar:1 1:1 failed:1 potential:1 treatment:4 which:2 development:3 puts:1 earlier:1 's:2 halt:2 efficacy:1 loss:1 company:1 after:1 but:1 possibly:1 paid:1 upfront:1 path:1 analyst:1 diabetes:3 stock-price:1 last:1 candidate:2 effective:1 developing:2 --:1 study:2 companies:1 disease:1 drug:2 $:1 n't:1 benefit:1 plus:1 context:1 activity:1 meet:1 endpoints:1 other:1 million:1
stock_LLY r_up	session:1 moved:1 years:1 growth:1 trading:1 market:1 whose:1 actively:1 23:1 rose:1 shares:1 continue:1 5:1 animal:1 expected:1 health:1 500:1 higher:1 coming:1 102:1 stocks:1 11:1 climbed:1 companies:1 up:1 points:3 traded:1
stock_LLY r_down	1.4:1 1.5:1 major:1 1.7:1 increasingly:1 moved:1 session:1 trading:1 establish:1 relationships:1 whose:1 rose:1 shares:1 500:1 higher:1 pharmaceutical:1 small:1 stocks:1 pool:1 organizations:1 --:1 traded:1 industry:1 climbed:1 companies:2 up:2 large:1 actively:1 after-hours:1 long-term:1 shaking:1
stock_LLY r_down	paying:1 's:1 unauthorized:1 lead:1 illegal:1 doctors:1 drug:1 promoting:1 take:1 kickbacks:1 uses:1 trying:1 lawsuit:1 unit:1 improperly:1
stock_LLY r_down	needs:1 said:1 --:1 global:1 tax:1 revamp:1 system:1 better:1 so:1 can:1 compete:1 businesses:1 its:1 economy:1
stock_LLY r_down	10:3 crazy:1 everyone:1 's:2 top:1 list:1 we:2 slap:1 up:1 '':1 moment:1 'd:1 so:1 dividend:1 stocks:1 ``:1
stock_LLY r_up	said:1 potential:1 rights:1 drugs:1 reach:1 seeking:1 acquire:1 companies:1 next:1 few:1 chief:1 actively:1 market:1 research:1 years:1 its:1 other:1 experimental:1
stock_LLY r_up	already:1 says:1 help:1 involve:1 including:1 have:1 year:1 its:1 1,000:1 trials:1 three:1 start:1 3:1 program:1 pivotal:1 treatment:1 clinical:1 has:1 pill:1 announced:1 's:1 ability:1 transactions:1 company:1 arthritis:2 standard:1 new:1 phase:1 2014:2 --:1 studies:1 medicines:1 well:1 responded:1 n't:1 considered:1 patients:1 chief:1 investigating:1 other:1 rheumatoid:2 called:1 late-stage:1
stock_LLY r_up	comment:1 control:1 they:1 deal:4 clinical:1 doses:1 searching:1 competition:1 sign:1 10-year:3 drug:3 picked:1 partner:2 2.2:3 throughout:1 seek:1 its:2 significantly:1 pharmaceutical:1 giant:1 cut:1 $:3 trial:1 generic:1 sugar:1 outsourcing:2 comments:1 research:5 also:1 2:1 safety:1 details:2 statement:1 new:1 has:2 worth:3 treat:1 development:3 increased:1 drugs:3 sixth:1 company:2 said:1 agreement:1 looming:1 results:1 contract:2 outsource:1 levels:1 blood:1 background:1 coming:1 services:1 years:1 investor:1 day:1 diabetes:1 billion:3 concerns:1 no:1 improved:1 showed:1 ahead:1 reported:1 --:3 could:3 later:1 companies:1 up:3 signed:1 face:1 chosen:1 patients:1 costs:1 products:1 promising:1 study:1 starting:1 maker:3 experimental:1 latest:1
stock_LLY r_down	respond:1 saying:1 smaller:1 deal:1 biotech:1 share:1 sales:1 slap:1 up:1 likely:1 gobbling:1 directly:1 69:1 seem:1 speed:1 makers:1 pharma:1 shareholders:1 bribes:1 end:1 $:2 variety:1 ways:1 much:1 mark:1 looking:1 their:1 only:1 2:2 call:1 take:1 goes:3 dividends:1 finding:1 boost:1 firm’s:1 500:2 billion:1 we:2 enable:1 offer:1 approvals:1 bid:1 earlier:1 studies:1 fat:1 site:1 big-ticket:1 pursuit:2 mount:1 goal:1 paying:1 hostile:3 anything:1 launches:1 could:2 companies:1 cash:1 drug:5 patients:1 future:1 analysts:1 through:1 overseas:1 late-stage:1 18.5:1 maker:1 related:1 investigators:1
stock_LLY r_up	paying:2 bribes:2 variety:2 ways:2 speed:2 could:2 sales:2 drug:4 looking:2 approvals:2 overseas:2 boost:2 makers:2 investigators:2
stock_LLY r_up	0.9:1 advisory:1 raised:1 receiving:1 file:1 cancer:1 ca:1 testing:1 some:1 head:1 existing:1 down:1 misuse:1 trading:1 concerns:1 committee:1 compared:1 endpoint:1 its:2 said:2 potential:1 treat:1 trial:1 agency:1 application:1 clinical:1 safety:1 treatment:2 which:1 recent:1 meeting:1 company:1 told:1 wants:1 product:1 focuses:1 's:2 premarket:1 form:1 wo:1 price:1 after:1 primary:1 abuse:1 placebo:1 others:1 included:1 approval:1 analyst:1 present:1 $:1 reaction:1 short:1 fibromyalgia:1 neck:1 developing:1 --:1 study:1 drug:3 n't:2 more:1 patients:1 fell:1 products:1 were:1 taking:1 stock:1 approve:1 maker:1 late-stage:1
stock_LLY r_up	supply:1 major:1 because:2 revenue:1 cuts:1 lines:1 national:1 health-care:1 some:1 sales:1 quarters:1 added:1 expect:1 have:3 year:1 makers:1 declined:1 subject:1 cut:1 consumers:1 reform:1 patent:1 bigwigs:1 third-quarter:1 been:2 credit-ratings:1 also:2 health:1 earnings:1 several:1 sagging:1 earlier:1 recently:1 upcoming:1 offer:1 drugs:2 big:1 price:1 after:1 problems:1 pipeline:1 big-name:1 back:1 most:1 boosting:1 news:1 post:1 expiry:1 than:1 those:1 recent:2 acquisitions:1 well:1 lower:1 issues:1 programs:1 charges:1 industry:1 bottom:1 companies:2 drug:1 skewed:1 their:1 downbeat:1 costs:1 either:1 pressure:1 slightly:1
stock_LLY r_up	prospects:1 cautious:1 but:1 investors:1 getting:1 --:1 expanded:1 sales:1 shares:1 looking:1 only:1 treatment:1 horizon:1 small:1 approval:1 addiction:1 still:1 boost:1 bigger:1 developments:1
stock_LLY r_up	examining:1 dogged:1 anti-obesity:1 variety:1 drugs:1 some:1 sold:1 humans:1 regulators:1 dog:1 n't:1 whether:1 only:1 safety:1 effects:1 treatment:1 genetically:1 health:1 side:1 issues:1 breeds:1
stock_LLY r_up	week:1 among:1 's:1 tape:1 earnings:1 others:1 thick:1
stock_LLY r_up	comment:2 rating:2 'better:1 woes:2 over:2 global:2 number:2 competition:2 group:6 disappointing:2 say:1 have:1 year:2 wider:2 close:2 economist:1 its:4 market:2 pharmaceutical:4 said:2 20:3 credit:2 patent:2 review:2 government:1 makers:2 citing:2 details:1 new:2 increasing:2 stock:1 development:2 product:2 's:7 business:2 bonds:1 company:2 continues:1 gander:1 halted:2 cut:2 part:2 background:1 dividend:1 stocks:1 than:1 closure:2 past:2 pickers:1 --:2 hunt:1 list:1 yield:1 generic:2 products:2 reception:2 faces:2 comes:2
stock_LLY r_down	sector:2 just:1 move:1 setback:1 rocked:1 during:1 its:7 issues:1 letting:1 $:2 lackluster:1 rose:1 has:1 2010:1 earnings:1 then:1 which:1 long-acting:1 early:1 background:2 report:1 using:1 bringing:1 bank:1 --:2 debut:2 companies:1 common:1 downward:2 quarter:1 reduced:1 estimates:1 trading:1 projections:1 exceeded:1 substantially:1 reconsider:1 makers:2 declined:2 total:1 opened:1 lead:3 profit:1 jumped:1 decision:1 since:1 outsourcing:1 shares:3 research:1 increase:1 version:1 new:2 net:1 bought:1 sold:1 million:1 repurchase:1 approval:1 strong:1 beginning:1 faced:1 drug:6 massive:1 approve:1 maker:2 comment:2 major:1 revenue:1 year:1 two:1 regulatory:2 news:3 throughout:1 market:1 third-quarter:1 clinical:1 rates:1 interest:1 1.55:1 expected:1 wants:1 flat:1 debit-card:1 company:3 analyst:1 10:1 developing:1 18:1 while:2 ongoing:1 were:1 firm:1 investors:1 outstanding:1 delaying:1 sales:2 partner:1 technology:1 again:1 4.7:3 agency:1 details:2 widely:1 income:1 performance:1 stock:3 week:2 's:5 boosted:1 price:1 after:2 treatments:1 falls:1 fell:1 plan:1 data:1 diabetes:1 billion:2 decliners:1 order:1
stock_LLY r_down	looked:1 pointing:2 fears:2 focus:1 setback:2 session:5 article:1 yet:1 thyroid:1 whose:3 20:1 22:1 rose:7 had:1 only:1 going:1 approve:2 has:3 3.8:1 which:2 long-acting:3 big:1 firmer:1 early:2 five:1 new:4 report:1 using:2 day:1 drugmaker:1 59:1 lost:2 --:5 drop:2 companies:7 bad:2 16:1 after-hours:1 worries:1 higher:4 gaining:1 set:1 competition:1 batch:1 3.6:1 see:1 actively:3 trading:4 substantially:2 reconsider:2 declined:2 gainers:1 rate:2 since:2 repurchase:2 while:2 shares:3 version:3 closed:1 surprise:3 letting:2 rolled:1 sold:2 pressure:1 key:2 others:1 regulatory:3 approval:2 100:2 declining:1 gained:5 reaction:1 recovering:1 rethink:1 30:1 drug:6 plunging:1 prior:1 s:1 published:1 traded:2 major:3 near-term:1 one:1 active:1 soaring:1 rising:1 another:1 news:2 tomorrow:1 market:4 investors:3 likely:1 start:2 hospital:1 three:1 their:1 clinical:2 biggest:1 500:5 wants:3 roundup:2 expected:2 those:2 10:2 ahead:1 developing:2 recall:1 up:3 hike:2 patients:1 were:2 wild:1 strategies:1 treated:1 1.4:1 1.5:2 1.1:1 1.2:2 1.3:1 delaying:2 moved:3 have:2 9.75:1 technology:2 again:3 drubbing:1 agency:2 radiation:1 delay:2 other:1 earnings:3 widely:2 stock:4 week:3 product:1 's:4 5.1:1 may:2 stay:1 connected:1 two:2 stocks:5 data:2 diabetes:4 amid:1 futures:2 daily:1 mortgages:2 points:12 components:1 worst:2 decliners:1 order:2
stock_LLY r_down	sector:3 breadth:1 help:2 proposed:1 saying:1 sales:4 over:1 move:1 sights:1 results:2 years:2 not:2 session:2 including:4 comments:1 cuts:2 year-earlier:2 its:15 fifth:1 previous:2 setbacks:5 whose:2 giant:1 ratio:1 $:9 hovers:1 justice:1 rose:7 workers:1 expectations:1 than:1 makers:2 charge:2 compelling:1 premarket:1 annual:1 quarterly:3 has:1 might:2 2010:3 details:1 modestly:1 retire:1 gains:2 long-acting:1 material:1 possible:1 propelled:2 wave:2 updates:1 background:1 international:1 report:2 trade:1 continued:1 day:3 string:2 target:1 loss:1 name:1 hiring:1 --:6 12th:1 companies:6 appropriate:1 loses:1 benefit:1 continue:3 index:1 follows:3 further:2 stock:2 noted:1 better-than-expected:1 commitment:1 deal:1 series:2 successfully:2 estimates:1 around:1 cash:1 growth:2 trading:4 optimism:2 measure:2 7th:1 2.2:1 insurance:1 2.4:1 widely:1 initiatives:1 said:7 encouraging:3 38.60:2 decision:3 profit:8 review:2 shares:3 forecast:3 current:4 version:2 stock-index:1 graph:1 hefty:1 new:1 before:2 boost:1 leader:2 cost-cutting:1 franc:1 after:3 recently:1 ability:2 extend:2 seventh:1 million:4 weak:2 flow:1 drug:9 protection:3 buyback:2 downgrade:2 dividend:1 100:1 strong:3 beginning:1 relying:2 earlier:1 gained:4 reaction:2 39:1 38:12 reported:1 1.4:1 climbed:2 put:1 asset-sale:2 prior:1 takeover:2 a.m.:1 analysts:1 published:1 usually:1 traded:3 maker:4 comes:1 comment:2 among:2 raised:6 airline:2 revenue:4 effective:1 year:1 period:4 due:1 down:3 improving:1 62:1 1.7:1 commissioners:1 names:1 diabetes:4 climbing:1 vote:1 strategy:4 consider:2 buoyed:1 cost:2 use:1 pushes:1 confident:1 rebounded:1 third-quarter:7 been:1 next:3 few:2 choppy:1 interest:1 tepid:3 taken:1 closed:3 start:1 500:2 more:1 firm:1 resumed:1 ``:3 peer:1 stokes:1 drugs:2 share:4 company:6 under:1 corrected:1 pipeline:2 but:3 0.4:1 2015:1 economic:1 wake:1 year’s:1 doubts:2 believe:1 95:1 analyst:3 he:1 '':3 rush:2 property-casualty:1 rejection:1 14:1 currency:1 edged:1 up:5 1180:1 pace:1 while:2 actively:2 can:1 9th:1 were:1 following:1 again:1 led:1 0.9:1 block:1 larger:1 investors:2 navigate:4 10th:1 moved:2 1.9:2 weighed:2 quarter:2 full-year:1 itself:1 reports:5 have:3 guidance:1 partner:2 blockbuster:3 yet:1 viewed:1 relatively:2 information:1 moves:2 recovery:2 5.6:1 patent:5 47:1 make:1 detail:1 topped:2 2.6:1 also:2 high:1 concerns:1 earnings:12 which:7 interview:1 difficult:2 several:1 erosion:2 higher:11 development:1 added:3 's:26 plans:3 though:3 our:1 boosted:1 price:2 reporting:1 expirations:2 took:1 replace:1 helped:3 hamstrung:1 easing:1 throughout:1 adds:2 stocks:5 data:1 recent:3 posted:1 800:1 off:1 third:1 largely:1 charges:2 approve:1 medical:1 futures:3 well:1 overshadowed:1 thought:1 jitters:1 points:11 so:1 '09:2 failures:2 senior:1 2009:7 corporate:5 blue-chip:2 gain:2
stock_LLY r_down	biotech:1 partial:1 examining:1 month:1 held:1 mater:1 3.5:1 privately:1 reports:1 innovative:1 subpoenaed:1 its:1 use:1 said:2 profit:1 surprises:2 been:1 next:1 advisories:2 earnings:1 disclosed:1 listing:1 net:1 has:1 discovery:1 firm:1 's:2 familiar:1 million:1 fell:1 plan:1 saying:1 authorities:1 quarters:1 generate:1 diabetes:1 roundup:1 third:1 companies:1 up:1 drug:2 person:1 future:1 quarter:1 corporate:1 latest:1
stock_LLY r_down	comment:1 biotech:2 major:2 closely:2 being:2 sepsis:4 within:2 sales:2 dosing:2 held:2 substantial:2 measure:2 100:2 its:4 market:2 if:2 said:4 $:2 giving:2 began:4 28:2 shares:2 than:2 300:2 treatment:2 interest:2 which:2 medicine:2 new:4 boost:2 more:2 royalties:2 's:4 mid-stage:2 drugs:2 million:2 number:2 expected:2 compared:2 background:1 announce:2 receive:2 line:2 analyst:1 those:2 treating:2 purchase:2 off:2 --:2 treated:4 infections:2 days:4 drug:4 spend:2 aim:2 trial:6 patients:4 acquisition:2 venture:2 small:2 makes:2 maker:2 experimental:2 first:6
stock_LLY r_down	still:1 does:1 shed:1 because:1 sales:2 certain:1 some:1 results:1 expectations:1 weighed:1 divestitures:1 full-year:1 been:1 dropped:1 have:1 throughout:1 tools:1 its:3 declined:1 pharmaceutical:1 while:3 settlement:1 end:1 quality:1 also:2 profit:1 seek:1 guidance:3 sidelined:1 third-quarter:1 comments:1 research:1 adjusted:1 issues:1 citing:1 noting:1 details:1 which:1 raft:1 outlook:1 recent:1 2010:1 low:1 slowdowns:1 's:1 business:2 excludes:1 any:1 earnings:1 company:2 exactly:1 diagnostic:1 although:1 legal:1 down:1 39:1 include:1 improved:1 ahead:1 triggers:1 charges:2 light:1 companies:1 disease:1 n't:1 --:2 benefit:1 products:1 stand:1 were:1 following:1 raised:1 quarter:1
stock_LLY r_up	raised:1 1.2:1 sales:1 full-year:1 actively:1 trading:1 dropped:1 research:1 seek:1 its:1 whose:1 emerging:1 strong:1 tools:1 third-quarter:1 shares:1 forecast:1 increase:1 points:2 shed:1 diabetes:1 markets:1 2010:1 500:1 's:1 pharmaceutical:2 company:1 exactly:1 treatments:1 diagnostic:1 driven:1 fell:1 stocks:1 posted:1 lower:1 12:1 improved:1 14:1 lost:1 triggers:1 light:1 companies:2 disease:1 benefit:1 session:1 stand:1 traded:1 profits:1
stock_LLY r_up	help:1 investors:1 venture-backed:1 sign:1 shutdown:1 develop:1 hitting:1 finally:1 today:1 notice:1 around:1 dividends:1 highs:1 treatments:1 but:1 setback:1 come:1 diabetes:1 could:1 n't:1 push:1 fresh:1 starting:1 latest:1
stock_LLY r_up	rejection:1 get:1 --:1 year:1 drug:2 next:1 confident:1 weight-loss:1 can:1 approval:1 regulatory:1 meet:1 requests:1 2011:2 its:2
stock_LLY r_down	deals:1 right:1 says:2 sail:1 no:1 should:1 executive:1 day:1 n't:2 chief:1 ignore:1 call:1 officer:1 transformative:1 yes:1 boss:1 's:1 until:1 he:1
stock_LLY r_up	projections:1 pipeline:1 big:1 third-quarter:1 call:1 earnings:1 generics:1 10-year:1 new:1 its:2 today:1 gave:1
stock_LLY r_up	withstand:1 proposed:1 health-care:1 expects:1 setback:1 election:1 diabetes:1 year:1 intact:1 its:1 declined:1 said:2 overhaul:1 remain:1 suffered:1 he:1 's:2 bulk:1 regulators:1 despite:1 anti-overhaul:1 recent:1 --:2 drug:3 chief:1 victories:1 can:1 landmark:1 approve:1 maker:2
stock_LLY r_up	current:1 cut:1 group:1 unsustainable:1 form:1 ways:1 --:1 generally:1 looking:1 spending:1 wrong:1 program:1 's:3 accepted:1 its:1
stock_LLY r_down	control:1 insurers:1 overhaul:1 still:1 many:1 taking:1 health-care:1 companies:1 drug:1 planning:1 campaigns:1 said:1 health:1 stick:1 they:1 were:1 central:1 repeal:1 hospitals:1 law:1 if:1
stock_LLY r_up	all:1 they:1 agreed:1 global:1 competitive:1 month:1 held:1 signs:1 its:1 help:1 setbacks:1 giant:2 based:1 $:4 had:1 citing:1 other:1 equity:1 stable:1 merged:1 giants:1 long-acting:1 portfolios:1 showing:1 watch:1 consolidation:1 closely:1 compound:1 developments:1 brain:1 identified:1 morning:1 mergers:1 bankruptcies:1 bolstering:1 related:1 platforms:1 said:1 version:1 between:1 bought:2 litigation:1 300:3 spot:1 million:2 imaging:2 recent:2 others:1 downgrade:2 news:1 downgraded:2 pipeline:2 last:1 industry:1 drug:2 leaving:1 trial:1 products:1 midway:1 patents:1 late-stage:1 among:1 outlook:1 private:1 put:1 tiny:1 bolster:1 pharmaceutical:1 working:1 been:1 their:2 clinical:1 biggest:1 territory:1 reflects:1 more:1 firm:1 ``:2 upcoming:1 drugs:1 company:3 acquire:1 rejected:1 indicators:1 doctors:1 those:1 financing:1 look:1 up:1 flagship:1 binds:1 patients:1 gathers:1 expiration:1 called:1 '':2 have:2 ratings:2 patent:1 adverse:1 potential:2 which:1 plus:1 erosion:1 development:1 junk:1 's:10 after:1 problems:1 preliminary:1 500:1 data:1 concerns:1 diabetes:1 acquisitions:1 peers:1 amid:2 well:1 disease:3 diagnostics:1 position:1 notch:1
stock_LLY r_up	attorney:3 statements:4 deal:1 into:2 influence:2 back:1 one:4 down:1 weakens:1 something:1 lawyer:1 false:4 counts:2 throughout:1 makers:1 uptick:1 documents:2 proceeding:2 federal:3 spur:1 writes:1 agency:2 handed:1 deal-making:1 start:1 investigation:2 details:1 statement:1 grand:1 indictment:1 's:1 company:1 hope:2 stock:1 illegally:2 jury:1 may:1 dollar:2 price:1 regulators:2 4th:1 updates:1 background:1 cash-rich:1 prescription:2 obstructing:4 beginning:1 former:3 recent:1 count:4 four:2 prosecutors:2 whether:2 official:2 companies:1 drug:6 spend:1 deals:1 giving:1 growth:1 announced:1 promoted:2 making:4 speculation:1 more:2 maker:1 charged:4
stock_LLY r_down	temporarily:1 health-care:1 second:1 least:1 have:2 affected:1 said:1 weakened:1 trials:1 been:1 clinical:1 's:4 schedule:1 company:1 running:1 appears:1 recent:1 ahead:1 studies:1 disease:2 drug:2 n't:1 termination:1 start-ups:1 experimental:1
stock_LLY r_down	sector:1 erasing:1 producer:1 less:1 over:2 global:1 dollar:1 ended:1 its:1 rose:1 ease:2 4:1 indicating:1 gains:1 weakness:1 lost:1 --:1 bailouts:1 yield:1 morning:1 worries:1 nerves:1 speculation:1 higher:1 reduced:1 shed:1 eased:1 financial:1 some:1 loses:1 declined:1 index:1 blue-chip:1 remain:1 pressures:1 bailout:1 new:1 led:1 strained:1 unease:1 pressure:1 although:1 100:2 most:1 losses:2 round:1 slightly:2 slipped:1 down:1 67:1 intraday:1 their:2 pared:1 rates:2 stock:3 interest:2 expected:1 500:2 slips:1 finished:1 prices:1 than:1 showed:1 16:1 whether:1 18:1 up:1 while:3 ongoing:1 ruling:2 were:1 investors:1 0.1:1 accept:1 dropped:2 strength:1 weakened:1 patent:2 45:1 fears:1 potential:1 economy:2 's:1 after:2 fueled:1 fell:1 stocks:3 data:1 lower:1 futures:8 hikes:1 points:6
stock_LLY r_down	lowering:1 kind:1 good:1 's:1 significantly:1 showed:1 --:1 study:1 cholesterol:1 levels:1 bad:1 drug:1 met:1 while:1 involving:1 safety:1 goals:1 boosting:1 experimental:1
stock_LLY r_down	heart:1 because:1 pain:1 risk:1 --:1 leading:1 agreed:1 rhythms:1 pills:1 increase:1 drugs:1 concerns:1 products:1 take:1 serious:1 known:1 off:1 makers:1 market:1 said:1
stock_LLY r_up	agency:1 end:1 offering:1 real-estate:1 initial:1 estimates:1 public:1 debut:1 fell:1 low:1 edged:1 priced:1 its:2 after:1 higher:1
stock_LLY r_down	1.6:1 actively:1 trading:1 shares:1 have:1 families:1 seem:1 yet:1 declined:1 out:1 whose:1 use:1 potential:1 media:1 40:1 their:1 points:3 closed:1 conditions:1 500:1 9.3:1 's:3 may:1 social:1 regulators:1 fell:1 stocks:1 friends:1 day:1 those:1 lower:1 engage:1 lost:1 age:1 companies:1 drug:1 n't:1 patients:2 session:1 can:1 after-hours:1 serious:1 medical:1
stock_LLY r_up	comment:1 biotech:1 associated:1 although:1 do:1 executive:1 deals:1 '':1 large:1 tissue:1 want:1 type:1 's:3 surgery:1 any:1 n't:2 said:3 would:1 positive:1 due:1 adopted:1 event:1 application:1 interested:1 wants:1 treatment:1 which:2 largest:1 sidelines:1 2011:1 dogs:1 authorization:1 details:1 firm:1 independent:1 ``:1 pain:2 marketing:1 company:2 here:1 stay:1 orthopedic:1 shareholder:1 background:1 opinion:1 peers:1 --:2 discussing:1 industry:1 headquarters:1 consensus:1 chief:1 produce:1 management:1 2012:1 soft:1 could:1 block:1 partnerships:1
stock_LLY r_up	another:2 cancer:3 people:2 testing:1 year:1 setback:2 suspended:2 skin:1 its:2 information:1 said:3 melanoma:1 began:1 had:1 patients:3 any:1 better:1 clinical:2 treatment:2 advanced:1 more:1 ago:1 form:1 300:1 company:2 after:2 possibly:2 than:2 died:3 treating:1 12:2 third:1 older:1 whether:1 drug:4 spokeswoman:1 trial:3 connection:2 efforts:2 experimental:2
stock_LLY r_down	respond:1 says:1 ability:1 trial:1 certain:1 drug:1 n't:2 confident:1 clinical:1 questions:1 's:4 its:1
stock_LLY r_up	blue:1 index:1 caps:1 's:2 chips:1 list:1 midcaps:1 includes:1 know:1 dividend:1 small:1 fresh:1 senior:1 stocks:1 payers:1 analyst:1
stock_LLY r_up	drop:1 investors:1 point:1 bigger-than-expected:1 0.3:1 global:1 awaited:1 general:1 '':1 economic:1 trading:1 higher:1 add-on:1 weighing:1 factors:1 orders:1 market:1 before:1 index:1 use:1 said:1 sentiment:1 no:1 spending:1 negative:1 slew:1 increase:1 state:1 points:2 6:1 durable-goods:1 has:1 strategist:1 final:1 500:1 stock:2 firm:1 ``:2 edged:1 seeking:1 drift:1 's:1 mixed:1 moment:1 fell:2 therapy:1 half:1 approval:1 100:1 data:1 than:1 expand:1 diabetes:1 ahead:1 --:1 slightly:2 futures:4 up:1 drug:2 morning:1 session:1 insulin:1 were:2 following:1 more:1 consumer:1
stock_LLY r_down	9:2 's:2
stock_LLY r_down	26:1 now:1 word:1 expects:1 around:1
stock_LLY r_up	figure:1 tougher:1 year:1 number:1 years:1 escaped:1 looks:1 during:1 's:1 its:1 relatively:1 24:1 pharmaceutical:1 21:2 monthly:1 higher:1 yet:1 environment:1 few:1 potential:1 safety:1 low:2 new:2 has:1 2010:4 18:1 shows:1 website:1 partly:1 25:1 drugs:2 got:1 delayed:1 but:2 blockbusters:1 reflecting:1 others:1 regulatory:1 approval:1 drought:1 approved:2 types:1 recent:2 down:1 concerns:1 won:1 --:1 amid:1 industry:1 drug:1 n't:1 reports:1 ongoing:1 2007:1 were:1 2008:3 2009:3
stock_LLY r_down	one:1 better:1 buy:1 's:2 like:1 expert:2 10:2 may:1 year:1 least:1 picks:2 n't:2 analysts:1 pick:1 off:1 hold:1 stocks:1 2011:2 buying:1 stock:3
stock_LLY r_down	standing:2 shareholders:2 potential:2 's:2 way:2 would:2 unload:2 big:2 could:2 initiatives:2 likely:2 decided:2 growth:2 slash:2 many:2 dividend:4 its:2 stock:2
stock_LLY r_down	own:1 being:1 developed:2 chunk:1 executive:1 sales:1 pushed:1 stroke:1 including:1 expect:1 reports:1 vote:1 80:2 blockbuster:1 pills:1 market:2 staff:1 said:1 $:2 away:1 repeal:1 rivals:1 does:1 take:1 new:2 health-law:1 type:2 questioned:2 product:2 's:1 big:1 arthritis:2 now:2 he:1 off:1 success:1 effective:2 --:2 approach:1 drug:1 n't:1 whether:2 patients:1 products:2 shows:1 rheumatoid:1 replacement:2
stock_LLY r_up	alliance:4 help:1 hears:1 partnership:1 share:1 period:1 years:1 four:1 weather:1 benefit:1 unveiled:2 seen:1 next:1 plans:2 pharmaceutical:2 mid-:2 develop:4 business:1 asks:1 also:1 patent:1 trials:1 make:1 initial:1 detail:1 least:1 should:1 1:2 few:1 health:1 which:1 new:1 product:1 announced:2 difficult:1 development:3 beyond:1 generating:1 's:4 expirations:1 form:2 marketing:1 company:2 million:2 treatments:3 jointly:3 sales:1 said:1 peak:1 milestone:1 regulatory:1 strategic:4 payment:1 diabetes:5 billion:1 pipeline:4 --:3 eligible:1 companies:1 up:1 mid:1 replacement:1 agreement:1 chief:1 costs:1 2020:1 payments:1 venture:1 2008:2 diabetes-drug:1 essential:1 maker:1 late-stage:3
stock_LLY r_up	comment:1 developed:2 health-care:1 ``:1 evidence:1 '':1 substantial:1 audiences:1 drug:2 subsidiary:1 vote:1 their:1 unit:1 standing:1 appear:1 said:3 additional:1 prior:1 support:1 should:1 current:1 also:1 clinical:1 potentially:1 market:1 new:2 effectiveness:1 type:2 product:2 's:2 efficacy:1 business:1 rejected:1 compared:1 approval:1 data:1 concerns:1 panel:4 effective:2 --:2 companies:1 submitted:1 n't:5 did:2 products:1 strategies:1 studies:1 replacement:3
stock_LLY r_down	producer:1 less:1 developed:1 lack:1 trade:2 produced:1 committee:2 its:2 digest:1 weekly:1 25:1 giant:1 rose:1 workers:1 had:3 labor:1 voted:1 dominated:1 2010:2 his:1 increased:1 food:1 therapy:1 international:2 front:1 during:1 --:4 did:1 replacement:2 shed:1 because:1 questions:1 people:1 unexpectedly:1 economic:1 submitted:1 close:1 index:2 said:4 funding:1 blue-chip:1 since:1 sites:1 current:1 1.70:1 unit:1 new:2 degree:1 drug:2 put:1 approval:2 100:3 additional:3 pancreatic:2 benefits:1 ahead:1 's:4 prior:2 a.m.:1 massive:1 usually:1 studies:2 raised:1 slipped:2 point:4 number:1 one:1 down:2 dividend:1 vote:1 should:1 market:2 considering:1 use:1 jobless:2 support:1 been:3 clinical:1 recommend:1 pancreas:1 meeting:1 500:2 treatment:1 ``:2 posting:1 efficacy:2 rejected:1 released:1 prices:1 highest:1 than:1 high:1 14:1 16:1 type:1 up:2 advocacy:1 n't:4 while:2 substantial:1 can:1 panels:1 site:1 0.7:1 evidence:1 '':2 examined:1 caution:1 dropped:1 compared:1 end:1 2.75:1 1:3 also:1 recommended:1 concerns:1 potentially:1 details:1 which:1 products:1 effectiveness:1 pal:1 stock:2 product:1 edged:2 after:1 panel:3 fell:2 adds:1 data:5 lower:1 off:1 effective:1 tricks:1 futures:10 points:5 researchers:1 claims:2 2008:1 filing:1 1.25:1
stock_LLY r_up	major:1 smaller:1 tax:1 say:2 talks:2 corporations:1 pharmaceutical:1 said:1 likely:1 reform:1 administration:1 start:3 concerns:1 between:1 got:1 firms:1 meeting:1 good:3 's:2 get:2 big:1 after:1 flurry:1 grow:1 acquisitions:1 off:1 lead:1 piles:1 involved:1 companies:3 cash:1 renew:1 overpay:1 diversify:1 spend:1
stock_LLY r_down	saying:1 associated:3 significant:1 proposed:2 reviewers:2 successfully:1 ``:2 agent:3 identified:1 '':1 brain:4 imaging:3 been:2 program:2 against:1 have:1 staff:1 information:1 glimpse:1 detect:4 eye:1 no:2 agency:1 able:2 comments:1 field:1 recommended:1 clinical:3 questioned:1 test:1 has:1 either:1 development:2 ...:1 product:3 's:5 offering:1 convincing:1 use:1 but:1 approving:1 regulators:1 said:2 whether:1 designed:3 although:1 not:1 evidence:1 skeptical:1 --:2 could:1 disease:3 drug:1 cast:1 benefit:1 risks:1 diagnosis:1 recommendations:1 first:1 noted:1 view:1
stock_LLY r_down	associated:2 significant:1 proposed:1 reviewers:1 ``:1 results:1 agent:1 one:1 brain:1 identified:1 have:1 staff:1 information:1 use:1 said:1 additional:1 no:2 agency:1 able:1 been:1 writing:1 recommended:1 questioned:1 ...:1 product:2 's:1 convincing:1 but:1 approving:1 detect:1 although:1 evidence:1 publication:1 --:1 notes:1 disease:1 against:1 benefit:1 risks:1 study:1
stock_LLY r_up	major:1 smaller:2 increasingly:1 well:1 into:1 health-care:1 results:1 likely:1 licensing:1 have:1 pipelines:1 makers:2 bolster:1 again:1 cut:1 consumers:1 also:1 patent:1 large:1 there:1 been:1 research:1 their:1 costs:2 agreements:1 fourth:1 developers:1 markets:1 more:1 relationships:1 affected:1 expirations:1 drugs:1 contract:1 looming:1 back:1 joint:1 fast-growing:1 cutting:1 try:1 push:1 they:1 organizations:1 working:1 ahead:1 pursue:1 many:1 companies:1 see:1 drug:2 deals:1 ventures:1 continue:1 amid:1 long-term:1 quarter:1
stock_LLY r_up	health-care:1 alternatives:1 evidence:1 brain:1 votes:1 detect:1 generally:1 won:1 more:1 's:1 mull:1 read:1 but:1 pressure:1 properly:1 favorable:1 hands:1 prices:1 panel:2 off:1 disease:1 drug:4 reviews:1 can:1 scans:1 my:1 called:1
stock_LLY r_down	strengthened:1 named:2 played:1 family:1 biotech:1 acquired:1 efforts:1 executive:5 history:1 oncology:3 month:1 '':2 6.5:1 drug:1 portfolio:1 resigned:2 its:5 unit:1 fill:1 announcement:1 said:4 $:1 personal:1 leading:1 since:3 had:3 integration:1 capabilities:1 former:1 late:2 involuntary:1 role:3 board:1 which:1 largest:1 developer:1 has:4 cause:1 details:1 division:1 ``:2 his:1 's:6 business:1 started:1 company:4 after:1 pipeline:1 joined:1 key:1 termination:1 regulatory:1 president:3 post:3 senior:1 previous:1 billion:1 search:1 vice:1 vacant:1 according:1 deal:1 n't:2 chief:3 without:1 acquisition:1 time:1 position:1 2008:3 more:1 filing:1 came:1 left:1
stock_LLY r_up	fourth-quarter:1 financial:1 heart:1 funded:1 global:1 share:1 focus:1 trade:1 see:1 session:1 drug:2 big-cap:1 find:1 industries:1 whose:1 needs:1 pharma:1 ways:2 providers:1 shares:1 research:1 outside:1 tape:1 too:1 way:1 capital:1 expected:1 new:1 firms:1 development:1 greater:1 pharmaceutical:1 read:1 watch:1 they:1 active:1 along:1 than:1 change:2 must:2 sectors:1 --:2 industry:2 companies:1 reports:1 flux:1 risks:1
stock_LLY r_up	12000:4 all:1 3.75:1 over:2 shaky:2 results:1 years:4 including:2 looks:1 forecast:1 data:5 its:5 weekly:3 antipsychotic:2 rose:10 28:12 better:3 add:1 treatment:2 details:1 2011:2 earnings:9 good:2 expirations:2 views:1 overall:2 wave:2 early:1 background:1 continued:2 string:2 lose:1 higher:9 depression:1 heavy:1 because:2 financial:2 competition:2 jump:2 rate:1 economic:3 trading:2 year:1 margins:1 2.5:1 gross:1 said:2 profit:3 comments:1 find:1 increase:1 above:1 new:1 recently:2 risen:1 schedule:1 reported:3 address:2 downgrade:3 100:2 debt:3 beginning:4 $:3 reaction:1 pipeline:1 improved:1 penny:1 drug:5 range:1 analysts:1 faces:2 mixed:1 share:1 narrow:1 maker:4 first:2 fourth-quarter:4 outlook:2 12,000:1 cancer:3 revenue:5 period:1 awaited:2 due:1 down:2 says:1 positive:2 market:1 jobless:5 8.7:1 basis:2 best-selling:2 housing:2 sovereign:3 6:1 expected:1 company:3 today:1 flat:1 direction:1 0.2:1 drugs:3 0.5:1 expose:2 but:2 volume:2 part:1 wake:2 prices:2 analyst:1 those:3 helped:5 15:1 19:1 while:3 500:2 were:2 closing:1 spotlight:2 investors:3 bigger-than-expected:1 5th:1 tax:1 sales:3 13th:1 reports:4 have:1 blockbuster:2 saw:2 relatively:2 again:1 no:1 generic:2 began:1 detail:1 topped:2 also:4 points:6 take:1 struggling:1 roll:1 gains:1 stock:3 topping:1 's:11 after:1 most:2 fell:2 two:3 coming:2 along:1 such:2 prostate:1 preventive:1 recent:1 lower:1 short:1 deluge:1 lift:2 futures:4 antidepressant:2 patent:2 edge:2 time:2 claims:5 diversify:1 corporate:1 left:1
stock_LLY r_down	still:1 biotech:1 unexpected:1 1300:1 higher:2 being:1 series:1 into:1 supported:1 dollar:1 hurdles:2 sleeping:1 helped:1 second:1 been:1 hurdle:1 shares:1 have:1 fail:2 close:1 recover:1 its:1 viewed:1 blow:1 has:1 said:2 adds:1 ends:1 jump:1 had:1 comments:1 traders:1 misses:1 potential:1 safety:1 which:3 largest:1 medicine:1 suffered:2 rumors:1 hardly:1 pill:1 500:1 stock:1 development:2 setbacks:1 ``:2 's:2 turned:1 company:1 after:1 but:3 takeover:3 stick:1 12000:2 latest:1 refuses:1 news:1 hair:1 stocks:1 day:1 recent:1 '':2 blockbuster:1 target:1 --:1 trader:1 months:1 drug:1 trial:1 below:1 edge:1 analysts:1 speculation:1 grounds:1 clear:2 first:1
stock_LLY r_up	two:1 because:1 have:1 cancer:1 people:1 series:1 doubt:1 number:1 competition:1 replace:1 clot:1 regulatory:1 including:1 drug:6 another:1 recommendation:1 's:4 throughout:1 market:1 setbacks:1 one:1 based:1 cast:1 generic:1 revenue:1 due:2 lung-cancer:2 research:1 current:1 their:1 investigational:1 clinical:2 safety:1 details:1 new:1 stock:1 patient:2 halt:1 drugs:2 sixth:1 clots:3 halted:1 updates:1 background:1 prices:1 future:1 concerns:3 advanced:1 panel:1 received:1 lost:1 bring:1 follows:1 enrollment:3 reports:1 trial:4 continue:1 stopped:2 following:1 lung:1 efforts:1 first:1 studies:1 could:1 experimental:2 blood:3
stock_LLY r_up	leaders:1 investors:1 billions:1 against:1 two:1 research:1 better:1 returns:1 biggest:1 new:1 divergent:1 week:1 's:1 deliver:1 pressure:1 balancing:1 they:1 world:1 made:1 dollars:1 companies:1 drug:2 choices:1 spend:1
stock_LLY r_down	saying:2 consider:1 executive:2 against:1 human:1 battle:2 shrugged:2 its:2 overhaul:2 should:1 better:1 version:1 4:1 boardroom:2 has:1 sent:1 divergent:1 bid:1 pave:2 balancing:1 they:1 world:1 hedge:1 investor:4 --:3 fully:2 companies:1 follows:1 leaders:1 election:1 investment:1 lead:2 research:1 asking:1 new:1 correct:1 attention:1 deliver:1 drew:2 pressure:1 takeover:3 group:1 received:1 could:4 comment:1 leadership:1 a.m.:1 antibody:2 top:2 experimental:1 criticism:2 cancer:1 billions:1 unit:1 5th:1 two:1 returns:1 2:1 interest:1 biggest:1 launching:2 more:1 firm:6 ``:1 way:2 company:5 fund:2 hopes:2 surged:1 than:1 made:1 board:3 choices:1 remain:2 called:2 shakeup:2 biotech:6 investors:1 backing:2 '':1 pushed:1 drug:3 no:1 dollars:1 also:1 chairman:3 largest:6 week:1 independent:3 's:15 after:1 resign:1 shareholder:1 letter:1 brass:2 off:2 amid:1 sale:3 chief:2 spend:1
stock_LLY r_up	biotech:1 challenging:1 including:1 investment:1 renewed:1 lead:1 no:1 lawsuits:1 strategy:1 call:1 take:1 largest:1 promoting:1 has:1 board:1 firm:2 illegally:1 's:4 plans:1 offer:1 regulators:1 takeover:1 shake-up:1 not:1 approved:1 received:1 --:1 drug:1 uses:1 its:1
stock_LLY r_down	deal:1 sales:1 due:1 beyond:1 blow:1 huge:1 patent:1 best-selling:1 two:1 pharmacy:1 2012:3 hit:1 expirations:1 drugs:1 wave:1 kicking:1 fall:1 world:1 10:1 off:1 versions:1 shelves:1 drug:1 generic:1
stock_LLY r_up	control:1 biotech:1 smaller:1 depart:1 deal:1 then:1 acquired:1 hard:1 challenges:1 ended:1 long:1 another:1 hit:1 makers:1 risk:1 pharmaceutical:1 said:1 $:1 specialty-drug:1 avoid:1 had:1 purchasing:1 tend:1 finally:1 attractive:1 new:1 has:1 project:1 full:1 's:1 tried:1 track:1 got:1 company:1 but:2 following:1 part:1 biotechnology:1 frequently:1 courtship:1 now:1 those:1 billion:1 made:1 talent:1 assets:1 these:1 deals:1 --:1 work:1 companies:1 large:1 record:1 pitfalls:1 marriage:1 acquisition:2 mixed:1 making:1 2009:1 its:1 comes:1
stock_LLY r_up	``:1 16:1 remains:1 corrected:1 had:1 site:1 '':1 version:1 closed:1 published:1 follows:1 11th:1 open:1 operation:1 pm:1
stock_LLY r_down	comment:2 attorney:1 official:3 civil:4 demand:4 related:6 general:1 '':2 production:2 makers:3 information:2 documents:6 rose:1 spokesman:2 investigation:4 disclosed:3 which:1 details:1 has:4 seeks:2 wide:2 ``:2 receipt:1 's:1 demands:2 said:5 filed:3 report:3 years:1 diabetes:4 ago:1 received:3 several:1 annual:3 companies:3 drug:8 maker:1 range:2 part:4 asked:4 fell:1
stock_LLY r_up	25:1 says:1 last:1 company:1 had:1 joined:1 drug:1 maker:1 spokeswoman:1 2004:1 's:3 day:1
stock_LLY r_up	sector:1 background:1 unemployment:1 being:2 developed:2 over:2 move:1 competitive:2 dose:2 session:3 its:4 weekly:2 rundown:1 whose:3 20:1 pharma:1 rose:5 workers:1 less:1 sugar:1 failed:4 investigational:1 treatment:4 premarket:1 14:1 suffered:1 has:1 increased:3 than:1 injection:1 crushed:2 number:1 12:1 setback:2 closely:1 report:1 day:1 areas:1 --:4 follows:1 drop:2 companies:3 underscores:1 25:1 after-hours:1 worries:1 higher:4 added:2 heavy:1 development:1 plummet:1 financial:1 sigh:2 reduce:1 competition:2 up:4 unexpectedly:1 strongest:1 actively:3 trading:7 led:1 employment:3 best:1 85:1 index:2 throughout:2 recently:1 driving:1 shares:6 may:1 version:1 closed:2 new:2 reading:3 correct:1 movement:2 jobs:1 missing:1 sixth:1 jumps:1 activity:1 bulls:1 meet:1 102:3 100:2 strong:3 declining:1 $:6 gained:6 reaction:1 prospects:1 talent:1 ahead:1 33:1 study:3 months:2 21:1 drug:6 surge:1 fell:1 a.m.:1 traded:2 comment:1 industrial:1 followed:1 effective:3 primary:2 down:1 rising:1 another:2 174:1 open:1 market:1 pharmaceutical:1 use:1 prove:2 bears:1 three:2 class:1 2:1 growth:1 treat:1 biggest:1 diabetes:5 500:4 breathe:2 191.40:2 ``:2 sending:1 drugs:1 under:1 taken:2 announcement:1 greater-than-expected:1 analyst:2 pre-market:1 '':1 13:1 made:2 sectors:1 halted:1 reducing:1 18:1 2.9:2 while:3 2.8:1 were:6 making:1 endpoints:1 called:1 1.4:2 1.5:4 1.6:2 1.7:1 investors:3 1.3:1 cents:1 1.8:2 1.9:1 helped:2 dropped:3 seen:1 rally:1 moves:1 if:1 different:1 compared:1 goal:1 49:1 maximum:1 same:1 concerns:3 details:2 gains:1 stock:5 gaining:1 oil:3 's:11 track:1 price:3 cheers:1 most:1 levels:2 blood:1 significant:1 fierce:1 stocks:7 data:1 approved:3 recent:2 bullish:1 ignites:1 futures:4 well:1 daily:1 face:1 points:6 relief:2 2005:1 claims:1 filing:1 charged:1
stock_LLY r_up	comment:1 all:2 tap:2 hoping:2 being:2 into:2 coming:2 sales:1 competition:2 one:2 four:1 second:2 including:2 reducing:2 its:2 market:2 help:2 throughout:1 generic:2 six:2 projected:1 research:2 symptoms:2 drugs:2 details:1 which:2 newly:2 main:2 painful:2 's:2 reaction:1 may:2 company:1 arthritis:2 met:2 important:2 lucrative:2 goals:2 key:2 offset:2 years:2 analyst:1 condition:2 loss:2 pipeline:2 include:1 success:2 reported:2 --:2 studies:2 drug:7 trial:4 rheumatoid:2 called:2 late-stage:4
stock_LLY r_up	said:1 's:1 pay:1 company:1 executive:1 some:1 investment:1 banking:1 chief:1 expire:1 key:1 coming:1 years:1 off:1 research:1 maker:1 patents:1
stock_LLY r_down	even:1 biotech:1 major:1 diseases:2 investors:1 implications:1 cells:2 holds:1 tissue:1 patients:1 live:2 other:2 promise:2 if:1 medicine:1 firms:1 has:1 pharma:1 rebuild:1 diabetes:2
stock_LLY r_down	billion:3 little:1 's:1 $:3 could:1 year:1 sales:1 35:1 shrink:1 base:1 40:1 between:1 67:1 writes:1
stock_LLY r_down	's:1 $:1 drugs:1 million:1 than:1 3.1:1 report:1 out:1 finds:1 more:1
stock_LLY r_up	firm:1 major:1 's:1 six:1 redefine:1 should:1 accelerated:1 board:2 members:1 new:1 naming:1 strategy:1 efforts:1 shakeup:1
stock_LLY r_up	multiple-sclerosis:1 animal-health:1 close:1 open:1 before:1 4.1:1 power:1 shares:1 call:1 ...:1 's:2 combination:1 drugs:1 price:1 after:1 rising:1 news:1 off:1 up:1 reports:1 prescribing:1 following:1 trading:1 came:1
stock_LLY r_down	sector:1 ...:1 one-year:1 right:1 's:2 look:1 we:2 big:1 bill:1 anniversary:1 past:1 'd:3 health:2 have:1 year:1 overhaul:1 has:1 treated:1 care:2
stock_LLY r_down	week:1 industries:1 owners:1 explores:1 showed:1 investors:1 money:1 into:1 small-business:1 confidence:1 fewer:1 quickly:1 growing:1 moving:1 put:1 's:2 life-sciences:1 medical:1 why:1 economy:1
stock_LLY r_up	among:1 deck:1 trading:3 daily:1 larger-cap:1 our:1 moves:1 market:1 rundown:1 shares:1 note:1 hot:1 biggest:2 advancers:3 drug:1 stock:1 gains:2 watch:3 quarterly:1 courtesy:1 stocks:2 friends:1 sizable:1 reports:1 morning:1 afternoon:3 rallies:2 making:1 decliners:2
stock_LLY r_down	rating:1 deck:2 dollar:1 results:1 month:1 against:1 mild:1 including:1 cuts:1 its:1 giant:1 renewed:1 rose:1 revenue:1 charge:1 tape:1 employee:1 ...:1 expirations:1 get:1 continues:1 watch:5 nation:1 early:1 fall:1 pharmaceutical:1 drop:2 morning:2 banking:1 worries:3 higher:1 headwinds:1 long-running:1 related:1 our:1 makers:1 appear:1 profit:1 recorded:1 investigation:1 new:1 price:1 opening:1 hefty:1 quits:1 strong:1 first-quarter:2 drug:3 credit:1 figures:1 maker:1 load:1 headed:1 into:2 decline:2 debt:1 flying:1 due:1 their:2 6:1 biggest:1 upbeat:1 markets:1 more:1 gear:1 some:1 company:1 but:2 quarterly:1 lift:1 than:1 15:4 while:1 were:1 problem:1 spotlight:2 weaker:1 associated:1 trump:1 partnership:1 sales:1 high:1 beats:2 warning:1 reports:3 patent:1 government:1 highlighted:1 shifts:1 earnings:5 season:1 outbreak:1 layoffs:1 stock:2 's:8 140:2 collaboration:1 after:1 courtesy:1 fell:1 stocks:2 friends:1 lower:2 largely:1 futures:2 giving:1 costs:1 relief:1 weigh:2
stock_LLY r_up	losses:1 6:1 outlook:2 weaker:1 associated:1 just:1 saying:1 year-to-date:1 companies:1 health-care:1 wrestling:1 results:1 quarters:1 challenges:1 against:2 trends:1 value:1 year:1 its:3 current:1 giant:1 candidate:1 profit:1 surprises:2 soars:2 three:1 shares:1 forecast:1 brightened:1 advisories:2 other:3 earnings:1 assuming:1 has:2 2011:1 drug:1 higher:1 slips:2 product:1 currencies:1 's:4 increased:1 dollar:2 company:1 persist:1 overall:1 helping:1 released:1 were:1 lift:1 offset:1 strong:1 after:1 euro:1 roundup:1 down:1 lost:1 --:1 many:1 medicines:1 months:1 well:1 soaring:1 doubled:1 reports:1 future:1 products:1 afternoon:2 time:1 action:2 recalls:2 corporate:1 study:1 latest:1
stock_LLY r_up	says:1 may:1 drug:1 see:1 approval:1 2012:1 diabetes:1
stock_LLY r_up	agreed:2 results:1 brain:3 through:1 rose:1 lets:1 treatment:2 has:2 earnings:1 collaborate:2 diseases:1 get:1 posed:2 represents:1 benefit:1 common:1 including:1 quarter:1 challenge:2 better-than-expected:1 past:1 year:1 temporary:1 makers:2 packed:1 network:1 comments:1 research:1 version:1 recently:1 barrier:2 free:1 delivering:1 key:1 approval:2 major:1 strong:1 technical:1 could:1 drug:4 involves:1 outlook:1 although:1 cancer:2 long:1 directly:1 throughout:1 would:1 only:1 tightly:1 start:1 treat:1 widens:1 's:11 company:2 docetaxel:1 cells:1 project:1 were:1 following:1 launched:1 medication:2 hoping:1 certain:1 partnership:1 sales:1 have:1 goal:1 5.8:1 potential:1 details:1 effectiveness:1 blunt:1 higher:1 first-quarter:1 may:1 anatomy:1 fueled:1 services:1 such:1 recent:1 ago:1 attempt:1 disease:1 generic:2 costs:1 serious:1 latest:1
stock_LLY r_up	key:1 packed:1 medication:1 directly:1 certain:1 agreed:1 catheters:1 results:1 delivering:1 disease:1 brain:2 through:1 aimed:1 sea:1 using:1 exclusivity:1 blockbuster:1 its:1 market:1 tightly:1 said:1 court:1 $:2 21.3:2 federal:1 treatment:1 least:1 makers:2 target:1 only:1 potential:1 earnings:1 strong:1 implantable:1 boost:1 until:1 2013:1 details:1 preserve:1 such:1 collaborate:1 's:5 fourth:1 barrier:1 roster:1 confusion:1 collaboration:1 rise:2 sales:1 early:1 lets:1 pumps:1 network:1 making:1 adds:1 stocks:2 beginning:1 projects:1 stage:1 pact:1 elusive:1 disorders:1 healthy:1 cells:1 up:1 drug:3 antidepressant:1 project:1 spending:1 ruling:1 team:1 attributes:1 salt:1 maker:1 involves:1 research:1
stock_LLY r_down	comment:1 disclosure:1 certain:1 into:2 health-care:2 bribery:2 officials:2 discussions:2 declined:1 filing:1 said:3 $:2 pay:1 three:1 than:1 other:1 advanced:2 violations:2 2010:3 weeks:1 versus:1 after:1 's:4 negotiations:1 company:3 million:2 giant:1 representative:1 70:1 doctors:1 services:1 law:2 potential:2 declining:1 11:3 professionals:1 resolve:2 last:1 investigation:2 drug:1 foreign:2 more:1 settle:1 payments:1 agreed:1 2009:1 maker:3 comes:1
stock_LLY r_up	shed:2 prompted:1 slipped:1 health-care:1 actively:2 trading:3 cancel:1 2.7:1 24:1 whose:2 4.6:2 22:1 bad:1 shares:2 points:5 4:3 closed:1 500:2 more:1 evening:1 's:3 basket:1 said:1 exchanges:1 brokerage:1 stocks:3 than:1 gained:1 lower:1 off:2 trades:1 companies:3 50:1 while:1 session:2 after-hours:2 mixed:1 traded:1 order:1
stock_LLY r_up	remedies:1 increase:1 ``:1 asthma:1 16:2 warns:1 equal:1 '':1 merging:1 health:1 rates:1 open:1 its:1 unit:1
stock_LLY r_up	illegally:1 $:1 drugs:1 pay:1 agreed:1 million:1 allegations:1 one:1 doctors:1 settle:1 kickbacks:1 promoted:1 using:1 has:1 its:1
stock_LLY r_up	pharmaceutical:1 creating:1 apps:1 increasingly:1 websites:1 void:1 reps:1 sales:1 been:1 tools:1 filling:1 other:1 drug:1 have:1 digital:1 eliminated:1 now:1 thousands:1 makers:1
stock_LLY r_up	emerging:1 strength:1 first-quarter:1 weakness:1 rose:1 helped:1 7:3 offset:1 markets:1 profits:1
stock_LLY r_up	sector:2 sells:2 trades:2 sharply:1 soars:2 partnership:2 among:2 sales:2 disease:1 alliance:3 including:1 drug:3 have:1 seen:2 7th:1 terms:1 headlines:1 throughout:1 injection:1 market:1 plans:2 strategic:2 complaint:2 beyond:2 develop:3 things:2 its:2 breaches:3 details:1 which:1 under:1 pipeline:2 dating:1 type:1 brand:1 announced:2 agreements:2 flat:2 generating:2 injunction:2 's:4 venture:4 seeking:2 drugs:1 sold:1 watch:1 agreement:1 jointly:2 permanent:2 said:2 peak:2 background:1 filed:3 2:1 buyout:1 now:1 lawsuit:3 recent:1 billion:2 reaction:1 lower:2 has:2 preliminary:2 older:1 alleging:3 well:1 up:1 against:3 morning:1 2002:1 2020:2 diabetes:7 anticompetitive:2 other:3 diabetes-drug:1
stock_LLY r_down	we:1 buy:1 off:2 higher:1 writes:1 meds:2 dreams:1 goes:2 go:1 premium:1 stock:1 its:2 market:3 if:2
stock_LLY r_down	illness:2 investors:2 sepsis:2 agreed:2 focus:2 private:2 have:2 bacteria:2 out:1 radiology:1 based:2 create:2 also:2 potentially:2 which:2 you:1 reading:1 might:1 development:4 's:6 company:2 acquire:4 jointly:2 not:1 several:2 rights:4 always:1 study:1 drug:2 severe:4 points:1 biotechnology:2 think:1
stock_LLY r_down	logistics:1 alliance:2 being:1 filed:2 month:3 globally:2 13,000:3 temporary:2 its:4 market:2 sell:4 delivered:1 said:1 breached:2 generic:1 develop:2 same:2 other:2 units:1 formed:2 diabetes:2 partnership:4 's:11 string:1 pharmaceutical:1 drugs:3 stop:2 company:1 earlier:3 thefts:1 medicine:2 salesforce:2 nearly:1 competing:2 using:2 years:1 lawsuit:2 recent:3 stolen:1 center:1 older:2 alleging:2 well:2 disease:2 against:2 2002:2 while:1 were:1 diabetes-drug:2 order:2 terms:2 latest:1
stock_LLY r_up	later:1 cancer:2 people:1 focus:1 one:1 '':1 skin:1 melanoma:1 attend:1 conferences:1 deadly:1 version:1 largest:1 more:1 week:1 ``:1 's:2 form:1 corrected:1 world:1 than:1 11:1 17th:1 name:1 --:1 follows:1 annual:1 drug:1 a.m.:1 published:1 30,000:1 called:1
stock_LLY r_down	later:1 cancer:2 people:1 focus:1 one:2 including:1 skin:1 melanoma:2 attend:1 conferences:1 deadly:1 two:1 clinical:1 largest:1 weeks:1 meeting:2 more:1 week:1 handful:1 's:1 4,000:1 form:1 were:1 notable:1 most:1 world:1 article:1 revealed:1 than:2 those:1 ago:1 released:1 --:2 annual:1 discussed:1 reports:1 published:1 30,000:1 studies:2 called:1
stock_LLY r_up	measuring:1 because:1 investors:1 win:1 ca:1 held:1 year:1 deal:1 patent:1 which:1 surprise:1 meeting:1 interests:1 's:1 samples:1 infringement:1 company:1 blood:1 plenty:1 subsidiary:1 ruled:1 case:1 --:1 could:1 against:1 n't:1 buzz:1 patents:1
stock_LLY r_up	comment:1 measuring:1 smaller:1 deal:1 win:1 ca:1 patent-infringement:1 argues:1 held:1 because:1 1990s:1 its:1 booming:1 said:1 court:1 should:1 written:1 which:1 developed:1 researchers:1 markets:1 method:1 interests:1 do:1 's:5 samples:1 business:1 company:1 funding:1 blood:1 subsidiary:1 ruled:1 case:1 look:1 countries:1 --:1 came:1 region:1 companies:1 against:1 n't:1 keen:1 ruling:1 opinion:1 patents:1
stock_LLY r_up	said:1 's:1 handed:1 federal:1 marketing:1 over:1 drug:1 drugs:1 legal:1 diabetes:1 judge:1 partner:1 dispute:1 maker:1 victory:1
stock_LLY r_up	addressing:2 financial:2 deal:2 allows:2 agreed:2 within:2 trade:1 services:1 see:3 session:1 licensing:2 have:2 moves:1 digest:1 osteoporosis:2 whose:1 needs:2 said:3 additional:2 surgeons:2 shares:1 also:2 trauma:2 expected:1 investors:1 implant:1 development:2 them:2 collaborate:2 's:2 update:1 use:2 watch:4 treatments:2 jointly:2 agreement:1 joint:2 orthopedic:5 uses:2 mobile:1 pair:1 active:1 had:1 areas:2 pact:2 signed:1 license:1 spine:2 early-stage:2 companies:3 surgical:1 drug:2 --:1 patients:2 products:1 evaluating:2 makes:1 maker:3 medical-device:2
stock_LLY r_up	turmoil:1 now:1 better:1 bonds:2 beat:2 dividends:2 over:2 offer:1 than:1 blue-chip:1 writes:1 income:1 many:1 stocks:1 top:2
stock_LLY r_up	billion:1 1.5:1 sees:1 $:1 annual:1 sales:1 2020:1
stock_LLY r_up	hoping:2 being:2 developed:2 move:2 strategic:1 daily:2 year:4 still:2 declined:2 positive:2 granted:2 same:2 version:2 which:2 clinical:2 has:1 more:2 development:2 do:1 get:2 long-acting:2 marketing:2 company:1 after:2 early:2 regulators:2 filed:1 approval:6 data:2 approved:2 diabetes:2 made:2 rejection:2 last:4 companies:2 drug:7 twice:2 2005:2 injectable:2 approve:2 something:1
stock_LLY r_down	encouraging:1 's:1 versions:1 boosted:1 glut:1 after:1 companies:1 treatments:1 shares:1 research:1 hours:1 unleashed:1 including:1 treatment:2 which:1 inhaled-insulin:1 popular:1 statements:1 data:1 well:1 diabetes:1
stock_LLY r_up	antipsychotic:1 --:1 class-action:1 revive:1 rejected:1 n't:2 drug:1 involving:1 against:1 sought:1 claims:1 appeal:1 its:1
stock_LLY r_up	biotech:1 already:1 deal:1 providers:1 over:1 innovative:1 hospice:1 sprouts:1 find:1 top:1 scrutinizing:1 their:1 candidates:1 under:1 cash-strapped:1 added:1 's:2 pressure:1 putting:1 such:1 salmonella:1 class:1 stress:1 world:1 --:1 medicines:1 companies:1 drug:1 n't:3 passing:1 first:1 industry:1 bond:1
stock_LLY r_down	body:1 all:1 says:1 cancer:7 people:1 backing:2 win:2 health-care:1 back:4 hearing:2 second:1 cost:2 lung:3 names:1 have:1 throughout:1 its:4 expensive:2 again:3 use:5 $:2 their:1 support:2 disease:1 had:1 treatment:1 failed:2 too:2 largest:2 increasing:2 pill:3 attractive:1 firm:3 's:18 government:2 drugs:2 problems:2 rejected:1 tries:2 reflecting:2 breast:2 background:1 regulatory:2 world:2 cost-effectiveness:1 treating:1 has:1 stabilize:1 receive:2 medicines:2 56:2 suffering:1 drug:1 regulator:4 --:1 patients:2 convince:2 ongoing:2 comes:2 long-term:3 grounds:1 maker:2 bodies:2 view:2
stock_LLY r_up	saying:1 help:2 heavily:2 over:2 focus:2 quarters:1 appetite:1 its:1 previous:1 blow:2 partners:1 27:1 surprises:2 show:1 add:1 advisories:2 premarket:1 include:1 2013:1 earnings:2 updated:1 hit:2 gains:4 regional:2 number:1 putting:1 closely:1 new:2 years:2 day:2 increasing:1 --:6 medicines:2 drop:1 companies:1 facing:1 small:1 higher:7 financial:1 pledge:2 soften:2 testing:1 second:1 economic:2 trading:1 year:1 's:2 expects:2 out:2 index:2 blue-chip:1 comments:1 state:2 buoyed:1 consecutive:2 falling:1 before:1 conditions:2 after:2 business:2 expire:2 key:1 clues:2 dividend:1 100:1 strong:1 beginning:2 additional:1 roundup:1 reaction:1 quarter:1 climbed:1 drug:2 edges:2 products:1 rose:1 climb:2 5th:1 patents:2 executives:1 outlook:1 point:2 encouraging:2 awaited:1 rising:1 least:1 news:1 vote:1 total:1 market:2 jobless:2 austerity:1 come:2 support:2 per-share:1 next:2 clinical:1 500:1 more:3 gained:2 parliament:1 drugs:5 company:2 but:2 gain:1 surged:1 analyst:1 those:1 10:1 has:2 target:1 straight:1 measures:1 late-stage:1 future:1 sees:1 investors:3 give:1 backing:1 sales:2 0.6:1 pushed:1 reports:1 have:1 watched:1 close:1 take:2 risk:1 information:1 end:1 recovery:2 patent:1 points:3 3.25:1 details:1 fourth:2 several:2 stock:6 development:2 edged:2 track:2 quote:1 await:1 expirations:1 extending:2 4th:1 70:1 stocks:4 data:4 approved:1 recent:2 off:1 third:1 amid:1 futures:6 edge:2 profits:2 banks:2 claims:4 latest:1 corporate:1 end-of-quarter:2 8th:1
stock_LLY r_up	show:1 partnership:1 partner:1 documents:2 court:2 detail:1 faults:1 longtime:1 between:1 new:2 breakdown:1 head:1 felt:1 's:4 relationship:1 started:1 marketing:1 sparked:1 released:2 objects:1 plan:1 blindsided:1 lawsuit:1 --:3 feud:1 communications:1 recently:1 lover:1 diabetes-drug:1 scorned:1
stock_LLY r_up	proposed:1 show:1 companies:1 partnership:1 felt:1 global:1 n't:2 partner:1 pharmaceutical:1 said:1 court:2 doctor:1 detail:1 comments:1 their:1 longtime:1 between:1 new:2 has:1 final:1 breakdown:1 head:1 pleads:1 's:6 relationship:1 started:1 marketing:1 company:1 sparked:1 released:2 documents:2 plan:1 blindsided:1 cleared:1 lawsuit:1 faults:1 --:4 no:1 guilty:1 air:1 feud:1 communications:1 benefit:1 objects:1 lover:1 recently:1 diabetes-drug:1 acquisition:1 scorned:1
stock_LLY r_down	slow:3 slid:1 flat:1 slower:1 1.1:1 session:4 heart:3 testing:3 year:3 $:5 trade:2 rate:2 116:1 trading:6 reports:1 recovery:1 further:3 jobs:2 after-hours:1 employment:1 declined:1 whose:4 27:1 actively:4 1.2:1 candidate:1 positive:1 6.1:1 4:1 shares:6 1:2 their:2 9.4:1 rates:1 treatment:3 expected:3 jumped:1 500:2 stock:1 requested:3 's:7 said:3 partners:3 after:3 weak:2 nonfarm:1 20:1 15:1 fueled:1 fell:3 sink:2 sharply:1 report:2 news:2 payrolls:1 stocks:2 than:1 pre-market:1 diabetes:4 shine:3 lower:2 12:1 last:3 showed:1 lost:2 level:1 --:6 drug-stocks:2 futures:3 companies:4 up:4 drug:4 n't:3 did:3 while:2 points:2 were:5 closing:1 traded:2 latest:1
stock_LLY r_down	's:2 process:1 review:1 expects:1 drug:1 six-month:1 diabetes:1 2012:2
stock_LLY r_up	back:1 pricing:1 might:1 pharmaceutical:1 cut:1 there:1 their:1 innovation:1 interview:1 new:2 cause:1 launching:1 eventually:1 head:1 's:1 pose:1 stop:1 said:1 country:1 medicines:1 companies:1 drug:1 threat:1 investments:1 laws:1
stock_LLY r_up	sector:2 operations:2 all:2 help:2 innovative:2 cut:1 overhaul:2 21:2 other:2 has:2 might:1 2010:2 noncore:2 eventually:1 big:2 stop:1 interview:1 nearly:2 cushion:2 during:2 continued:2 medicines:3 companies:5 deals:2 quarter:2 shedding:2 significantly:2 opting:2 some:2 back:1 challenges:2 second:2 pricing:1 year:2 makers:2 closer:2 said:1 bottom:2 research:2 looking:2 innovation:1 new:4 cause:1 marketing:2 pose:1 20:2 approaches:2 regulatory:2 approval:2 improve:2 many:2 drug:5 products:2 threat:1 faces:2 major:2 own:2 tough:2 licensing:2 pharmaceutical:1 there:1 been:2 their:11 launching:1 head:1 pipelines:4 cope:2 hurt:2 effort:2 up:4 country:1 steep:2 scramble:2 health-care:2 sales:2 have:4 alliances:2 patent:2 threatens:2 granted:2 shore:4 also:4 internal:2 units:2 instead:2 development:2 hurdles:2 's:1 such:2 approved:2 cliff:2 acquisitions:2 lines:2 investments:1 savings:2 costs:4 keeps:2 drawing:2 laws:1
stock_LLY r_down	billion:1 play:1 10.2:1 $:1 buyers:1 seek:1 bid:1 moved:1 possible:1 other:1 company:1 pressing:1 values:1 household:1 put:1 products:1 has:1 investor:1 maker:1 launching:1
stock_LLY r_down	sector:4 advisory:1 help:1 issued:1 move:1 expects:1 trade:1 benefited:1 portfolio:1 its:3 profitable:1 whose:1 $:1 22:1 over-the-counter:1 merger:2 guidance:1 revenue:2 expectations:1 should:1 investigational:1 treatment:4 transformation:1 global:2 hit:1 risk:2 beat:1 rebound:1 results:2 break:1 burden:1 milestone:1 during:1 austerity:3 developments:1 like:1 --:4 54:1 medicines:1 companies:2 labeling:4 watched:1 session:1 minimal:2 cholesterol:4 quarter:2 set:2 deal:1 jump:1 second:1 actively:1 trading:1 close:1 calendar:1 makers:1 subject:1 said:4 stats:1 driving:1 showcase:1 profit:2 broad:1 shares:1 above:1 new:4 announced:1 common:4 outperforming:2 after:1 recently:2 scientific:1 grandparents:1 continuing:1 diagnostic:1 reported:1 restructuring:1 imaging:1 key:1 regulatory:1 approval:1 post:2 change:2 study:4 losses:1 drug:4 surge:1 analysts:1 efforts:1 approve:2 maker:1 block:1 otherwise:2 adjusted:1 inflection:1 point:1 into:1 down:3 fees:1 tools:1 unit:1 pharmaceutical:2 use:2 their:1 removing:2 there:2 led:2 indicate:2 expected:4 recent:1 touted:1 ``:1 drugs:2 company:3 lower:1 infection:2 prices:2 second-quarter:4 pre-market:1 solid:3 car:1 up:1 were:1 growing:1 revenues:1 called:1 associated:2 1.2:1 weighed:3 currency:1 seen:1 partner:2 moves:1 margins:1 patent:4 make:1 therapies:2 other:1 earnings:3 which:1 outperform:1 higher:1 week:1 product:1 's:11 crashes:1 may:1 measures:3 includes:1 shareholder:1 significant:1 data:2 soared:1 diabetes:1 acquisitions:1 peers:1 third:1 well:2 disease:1 generic:1 latest:1
stock_LLY r_up	point:1 margins:1 help:1 deal:1 revenue:1 issued:1 into:1 move:1 expects:1 high:1 held:1 aimed:1 close:1 partner:1 calendar:1 its:2 unit:1 make:1 profitable:1 slow:1 merger:1 guidance:1 inflection:1 patients:1 their:1 expected:1 new:2 increasing:1 boost:1 touted:1 hope:1 third:1 ``:1 's:5 combat:1 get:1 company:1 after:2 subject:1 significant:1 announced:1 shareholder:1 key:1 milestone:1 regulatory:1 during:1 approval:1 data:1 transformation:1 diabetes:1 both:1 revenues:1 reverse:1 showed:1 --:1 disease:1 drug:2 maker:1 n't:2 s:1 can:1 threat:1 cholesterol:2 growing:1 quarter:1 called:2 privately:1
stock_LLY r_down	because:1 says:1 high:1 including:1 doses:1 crisis:1 jobless:1 initial:1 two:1 rates:1 too:1 today:1 higher:2 's:7 pushing:1 produce:1 groups:1 claims:1 hopes:1 debt:1 those:1 amid:1 solution:1 galore:1 summit:1 were:1 fresh:1 discontinued:1
stock_LLY r_up	emerging:1 shot:1 increasingly:1 over:1 trade:1 drug-price:1 focusing:1 manager:1 session:1 including:2 thanks:4 forecast:1 its:3 boosts:2 whose:1 buyers:1 group:2 $:4 merger:1 rose:4 sale:2 29:2 than:2 better:2 charge:1 pre-market:1 employee:2 2011:2 earnings:5 customers:1 increased:1 weakness:2 continues:2 watch:1 boxed:1 effects:2 background:3 world:3 continued:1 bigger:1 --:15 companies:2 morning:1 facing:1 trimmed:1 through:1 higher:4 noted:1 better-than-expected:1 shipments:1 because:1 says:2 deal:1 bleeding:1 related:2 growth:2 trading:1 pricing:2 year:1 2.3:1 margins:1 slew:1 actively:1 severance:2 profit:1 jumped:1 anticlotting:1 comments:2 research:2 increase:1 discounts:1 safety:1 market:3 goes:1 new:2 across:1 risks:2 marketing:2 promising:1 rebates:1 pressure:4 regulators:2 operating:4 key:2 comeback:1 beginning:2 prescription:1 could:1 firing:1 drug:10 bow:1 fell:5 planned:1 slightly:1 maker:4 comment:1 outlook:2 already:1 revenue:4 feel:1 fifth:1 clout:2 carry:1 throughout:2 unit:1 conference:1 pharmaceutical:1 would:1 top:1 anti-clotting:1 been:1 their:1 genetic:1 2:1 call:1 pharmacy-benefits:1 expected:3 markets:1 toughest:1 drugs:4 company:2 negotiating:1 volume:2 demand:5 prices:1 improved:4 second-quarter:5 behalf:1 11:12 rival:1 clients:1 levels:1 economic:2 can:1 shares:1 were:1 making:1 male:1 greater:1 defect:1 expenses:4 high:1 currency:6 warning:1 reports:1 have:2 negotiations:1 if:1 patent:1 makers:3 also:1 concerns:1 details:2 largest:2 9:2 layoffs:2 stock:2 gaining:1 rise:2 's:19 though:5 may:1 price:2 after:2 expirations:1 analyst:1 most:1 4th:2 adds:1 stocks:1 29.1:1 approved:2 billion:1 purchase:1 off:1 charges:4 overnight:1 costs:2 relief:2 enter:1 corporate:1 updates:2
stock_LLY r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_LLY r_down	comment:1 deal:1 higher:2 dollar:1 sales:1 helped:1 earnings:1 projections:1 robust:1 's:5 throughout:1 its:2 28:1 expectations:1 analyst:1 beat:1 details:1 fourth:1 income:1 quarterly:1 net:1 2011:3 price:1 stock:1 updated:1 hit:1 generics:3 business:1 multiple:1 dropped:1 weakness:3 company:1 largest:1 forecasts:1 reported:1 therapy:1 key:1 world:1 along:1 strong:1 beginning:1 second-quarter:1 benefits:1 third:1 --:4 sclerosis:1 disease:1 drug:1 pill:1 charges:1 costs:1 quarter:2 starting:1 maker:1 first:1
stock_LLY r_up	heart:2 testing:2 competition:2 drug:8 year:2 further:2 its:2 partners:2 slow:2 additional:2 would:2 profit:2 positive:2 top:2 since:2 also:2 going:2 rates:2 which:4 new:2 has:2 public:2 indicating:2 development:2 requested:2 's:2 seeking:2 drugs:2 looming:2 includes:2 reported:2 key:2 offset:2 data:2 response:2 diabetes:2 last:2 success:2 --:4 submitted:2 n't:4 did:2 future:2 products:2 generic:2
stock_LLY r_up	appeals:2 into:1 strategic:1 through:2 diabetes:1 year:2 protecting:2 sell:1 court:2 federal:2 had:2 upheld:2 treatment:1 which:4 expected:2 2017:4 has:3 until:2 overturns:2 's:5 company:1 validity:2 protection:2 entered:1 ruled:2 pact:1 patent:6 last:4 treats:2 --:1 drug:4 prior:2 range:1 products:1 ruling:4 disorder:2
stock_LLY r_down	emerging:1 human:1 global:1 expects:1 years:1 '':1 brain:1 second:1 pricing:1 have:1 's:4 aggressive:1 its:1 market:1 before:1 even:1 1:1 competitor:1 silent:1 narrowing:1 research:1 symptoms:1 start:1 enough:1 new:1 ground:1 decades:1 insulin:2 ``:1 explosion:1 first:1 bolsters:1 anticipated:1 but:1 half:2 phase:1 world:1 gap:1 than:1 declining:1 begins:1 main:1 lost:1 --:1 2011:1 disease:1 patients:1 diagnosed:1 more:2 maker:1 view:1
stock_LLY r_down	customer:1 used:1 faithful:1 government:1 contracts:1 holes:1 deep:1 have:1 ultimate:1 pockets:1 its:2
stock_LLY r_down	increasingly:1 through:1 farther:1 such:1 market:1 use:1 leverage:1 only:1 attractive:1 way:1 gains:1 offer:1 but:1 not:1 dividend:1 those:1 --:1 companies:1 skittish:1 yields:1 options:1 thanks:1
stock_LLY r_up	acquired:1 certain:1 sales:1 '':2 discussions:1 provided:2 said:3 government:1 question:1 outside:2 potentially:1 which:1 has:1 activities:1 ``:2 information:2 made:3 authorities:1 improper:1 resolve:1 maker:1 matter:1 connection:1 payments:3 were:1 voluntarily:1 2009:1 filing:1
stock_LLY r_down	provided:1 ``:1 said:1 information:1 '':1 improper:1 outside:1 made:1 potentially:1 payments:1 authorities:1 voluntarily:1 has:1 maker:1
stock_LLY r_up	active:2 appeals:2 proposed:2 challenged:2 into:7 preserving:5 allegations:2 ninth:2 one:2 '':2 judge:7 drug:9 exclusivity:5 federal:7 market:5 dysfunction:2 sell:2 use:2 blockbuster:4 court:2 treat:2 would:2 patent:15 beginning:2 had:2 copies:2 version:2 2019:9 details:2 upheld:5 pill:5 stock:2 preserve:2 ``:2 's:18 detail:2 seventh:2 cheaper:2 erectile:2 protection:2 covers:2 background:2 prices:2 effort:2 valid:2 ruled:2 calls:2 --:6 barring:2 infringe:2 generic:4 ruling:2 ingredient:2 16th:2
stock_LLY r_up	current:1 buy:1 uncertain:1 high:1 high-yielding:1 stocks:1 options:1 market:1 volatility:1
stock_LLY r_up	offering:1 investors:1 --:1 entrepreneurs:1 industry:1 support:1 turbulent:1 hubs:1 new:1 start-ups:1 drawing:1 economy:1
stock_LLY r_down	received:1 said:1 they:1 also:1 --:1 marketing:1 merit:1 show:1 drug:1 high:1 their:1 yields:1 low:1 have:1 multinationals:1 technical:1 diabetes:1
stock_LLY r_up	--:2 money:1 taking:1 have:1 not:1 making:1 history:1
stock_LLY r_down	emerging:1 says:1 partnership:1 some:1 growth:1 talks:1 tap:1 best:2 out:1 marking:1 generic-drug:1 blue-chip:1 potentially:1 low:1 income:1 markets:1 higher:1 multinational:1 risk:1 form:1 big:1 company:1 dividend:1 stocks:3 effort:1 than:1 invest:1 yields:1 latest:1
stock_LLY r_down	control:1 significantly:1 vie:1 idea:1 valuable:1 month:1 down:3 invention:1 decade:1 profitable:1 overhaul:1 writes:1 storms:2 same:1 passage:1 anyone:1 market:2 expected:1 markets:1 final:1 congressional:1 head:1 's:1 batten:1 today’s:1 nearly:1 true:1 weathering:1 extreme:1 tactics:1 assets:1 level:1 receive:1 weather:1 hatches:3 keep:1 altering:1 future:1 making:1 choppy:1
stock_LLY r_up	prompt:1 according:1 its:1 relatively:1 25:2 use:1 make:1 pile:1 performance:1 thin:1 poor:1 product:1 's:1 may:1 big:1 company:1 operating:1 analyst:1 pipeline:1 cash:1 leaving:1 large:1 officer:1 acquisition:1
stock_LLY r_down	disease:1 50:1 times:1 likely:1 without:1 have:1 artery:1 man:1 than:1 more:1
stock_LLY r_up	control:5 comment:1 insulin:2 significantly:2 findings:2 show:2 previously:2 results:2 one:2 reached:2 fifth:1 before:2 use:1 said:2 provide:1 had:2 benefit:1 sugar:4 better:3 their:4 only:2 2:9 treatment:6 largest:2 type:2 patients:7 shows:1 ``:2 experienced:2 's:6 seventh:1 given:2 early:6 released:2 levels:2 blood:5 not:2 world:2 diabetes:5 received:2 target:2 showed:2 --:4 science:1 taking:1 drug:4 chief:1 officer:1 study:2 higher:2 oral:2 maker:2 view:1
stock_LLY r_up	says:1 money:1 off:1 mortgage:2 pay:3 cash:1 spend:1 take:1 equity:1 home:1 you:1 stocks:3 might:1 your:3 buying:1 out:1
stock_LLY r_down	prospects:1 takeover:1 's:1 target:1 according:1
stock_LLY r_up	cancer:1 continuation:1 one:1 '':1 lung:1 been:1 have:1 pipelines:1 blockbuster:1 its:1 string:1 bolster:1 pharmaceutical:1 said:1 no:1 patent:1 positive:1 same:1 cell:1 pharmaceuticals:1 other:1 treatment:1 statement:1 which:1 chemotherapy:1 ``:1 used:1 's:2 maintenance:3 form:1 big:1 company:1 expirations:1 therapy:2 they:1 regulatory:1 cases:1 aiming:1 continued:1 approved:1 advanced:1 panel:1 received:1 medicines:1 face:1 their:1 patients:1 products:1 opinion:1
stock_LLY r_down	everyone:1 presence:1 maladies:1 stepping:1 poll:1 bigger:1 makers:1 market:1 pink:1 melanoma:1 pharmaceuticals:1 much:2 overly:1 their:1 other:1 those:1 supports:1 too:1 ...:1 's:1 s:2 after:1 finds:1 nearly:1 world:1 steals:1 like:1 third:1 up:1 drug:1 spotlight:1 while:1 race:1 think:1 gain:1
stock_LLY r_up	now:2 investors:1 cheap:2 yield:1 market:1 giant:1 4.6:1 writes:1 seems:1 opportunities:1 than:1 better:1 has:1 creating:1 slump:1 nothing:1 dividend:1 stocks:2 sneeze:1 realize:1 pipeline:1 many:1 drug:1
stock_LLY r_up	affordable:1 agency:1 says:1 session:2 deck:1 money:3 increased:1 trade:2 actively:2 unlikely:1 need:1 dysfunction:3 moves:2 yet:1 market:1 out:1 one:1 whose:2 little:1 compared:1 since:1 also:1 trials:1 top:2 means:1 treatment:1 shares:2 improvement:1 symptoms:1 benign:1 been:1 5:2 treat:2 storm:1 dangers:1 expected:2 instead:1 has:2 tolerance:1 awareness:1 more:1 yield-hunting:2 's:6 risk:1 get:1 drugs:1 becomes:1 men:2 use:1 visits:1 most:2 said:1 two:1 significant:1 now:2 prostate:2 approved:3 condition:1 must:1 borrowers:1 benefits:1 showed:1 erectile:3 treated:1 trader:3 clinical:1 companies:2 drug:1 their:1 2003:1 which:1 points:1 were:1 making:2 placebo:1 corporate:1 essential:1 bond:1
stock_LLY r_down	help:1 undervalued:1 executive:1 month:2 bring:1 looks:1 cuts:1 exclusivity:1 15-year:1 its:3 retirement:2 antipsychotic:1 late:1 other:1 has:3 them:1 expirations:1 government:1 drugmaker:1 ever:1 affiliate:1 cholesterol:1 served:1 stock:1 woes:1 challenges:1 pricing:1 year:1 makers:2 closer:1 medications:1 lead:1 since:1 pressures:1 behind:1 market:1 goes:1 hold:1 sluggish:1 led:1 business:1 handful:1 affiliates:1 promoted:1 succeed:1 key:2 put:1 quarter:1 ahead:1 industry:1 drug:2 turn:1 faces:2 changes:1 patents:1 executives:1 major:2 plethora:1 one:1 president:2 landscape:1 leading:1 two:1 next:1 their:1 expiring:1 head:1 company:3 line:1 trying:2 recall:1 while:1 following:1 health-care:1 blockbuster:1 end:2 patent:3 veteran:1 also:1 potential:1 economy:1 draw:1 's:6 changing:1 off:1 third:1 tenure:1 2009:1
stock_LLY r_down	joining:1 create:1 large:1 health:1 forces:1 enterprise:1 expertise:1 firms:1 law:1 care:1
stock_LLY r_up	body:1 use:1 said:1 's:2 --:1 type:1 recommending:1 2:1 drug:1 healthcare:1 cost-effectiveness:1 diabetes:1
stock_LLY r_up	1.5:3 allegations:1 settlement:1 check:1 out:1 $:3 breakup:1 recorded:1 its:1 charge:1 potential:1 stemming:1 government:1 possible:1 uses:1 investigation:1 billion:1 unauthorized:1 cover:1 drug:1 planned:1 promoted:1 history:1
stock_LLY r_down	saying:1 help:1 show:1 over:3 move:1 quarters:1 session:2 comments:1 exclusivity:1 still:1 weekly:1 whose:2 busy:1 antipsychotic:2 surprises:2 revenue:1 late:1 advisories:2 treatment:1 8:1 reforms:1 seller:1 details:1 then:1 watch:2 increases:1 therapy:1 eyed:1 international:1 front:1 tick:1 day:1 loss:2 lost:2 --:3 companies:3 loses:2 worries:1 stock:4 diabetes-drug:1 unexpected:1 says:1 leaders:1 some:1 back:1 euro-zone:2 likely:1 actively:2 trading:2 edged:1 3.8:1 index:2 said:2 profit:1 while:1 shares:2 research:1 version:1 graph:1 between:2 ongoing:1 nervously:1 recently:2 agreement:1 reported:1 protection:2 key:1 offset:3 100:1 strong:1 beginning:2 issuing:1 roundup:1 both:1 pipeline:1 quarter:1 launch:1 double-digit:1 drug:3 4th:1 insulin:1 rose:3 mixed:2 efforts:1 traded:2 maker:1 fell:1 among:1 stream:1 point:3 address:1 2nd:1 down:1 rising:1 add-on:1 open:1 crisis:1 market:2 decline:3 use:1 debt:1 officials:1 jobless:1 their:1 top:1 third-quarter:1 quickly:1 start:1 authorized:1 expected:2 meeting:2 500:3 summit:1 gained:1 ``:1 received:1 drugs:1 company:1 apparent:1 but:3 gain:2 potential:1 posted:1 16:1 package:1 up:1 signed:1 near:1 future:1 cautiously:2 looms:1 investors:2 sales:2 expenses:1 '':1 reports:1 blockbuster:2 saw:1 elements:1 5.1:4 4.7:1 generic:2 imminent:1 44:1 4.8:1 40:1 other:1 points:9 5:4 earnings:4 new:1 higher:6 added:2 's:4 though:1 popular:1 collaboration:1 after:2 forecasts:1 fueled:1 modest:1 levels:1 stocks:2 approved:1 diabetes:1 rift:2 third:1 slightly:1 futures:6 patent:3 costs:2 claims:1 corporate:2 latest:1
stock_LLY r_down	companies:1 actively:1 trading:1 's:1 still:1 whose:1 authorizes:1 5.4:1 5.5:1 generic:1 rose:1 shares:1 much:1 too:1 closed:1 500:1 added:1 eating:1 but:1 stocks:1 potential:1 session:1 lost:1 37:1 points:3 after-hours:1 mixed:1 salt:1
stock_LLY r_down	all:6 show:5 over:1 executive:1 results:2 years:1 session:1 comments:2 its:7 preventing:4 $:4 had:8 better:4 failed:7 treatment:6 factor:1 has:2 2010:4 details:2 advances:1 survival:1 discontinue:1 updates:3 background:3 trouble:4 continued:1 treating:1 lost:1 identifying:4 --:13 shock:4 companies:1 benefit:5 worldwide:1 findings:1 past:1 actively:1 trading:1 informed:1 patient:1 declined:1 said:10 adds:1 3rd:1 decision:1 shares:1 safety:1 new:4 receiving:4 cause:4 recently:1 whose:1 million:4 seventh:1 standard:1 102:1 beginning:1 104:4 care:1 received:4 improved:1 withdrawing:3 study:11 drug:18 trial:5 placebo:4 traded:1 comment:1 among:8 previously:4 sepsis:10 into:1 primary:1 adding:2 fake:4 throughout:2 market:2 use:1 additional:1 5th:1 there:5 question:1 been:1 reduction:4 clinical:6 markets:5 500:1 ``:1 than:4 10:1 endpoint:1 15:1 patients:16 decided:1 ongoing:1 were:1 meet:1 could:1 1.1:1 deaths:8 sales:4 '':1 further:1 any:4 compared:4 no:9 trials:1 1:1 also:1 other:1 best:4 stock:3 profile:1 's:3 price:3 after:6 fell:1 significant:4 stocks:1 recent:1 lower:1 calls:1 doctor:1 points:1 withdraw:1
stock_LLY r_up	amendment:1 would:1 deaths:1 sepsis:1 drug:1 person:1 pulls:1 egg:1 declare:1 more:1
stock_LLY r_up	giant:1 's:1 over:1 near-term:1 prospects:1 drug:1 priced:1 growth:1
stock_LLY r_down	among:1 30:1 says:1 have:1 cancer:4 summer:1 testing:1 due:1 put:1 against:1 2,500:1 's:3 cut:1 potential:1 trials:1 delays:1 only:1 been:1 research:1 also:1 waiting:1 clinical:2 treatment:1 which:1 supplier:1 has:1 more:1 affected:1 drugs:2 problems:1 but:1 not:1 hold:2 than:1 those:1 off:1 manufacturing:1 --:3 amid:1 many:1 list:1 drug:1 face:1 patients:2 ongoing:1 either:1 shortage:3 requests:1 studies:1 other:1 result:1
stock_LLY r_up	heart:2 associated:1 adults:2 1.2:2 two:1 children:2 cardiovascular:1 n't:6 young:2 research:1 increase:2 potential:1 deficit:1 online:1 medicine:1 treat:2 used:2 led:1 risk:2 drugs:3 million:2 problems:2 agencies:1 involving:2 date:1 largest:1 showed:2 --:1 study:4 funded:1 large:2 did:2 risks:1 attention:1 published:1 serious:2 looking:1 disorder:1 professor:1
stock_LLY r_up	saying:1 oncology:1 executive:2 results:4 quarters:1 held:1 legal:1 its:9 based:1 longstanding:1 field:1 surprises:2 guidance:2 advisories:2 systems:1 has:1 them:1 overall:3 updates:2 not:1 world:2 disappointed:2 projects:1 --:8 medicines:1 companies:1 quarter:2 reduces:2 view:2 some:2 handing:1 related:1 past:2 growth:3 year:2 further:1 makers:1 said:2 3rd:2 profit:5 comments:2 forecast:2 new:2 pharmaceutical:1 agreement:1 reported:2 beginning:2 roundup:1 launch:2 drug:2 range:2 analysts:2 defeat:1 gene:1 maker:3 low-end:2 campaign:1 revenue:3 two:1 down:3 decline:3 mounting:1 top:2 third-quarter:5 upheld:1 listed:1 pitching:1 company:4 delayed:2 lowered:2 overturn:1 13:11 signed:1 future:1 sees:2 sales:3 weighed:3 full-year:4 reports:1 sharp:3 if:2 end:2 patent:1 also:2 earnings:3 fourth:2 largest:2 stock:2 product:2 's:3 generic-drug:5 price:2 falls:2 regulations:1 fell:3 uses:1 lupus:1 perform:1 bottle:1 corporate:1 latest:1
stock_LLY r_up	saying:1 already:1 sales:1 over:1 ``:2 years:1 '':2 ended:1 accelerate:1 tenuous:1 year:1 exclusivity:1 its:1 market:1 pharmaceutical:1 said:3 patent:3 three:1 next:1 late:1 potential:1 between:1 has:1 firm:1 ranking:1 junk:1 's:2 adding:1 company:3 possible:1 period:1 most:2 hurt:1 recent:1 put:1 highest:1 downgraded:1 cliff:1 loss:2 industry:2 30:1 51:1 drug:1 maker:1 credit:1 severe:1 accounted:1 expiration:1 faces:1 position:1 notch:1 midway:1
stock_LLY r_up	saying:1 all:1 agreed:2 executive:1 terminate:1 quarters:1 session:4 shares:4 litigation:1 whose:5 terms:1 $:4 longstanding:3 surprises:2 had:2 advisories:2 treatment:6 decade-long:3 include:1 advanced:1 earnings:1 his:1 rose:3 get:3 watch:1 handily:1 trade:1 bigger:4 resolve:1 name:1 success:3 --:15 follows:1 companies:6 morning:1 collect:1 payments:1 after-hours:1 diabetes-drug:6 shed:1 deal:1 used:2 2.9:1 actively:4 trading:3 year:1 tumultuous:2 2.1:1 declined:1 adds:1 jumped:1 review:3 comments:2 closed:1 new:6 outperforming:1 ends:2 earlier:1 recently:2 million:1 agreement:1 step:1 102:1 approval:2 along:1 roundup:1 received:1 toward:1 ahead:3 launch:1 could:4 favorite:1 drug:8 times:2 paring:1 a.m.:1 planned:1 context:1 published:1 mixed:1 discusses:1 traded:1 comes:3 stakes:3 comment:1 already:1 cancer:4 revenue:1 colon:1 one-time:1 wider:2 250:1 throughout:1 crisis:1 market:1 terminated:3 story:1 additional:1 been:2 approved:2 their:7 types:1 expected:1 chemotherapy:2 500:3 4:1 ``:1 sharing:1 relationship:1 corrected:1 part:1 gain:1 injection:1 raising:3 pact:2 13:1 full:1 second:2 patients:2 future:1 were:1 more:1 similar:1 called:1 1.2:3 outstanding:1 certain:1 partnership:7 share:4 sales:1 '':1 reports:1 have:2 seen:1 gains:1 information:2 end:3 make:1 40:1 also:1 other:1 role:1 split:1 fourth:1 gets:1 resignation:1 higher:1 development:1 added:1 's:13 see:1 after:1 fell:2 ownership:1 head:2 stocks:4 payment:1 parting:1 diabetes:4 billion:1 lower:1 neck:2 third:1 resolving:1 points:7 allow:1 late-stage:2 corporate:1 profits:4 latest:1
stock_LLY r_down	heart:2 antibiotic:1 high-risk:1 painkiller:1 certain:1 agreed:1 reduce:1 primary:1 related:1 '':1 selling:1 another:1 measure:1 equity:1 surgery:1 its:1 market:1 risk:1 information:2 said:3 $:1 pay:1 lawsuits:1 class-action:1 three:1 legal:1 linked:1 doomsday:1 strokes:2 does:1 wants:1 which:1 issued:1 biggest:1 has:1 markets:1 2010:1 more:1 development:1 activities:1 ``:1 after:1 's:1 increased:1 government:1 drugs:1 marketing:2 million:1 private:1 defeated:1 news:1 former:1 care:1 acquisitions:1 received:1 attacks:1 into:1 bypass:1 drug:1 morning:1 n't:1 2003:1 patients:1 settle:1 subpoena:1 2004:1 push:1 requests:1 filing:1 mergers:1 investigators:1
stock_LLY r_up	lowers:1 researcher:1 while:2 second:1 boosts:1 information:1 additional:1 able:2 two:1 comments:1 needed:1 potential:1 fifth:1 new:1 presentation:1 final:1 lowering:2 good:4 's:2 drugs:2 sixth:1 involving:2 aiming:1 class:1 kind:2 showed:2 --:5 boost:3 study:3 larger:1 say:1 drug:3 bad:3 levels:2 cholesterol:4 studies:1 experimental:2
stock_LLY r_up	customers:1 business:1 covering:1 drugs:1 30:1 stop:1 pharmacy-benefit:1 recommending:1 next:1 year:1 than:1 more:1
stock_LLY r_down	even:1 schemes:1 benefits:1 said:1 business:1 medicines:1 --:1 medical:1 brand-name:1 bias:1 intellectual:1 challenges:1 against:1 continue:1 build:1 theft:1 faces:1 interview:1 property:1 its:1 recent:1
stock_LLY r_down	illegally:1 $:1 painkiller:1 civil:1 pay:1 million:1 charges:1 settle:1 950:1 promoted:1 criminal:1 announced:1
stock_LLY r_down	sees:1 back:2 technicians:1 one:1 say:1 promise:1 pharmaceutical:2 pharma:1 would:2 revisit:1 you:2 never:2 but:3 indices:1 cutting:2 lows:1 these:2 could:1 days:2 construction:2 underway:2 long-term:1 industry:2 know:2
stock_LLY r_up	shed:1 1.1:1 slipped:1 warns:1 spectrum:1 euro-zone:2 actively:1 trading:1 yield:1 investors:1 's:3 crisis:2 hoping:1 sell:1 index:1 debt:1 combat:1 lead:1 rose:1 review:1 42:1 shares:2 agrees:1 points:4 0.3:1 hope:1 higher:1 week:1 added:1 recently:1 plans:1 mostly:2 whose:1 downgrades:1 after:3 action:1 stems:1 put:1 leaders:1 stocks:3 trade:1 day:2 advanced:1 summit:2 12:1 15:1 countries:1 --:4 companies:1 up:1 35:1 nations:1 credit:1 while:1 session:1 mixed:1 traded:1
stock_LLY r_up	1.4:1 index:1 shed:1 added:1 's:4 session:1 whose:1 actively:1 rose:1 companies:1 shares:1 52:1 while:1 points:3 trading:1 6.2:1 closed:1 after-hours:1 mixed:1 stocks:1
stock_LLY r_down	plant:1 increasing:1 's:3 manufacturing:1 big:1 cited:1 posed:1 drug:2 reliance:1 challenges:1 regulators:1 contractors:1 lapses:1 highlighting:1 troubled:1 quality:1 makers:1 manufacturer:1
stock_LLY r_up	sector:1 survivors:1 21st:1 cautious:1 cancer:1 bullish:1 covering:1 birthday:1 stocks:1 looked:1 born:1 kids:1 diagnosed:1 before:1 2012:2 several:1 data:1 their:1 he:1
stock_LLY r_up	unemployment:1 high:1 cost:1 year:1 confidence:1 said:1 weakened:1 patent:1 due:1 rash:1 next:1 low:1 2012:2 expirations:1 government:1 pressure:1 significant:1 demand:1 amid:1 companies:1 face:1 containment:1 consumer:1
stock_LLY r_up	premium:1 exclusive:2 tough:1 version:4 cancer:2 revenue:1 agreed:2 global:1 year:1 '':6 actively:2 trading:2 value:2 have:1 3.1:1 2.2:1 's:5 2.7:1 2.6:1 predicted:1 some:2 index:4 giant:3 error:2 20:2 $:2 million:2 challenging:1 rose:2 get:2 shares:2 potential:2 growth:1 earnings:1 which:2 approvals:1 developer:2 2012:1 2.4:1 2011:1 correct:4 therapies:2 higher:2 potentially:2 ``:6 added:2 recently:2 whose:2 a.m:2 collaboration:4 time:1 watch:1 return:1 wave:1 most:1 valued:2 sharply:2 milestone:2 licensing:2 despite:1 stocks:2 pharmaceutical:3 220:2 include:1 2.8:1 third:2 cresting:1 rights:2 follows:4 industry:1 climbed:2 companies:2 roughly:2 drug:3 morning:1 more:1 amount:2 session:2 a.m.:4 payments:2 were:1 first:4 traded:2 published:6
stock_LLY r_up	aided:1 help:1 sales:1 2.9:1 actively:1 3.2:1 after-hours:1 recover:1 its:2 index:2 would:1 generic:1 rose:1 shares:1 3:1 earnings:1 closed:1 new:1 500:1 higher:1 added:1 's:1 business:1 whose:1 drugs:1 weakness:1 rise:1 sharply:1 stocks:1 recent:1 could:1 climbed:1 companies:1 session:1 predicted:1 were:1 trading:1 2012:3 stock:1
stock_LLY r_down	headwinds:1 health-care:1 related:2 likely:1 identify:2 year:1 protein:2 next:1 targets:2 acceleration:1 said:1 lead:2 patent:1 research:2 concerns:1 potentially:2 new:2 therapies:2 fiscal:1 's:6 expirations:1 fund:2 key:2 affect:2 abroad:1 stresses:1 industry:1 disease:2 remain:1 efforts:2 could:2
stock_LLY r_down	index:1 runs:1 buy:2 worse:1 fund:1 did:1 top:2 actually:1 simple:1 numbers:1 year:1 you:2 stocks:3 than:1 2012:2
stock_LLY r_down	saying:1 sales:1 quarters:1 its:1 steeper:1 decline:2 20:3 antipsychotic:1 patent:1 surprises:2 advisories:2 much:1 earnings:1 which:1 2012:3 recently:1 expects:1 protection:1 roundup:1 lost:1 companies:1 reports:1 future:1 corporate:1 profits:1 latest:1
stock_LLY r_down	fourth-quarter:1 20:2 releases:1 less:1 sales:1 regulating:1 common:1 2012:2 better-than-expected:1
stock_LLY r_down	supporting:1 resource:1 like:1 physicians:1 sales:2 tightly:1 pitches:1 their:1 switch:1 asking:1 treatment:1 acting:1 making:1 now:1 makers:1 more:1
stock_LLY r_down	resolve:1 declined:1 $:3 clinical:1 158:3 marketing:1 million:1 sales:1 related:1 data:1 experimental:1 asking:1 drug:2 pay:1 claims:1 more:1 diabetes:1 approve:1 its:1 unit:1 antipsychotic:1
stock_LLY r_down	's:4 long:1 drug:1 been:1 bumpy:1 approval:1 developer:1 road:1 diabetes:1
stock_LLY r_up	results:1 alternative:1 seek:1 sell:1 confidence:1 housing:1 much:1 tape:1 new:1 therapies:1 more:1 's:5 company:1 pose:1 includes:1 preparing:1 regulatory:1 approval:1 data:1 older:1 could:1 drug:1 consumer:1
stock_LLY r_up	fourth-quarter:1 figure:1 point:3 declines:1 over:1 each:1 ``:1 competition:1 trade:1 disappointing:1 actively:1 reports:1 signs:1 talks:1 drugs:1 whose:1 generic:1 also:2 thinking:1 favor:1 tougher:1 due:1 shares:2 forecast:1 start:1 earnings:1 which:1 expected:1 progress:1 higher:3 we:1 reporting:1 's:2 rules:1 after:1 agreement:1 hurt:1 reported:1 were:1 fell:1 new:1 debt:1 cliff:1 '':1 rival:1 futures:3 companies:1 budget:1 drug:1 patent:1 profit:1 session:1 amid:1 stock:4 slightly:1 maker:1 investors’:1
stock_LLY r_up	saying:1 they:1 just:1 show:1 dollar:1 expects:1 competitive:1 month:1 course:1 including:2 its:1 impact:1 giant:1 cut:1 zone:1 surprises:2 guidance:1 advisories:2 treatment:1 weakening:1 2012:3 has:1 hope:1 earnings:3 good:1 gains:1 government:1 weakness:1 continues:1 closely:1 report:2 quarters:1 day:2 entire:1 --:1 always:1 companies:3 slide:1 prescribing:1 become:2 says:1 dealing:1 some:2 jump:1 see:1 cost:1 year:1 jobs:1 employment:1 out:2 index:1 said:2 pattern:1 section:1 increase:1 outside:1 're:1 international:1 boost:1 recently:1 predicting:1 reported:1 succeed:1 put:1 manufacturing:1 improve:1 roundup:1 pipeline:1 last:1 ahead:1 getting:1 could:1 in-depth:1 priorities:1 spending:1 products:1 slightly:1 bite:1 first:1 fourth-quarter:1 named:1 puzzle:1 retailer:1 rolling:1 positives:1 throughout:1 miss:1 crisis:1 market:1 pharmaceutical:1 monthly:2 top:1 two:1 their:2 much:1 expected:4 recent:1 markets:1 today:3 more:1 ``:1 much-needed:1 but:2 producing:1 '':1 look:1 n't:2 below:1 growth:1 pressure:1 piece:1 weaker:1 sales:2 disappointing:1 currency:1 his:1 numbers:1 have:1 our:2 watched:1 huge:1 compared:1 get:1 other:1 take:1 which:1 auto:1 higher:1 week:1 such:1 's:11 warnings:1 most:1 coming:1 nothing:1 president:1 future:1 euro:6 surprising:1 average:1 stronger:2 reports:2 edge:1 position:1 corporate:2 profits:1 latest:1
stock_LLY r_down	increase:1 also:1 profit:1 amid:1 reported:1 revenue:1 modest:1 fewer:1 acquisition-related:1 charges:1 restructuring:1 swung:1 maker:1
stock_LLY r_down	exclusive:1 generic:1 's:3 third:1 also:1 profit:1 consolidated:1 rupee:1 rise:1 schizophrenia:1 sales:1 drug:1 reported:1 88:3 weak:1 led:1 net:1 quarter:1 better-than-expected:1
stock_LLY r_up	session:1 whose:1 's:1 companies:1 shares:1 trade:1 actively:1 expected:1
stock_LLY r_down	ability:1 improved:1 mental:1 form:1 sense:1 disease:1 drug:1 500:2 social:1 's:3 has:1 smell:1 restored:1 skin-cancer:1
stock_LLY r_up	fourth-quarter:1 costly:1 cancer:1 revenue:1 simple:1 offset:1 fakes:1 rising:1 yield:1 year:1 pills:1 declined:1 counterfeit:1 rather:1 highlights:1 away:1 increase:1 version:1 which:1 cash:1 8:1 therapies:1 higher:1 's:2 purchase:1 company:1 costs:1 acquisition-related:1 fueled:1 found:1 backed:1 such:1 than:2 going:1 last:1 up:1 drug:1 34:3 n't:1 profit:1 printing:1 threat:1 injectable:1 more:1
stock_LLY r_up	people:1 developed:1 some:1 may:1 treat:1 microchip:1 company:1 painful:1 injections:1 drugs:1 problems:1 implantable:1 serve:1 deliver:1 day:1 has:1 medical:1 daily:1 shots:1 require:1 experimental:1 replacement:1
stock_LLY r_up	rundown:1 watch:2 early:1 making:1 news:1 headlines:1 corporate:1
stock_LLY r_up	billion:1 resolve:1 prosecutors:1 $:1 proposed:1 allegations:1 roughly:1 rejected:1 1:1 uses:1 drug:1 unapproved:1 promoted:1 settlement:1 antipsychotic:1
stock_LLY r_down	heart:1 have:2 agreed:1 including:1 looks:1 want:1 best:1 votes:1 investing:1 auditors:1 reality:1 very:1 biggest:1 public:1 difficult:1 interests:1 's:2 may:1 propose:1 but:1 director:1 regulators:1 shareholder:1 plan:1 such:1 pull:1 off:1 require:1 annual:1 companies:2 appointments:1 practical:1 switch:1 corporate:1
stock_LLY r_down	giants:1 led:1 threat:1 business:1 getting:2 rattled:2 industry:1 after:1 companies:1 access:1 applications:1 bigger:1 way:1 become:1 new:1 firms:1 decade:1
stock_LLY r_up	set:1 's:1 trial:1 see:1 favorable:1 result:1
stock_LLY r_up	investors:2 lock:1 some:1 '':3 soaring:1 3.5:1 caution:3 advising:1 skin:1 run-up:3 given:1 proceed:1 offer:1 had:1 due:1 shares:1 should:1 advise:2 company:1 analysts:3 ``:3 's:1 pharmaceutical:1 bid:1 but:1 reported:1 game:1 takeover:1 report:1 $:1 billion:1 made:1 amid:2 keep:1 massive:1 stock:3 profits:1
stock_LLY r_up	agreed:1 sale:1 open:1 investment:1 rejecting:1 should:1 board:1 ramping:1 medicine:1 personalized:1 buy:1 's:1 reportedly:1 offer:1 company:1 conglomerate:1 takeover:1 letter:1 now:1 blasted:1 pursue:1 up:1 drug:1 maker:1
stock_LLY r_down	followed:1 sharply:3 deal:1 soars:3 one:1 through:1 against:1 ready:1 seem:1 its:1 if:1 sue:1 detect:1 court:1 reportedly:1 patent:1 disease:1 help:1 treatment:1 stock-market:1 does:1 board:2 boon:1 test:1 has:1 company:1 stock:2 week:1 's:2 extend:1 offer:1 drugs:1 blasting:1 after:1 stop:1 react:1 chance:1 takeover:1 weaker-than-expected:1 members:1 trade:1 data:1 approved:1 he:1 case:1 lower:3 gets:1 last:1 developing:1 did:1 futures:3 days:1 drug:1 n't:2 potential:1 can:1 threat:1 deadline:1 passing:1 maker:1 first:1
stock_LLY r_down	extend:1 effort:1 company:1 continues:1 its:1 up:1 drug:1 maker:1 pressure:1 deadline:1 against:1 push:1 sale:1 lawsuit:1 filing:1 he:1
stock_LLY r_up	billion:1 selling:1 $:1 business:1 people:1 would:1 familiar:1 year:1 least:1 one:1 deals:1 matter:1 said:1 so:1 far:1 largest:1 9:1 close:1 its:1
stock_LLY r_up	among:1 could:1 watch:2 see:1 trading:1 active:1 stocks:1
stock_LLY r_up	deal:1 extra:1 into:1 700:1 sales:1 competition:1 month:1 '':1 buy:1 nearing:1 sought:1 's:3 blockbuster:1 said:1 antipsychotic:1 million:1 4.2:3 generic:1 continued:1 lawsuits:1 people:1 had:1 fight:1 state:1 activist:1 earnings:1 dismissing:1 suit:1 nice:1 ``:1 his:1 multiple:1 generic-drug:1 familiar:1 company:1 earlier:1 hurt:1 fell:1 proxy:1 filed:1 first-quarter:1 appears:1 he:1 according:1 roughly:1 against:1 $:1 matter:1 time:1 release:1 voluntarily:1 playing:1 launched:1
stock_LLY r_up	would:1 against:1 drug:1 erectile:1 compete:1 treat:1 approved:1 dysfunction:1
stock_LLY r_up	arrested:1 two:2 have:1 find:1 pharmaceutical:1 said:1 $:1 large:1 aside:1 been:1 warehouse:1 new:1 more:1 brothers:1 government:1 drugs:2 million:1 uses:1 theft:1 70:1 authorities:1 years:1 than:1 ago:1 prescription:1 industry:1 work:1 companies:1 try:1 cast:1
stock_LLY r_up	major:1 medication:1 setback:1 high:1 second:1 its:1 said:1 raise:1 had:1 failed:1 which:1 type:1 ``:1 good:1 designed:1 hopes:1 '':1 industry:1 drug:1 large:1 cholesterol:1 study:1
stock_LLY r_up	findings:1 violated:1 probe:1 hypertension:1 its:1 pharmaceutical:1 said:2 their:1 trials:1 granted:1 rules:1 clinical:1 treat:1 lawmakers:1 drugs:1 governing:1 they:1 approval:1 conducting:1 country:1 companies:1 drug:1 waiver:1
stock_LLY r_up	fourth-quarter:1 slim:1 's:3 investors:1 profit:1 2.7:3 rise:1 mainly:1 due:1 one-time:1 charge:1 net:1 disappointed:1 its:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	week:1 molecular:1 releases:1 cancer:2 society:1 drugs:1 shift:1 away:1 continuing:1 treatments:1 cells:1 medical:1 clinical:1 features:1 unique:1 data:1 display:1 target:1
stock_LLY r_up	cancer:1 people:1 one-third:1 signs:1 surgery:1 yet:1 before:1 use:1 group:1 six:1 looking:1 memory:1 show:1 size:1 do:1 's:6 men:1 tested:1 eliminated:1 prostate:2 loss:1 showed:1 --:1 study:1 months:1 drug:1 reduced:1 n't:1 trial:1 patients:1 greatly:1 time:1 small:1 treated:1 tumors:1 first:1
stock_LLY r_down	cancer:1 one-third:1 surgery:1 before:1 use:1 group:1 six:1 looking:1 size:1 's:1 men:1 eliminated:1 prostate:2 showed:1 study:1 months:1 reduced:1 patients:1 greatly:1 small:1 treated:1 tumors:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	heart:2 being:2 primary:2 rate:2 doses:4 said:2 monitoring:2 technique:2 two:2 investigational:2 2:2 treatment:6 which:2 weeks:2 after:2 24-hour:2 pressure:6 compared:2 blood:6 placebo:2 using:2 diabetes:4 endpoint:4 met:4 study:4 16:2 mean:2 effects:2
stock_LLY r_up	respond:1 heart:2 thinner:1 3.0:1 world-wide:1 century:1 increasingly:1 companies:1 estimates:1 sales:1 month:1 included:1 clinic:1 drug:2 have:1 year:1 our:1 blockbuster:1 your:2 2.5:1 if:1 counting:1 based:1 21:1 patent:1 affects:1 people:1 question:1 per:1 current:1 secret:1 're:1 advanced:1 which:1 income:1 2.0:1 you:1 cause:1 analysts:2 status:1 them:1 's:3 ability:1 forming:1 clots:1 earlier:1 variation:1 important:1 operating:1 blood:2 share:1 not:1 last:1 password:1 bank:1 $:2 billion:2 account:1 off:2 name:1 limits:1 prevent:1 =:5 30:1 list:1 disease:1 us:1 n't:2 turn:1 patients:1 accounted:1 survey:1 can:1 quarters:1 went:1 gene:2 1.5:1
stock_LLY r_down	use:1 's:1 business:1 campaign:1 escalate:1 company:1 brand-name:1 pharmacy-benefit:1 against:1 prepared:1 drugs:1 encourage:1 expensive:1 says:1 drug-industry:1 coupons:1 unnecessary:1
stock_LLY r_down	use:1 's:1 business:1 campaign:1 escalate:1 company:1 brand-name:1 pharmacy-benefit:1 against:1 prepared:1 drugs:1 encourage:1 expensive:1 says:1 drug-industry:1 coupons:1 unnecessary:1
stock_LLY r_down	1.5:1 cancer:4 show:2 certain:2 estimates:1 results:2 quarters:1 '':2 promise:2 3.0:1 2.0:1 2.5:1 pharmaceutical:2 said:2 based:1 companies:1 answering:2 question:2 patients:2 per:1 current:1 company:2 treatment:4 maintenance:4 continuation:2 meeting:2 final:2 physicians:2 ``:2 's:2 share:1 survival:2 income:1 director:2 important:2 operating:1 =:5 included:1 treating:2 showed:2 --:2 type:4 study:6 annual:2 list:1 drug:2 benefit:2 survey:1 analysts:2 lung:4 senior:2 medical:2 first:2
stock_LLY r_up	pharmaceutical:1 his:1 said:1 mega:1 may:1 deals:1 experience:1 n't:1 wo:1 parts:1 making:1 bringing:1 any:1 he:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	people:1 being:1 sugar:1 its:3 20:5 $:7 generic:2 trials:1 investment:3 their:2 clinical:1 mid-stage:1 branded:2 's:2 increased:3 generic-drug:3 offer:2 collaboration:2 million:3 lowered:1 blood:1 diabetes:1 short:1 country:2 medicines:2 expanded:2 levels:1 form:1 insulin:1 enhance:2 efforts:2 maker:3 experimental:1
stock_LLY r_up	alliance:3 global:1 two:2 13th:1 7th:1 11th:1 between:1 said:1 adds:1 three:3 comments:1 makers:1 started:1 treatment:1 under:2 new:1 diabetes:1 more:2 selling:1 drugs:2 price:1 after:1 plan:1 they:1 years:1 than:1 executives:1 lower:1 launch:2 --:4 drug:1 products:2 9th:1 10th:1 launched:1 first:1
stock_LLY r_up	comment:1 1.5:1 2.5:1 buying:1 3.0:1 win:3 fall:1 estimates:1 sales:3 quarters:1 list:1 have:2 2.0:1 its:1 investment:1 based:1 drugs:1 pharmaceutical:3 requirements:2 working:2 rejects:1 federal:1 pay:2 decision:1 outside:1 per:1 labor:1 current:1 their:2 written:1 details:1 exempt:1 new:1 type:1 overtime:2 analysts:2 do:2 salespeople:1 's:6 income:1 rules:1 boosted:1 under:1 removes:1 hours:2 operating:1 significant:3 opinion:1 included:1 court:1 law:1 provision:1 those:1 ruled:3 rights:1 --:5 =:5 industry:3 companies:3 disease:1 drug:5 n't:2 survey:1 ruling:1 position:1 share:1 experimental:1
stock_LLY r_up	often:1 sales:1 have:1 effort:1 its:1 try:1 $:3 working:1 overtime:1 pay:1 ideas:1 shares:1 their:1 only:1 program:1 too:1 new:1 returns:1 boost:1 remaining:1 stock:1 do:1 them:1 plans:1 get:1 wo:1 million:1 hours:1 shareholder:1 additional:1 they:2 420:3 repurchase:1 come:1 buying:1 ruled:1 buybacks:1 look:2 always:1 companies:2 up:1 drug:1 n't:2 anywhere:1 resuming:1
stock_LLY r_down	adviser:1 informed:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	reactions:2 expanded:2 groups:1 certain:2 health-care:5 related:2 one:5 weighed:5 likely:2 years:5 decisions:5 makers:2 diagnostic:2 trade:1 different:4 law:5 court:5 drugstores:1 variety:5 things:2 administration:5 other:2 health:2 test:2 upheld:5 insurers:4 across:5 stand:2 's:14 provisions:2 means:2 hospitals:2 after:5 anticipated:5 most:5 gain:2 coverage:2 device:2 highly:5 care:2 sectors:7 pressure:2 medical:2 reform:2 companies:4 face:2 while:2 ruling:2
stock_LLY r_up	reactions:2 expanded:2 groups:1 certain:2 health-care:2 related:2 one:2 weighed:2 likely:2 years:2 decisions:2 makers:2 diagnostic:2 trade:1 different:4 law:2 court:2 drugstores:1 variety:2 things:2 administration:2 other:2 health:2 test:2 upheld:2 insurers:4 across:2 stand:2 's:8 provisions:2 means:2 hospitals:2 after:2 anticipated:2 most:2 gain:2 coverage:2 device:2 highly:2 care:2 sectors:4 pressure:2 medical:2 reform:2 companies:4 face:2 while:2 ruling:2
stock_LLY r_up	1.5:1 investors:1 companies:1 estimates:1 quarters:1 3.0:1 headlines:1 2.0:1 2.5:1 rundown:1 5.3:1 based:1 $:1 per:1 current:1 market:1 interest:1 income:1 =:5 gives:1 added:1 's:3 share:1 acquire:1 watch:2 agreement:1 early:1 fast-growing:1 heft:1 operating:1 included:1 billion:1 list:1 survey:1 analysts:2 corporate:1 maker:1 diabetes-drug:1
stock_LLY r_up	agreed:1 have:1 plead:1 $:3 pay:1 3:3 safety:1 criminal:1 do:1 illegally:1 government:1 drugs:1 marketing:1 regulators:1 data:1 billion:1 keeping:1 monopoly:1 charges:1 guilty:1 n't:1 bad:1 behavior:1
stock_LLY r_down	's:1 flow:1 discounted:1 cash:1 rising:1 sees:1
stock_LLY r_down	because:5 extra:2 results:2 through:2 have:3 exclusivity:7 blockbuster:2 seek:2 children:7 market:7 use:4 said:5 requirements:2 additional:5 patent:2 six:7 its:5 citing:2 gets:2 2013:2 's:5 expirations:2 efficacy:2 wo:4 company:3 were:2 wave:2 met:2 effects:3 regulatory:4 approval:4 regarding:2 has:2 pursue:2 study:2 months:7 drug:5 antidepressant:7 n't:4 --:10 pediatric:2 faces:2 studies:2 gain:2
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	control:1 sector:1 broader:1 number:1 competition:1 past:1 have:1 year:1 exclusivity:1 blockbuster:1 lower-priced:1 market:1 bolster:1 generic:1 struggles:1 been:1 makers:1 their:1 raft:1 firms:1 pipelines:1 cope:1 drugs:1 industrywide:1 during:1 cliff:1 loss:1 coping:1 drug:2 deals:1 patent:1 costs:1 entry:1
stock_LLY r_down	control:1 sector:1 broader:1 industrywide:1 results:2 competition:1 trade:3 past:1 schizophrenia:2 session:3 been:1 have:1 year:1 pipelines:1 exclusivity:1 blockbuster:1 its:2 market:1 bolster:1 said:2 number:1 missed:2 generic:1 struggles:1 shares:3 makers:1 lower-priced:1 their:1 clinical:2 treat:2 expected:3 raft:1 firms:1 's:5 cope:1 drugs:1 primary:2 suffering:2 entry:1 during:1 cliff:1 loss:1 endpoint:2 coping:1 study:2 patent:1 companies:3 drug:4 costs:1 deals:1 trial:2 patients:2 actively:3 investigating:2
stock_LLY r_up	says:1 alternatives:1 bulking:1 year:1 its:1 next:1 more:1 's:1 plans:1 business:1 drugs:2 company:1 continues:1 pharmacy-benefit:1 treatments:1 coverage:1 cheaper:1 17:3 list:1 up:1 against:1 high-cost:1 push:1 block:1
stock_LLY r_up	day:1 hit:1 defensive:1 sectors:1 sixth:1 highs:3 losses:1 heir:1 up:1 trade:2 52-week:3 near:3 broader:1 handful:1 stocks:3 its:1 racks:1 market:1
stock_LLY r_up	1.5:1 3.0:1 list:1 estimates:1 soon:1 quarters:1 underlying:1 have:1 2.0:1 2.5:1 based:1 per:1 current:1 their:1 pursuing:1 firms:1 =:5 's:3 share:1 income:1 treatments:1 paid:1 operating:1 know:1 address:1 included:1 off:1 whether:1 companies:1 drug:1 survey:1 analysts:2 efforts:1
stock_LLY r_up	stock:1 because:1 revenue:2 bump:1 sales:1 expenses:1 down:1 currency:3 trends:3 decrease:1 comments:1 second-quarter:1 hit:1 throughout:1 speed:1 out:2 decline:1 anticipation:1 details:1 49:4 profit:2 disruptions:2 contributed:1 negative:2 legal:3 forecast:1 earnings:2 fourth:1 new:2 2012:1 's:1 slight:1 falls:1 conglomerate:1 reported:1 fell:1 background:1 hurt:1 beginning:1 expectations:1 acquisitions:1 weighed:2 short:1 calls:1 charges:1 amid:1 reduces:1 full-year:1 against:1 --:3 while:2 costs:2 higher:1 acquisition-related:1 could:1 acquisition:1
stock_LLY r_down	billion:1 would:1 prosecutors:1 $:3 deal:1 investigations:1 federal:1 marketing:1 into:1 practices:1 settle:1 much:1 reached:1 2.2:3 's:1 company:1
stock_LLY r_down	1.5:1 all:2 set:2 companies:1 estimates:1 highly:2 four:2 bapineuzumab:4 including:2 3.0:1 2.0:1 find:2 2.5:1 millions:2 said:4 develop:2 their:4 spending:2 memories:2 per:1 makers:2 current:1 failed:2 3:2 potential:2 treatment:4 which:2 income:1 survey:1 =:5 's:10 form:2 continuing:2 reach:2 anticipated:2 its:6 operating:1 goals:2 address:2 included:1 based:1 quarters:1 changes:2 list:1 disease:2 drug:2 without:2 thinking:2 patients:2 underlying:2 ongoing:2 analysts:2 behavior:2 affects:2 share:1 studies:4 other:2 first:4
stock_LLY r_down	all:1 set:1 high-risk:1 find:1 slowing:1 highly:1 four:1 bapineuzumab:3 including:1 partner:1 its:3 thinking:1 millions:1 n't:1 said:3 develop:1 failed:1 spending:1 memories:1 3:1 makers:1 their:3 genetic:1 clinical:1 other:1 treatment:2 which:1 memory:1 's:8 form:1 continuing:1 reach:1 anticipated:1 goals:1 address:1 potential:1 loss:1 effective:1 changes:1 disease:1 drug:2 without:1 large:1 trial:1 patients:2 underlying:1 ongoing:1 behavior:1 affects:1 first:2 studies:2 called:1 experimental:1 late-stage:1
stock_LLY r_up	results:1 month:3 four:1 through:3 hepatitis:2 exclusivity:3 its:12 fifth:1 $:12 23:11 expectations:1 2014:1 2013:3 earnings:8 expirations:4 continues:1 watch:2 effects:4 background:1 --:9 raised:3 because:3 competition:1 see:1 growth:2 trading:1 exceeded:1 margins:1 declined:1 said:3 adds:1 profit:4 review:2 contributed:4 comments:1 forecast:4 between:3 new:2 decline:5 active:1 estimate:3 beginning:1 antipsychotic:1 hits:1 double-digit:4 days:1 drug:8 maker:1 first:1 among:1 outlook:1 revenue:4 feel:1 chronic:2 raises:1 throughout:1 market:3 pharmaceutical:4 industrials:1 additional:3 priority:2 expected:1 eltrombopag:2 company:11 infection:2 second-quarter:6 supplemental:2 also:3 patients:2 expiration:1 3.30:6 2012:2 months:3 sees:1 share:6 sales:3 helped:1 currency:1 full-year:4 partner:2 blockbuster:3 cites:1 patent:5 granted:5 six:3 application:2 details:1 which:2 rise:1 's:21 boosted:1 after:1 virus:2 fell:4 stocks:1 recent:1 treats:2 children:3 antidepressant:3 generic:1 time:1 profits:1
stock_LLY r_up	expects:1 years:1 quotes:1 cuts:2 exclusivity:1 its:2 looking:1 cut:1 $:1 euros:2 rose:2 quarterly:1 has:1 return:1 expirations:1 big:1 rise:1 fall:1 1.01:1 loss:1 ended:1 --:4 companies:1 quarter:1 because:2 some:1 competition:1 past:1 growth:1 year:2 further:1 margins:1 even:2 said:3 profit:5 shares:1 increase:1 net:4 boost:1 business:1 1.17:1 reported:1 restructuring:2 both:1 hits:1 cautious:1 ahead:1 industry:1 30:1 job:1 drug:2 products:1 fallen:1 maker:2 patents:1 major:1 via:1 throughout:1 market:1 pharmaceutical:2 would:1 few:1 top:2 their:1 much:1 9.8:1 way:1 expected:1 firm:1 ``:1 drugs:1 company:2 took:1 part:1 known:1 second-quarter:3 posted:1 case:1 '':1 16:1 expanded:1 up:1 optimism:1 cost:1 were:1 1.4:1 investors:2 sales:3 helped:2 blockbuster:1 patent:2 detail:1 earnings:1 income:1 forge:1 's:2 earlier:1 dented:1 cleared:1 cliff:1 billion:4 lower:1 off:1 generic:1 costs:2 profits:1
stock_LLY r_up	151:3 raised:1 series:1 over:1 allegations:1 month:1 states:1 result:1 fake:1 out:1 $:4 pay:1 29:1 only:1 raids:1 net:1 200:1 government:1 company:1 million:1 but:1 prices:1 years:1 last:1 carried:1 drug:2 investigators:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 2.5:1 based:1 per:1 current:1 income:1 =:5 higher:1 play:1 upcoming:1 share:1 company:1 action:1 operating:1 included:1 could:1 list:1 drug:1 surge:1 survey:1 analysts:2 small:1 options:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:2 based:2 list:2 estimates:2 per:2 quarters:2 current:2 companies:2 operating:2 analysts:4 3.0:2 income:2 included:2 survey:2 share:2 2.0:2 =:10 2.5:2
stock_LLY r_down	over:2 quarters:1 its:4 osteoporosis:4 difference:2 based:1 $:1 participants:2 failed:1 treatment:4 pivotal:1 therapy:1 effects:2 closely:1 during:1 aiming:1 investigator:2 --:4 medicines:2 companies:1 settle:1 found:2 bone:4 fractures:2 because:2 list:1 testing:1 estimates:1 back:4 second:1 design:2 3.0:1 's:11 2.0:1 2.5:1 said:2 lead:2 federal:1 per:1 current:1 3:2 investigation:1 between:2 medicine:2 available:2 million:1 operating:1 many:2 study:6 months:2 drug:3 trial:1 survey:1 analysts:2 options:2 late-stage:1 into:1 primary:2 bribery:1 two:4 comparing:2 clinical:1 treat:5 ``:2 direct:2 women:2 endpoint:2 18:2 involved:2 abandon:1 1.5:1 strengthening:2 prompting:1 share:1 '':2 watched:1 compared:2 no:2 pay:1 compares:2 income:1 =:5 pain:4 important:2 included:1 disease:2 overseas:1 head-to-head:2
stock_LLY r_up	credible:1 ``:1 's:1 study:1 drug:1 '':1 likely:1 optimism:1 lacked:1
stock_LLY r_down	month:2 brain:1 per:1 appetite:1 its:5 issues:1 previous:1 completion:2 $:9 guidance:2 had:2 other:1 has:1 2011:1 meanwhile:1 undisclosed:1 difficult:1 30:1 day:1 volatility:1 following:2 underscores:1 higher:2 disorder:1 week:1 because:1 financial:1 companies:1 revised:2 past:1 trading:3 year:3 close:1 84:1 said:2 shares:2 research:1 above:1 capital:1 new:1 payoff:1 scientific:1 months:1 million:2 understanding:1 reported:1 although:1 brokerage:2 debt:1 faced:1 climate:1 last:3 working:1 ahead:1 discount:1 trades:1 drug:2 retail:1 experimental:1 search:1 number:1 use:1 would:1 sovereign:1 billion:3 offering:1 offer:2 company:1 lower:1 but:1 priced:1 volume:1 failure:1 surged:1 than:3 posted:1 12:1 edged:1 up:3 were:1 wild:1 medical:1 acquisition:2 1.6:1 weaker:1 investors:1 outstanding:1 share:1 purposes:1 general:1 high:1 full-year:2 have:2 need:1 proceeds:1 totaled:1 4.4:3 5.3:3 end:1 1:4 potential:2 online:1 9:2 stock:1 development:1 's:8 price:1 earlier:1 treatments:1 reflect:2 payment:2 recent:1 acquisitions:1 peers:1 assets:1 average:2 disease:1 daily:1 client:2 1.26:6
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:2 have:1 investors:1 up:1 companies:2 estimates:2 private:1 quarters:2 prices:1 businesses:1 been:1 3.0:2 cuts:1 2.0:2 hospitals:1 linked:1 2.5:2 help:1 based:2 hunting:1 patent:1 hospital:1 revenue:1 per:2 makers:1 current:2 going:1 worry:1 income:2 personalized:1 insurers:1 =:10 tests:1 's:3 share:2 genes:1 replace:1 regulators:1 operating:2 included:2 reassuring:1 data:1 raising:1 suggested:1 off:1 like:1 lost:1 developing:1 markets:1 medicines:1 list:2 disease:1 drug:1 n't:1 survey:2 analysts:4 discussing:1 make:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	background:1 setback:2 trade:2 against:2 mild:3 session:2 per:1 signs:4 battle:2 revealed:1 its:7 staff:1 slow:2 based:1 $:2 23:1 rose:2 guidance:1 revenue:2 expectations:2 failed:6 treatment:3 premarket:1 weeks:1 3:3 overall:3 anticipated:3 updates:1 closely:1 highly:3 discuss:2 condition:2 loss:1 pooled:5 cognitive:6 --:6 companies:6 benefit:3 estimates:1 steps:2 either:3 each:4 higher:2 set:3 says:2 significantly:2 list:1 some:1 growth:2 trading:5 3.0:1 2.0:1 2.5:1 index:3 said:4 stands:1 expert:1 profit:1 year-earlier:1 shares:5 current:1 misses:2 closed:1 moderate:1 recently:2 million:1 hours:1 reported:1 regulators:2 operating:1 although:3 latest:2 101:1 beginning:2 software:1 reaction:1 shift:1 industry:2 climbed:1 drug:8 suggests:2 levels:1 survey:1 analysts:3 mixed:1 share:1 studies:9 maker:2 experimental:2 late-stage:2 fourth-quarter:1 key:1 point:1 address:1 primary:2 one:1 rising:1 throughout:1 cloud:1 bolster:1 decline:5 strong:1 additional:1 positive:1 5th:1 three:2 next:2 clinical:3 expected:2 9.3:1 ``:1 efficacy:2 both:3 reduce:1 company:2 executives:1 but:3 lowered:1 gain:1 cases:3 triple-digit:1 second-quarter:1 posted:1 showed:4 16:2 work:1 plunged:1 up:1 patients:5 actively:5 were:2 quarters:1 1.5:1 computing:1 tax:1 slowing:4 '':1 full-year:1 dropped:1 ready:1 watched:1 swung:1 saw:1 comments:1 marking:2 trials:3 potential:3 details:1 fourth:1 income:1 9:1 =:5 stock:1 added:3 's:27 plans:1 though:2 price:1 after:1 reach:3 76:1 fell:1 eight:1 two:10 significant:1 included:1 stocks:3 data:5 missed:2 fiscal:2 mobile:1 disease:8 points:9 first:1 goals:6
stock_LLY r_up	limited:1 managed:1 setback:1 quarters:2 cardiologist:1 cardiovascular:1 whose:1 based:2 better:1 multi-year:2 has:1 uptake:1 physicians:1 risk:1 not:1 companies:2 investigators:1 because:1 significantly:1 bleeding:1 list:2 estimates:2 3.0:2 our:1 2.0:2 2.5:2 said:1 dropping:1 patients:2 per:2 current:2 does:1 principal:1 ends:1 patient:1 operating:2 article:1 change:1 attacks:1 study:2 losses:1 drug:2 trial:2 carries:1 survey:2 analysts:4 published:1 efforts:1 thinner:1 heart:1 one:1 would:1 anti-clotting:1 been:1 doing:1 clinical:1 low:2 ``:1 mostly:1 than:1 population:1 n't:1 while:1 outcome:1 1.5:2 sees:1 share:2 '':1 say:1 curb:1 relatively:1 preventing:1 widely:1 income:2 =:10 gains:2 used:1 's:2 strokes:1 drift:1 modest:1 fell:1 blood:1 serious:1 included:2 stocks:2 expand:1 lower:1 fresh:1
stock_LLY r_up	1.5:1 raised:1 companies:1 estimates:2 quarters:1 3.0:1 2.0:1 its:2 2.5:1 25:2 based:1 per:1 current:1 earnings:1 income:1 =:5 stock:1 's:1 share:1 operating:1 included:1 well:1 list:1 drug:1 price-target:1 survey:1 analysts:2 maker:1
stock_LLY r_up	1.5:1 companies:1 estimates:1 quarters:1 schizophrenia:3 decided:3 analysis:3 3.0:1 2.0:1 2.5:1 based:1 per:1 current:1 potential:3 treatment:3 income:1 =:5 independent:3 's:2 share:1 after:3 stop:3 operating:1 included:1 effective:3 developing:3 list:1 drug:3 survey:1 analysts:2 found:3 unlikely:3
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	development:2 emerging:2 3.0:1 investors:4 1.5:1 2.5:1 companies:1 some:1 focus:1 presentation:1 growth:2 have:1 next:1 its:2 unit:1 lessons:2 n't:1 use:1 stocks:1 develop:1 pharma:1 also:1 spending:1 highlights:1 per:1 strategy:1 current:1 targeted:1 offers:1 fizzled:1 mid-stage:2 income:1 expected:1 new:1 grow:1 meeting:2 tell:1 week:1 increased:1 may:1 reassure:1 but:1 expects:1 operating:1 diet:1 =:5 share:1 included:1 based:1 hold:1 monkeys:2 insights:1 pipeline:2 --:4 markets:2 study:1 showcase:1 list:1 drug:2 maker:1 try:1 estimates:1 survey:1 analysts:2 diagnostics:1 quarters:1 making:1 skinny:2 2.0:1 medicines:1 talk:1
stock_LLY r_up	1.5:3 based:3 list:3 estimates:3 per:3 quarters:3 current:3 companies:3 operating:3 analysts:6 3.0:3 income:3 included:3 survey:3 share:3 2.0:3 =:15 2.5:3
stock_LLY r_up	1.5:1 staggered:1 3.0:1 trend:1 companies:2 estimates:1 quarters:1 governance:1 have:1 year:2 wider:1 2.0:1 find:1 2.5:1 pharmaceutical:1 cut:1 based:1 $:1 spending:1 per:1 current:1 continue:1 eliminate:1 income:1 taken:1 8:1 =:5 more:2 drugs:1 share:1 strides:1 operating:1 defying:1 new:1 included:1 develop:1 than:1 billion:1 industry:1 list:1 elections:1 costs:1 large:1 directors:1 advocates:1 survey:1 analysts:2
stock_LLY r_up	1.5:1 all:1 have:1 cancer:2 companies:1 estimates:1 primary:2 quarters:1 doesn’t:1 lung:2 reports:1 3.0:1 go:1 2.0:1 its:3 2.5:1 out:1 votes:1 said:2 based:1 missed:2 detail:1 per:1 actually:1 current:1 3:2 program:1 treatment:2 maintenance:2 income:1 short-term:1 type:2 common:2 do:1 we:1 buy:1 combination:2 government:1 may:1 share:1 unlimited:1 abounds:1 but:1 therapy:2 goals:2 easing:1 included:1 central:1 debt:1 concerns:1 bank:1 wait:1 rallying:1 =:5 study:2 list:1 drug:2 chief:1 survey:1 analysts:2 operating:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	shed:1 help:1 appeared:2 testing:2 some:3 have:2 further:1 11th:1 still:1 debate:1 subject:1 provide:2 beginning:1 had:1 benefit:2 research:2 targets:2 clinical:2 meaningful:2 's:9 any:2 effect:3 but:3 its:2 data:1 reaction:1 --:3 light:1 could:1 disease:2 drug:3 n't:3 did:3 patients:3 officer:1 release:1 similar:1 experimental:2
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	engage:1 assets:1 lead:1 eligible:1 may:1 could:1 companies:1 rule:1 hedging:1 treatment:1 which:1 activity:1 accounting:1 hedge:1 expand:1 more:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	likes:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	shown:2 said:2 associated:2 48:2 showed:2 study:2 reduction:2 reduce:2 investigational:2 sugar:2 also:2 patients:2 2:4 incidents:2 treatment:2 fear:2 anxiety:2 type:2 diabetes:2
stock_LLY r_up	1.5:1 3.0:1 companies:1 estimates:1 one:1 slowed:1 another:1 signs:1 2.0:1 2.5:1 based:1 positive:1 per:1 current:1 treatment:1 memory:1 new:1 =:5 's:3 share:1 income:1 operating:1 included:1 quarters:1 data:1 loss:1 showed:2 study:1 list:1 drug:1 trial:1 patients:1 survey:1 analysts:2 experimental:1
stock_LLY r_up	control:2 major:2 sales:2 likely:2 including:2 exclusivity:2 blockbuster:2 makers:2 market:2 3rd:4 watching:2 signals:2 cope:2 drugs:4 newer:2 continued:2 former:2 recent:2 third:2 --:2 losses:2 companies:2 drug:2 costs:2 strategies:2 efforts:4 quarter:2
stock_LLY r_down	raised:1 's:2 $:1 49:1 giant:1 drug:1 fair-value:1 estimate:1
stock_LLY r_up	detailed:1 restore:1 image:1 criticism:1 its:2 information:1 said:1 would:1 trials:1 make:1 secret:1 clinical:1 available:1 drugs:1 deflect:1 important:1 data:1 keeping:1 drug:1 works:1 maker:1 researchers:1
stock_LLY r_up	results:2 trade:1 session:2 including:1 shares:3 its:4 ground:1 based:1 slipped:1 treatment:4 survival:4 overall:2 12:1 quarters:1 14.6:1 list:1 prolonged:2 stock:1 better-than-expected:1 companies:4 estimates:1 actively:3 trading:4 3.0:1 led:1 supportive:4 makers:1 best:4 out:1 index:3 said:4 per:1 current:1 closed:1 recently:2 hours:1 met:2 operating:1 20:1 care:4 gained:2 improved:2 study:2 climbed:2 drug:5 trial:4 survey:1 analysts:2 mixed:1 retail:1 first:2 cancer:2 primary:2 positive:2 expected:1 raft:1 markets:1 flat:1 company:2 95:2 10:1 endpoint:2 15:1 showed:2 up:1 patients:2 cancers:2 were:4 1.5:1 investors:1 share:1 sales:1 compared:2 also:2 2.5:2 income:1 =:5 higher:2 added:3 's:7 after:1 2.0:1 included:1 stocks:3 data:3 placebo:2 points:8 banks:1 late-stage:2
stock_LLY r_up	consider:1 investors:1 revenue:2 health-care:3 sales:1 cuts:2 home:1 bolstered:1 market:1 out:1 deal:1 sentiment:1 bite:1 shares:1 increase:1 also:1 earnings:1 income:1 9:2 new:1 company’s:1 gains:1 insurer:1 showing:1 rise:2 lift:1 half:1 data:2 bank:3 takes:1 pact:1 buoyed:2 retail:1 sectors:2 reports:1 retail-sales:1 cutting:1 drops:2
stock_LLY r_up	received:2 use:2 said:2 's:4 continuation:2 some:2 lung-cancer:2 drug:2 patients:2 treatment:2 maintenance:2 approval:2 its:4
stock_LLY r_up	among:1 tap:1 trade:1 session:1 headway:1 another:1 packed:1 weekly:1 jobless:1 leading:1 make:1 shares:1 stock-market:1 earnings:1 expected:1 featuring:1 's:1 big:1 indicators:1 data:2 day:1 ahead:1 futures:1 companies:1 actively:1 claims:1 lineup:1
stock_LLY r_down	control:2 1.5:1 quarters:1 give:2 series:2 meetings:2 estimates:1 results:2 two:2 included:1 3.0:1 year:2 2.0:1 seek:2 2.5:1 scientific:2 26:2 compared:2 based:1 positive:2 three:2 per:1 next:2 current:1 companies:1 investigational:2 2:2 treatment:2 income:1 details:2 weeks:2 type:2 2013:2 glucose:2 lowering:2 's:6 plans:4 drugs:2 share:1 company:2 overall:2 levels:2 operating:1 blood:2 2014:2 regulatory:2 approval:2 years:2 data:2 diabetes:6 regarding:2 improved:2 showed:4 --:4 =:5 list:1 drug:2 more:2 length:2 survey:1 analysts:2 long-term:2 placebo:2 studies:6 other:2
stock_LLY r_down	all:1 global:1 results:6 month:2 comments:1 go:1 whose:2 1.12:1 program:2 quarterly:1 worse:3 very:1 rise:4 1,500:1 gloomy:1 17th:1 --:12 12th:1 notes:1 companies:5 round:1 says:1 trend:1 estimates:3 likely:1 makers:5 index:2 rate:2 wreck:1 shares:2 current:1 five-year:1 marketing:2 lower-than-expected:2 firms:1 kicked:1 reported:5 operating:3 along:1 wait:1 ahead:3 auction:1 losses:1 shades:1 reports:1 survey:1 analysts:5 action:1 maker:3 fourth-quarter:2 followed:1 brought:1 market:1 confidence:1 working:2 positive:1 petroleum:1 two:2 next:1 scenarios:1 few:1 calm:1 markets:3 more:5 company:1 train:1 200-point:1 disappointing:1 sour:1 three:2 drops:3 0.1:3 0.3:3 0.2:2 share:4 0.4:1 0.7:1 high:1 pushed:1 slip:1 swung:1 information:1 hampered:1 earnings:20 fourth:2 economy:1 huge:1 watch:2 earlier:1 tied:2 applications:1 such:3 data:4 grow:1 bleak:1 acquisitions:2 short:3 third:3 amid:2 futures:4 lines:1 patent:4 so:1 keeps:1 typical:1 over:1 expects:1 through:5 still:2 its:9 stock-index:1 before:1 industries:1 1:2 27:1 antipsychotic:6 23:1 lackluster:2 expectations:7 better:1 2011:4 2012:4 finance:1 they:2 half:1 not:3 now:2 investor:1 day:2 drop:6 quarter:4 trading:2 year:4 83:1 margins:2 81:1 slew:2 out:1 missed:2 profit:5 blue-chip:2 since:1 research:2 increase:3 misses:2 7:7 announced:1 after:5 turning:1 effect:1 labs:2 put:1 estimate:1 rises:1 beginning:1 could:1 days:3 thing:1 place:2 swing:1 support:1 major:3 revenue:5 feel:1 number:3 reaches:1 one:1 long:1 another:1 miss:3 wrath:1 anti-clotting:1 scrutiny:1 too:1 violated:1 speaking:1 lot:1 season:4 took:1 believe:1 than:2 11:3 13:1 12:1 18:1 second:1 were:1 steep:1 browser:1 investors:4 juice:1 say:1 have:14 seen:3 recover:1 note:1 emphasis:1 concerns:1 take:1 play:1 though:2 falls:1 react:2 bolsters:1 payment:8 mobile:1 clear:1 jittery:1 came:1 gold:1 7.3:8 session:1 exclusivity:2 slow:1 based:1 analysts’:1 it’s:1 only:1 going:3 raising:1 pretty:1 do:1 hit:2 gains:1 get:1 beat:1 overall:1 report:3 falling:1 volatility:2 countries:1 tumult:1 morning:1 including:1 view:3 frame:1 relative:1 arm:1 mortgage:1 forecast:2 between:1 across:2 15th:1 jobs:1 a.m:1 reaction:1 last:8 many:2 according:2 drug:9 s:1 became:1 3.5:1 experimental:1 among:1 adjusted:4 tough:1 point:2 reasons:1 period:1 60:1 62:1 throughout:2 100:1 decline:7 due:1 been:3 expected:3 500:2 offered:1 sales:5 former:5 straight:1 pace:1 while:1 costly:1 cents:2 37:1 expenses:2 helped:3 partner:5 expirations:2 generic:6 things:1 make:1 a.m.:1 struggling:1 several:2 higher:3 status:1 used:1 reporting:2 yesterday:1 forecasts:1 driven:4 levels:1 opportunity:1 recent:3 off:1 failing:2 well:1 without:1 components:2 organization:1 latest:3 just:1 ninth:1 quarters:2 weekly:2 cut:1 $:4 rose:2 had:5 board:1 has:2 around:1 big:2 showing:1 downtrend:1 matters:1 historic:1 background:1 disappointed:2 loss:1 lost:2 consensus:1 yields:1 right:1 back:2 competition:6 3.6:1 streaming:1 economic:1 bruising:1 facing:2 poll:1 memories:1 decision:1 hepatitis:1 p.m.:1 run:1 business:1 sixth:1 broken:1 restructuring:1 offset:3 manufacturing:1 pipeline:2 getting:2 range:1 outlook:1 own:2 into:1 third-quarter:10 down:6 rising:3 your:1 intraday:1 housing:3 question:1 one-time:3 way:2 offer:1 becoming:1 slump:1 but:3 reiterated:2 failure:1 gain:4 hopes:1 225:1 triple-digit:1 analyst:2 buying:1 official:1 bellwether:1 up:7 below:2 growth:1 problem:1 gone:1 penny:1 one-third:1 slowing:1 full-year:1 fill:2 'll:1 backs:3 40:1 other:4 details:1 picture:1 draw:1 's:6 includes:1 fell:1 shrank:2 coverage:1 stocks:1 ago:2 longer:2 daily:1 time:2
stock_LLY r_up	saying:1 sales:1 quarters:1 high:1 all-time:1 have:1 high-profile:1 follow:1 slow:1 fourth:1 remains:1 surprises:2 been:1 forecast:1 their:1 advisories:2 outlooks:1 earnings:5 slash:1 suit:1 falter:2 500:1 more:1 worse:2 operating:1 grow:2 roundup:1 prospects:2 companies:2 reports:1 future:1 analysts:1 quarter:1 corporate:1 latest:1
stock_LLY r_down	turning:1 divide:2 business:2 season:1 into:1 purse:1 loosening:1 their:1 while:1 tightens:1 earnings:2 seen:2 strings:1 consumers:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_down	promises:2 because:1 people:1 companies:2 health-care:3 down:1 questions:1 slumped:2 points:2 impact:1 law:5 overhaul:3 while:2 comments:1 mix:2 add:1 complex:2 health:4 earnings:1 which:2 details:1 firms:1 insurers:2 more:1 's:3 big:2 re-election:3 pressure:3 cutting:1 gain:1 new:2 device:1 stocks:3 surged:2 analyst:1 benefits:2 --:3 amid:1 industry:1 cover:1 unpaid:1 slide:1 future:2 following:2 bills:1
stock_LLY r_down	among:2 says:2 certain:2 alternatives:2 its:2 expensive:2 away:2 other:2 low:2 conditions:2 available:2 's:1 business:2 drugs:2 pharmacy-benefit:2 treatments:2 members:2 testosterone:2 taking:2 glaucoma:2 aim:2 push:2 steer:2 latest:2
stock_LLY r_up	1.5:1 cancer:2 companies:1 estimates:1 quarters:1 included:1 3.0:1 2.0:1 its:1 2.5:1 compared:1 based:1 no:1 there:1 two:1 per:1 current:2 much:1 rates:1 treatment:2 between:1 =:5 company:1 announced:1 development:1 income:1 drugs:1 share:1 survival:1 after:1 standard:1 fell:1 operating:1 91:1 difference:1 pancreatic:1 showed:1 study:1 list:1 drug:1 survey:1 analysts:2
stock_LLY r_down	rheumatoid:1 arthritis:1 says:1 potential:1 has:1
stock_LLY r_down	because:2 show:1 agreed:2 allegations:2 states:2 sense:1 work:1 its:2 pharmaceutical:2 $:6 pay:2 make:1 marketed:2 hepatitis:1 treatment:1 has:2 do:2 illegally:2 business:1 drugs:1 company:2 million:2 but:1 38:2 they:2 not:1 90:6 diabetes:2 resolve:2 prosecutors:2 die:1 sometimes:1 drug:2 n't:2 can:1 promising:1 derailment:1
stock_LLY r_up	1.5:1 companies:1 estimates:1 quarters:1 chronic:2 per:1 3.0:1 partner:2 2.0:1 its:4 2.5:1 said:2 based:1 granted:2 hepatitis:2 current:1 treatment:2 income:1 has:2 =:5 low:2 them:2 share:1 therapy:2 blood:2 included:1 approval:2 count:2 --:4 list:1 initiate:2 patients:2 maintain:2 survey:1 analysts:2 allow:2 operating:1
stock_LLY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	comment:1 requiring:1 over:1 some:2 device:1 say:1 rule:7 have:3 year:1 fear:2 makers:3 relationships:1 information:2 said:1 bracing:2 spending:1 broad:2 overly:2 restrained:1 spokesman:1 potential:1 prices:1 medicine:1 new:5 falling:1 issue:1 public:2 more:1 them:2 around:1 government:3 drugs:1 could:2 overall:1 pharmacy-benefit:1 although:1 doctors:3 report:4 last:1 surged:1 concerns:1 improve:1 prescription:1 --:5 require:2 brand-name:1 companies:3 manager:1 drug:1 generics:1 mislead:2 payments:1 transparency:1 popular:1 10th:1 scope:1 medical-device:2
stock_LLY r_up	over:1 past:1 report:1 manager:1 promise:1 have:2 year:1 dysfunction:1 said:2 spending:1 affects:1 young:1 generics:1 medicine:1 falling:1 more:1 used:1 form:1 drugs:1 popular:1 men:1 overall:1 pharmacy-benefit:1 boys:1 although:1 prices:1 prescription:1 surged:1 restrained:1 treating:1 rare:1 showed:1 erectile:1 study:1 brand-name:1 disease:1 drug:1 small:1 researchers:1
stock_LLY r_up	illnesses:1 cancer:1 executive:1 sales:1 chronic:1 its:1 said:1 propel:1 would:1 chairman:1 interview:1 across:1 's:1 drugs:1 company:1 rise:1 cardiac:1 expand:1 diabetes:1 amid:1 aims:1 chief:1
stock_LLY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_LLY r_up	development:2 terminated:1 's:3 efficacy:1 saying:1 far:1 testing:1 disease:1 results:1 n't:1 did:1 clinical:1 so:1 treatment:1 further:1 has:1 its:1 experimental:1 justify:1
stock_LLY r_up	emerging:2 cancer:1 one:1 see:1 drug:1 have:1 signs:1 partner:1 market:1 universities:1 banding:1 23:1 generic:2 create:1 anti-cancer:1 which:1 largest:1 branded:2 markets:2 's:5 diseases:1 drugs:2 marketing:1 company:1 stem:1 adult:1 tackle:1 world:1 pact:2 signed:1 --:1 cells:1 companies:1 together:1 order:1
stock_LLY r_up	1.5:1 list:1 estimates:1 quarters:1 '':1 included:1 3.0:1 2.0:1 best:1 out:1 based:1 service:1 per:1 current:1 2.5:1 income:1 =:5 dogs:2 ``:1 drugs:1 share:1 alert:1 operating:1 known:1 class:1 companies:1 sniffing:1 survey:1 analysts:2 bombs:1 growing:1
stock_LLY r_down	results:2 trade:1 7.2:1 mild:5 session:1 its:3 rose:2 delays:2 treatment:7 means:2 big:3 background:2 fall:2 during:1 --:6 companies:4 works:2 back:3 actively:4 trading:5 discussions:3 laboratory:1 index:3 trending:1 decision:2 blue-chip:2 while:1 shares:3 3:4 closed:1 conduct:8 probably:2 recently:2 wo:5 hours:1 regulators:3 regulatory:5 heads:3 movers:2 study:6 climbed:1 drug:6 trial:2 fell:1 mixed:4 experimental:3 late-stage:3 among:1 slipped:1 1.6:1 64:1 approval:5 throughout:2 8.5:1 additional:8 8.7:1 top:1 three:1 clinical:4 expected:1 's:24 company:1 but:3 10:1 up:4 n't:5 patients:5 drags:2 were:4 following:3 1.5:1 slid:1 evidence:2 moves:1 seek:3 make:1 potential:3 patient:2 details:2 test:1 instead:3 stock:3 added:2 edged:1 plans:3 price:2 after:1 reach:2 lab:2 falls:1 said:5 stocks:3 recent:2 disease:6 shore:2 points:8 time:3 tickers:1 filing:2
stock_LLY r_down	erasing:1 program:3 outlook:2 unexpected:2 says:1 chain:1 unchanged:1 health-care:1 ``:4 major:1 one:2 '':2 higher:1 investors:1 registration:2 excite:1 autoimmune:2 pharmacy:1 its:2 before:1 move:2 given:2 said:2 overhaul:1 efficacy:2 three:2 shares:2 should:1 end:1 failed:1 clinical:4 those:1 new:1 several:1 product:2 patients:2 gives:2 development:4 impact:2 life:2 arthritis:4 's:1 gains:1 provisions:1 committed:2 evaluate:2 bid:1 after:1 stop:2 results:2 overall:2 president:2 rises:1 data:4 day:1 earlier:2 skeptical:1 lupus:2 stocks:1 vice:2 these:2 rheumatoid:4 study:2 largely:1 hours:1 remain:2 drug:2 rapidly:2 stimulus:1 benefit:1 due:2 were:2 insufficient:2 stock:1 studies:4 late-stage:2
stock_LLY r_up	1.5:7 declared:2 retired:2 acquired:2 companies:3 year:2 share:5 expects:2 quarters:3 seen:2 per:1 3.0:1 dividend:2 recently:2 exclusivity:2 moves:2 its:2 market:4 whose:2 cents:2 said:2 based:1 $:8 49:2 profit:2 had:4 shares:2 current:1 also:2 program:4 authorized:2 which:4 income:1 recent:2 =:5 2013:2 board:2 's:2 complete:2 capitalization:2 decline:2 2.5:1 marketing:2 company:2 buyback:4 operating:3 included:1 during:2 expenses:2 first-quarter:2 antipsychotic:2 billion:4 2.0:1 last:2 lost:2 list:3 roughly:2 drug:4 estimates:1 survey:1 analysts:2 making:2 higher:2 maker:2 joining:2
stock_LLY r_up	agreed:1 focus:1 trade:2 session:1 shares:2 signs:2 exclusivity:1 its:2 whose:1 26:1 27:1 $:7 had:2 program:2 board:1 rhythm:1 include:2 2013:1 premium:1 expects:1 during:1 quarters:1 lost:1 list:1 higher:3 disorder:1 lifted:2 findings:1 acquired:1 companies:3 year:1 close:1 index:4 said:2 sentiment:4 profit:1 jumped:1 per:1 current:2 progress:2 recently:1 marketing:1 reported:1 operating:1 dividend:1 antipsychotic:1 last:1 study:1 premarket:1 drug:2 maker:1 late-stage:1 among:2 retired:1 declared:1 chronic:1 market:2 decline:1 positive:1 authorized:1 expected:1 recent:1 's:3 today:1 treatment:1 billion:3 complete:1 company:2 acquire:1 account:2 cash:1 patients:1 making:1 toward:2 builders:2 1.5:3 cents:1 share:3 expenses:1 numbers:2 home:2 seen:1 moves:1 48:1 49:1 pay:1 also:1 which:2 stock:3 first-quarter:1 capitalization:1 buyback:2 coming:2 data:2 cliff:2 fiscal:2 futures:2 roughly:2 resolution:2 1.26:1 joining:1
stock_LLY r_up	distributors:1 agreed:2 parties:2 allegations:3 ``:1 '':1 nothing:1 bribery:2 29.4:8 its:1 millions:1 pharmaceutical:1 little:1 $:8 chosen:1 pay:3 agreements:1 accusations:1 offshore:1 knowing:1 complaint:1 used:1 which:1 government:1 marketing:1 company:1 million:2 affiliates:2 despite:1 included:1 subsidiary:1 those:1 deny:1 third:2 did:1 n't:1 admit:1 settle:2 customers:1 overseas:2
stock_LLY r_up	bridge:1 population:1 figure:1 rating:1 into:1 some:1 sales:2 closures:1 slowdown:1 currency:1 rate:1 economic:1 through:1 3.3:1 12.5:1 29.4:3 terms:2 2.7:1 its:1 market:1 before:1 confirmed:1 publication:1 rose:2 weekends:1 had:1 below:1 increase:1 their:1 settle:1 which:1 equity:1 expected:1 holiday:1 markets:1 agreed:1 economy:1 begin:1 million:1 's:3 resume:1 may:1 allegations:1 largest:1 2.4:1 giant:1 affiliates:1 reiterated:1 five-day:1 expectations:1 jobless:2 many:1 region:2 annual:1 bribery:1 drug:1 face:1 festivities:1 growth:1 pay:1 position:1 overseas:1 retail:2 $:3
stock_LLY r_down	1.5:1 3.0:1 companies:1 estimates:1 wholesalers:1 quarters:1 have:2 2.0:1 2.5:1 based:1 network:1 purchased:1 per:1 current:1 income:1 =:5 controlled:1 may:1 share:1 operating:1 they:1 included:1 warned:1 medical:1 list:1 illicit:1 practices:1 survey:1 analysts:2 350:1
stock_LLY r_down	tax:1 authority:1 sign:1 year:1 children:1 scandals:1 said:1 been:1 intends:1 banning:1 corruption:1 2012:2 's:3 cozy:1 business:1 get:1 big:1 legendary:1 president:1 he:1 did:1 bill:1 so:1 adopting:1
stock_LLY r_up	held:1 accounts:1 seen:1 partner:1 trust:1 indicted:1 $:1 breach:1 's:2 offering:1 sitting:1 300:1 deposed:1 million:1 sons:1 minister:1 authorities:1 president:1 fraud:1 showed:1 charges:1 foreign:1 products:1
stock_LLY r_up	secure:1 apartments:1 money:1 allegations:1 evidence:1 bribery:1 officials:1 through:1 have:1 helm:1 out:1 bribes:1 end:1 hospital:1 flying:1 been:1 foster:1 growth:1 branch:1 get:1 racing:1 across:1 body:1 his:1 's:4 seeking:1 could:1 offered:1 reign:1 wallets:1 report:1 relating:1 recent:1 case:1 calls:1 country:1 employees:1 months:1 according:1 affluent:1 deals:1 economic:1 offices:1 transparency:1 order:1
stock_LLY r_up	skeleton:1 office:1 over:1 lack:1 expects:1 four:1 talks:1 its:8 welcomes:1 grapples:1 $:2 rose:1 controls:1 should:1 late:1 offers:1 details:1 has:1 2013:13 2012:1 above:1 rise:1 walls:1 background:1 despite:3 continued:1 investigator:1 --:3 level:1 companies:2 drug-patent:1 continue:1 predicted:2 lose:1 went:1 cliffs:1 better-than-expected:1 because:1 says:1 back:1 actively:2 trading:4 result:1 year:1 led:1 even:1 index:3 bullish:1 profit:2 nuclear:1 commitments:2 shares:4 forecast:1 current:1 ticking:1 got:1 disclose:1 recently:2 commits:1 million:1 protection:1 operating:1 buyback:2 share-buyback:1 repurchase:1 dividend:4 post:1 improved:2 battling:1 healthy:1 industry:1 losses:1 drug:4 foreign:1 mixed:2 climb:3 maker:3 1.5:1 golden:1 outlook:4 point:2 into:1 within:1 one:1 down:1 accounts:1 throughout:1 unit:1 least:1 live:1 program:2 6:1 taken:1 upbeat:3 authorization:1 more:1 company:3 apparent:1 requires:1 fund:2 money-laundering:1 hold:1 than:1 valued:1 14:1 edged:2 up:1 growth:3 cash-only:1 were:2 closing:1 gave:1 gone:1 1.7:1 sees:1 share:3 sales:3 high:1 dropped:1 blockbuster:1 identities:1 gains:2 patent:5 struggles:3 1:2 potential:1 potentially:1 earnings:4 new:3 erosion:1 added:2 's:9 plans:3 provided:1 track:1 effect:1 expirations:3 modest:2 services:1 stocks:2 recent:3 billion:1 refuse:1 resolution:1 age:1 rule:1 antidepressant:1 points:4 banks:1 corporate:1 affirmed:3
stock_LLY r_down	adds:1 have:2 world-wide:2 four:1 broader:1 year:1 throughout:1 market:1 terminated:2 compared:1 end:1 trials:1 submit:1 their:2 clinical:2 details:1 development:2 said:1 efficacy:1 collaboration:3 sole:2 levels:1 goals:1 background:1 compound:2 regulatory:1 approval:1 beginning:1 diabetes:2 hits:1 novel:2 third:1 rights:2 --:3 companies:1 drug:5 insulin:3 analog:2 placebo:1 studies:1 reduced:1 experimental:1 plan:1
stock_LLY r_down	most:1 says:1 look:1 2013:2 attractive:1
stock_LLY r_down	made:1 officials:1 hub:1 mostly:1 sanctions:1 money:1 back:1 against:2 response:1 10,000:1 fought:1 accusations:1 ban:1 's:1 adopting:1 law:1 passed:1 children:1 laundering:1
stock_LLY r_down	fourth-quarter:1 greater:1 just:3 among:1 later:1 companies:1 keep:1 growth:1 rising:1 earnings:3 they:1 year:1 hopes:1 performance:1 500:1 wanted:3 markets:1 market:2
stock_LLY r_up	operations:1 represent:1 all:1 just:2 results:2 trade:2 hiring:1 its:1 before:1 24:1 busy:1 $:2 earned:2 workers:1 quarterly:2 2011:1 somebody:1 gains:1 rise:1 sellers:1 consecutive:1 front:1 years:1 day:1 like:1 level:1 companies:3 morning:1 quarter:1 some:1 past:1 second:1 year:1 out:1 jumped:1 since:1 bearish:1 looking:1 health:1 new:1 checks:1 reporting:1 bandwagon:1 handful:1 quite:1 reported:1 months:1 surge:2 levels:1 among:1 bell:2 down:1 downside:1 another:1 ring:1 market:1 everybody:1 two:1 least:1 start:1 interest:1 9.2:1 gives:1 lowest:1 but:1 part:1 posted:1 paying:1 solid:1 decades:1 strongest:1 n't:1 500:1 trio:1 share:1 want:1 rally:1 moves:1 sits:1 make:1 write:1 earnings:5 performance:1 higher:1 bets:1 's:3 after:2 driven:1 strength:1 stocks:1 billion:2 2007:1 profits:1
stock_LLY r_down	powered:1 earnings:1 highs:1 better-than-expected:1 shares:1 data:1 72:2 stocks:1 sluggish:1 consumer-confidence:1 five-year:1
stock_LLY r_up	raised:1 initial:1 investors:1 trading:2 2.2:3 its:1 unit:1 20:3 deal:1 rose:1 since:2 shares:1 symbol:1 largest:2 expected:1 public:1 begin:1 's:1 offering:2 company:1 under:1 opportunity:1 $:3 billion:1 last:1 invest:1 debut:1 jumped:1 maker:1
stock_LLY r_down	says:1 leaders:1 deal:1 certain:1 top:1 number:1 defended:1 '':2 telling:1 years:1 return:1 total:1 technology:1 delivers:1 shareholders:1 $:1 away:1 transform:1 does:1 forces:1 new:1 stock:1 ``:2 rewards:1 's:2 business:1 big:1 company:2 restricting:1 shareholder:1 negative:1 nothing:1 immediately:1 buyout:1 debt:1 investor:1 he:2 billion:1 down:1 15:1 saddle:1 industry:1 companies:1 value:1 limiting:1 compensation:1 can:1 reshaping:1 growing:1 making:1 outcry:1 avoid:1 bet:1
stock_LLY r_down	due:3 smaller:2 less:3 generic-drug:1 well:2 evaluate:2 lack:3 share:1 myeloma:1 systemic:1 registration:5 multiple:1 its:5 after:3 announcement:3 said:9 continuing:2 $:1 would:3 profit:1 revenue:1 contributed:1 3:7 business:1 charge:1 program:4 take:1 weakness:1 several:2 details:1 development:2 core:1 million:1 first-quarter:1 efficacy:6 decline:1 stop:3 company:3 continues:1 discontinue:4 overall:1 fourth-quarter:1 two:5 citing:3 7.5:1 2:1 one:3 than:3 arthritis:4 additional:1 lupus:1 extension:2 --:3 studies:7 study:2 months:3 37:3 50:1 drug:6 fell:1 three:3 time:2 insufficient:3 movement:1 rheumatoid:4 other:2 comes:3 late-stage:3
stock_LLY r_up	billion:1 because:1 's:2 $:1 may:1 2011:1 sold:1 up:1 drug:1 copies:1 hook:1 exclusivity:1 damages:1 patent:1 2.1:1 before:1 expired:1 heartburn:1 generic:1
stock_LLY r_up	success:1 powerful:1 create:1 computers:1 companies:1 increase:1 their:1 chance:1 using:1
stock_LLY r_down	's:4 risk:1 puts:1 door:1 rival:1 drug:1 more:1 pricey:1 profits:1 new:1 recent:1 approve:1 opens:1 diabetes:1
stock_LLY r_up	body:1 marketed:2 cancer:6 certain:1 powerful:3 agent:2 existing:1 second:1 have:1 types:1 information:1 use:1 additional:1 initial:1 other:1 spread:1 treatment:1 chemotherapy:2 type:3 treat:4 meant:1 's:2 packs:1 combines:1 breast:5 new:2 approved:4 advanced:1 --:3 parts:1 drug:4 starting:1 called:1
stock_LLY r_up	disclose:1 liabilities:1 set:1 enforcement:1 owe:1 skilled:1 some:1 we:1 cyber:1 top:1 losing:1 say:1 gaps:1 businesses:1 expect:1 have:3 seen:1 talks:1 close:1 actions:1 attract:1 its:1 relief:1 huge:1 statistics:1 writes:1 open:1 pay:1 workers:1 offer:1 been:2 current:1 necessary:1 unions:1 other:1 rates:1 earnings:1 interest:1 between:1 new:1 confronting:1 's:2 war:1 today:1 deficit:1 satisfy:1 do:1 them:2 led:1 plans:3 must-read:1 lawmaker:1 season:1 routine:1 hand:1 hires:1 most:1 whether:1 they:1 boosting:1 not:1 such:1 widening:1 has:1 off:1 like:1 package:1 --:1 powers:1 sanctions:1 companies:3 according:1 brutal:1 've:1 traditional:1 record:1 near:1 costs:1 so:1 pension:3 through:1 wants:1 corporate:1 retirees:1
stock_LLY r_down	said:1 pay:1 medicines:1 pose:1 region:1 should:1 current:1 prices:1 warning:1 low:1 threat:1 innovation:1 interview:1 new:1 nations:1 could:1 more:1
stock_LLY r_up	do:1 protect:1 investors:1 corporation:1 against:1 current:1 wrongdoing:1 not:1
stock_LLY r_up	behavior:1 executive:2 including:1 have:1 cancel:1 recover:3 violates:2 pharma:1 would:1 also:1 make:2 able:1 bad:1 next:1 makers:1 their:2 biggest:1 firms:1 easier:2 's:1 buckling:1 payouts:3 rules:2 big:1 pressure:1 pay-for-performance:1 report:1 ethics:2 investor:1 level:1 --:1 should:1 taking:1 companies:2 drug:1 compensation:2 future:1 stopped:1 payments:1 policies:2 revising:2 executives:1 otherwise:2
stock_LLY r_up	4.5:3 giant:1 resolve:1 $:3 pay:1 agreed:1 million:1 allegations:1 bribery:1 foreign:1 regulators:1 electronics:1
stock_LLY r_down	less:1 scratch:1 results:1 years:1 including:1 its:1 before:1 cut:1 $:3 equipment:1 50,000:1 only:1 money:1 fines:1 his:1 read:1 bid:1 fraud:1 five:1 got:1 now:1 rental:1 him:1 school:1 did:1 notes:1 morning:1 facing:1 --:1 payments:1 release:1 reduced:1 financial:1 deal:1 250,000:1 competition:1 up:3 year:1 best:1 out:1 securities:1 jewelry:1 federal:1 beaten:1 provider:1 new:1 tips:2 business:1 million:1 drug:1 restructuring:1 news:1 last:1 getting:1 could:1 double-digit:1 days:1 reports:1 times:1 illicit:1 place:1 due:1 commit:1 traded:1 maker:2 lay:1 major:1 one:1 footwear:1 says:1 offered:1 spending:1 three:2 least:2 convicted:1 draft:1 friend:1 more:1 preparation:1 allegedly:1 company:1 prison:1 doctors:1 insider-trading:1 than:1 he:1 kind:1 12:2 clients:1 cash:1 aims:1 n't:1 were:1 providing:1 called:1 say:2 30:2 1.2:1 give:1 pass:1 sales:1 helped:1 reads:1 conspiracy:1 experts:1 presentations:1 partner:1 dealer:1 dozen:1 information:2 dinners:1 make:1 graduate:1 also:2 other:2 products:1 if:1 events:1 stock:1 's:4 plans:1 paid:1 gifts:1 two:2 coming:1 building:1 off:1 charges:1 sometimes:1 face:2 1,000:1 generic:1 costs:1 profits:1
stock_LLY r_up	costly:1 direction:1 's:4 last:1 treatments:1 deepens:1 taking:1 move:1 find:1 disease:1 drug:1 research:1 maker:1 tests:1 setback:1 despite:1 year:1 new:1 efforts:1 disorder:1 its:1
stock_LLY r_up	unusual:1 three:1 $:1 deal:1 over:1 million:1 capitalists:1 up:1 next:1 start:1 drug-discovery:1 venture:1 years:1 partner:1 firms:1 several:1 worth:1
stock_LLY r_down	erasing:1 200:1 revenue:1 some:1 hoax:1 145:1 thanks:1 first-quarter:1 margins:1 quickly:1 down:1 before:1 whose:1 stocks:1 instant:1 profit:1 rose:1 shares:1 lately:1 traders:1 commercial:1 earnings:1 quarterly:1 net:1 markets:1 sent:1 stock:1 flat:1 briefly:1 transferring:1 's:3 valuations:1 boosted:1 after:1 watch:2 yesterday:1 but:1 reported:1 part:1 fastest:1 despite:1 not:1 dividend:1 highest:1 developments:1 those:1 $:1 billion:1 growing:1 recovered:1 improved:1 rights:1 --:1 18:1 drop:2 companies:1 roughly:1 53:3 leaving:1 n't:4 short-lived:1 while:1 points:1 command:1 afternoon:1 many:1 usually:1 value:1 maker:1 gain:1
stock_LLY r_up	raised:1 's:2 target:1 price:1 estimates:1 lifted:1 53:1 57:1 $:2
stock_LLY r_down	costly:1 setback:1 year:1 its:2 market:1 said:1 ambitions:1 late:1 start:1 potentially:1 2018:1 until:1 launching:1 head:1 hit:1 may:1 lucrative:1 not:1 wrinkle:1 getting:1 drug:1 competitors:1 latest:1
stock_LLY r_down	repair:1 already:1 help:1 up:1 undergoes:1 over:1 few:1 recovers:1 brain:1 counterfeits:1 expect:1 surgery:1 recover:1 its:1 market:1 counter:1 said:2 system:1 disorders:1 failed:2 ordering:1 sale:1 while:1 shares:1 research:1 immune:1 clinical:1 treat:1 online:2 medicine:1 widespread:1 setting:1 duties:1 stock:1 we:1 his:1 's:7 company:1 but:1 hand:1 erectile:1 others:1 artery:1 effort:1 pressuring:1 he:1 months:1 disease:1 drug:1 pill:1 trial:2 patients:1 disappointment:1 late-stage:1 antibody:1 maker:1 medical-device:1 latest:1
stock_LLY r_down	increased:1 said:1 mineral:1 significantly:1 type:1 men:1 drug:2 specific:1 compared:1 new:1 shows:1 data:1 its:1 bone:1 osteoporosis:2
stock_LLY r_down	lung:1 cell:1 said:1 's:2 cancer:1 combination:1 did:1 study:1 primary:1 drug:1 n't:1 patients:1 endpoint:1 superiority:1 treatment:1 another:1 phase:1 meet:1 its:1
stock_LLY r_up	billion:1 $:1 generic:1 launches:1 patent-infringement:1 their:1 damages:1 have:1 reached:1 2.15:1 settlement:1
stock_LLY r_up	aims:1 can:1 series:1 some:1 back:1 related:1 trade:3 four:2 session:3 stops:1 throughout:1 cites:1 setbacks:1 terminated:2 functions:1 said:1 had:2 shares:3 research:1 better:1 other:1 investigational:1 clinical:2 basic:1 treatment:2 mid-stage:1 which:1 expected:3 new:1 setback:1 details:1 memory:1 tests:5 's:18 halt:1 after:2 ending:1 slow:1 therapy:1 liver:5 background:1 believe:1 elderly:1 reverse:1 --:3 came:1 study:2 hunt:2 companies:4 disease:4 drug:6 maker:1 n't:1 trial:2 patients:3 actively:3 does:1 action:1 voluntarily:1 industry:1 experimental:2 latest:1
stock_LLY r_up	all:1 actively:2 trading:4 its:1 index:2 rights:1 $:3 candidate:1 jumped:2 shares:2 41:1 points:6 7:3 're:1 higher:2 development:1 we:1 added:2 's:5 option:1 watching:1 company:1 million:1 early:1 milestone:1 exercises:1 2:1 stocks:3 payment:1 diabetes:1 38:1 16:2 receive:1 climbed:2 companies:2 drug:2 assume:1 session:2 were:2
stock_LLY r_down	received:1 death:1 's:2 antipsychotic:1 people:1 two:1 drug:1 regulators:1 investigating:1 injection:1
stock_LLY r_down	methods:1 two:2 checks:1 through:2 have:1 subsidiary:1 its:2 pharmaceutical:1 said:3 targeting:1 job-seekers:1 been:1 other:1 online:1 subsidiaries:1 public:1 activities:1 's:3 company:3 involving:1 not:1 using:2 identity:1 affiliated:1 name:1 these:1 email:1 scams:3 requests:1
